e20vf
United States
Securities and Exchange Commission
Washington, D.C. 20549
Form 20-F
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
for the fiscal year ended December 31,
2009
Commission file number 025566
ASML HOLDING N.V.
(Exact Name of Registrant as Specified in Its Charter)
THE NETHERLANDS
(Jurisdiction of Incorporation or Organization)
DE RUN 6501
5504 DR VELDHOVEN
THE NETHERLANDS
(Address of Principal Executive Offices)
Craig DeYoung
Telephone: +1 480 383 4005
Facsimile: +1 480 383 3978
E-mail:
craig.deyoung@asml.com
8555 South River Parkway,
Tempe, AZ 85284, USA
(Name, Telephone,
E-mail, and
/ or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to
Section 12(b) of the Act:
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Ordinary Shares
|
|
The NASDAQ Stock Market LLC
|
(nominal value EUR 0.09 per share)
|
|
|
Securities registered or to be registered pursuant to
Section 12(g) of the Act:
None
(Title of Class)
Securities for which there is a reporting obligation pursuant to
Section 15(d) of the Act:
None
(Title of Class)
Indicate the number of outstanding shares of each of the
issuers classes of
capital or common stock as of the close of the period covered by
the annual report.
433,638,976 Ordinary Shares
(nominal value EUR 0.09 per share)
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act.
Yes
(ü) No
( )
If this report is an annual or transition report, indicate by
check mark if the registrant
is not required to file reports pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934.
Yes ( ) No
(ü)
Indicate by check mark whether the registrant: (1) has
filed all reports required to be filed by Section 13 or
15(d) of the
Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes
(ü) No
( )
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
(§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes
(ü) No
( )
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer.
See definition of accelerated filer and large accelerated
filer in
Rule 12b-2
of the Exchange Act. (Check one):
Large accelerated filer
(ü) Accelerated
filer ( ) Non-accelerated filer ( )
Indicate by check mark which basis of accounting the registrant
has used to prepare
the financial statements included in this filing:
U.S. GAAP
(ü) International
Financial Reporting Standards as issued by the
International Accounting Standards Board ( ) Other ( )
If Other has been checked in response to the
previous question, indicate by checkmark
which financial statement item the registrant has elected to
follow.
Item 17 ( ) Item 18( )
If this is an annual report, indicate by check mark whether the
registrant is a
shell company (as defined in
Rule 12b-2
of the Exchange Act)
Yes ( ) No
(ü)
Name and address of person authorized to receive notices and
communications
from the Securities and Exchange Commission:
Richard A. Ely
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street, Canary Wharf
London E14 5DS England
ASML ANNUAL REPORT 2009
Contents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1 Identity of
Directors, Senior Management and Advisors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 2 Offer Statistics and
Expected Timetable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 3 Key
Information
|
|
|
|
|
|
|
A.
|
|
Selected Financial Data
|
|
|
|
|
|
|
B.
|
|
Capitalization and Indebtedness
|
|
|
|
|
|
|
C.
|
|
Reasons for the Offer and Use of Proceeds
|
|
|
|
|
|
|
D.
|
|
Risk Factors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 4 Information on the
Company
|
|
|
|
|
|
|
A.
|
|
History and Development of the Company
|
|
|
|
|
|
|
B.
|
|
Business Overview
|
|
|
|
|
|
|
C.
|
|
Organizational Structure
|
|
|
|
|
|
|
D.
|
|
Property, Plant and Equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 4A Unresolved Staff
Comments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 5 Operating and
Financial Review and Prospects
|
|
|
|
|
|
|
A.
|
|
Operating Results
|
|
|
|
|
|
|
B.
|
|
Liquidity and Capital Resources
|
|
|
|
|
|
|
C.
|
|
Research and Development, Patents and Licenses, etc.
|
|
|
|
|
|
|
D.
|
|
Trend Information
|
|
|
|
|
|
|
E.
|
|
Off-Balance Sheet Arrangements
|
|
|
|
|
|
|
F.
|
|
Tabular Disclosure of Contractual Obligations
|
|
|
|
|
|
|
G.
|
|
Safe Harbor
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 6 Directors,
Senior Management and Employees
|
|
|
|
|
|
|
A.
|
|
Directors and Senior Management
|
|
|
|
|
|
|
B.
|
|
Compensation
|
|
|
|
|
|
|
C.
|
|
Board Practices
|
|
|
|
|
|
|
D.
|
|
Employees
|
|
|
|
|
|
|
E.
|
|
Share Ownership
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 7 Major Shareholders
and Related Party Transactions
|
|
|
|
|
|
|
A.
|
|
Major Shareholders
|
|
|
|
|
|
|
B.
|
|
Related Party Transactions
|
|
|
|
|
|
|
C.
|
|
Interests of Experts & Counsel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 8 Financial
Information
|
|
|
|
|
|
|
A.
|
|
Consolidated Statements and Other Financial Information
|
|
|
|
|
|
|
B.
|
|
Significant Changes
|
|
|
|
|
ASML ANNUAL REPORT 2009
|
|
|
|
|
|
|
|
|
|
|
Item 9 The Offer and
Listing
|
|
|
|
|
|
|
A.
|
|
Offer and Listing Details
|
|
|
|
|
|
|
B.
|
|
Plan of Distribution
|
|
|
|
|
|
|
C.
|
|
Markets
|
|
|
|
|
|
|
D.
|
|
Selling Shareholders
|
|
|
|
|
|
|
E.
|
|
Dilution
|
|
|
|
|
|
|
F.
|
|
Expenses of the Issue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 10 Additional
Information
|
|
|
|
|
|
|
A.
|
|
Share Capital
|
|
|
|
|
|
|
B.
|
|
Memorandum and Articles of Association
|
|
|
|
|
|
|
C.
|
|
Material Contracts
|
|
|
|
|
|
|
D.
|
|
Exchange Controls
|
|
|
|
|
|
|
E.
|
|
Taxation
|
|
|
|
|
|
|
F.
|
|
Dividends and Paying Agents
|
|
|
|
|
|
|
G.
|
|
Statement by Experts
|
|
|
|
|
|
|
H.
|
|
Documents on Display
|
|
|
|
|
|
|
I.
|
|
Subsidiary Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 11 Quantitative and
Qualitative Disclosures About Market Risk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 12 Description of
Securities Other Than Equity Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 13 Defaults, Dividend
Arrearages and Delinquencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 14 Material
Modifications to the Rights of Security Holders and Use of
Proceeds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 15 Controls and
Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 16
|
|
|
|
|
|
|
A.
|
|
Audit Committee Financial Expert
|
|
|
|
|
|
|
B.
|
|
Code of Ethics
|
|
|
|
|
|
|
C.
|
|
Principal Accountant Fees and Services
|
|
|
|
|
|
|
D.
|
|
Exemptions from the Listing Standards for Audit Committees
|
|
|
|
|
|
|
E.
|
|
Purchases of Equity Securities by the Issuer and Affiliated
Purchasers
|
|
|
|
|
|
|
F.
|
|
Change in Registrants Certifying Accountant
|
|
|
|
|
|
|
G.
|
|
Corporate Governance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 17 Financial
Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 18 Financial
Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 19
Exhibits
|
|
|
|
|
EX-8.1 |
EX-12.1 |
EX-13.1 |
EX-15.1 |
ASML ANNUAL REPORT 2009
Part I
Special Note
Regarding Forward-Looking Statements
In addition to historical information, this annual report on
Form 20-F
contains statements relating to our future business
and/or
results. These statements include certain projections and
business trends that are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995.
You can generally identify these statements by the use of words
like may, will, could,
should, project, believe,
anticipate, expect, plan,
estimate, forecast,
potential, intend, continue
and variations of these words or comparable words.
Forward-looking statements do not guarantee future performance
and involve risks and uncertainties. Actual results may differ
materially from projected results as a result of certain risks
and uncertainties. These risks and uncertainties include,
without limitation, those described under Item 3.D.
Risk Factors and those detailed from time to time in
our other filings with the United States Securities and Exchange
Commission (the Commission or the SEC).
These forward-looking statements are made only as of the date of
this annual report on
Form 20-F.
We do not undertake to update or revise the forward-looking
statements, whether as a result of new information, future
events or otherwise.
Item 1
Identity of Directors, Senior Management and Advisors
Not applicable.
Item 2 Offer
Statistics and Expected Timetable
Not applicable.
Item 3 Key
Information
A. Selected
Financial Data
The following selected consolidated financial data should be
read in conjunction with Item 5 Operating and
Financial Review and Prospects and Item 18
Financial Statements.
ASML ANNUAL REPORT 2009
1
Five-Year
Financial Summary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
|
2005
|
|
|
|
2006
|
1
|
|
|
2007
|
1
|
|
|
2008
|
|
|
|
2009
|
|
|
|
(in thousands, except per share data)
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
|
Consolidated statements of operations data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
2,528,967
|
|
|
|
3,581,776
|
|
|
|
3,768,185
|
|
|
|
2,953,678
|
|
|
|
1,596,063
|
|
|
|
Cost of sales
|
|
|
1,554,772
|
|
|
|
2,127,797
|
|
|
|
2,218,526
|
|
|
|
1,938,164
|
|
|
|
1,137,671
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit on sales
|
|
|
974,195
|
|
|
|
1,453,979
|
|
|
|
1,549,659
|
|
|
|
1,015,514
|
|
|
|
458,392
|
|
|
|
Research and development
costs2
|
|
|
323,874
|
|
|
|
386,567
|
|
|
|
486,141
|
|
|
|
516,128
|
|
|
|
466,761
|
|
|
|
Amortization of in-process research and development costs
|
|
|
|
|
|
|
|
|
|
|
23,148
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative costs
|
|
|
201,204
|
|
|
|
204,799
|
|
|
|
225,668
|
|
|
|
212,341
|
|
|
|
156,644
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
449,117
|
|
|
|
862,613
|
|
|
|
814,702
|
|
|
|
287,045
|
|
|
|
(165,013
|
)
|
|
|
Interest income (expense), net
|
|
|
(14,094
|
)
|
|
|
(854
|
)
|
|
|
33,451
|
|
|
|
22,599
|
|
|
|
(6,537
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations before income taxes
|
|
|
435,023
|
|
|
|
861,759
|
|
|
|
848,153
|
|
|
|
309,644
|
|
|
|
(171,550
|
)
|
|
|
(Provision for) benefit from income taxes
|
|
|
(123,559
|
)
|
|
|
(243,211
|
)
|
|
|
(177,152
|
)
|
|
|
12,726
|
|
|
|
20,625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
311,464
|
|
|
|
618,548
|
|
|
|
671,001
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income (loss) from continuing operations per ordinary
share
|
|
|
0.64
|
|
|
|
1.30
|
|
|
|
1.45
|
|
|
|
0.75
|
|
|
|
(0.35
|
)
|
|
|
Basic net income (loss) per ordinary share
|
|
|
0.64
|
|
|
|
1.30
|
|
|
|
1.45
|
|
|
|
0.75
|
|
|
|
(0.35
|
)
|
|
|
Diluted net income (loss) per ordinary
share3
|
|
|
0.64
|
|
|
|
1.26
|
|
|
|
1.41
|
|
|
|
0.74
|
|
|
|
(0.35
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares used in
computing per share amounts (in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
484,103
|
|
|
|
474,860
|
|
|
|
462,406
|
|
|
|
431,620
|
|
|
|
432,615
|
|
|
|
Diluted
|
|
|
542,979
|
|
|
|
503,983
|
|
|
|
485,643
|
|
|
|
434,205
|
|
|
|
432,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
As of January 1, 2008, ASML
accounts for award credits offered to its customers as part of a
volume purchase agreement using the deferred revenue model.
Until December 31, 2007, ASML accounted for award credits using
the cost accrual method. The comparative figures for the years
2007 and 2006 have been adjusted to reflect this change in
accounting policy. The change in accounting policy did not
affect the 2005 figures.
|
2
|
As of January 1, 2009, Research and
Development (R&D) credits are presented as part
of R&D costs instead of as a separate line item. The
comparative figures for the years 2005 through 2008 have been
adjusted accordingly.
|
3
|
The calculation of diluted net
income (loss) per ordinary share assumes the exercise of options
issued under ASML stock option plans for periods in which
exercises would have a dilutive effect. The calculation of
diluted net income (loss) per ordinary share does not assume
exercise of such options when such exercises would be
anti-dilutive.
|
ASML ANNUAL REPORT 2009
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
|
2005
|
|
|
|
2006
|
1
|
|
|
2007
|
1
|
|
|
2008
|
|
|
|
2009
|
|
|
|
(in thousands, unless otherwise indicated)
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
EUR
|
|
|
|
|
Consolidated balance sheets data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
1,904,609
|
|
|
|
1,655,857
|
|
|
|
1,271,636
|
|
|
|
1,109,184
|
|
|
|
1,037,074
|
|
|
|
Working
capital4
|
|
|
1,785,836
|
|
|
|
2,236,173
|
|
|
|
1,997,988
|
|
|
|
1,964,906
|
|
|
|
1,704,714
|
|
|
|
Total assets
|
|
|
3,756,023
|
|
|
|
3,953,888
|
|
|
|
4,073,128
|
|
|
|
3,939,394
|
|
|
|
3,727,497
|
|
|
|
Long-term debt
|
|
|
382,558
|
|
|
|
381,433
|
|
|
|
602,016
|
|
|
|
647,050
|
|
|
|
663,102
|
|
|
|
Total shareholders equity
|
|
|
1,711,837
|
|
|
|
2,148,003
|
|
|
|
1,891,004
|
|
|
|
1,988,769
|
|
|
|
1,774,768
|
|
|
|
Capital stock
|
|
|
9,694
|
|
|
|
10,051
|
|
|
|
39,206
|
|
|
|
38,887
|
|
|
|
39,028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated statements of cash flows data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
90,531
|
|
|
|
87,092
|
|
|
|
126,344
|
|
|
|
119,190
|
|
|
|
140,201
|
|
|
|
Impairment
|
|
|
8,350
|
|
|
|
17,354
|
|
|
|
9,022
|
|
|
|
25,109
|
|
|
|
15,896
|
|
|
|
Net cash provided by total operating activities
|
|
|
711,493
|
|
|
|
492,280
|
|
|
|
701,011
|
|
|
|
280,746
|
|
|
|
97,764
|
|
|
|
Purchases of property, plant and equipment
|
|
|
(72,660
|
)
|
|
|
(70,619
|
)
|
|
|
(179,152
|
)
|
|
|
(259,770
|
)
|
|
|
(104,959
|
)
|
|
|
Acquisition of subsidiary (net of cash acquired)
|
|
|
|
|
|
|
|
|
|
|
(188,011
|
)
|
|
|
|
|
|
|
|
|
|
|
Net cash used in total investing activities
|
|
|
(60,803
|
)
|
|
|
(70,629
|
)
|
|
|
(362,152
|
)
|
|
|
(259,805
|
)
|
|
|
(98,082
|
)
|
|
|
Capital
repayment5
|
|
|
|
|
|
|
|
|
|
|
(1,011,857
|
)
|
|
|
|
|
|
|
|
|
|
|
Purchase of shares in conjunction with conversion rights of
bondholders and share-based payments
|
|
|
|
|
|
|
(678,385
|
)
|
|
|
(359,856
|
)
|
|
|
(87,605
|
)
|
|
|
|
|
|
|
Dividend paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(107,841
|
)
|
|
|
(86,486
|
)
|
|
|
Net proceeds from issuance of bond
|
|
|
|
|
|
|
|
|
|
|
593,755
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) total financing activities
|
|
|
2,879
|
|
|
|
(657,624
|
)
|
|
|
(715,363
|
)
|
|
|
(184,238
|
)
|
|
|
(73,444
|
)
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
676,479
|
|
|
|
(248,752
|
)
|
|
|
(384,221
|
)
|
|
|
(162,452
|
)
|
|
|
(72,110
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratios and other data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit as a percentage of net sales
|
|
|
38.5
|
|
|
|
40.6
|
|
|
|
41.1
|
|
|
|
34.4
|
|
|
|
28.7
|
|
|
|
Income (loss) from operations as a percentage of net sales
|
|
|
17.8
|
|
|
|
24.1
|
|
|
|
21.6
|
|
|
|
9.7
|
|
|
|
(10.3
|
)
|
|
|
Net income (loss) as a percentage of net sales
|
|
|
12.3
|
|
|
|
17.3
|
|
|
|
17.8
|
|
|
|
10.9
|
|
|
|
(9.5
|
)
|
|
|
Shareholders equity as a percentage of total assets
|
|
|
45.6
|
|
|
|
54.3
|
|
|
|
46.4
|
|
|
|
50.5
|
|
|
|
47.6
|
|
|
|
Income taxes as a percentage of income (loss) before income taxes
|
|
|
(28.4
|
)
|
|
|
(28.2
|
)
|
|
|
(20.9
|
)
|
|
|
4.1
|
|
|
|
(12.0
|
)
|
|
|
Sales of systems (in units)
|
|
|
196
|
|
|
|
266
|
|
|
|
260
|
|
|
|
151
|
|
|
|
70
|
|
|
|
Average selling price of system sales (in millions)
|
|
|
11.4
|
|
|
|
12.1
|
|
|
|
12.9
|
|
|
|
16.7
|
|
|
|
16.8
|
|
|
|
Value of systems backlog (in millions)
|
|
|
1,434
|
|
|
|
2,146
|
|
|
|
1,697
|
|
|
|
755
|
|
|
|
1,853
|
|
|
|
Systems backlog (in
units)6
|
|
|
95
|
|
|
|
163
|
|
|
|
89
|
|
|
|
41
|
|
|
|
69
|
|
|
|
Average selling price of systems backlog (in millions)
|
|
|
15.1
|
|
|
|
13.2
|
|
|
|
19.1
|
|
|
|
18.4
|
|
|
|
26.8
|
|
|
|
Value of booked systems (in millions)
|
|
|
1,998
|
|
|
|
4,075
|
|
|
|
2,970
|
|
|
|
1,569
|
|
|
|
2,334
|
|
|
|
Net bookings for the year (in
units)7
|
|
|
160
|
|
|
|
334
|
|
|
|
186
|
|
|
|
103
|
|
|
|
98
|
|
|
|
Average selling price of booked systems (in millions)
|
|
|
12.5
|
|
|
|
12.2
|
|
|
|
16.0
|
|
|
|
15.2
|
|
|
|
23.8
|
|
|
|
Number of payroll employees in FTEs
|
|
|
5,055
|
|
|
|
5,594
|
|
|
|
6,582
|
|
|
|
6,930
|
|
|
|
6,548
|
|
|
|
Number of temporary employees in FTEs
|
|
|
1,106
|
|
|
|
1,486
|
|
|
|
1,725
|
|
|
|
1,329
|
|
|
|
1,137
|
|
|
|
Increase (decrease) net sales in percentage
|
|
|
2.6
|
|
|
|
41.6
|
|
|
|
5.2
|
|
|
|
(21.6
|
)
|
|
|
(46.0
|
)
|
|
|
Number of ordinary shares outstanding (in thousands)
|
|
|
484,670
|
|
|
|
477,099
|
|
|
|
435,6265
|
|
|
|
432,074
|
|
|
|
433,639
|
|
|
|
ASML share
price8
|
|
|
16.90
|
|
|
|
18.84
|
|
|
|
21.66
|
|
|
|
12.75
|
|
|
|
24.00
|
|
|
|
Volatility 260 days in percentage of ASML
shares9
|
|
|
26.00
|
|
|
|
28.08
|
|
|
|
27.52
|
|
|
|
51.14
|
|
|
|
38.45
|
|
|
|
Dividend per ordinary share in Euro
|
|
|
|
|
|
|
|
|
|
|
0.25
|
|
|
|
0.20
|
|
|
|
0.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
Working capital is calculated as
the difference between total current assets, including cash and
cash equivalents, and total current liabilities.
|
5
|
In 2007, as part of a capital
repayment program, EUR 1,012 million of share capital was repaid
to our shareholders and the number of outstanding ordinary
shares was reduced by 11 percent (pursuant to a synthetic share
buyback).
|
6
|
Our systems backlog as of December
31 includes only system orders for which written authorizations
have been accepted and shipment and revenue recognition dates
within 12 months have been assigned.
|
7
|
Our net bookings, during the year,
include only system orders for which written authorizations have
been accepted and shipment and revenue recognition dates within
12 months have been assigned.
|
8
|
Closing price of ASMLs
ordinary shares listed on the Official Segment of the stock
market of Euronext Amsterdam (source: Bloomberg Finance LP).
|
9
|
Volatility represents the
variability in our share price on the Official Segment of the
stock market of Euronext Amsterdam as measured over the 260
business days of each year presented (source: Bloomberg Finance
LP).
|
ASML ANNUAL REPORT 2009
3
Exchange Rate
Information
We publish our consolidated financial statements in Euros. In
this Annual Report, references to ,
euro or EUR are to Euros, and references
to $, U.S. dollar, USD
or US$ are to United States dollars.
A portion of our net sales and expenses is, and historically has
been, denominated in currencies other than the euro. For a
discussion of the impact of exchange rate fluctuations on our
financial condition and results of operations, see
Item 5.A. Operating Results, Foreign Exchange
Management, Note 1 General Information, Summary
of Significant Accounting Policies and Note 3
Market Risk and Derivatives to our consolidated
financial statements.
The following are the Noon Buying Rates certified by the Federal
Reserve Bank of New York for customs purposes (the Noon
Buying Rate), expressed in U.S. dollars per euro.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 2010 (through
|
|
Calendar year
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
January 22, 2010)
|
|
Period End
|
|
|
1.18
|
|
|
|
1.32
|
|
|
|
1.46
|
|
|
|
1.39
|
|
|
|
1.43
|
|
|
|
1.42
|
|
Average1
|
|
|
1.24
|
|
|
|
1.26
|
|
|
|
1.37
|
|
|
|
1.47
|
|
|
|
1.39
|
|
|
|
1.44
|
|
High
|
|
|
1.35
|
|
|
|
1.33
|
|
|
|
1.49
|
|
|
|
1.60
|
|
|
|
1.51
|
|
|
|
1.45
|
|
Low
|
|
|
1.17
|
|
|
|
1.19
|
|
|
|
1.29
|
|
|
|
1.24
|
|
|
|
1.25
|
|
|
|
1.41
|
|
|
|
|
1
|
The average of the Noon Buying
Rates on the last business day of each month during the period
presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July
|
|
|
August
|
|
|
September
|
|
|
October
|
|
|
November
|
|
|
December
|
|
|
January 2010 (through
|
|
Months of
|
|
2009
|
|
|
2009
|
|
|
2009
|
|
|
2009
|
|
|
2009
|
|
|
2009
|
|
|
January 22, 2010)
|
|
High
|
|
|
1.43
|
|
|
|
1.44
|
|
|
|
1.48
|
|
|
|
1.50
|
|
|
|
1.51
|
|
|
|
1.51
|
|
|
|
1.45
|
|
Low
|
|
|
1.39
|
|
|
|
1.41
|
|
|
|
1.42
|
|
|
|
1.45
|
|
|
|
1.47
|
|
|
|
1.42
|
|
|
|
1.41
|
|
|
B. Capitalization
and Indebtedness
Not applicable.
C. Reasons for
the Offer and Use of Proceeds
Not applicable.
D. Risk
Factors
In conducting our business, we face many risks that may
interfere with our business objectives. Some of these risks
relate to our operational processes, while others relate to our
business environment. It is important to understand the nature
of these risks and the impact they may have on our business,
financial condition and results of operations. Some of the more
relevant risks are described below. These risks are not the only
ones that ASML faces. Some risks may not yet be known to ASML
and certain risks that ASML does not currently believe to be
material could become material in the future.
Risks Related to
the Semiconductor Industry
The
Semiconductor Industry is Highly Cyclical and We May Be
Adversely Affected by Any Downturn
As a supplier to the global semiconductor industry, we are
subject to the industrys business cycles, the timing,
duration and volatility of which are difficult to predict. The
semiconductor industry has historically been cyclical. Sales of
our lithography systems depend in large part upon the level of
capital expenditures by semiconductor manufacturers. These
capital expenditures depend upon a range of competitive and
market factors, including:
|
|
|
the current and anticipated market demand for semiconductors and
for products utilizing semiconductors;
|
|
semiconductor prices;
|
|
semiconductor production costs;
|
|
changes in semiconductor inventory levels;
|
|
general economic conditions; and
|
|
access to capital.
|
Reductions or delays in capital equipment purchases by our
customers could have a material adverse effect on our business,
financial condition and results of operations.
ASML ANNUAL REPORT 2009
4
In an industry downturn, our ability to maintain profitability
will depend substantially on whether we are able to lower our
costs and break-even level, which is the level of sales that we
must reach in a year to achieve net income. If sales levels
decrease significantly as a result of an industry downturn and
we are unable to adjust our costs over the same period, our net
income may decline significantly or we may suffer losses. As we
need to keep certain levels of inventory on hand to meet
anticipated product demand, we may also incur increased costs
related to inventory obsolescence in an industry downturn. In
addition, industry downturns generally result in overcapacity,
resulting in downward pressure on prices and impairment of
machinery and equipment, which in the past has had, and in the
future could have, a material adverse effect on our business,
financial condition and results of operations.
The current financial crisis affecting the banking system and
global financial markets is in many respects unprecedented in
the history of our Company. The continued concern over the
instability of the financial markets and the global economic
downturn could result in a number of follow-on effects on our
business, including: declining business and consumer confidence
resulting in reduced, delayed or shorter-term capital
expenditures for our products; insolvency of key suppliers
resulting in product delays; the inability of customers to
obtain credit to finance purchases of our products, delayed
payments from our customers
and/or
customer insolvencies; and other adverse effects that we cannot
currently anticipate. If global economic and market conditions
remain uncertain or deteriorate further, we are likely to
experience continuing material adverse impacts on our business,
financial condition and results of operations.
Conversely, in anticipation of periods of increasing demand for
semiconductor manufacturing equipment, we must maintain
sufficient manufacturing capacity and inventory, and we must
attract, hire, integrate and retain a sufficient number of
qualified employees to meet customer demand. Our ability to
predict the timing and magnitude of industry fluctuations is
limited and our products require significant lead-time to
complete. Accordingly, we may not be able to effectively
increase our production capacity to respond to an increase in
customer demand in an industry upturn resulting in lost
revenues, damage to customer relationships and we may lose
market share.
Our Business
Will Suffer If We Do Not Respond Rapidly to Commercial and
Technological Changes in the
Semiconductor Industry
The semiconductor manufacturing industry is subject to:
|
|
|
rapid change towards more complex technologies;
|
|
frequent new product introductions and enhancements;
|
|
evolving industry standards;
|
|
changes in customer requirements; and
|
|
continued shortening of product life cycles.
|
Our products could become obsolete sooner than anticipated
because of a faster than anticipated change in one or more of
the technologies related to our products or in market demand for
products based on a particular technology. Our success in
developing new products and in enhancing our existing products
depends on a variety of factors, including the successful
management of our research and development
(R&D) programs and timely completion of product
development and design relative to competitors. If we do not
develop and introduce new and enhanced systems at competitive
prices and on a timely basis, our customers will not integrate
our systems into the planning and design of new production
facilities and upgrades of existing facilities, which would have
a material adverse effect on our business, financial condition
and results of operations.
In addition, we are investing considerable financial and other
resources to develop and introduce new products and product
enhancements, such as Extreme Ultraviolet lithography
(EUV), that our customers may not ultimately adopt.
If our customers do not adopt these new technologies, products
or product enhancements that we develop due to a preference for
more established or alternative new technologies and products or
for other reasons, we would not recoup any return on our
investments in these technologies or products, which would
result in the recording of impairment charges on these
investments and could have a materially adverse effect on our
business, financial condition and results of operations.
The success of EUV will be particularly dependent on light
source (laser) availability and continuing technical advances as
well as infrastructure developments in masks and resists,
without which the tools cannot achieve the productivity and
yield that are required to justify their capability economically.
We Face
Intense Competition
The semiconductor equipment industry is highly competitive. The
principal elements of competition in our market segments are:
|
|
|
the technical performance characteristics of a lithography
system;
|
|
the value of ownership of that system based on its purchase
price, maintenance costs, productivity and customer service and
support;
|
|
a strengthening of the euro particularly against the Japanese
yen which results in lower prices and margins;
|
|
the strength and breadth of our portfolio of patents and other
intellectual property rights; and
|
ASML ANNUAL REPORT 2009
5
|
|
|
our customers desire to obtain lithography equipment from
more than one supplier.
|
Our competitiveness increasingly depends upon our ability to
develop new and enhanced semiconductor equipment that is
competitively priced and introduced on a timely basis, as well
as our ability to protect and defend our intellectual property
rights. See Item 4.B. Business Overview, Intellectual
Property and Note 17 to our consolidated financial
statements.
ASMLs primary competitors are Nikon Corporation
(Nikon) and Canon Kabushika Kaisha
(Canon). Both Nikon and Canon have substantial
financial resources and broad patent portfolios. Each continues
to introduce new products with improved price and performance
characteristics that compete directly with our products, and may
cause a decline in our sales or loss of market acceptance for
our lithography systems. In addition, adverse market conditions,
industry overcapacity or a further decrease in the value of the
Japanese yen in relation to the euro or the U.S. dollar
could further intensify price-based competition in those regions
that account for the majority of our sales, resulting in lower
prices and margins and a material adverse effect on our
business, financial condition and results of operations.
Risks Related to
ASML
The Number of
Systems We Can Produce Is Limited by Our Dependence on a Limited
Number of Suppliers of Key Components
We rely on outside vendors for the components and subassemblies
used in our systems, each of which is obtained from a single
supplier or a limited number of suppliers. Our reliance on a
limited group of suppliers involves several risks, including a
potential inability to obtain an adequate supply of required
components and the risk of untimely delivery of these components
and subassemblies.
The number of lithography systems we are able to produce is
limited by the production capacity of Carl Zeiss SMT AG
(Zeiss). Zeiss is our single supplier of lenses and
other critical optical components. If Zeiss were unable to
maintain and increase production levels or if we are unable to
maintain our business relationship with Zeiss in the future we
could be unable to fulfill orders, which could damage
relationships with current and prospective customers and have a
material adverse effect on our business, financial condition and
results of operations. If Zeiss were to terminate its
relationship with us or if Zeiss were unable to maintain
production of lenses over a prolonged period, we would
effectively cease to be able to conduct our business. See
Item 4.B. Business Overview, Manufacturing, Logistics
and Suppliers.
In addition to Zeiss current position as our single
supplier of lenses, the excimer laser illumination systems that
provide the ultraviolet light source, referred to as deep
UV, used in our high resolution steppers and
Step & Scan systems, and the extreme ultraviolet light
source, referred to as EUV, used in our next
generation EUV systems, are available from only a very limited
number of suppliers.
Although the timeliness, yield and quality of deliveries to date
from our other subcontractors generally have been satisfactory,
manufacturing of certain of these components and subassemblies
that we use in our manufacturing processes is an extremely
complex process and delays caused by suppliers may occur in the
future. A prolonged inability to obtain adequate deliveries of
components or subassemblies, or any other circumstance that
requires us to seek alternative sources of supply, could
significantly hinder our ability to deliver our products in a
timely manner, which could damage relationships with current and
prospective customers and have a material adverse effect on our
business, financial condition and results of operations.
A High
Percentage of Net Sales Is Derived from a Few
Customers
Historically, we have sold a substantial number of lithography
systems to a limited number of customers. We expect customer
concentration to increase because of continuing consolidation in
the semiconductor manufacturing industry. Consequently, while
the identity of our largest customers may vary from year to
year, we expect sales to remain concentrated among relatively
few customers in any particular year. In 2009, sales to our
largest customer accounted for EUR 349 million, or
21.9 percent of net sales, compared to
EUR 754 million, or 25.5 percent of net sales, in
2008. The loss of any significant customer or any significant
reduction in orders by a significant customer may have a
material adverse effect on our business, financial condition and
results of operations.
Additionally, as a result of the limited number of our
customers, credit risk on our receivables is concentrated. Our
three largest customers (based on net sales) accounted for
44.0 percent of accounts receivable at December 31,
2009, compared to 42.2 percent at December 31, 2008.
As a result, business failure or insolvency of one of our main
customers may have a material adverse effect on our business,
financial condition and results of operations.
We Derive Most
of Our Revenues from the Sale of a Relatively Small Number of
Products
We derive most of our revenues from the sale of a relatively
small number of lithography equipment systems (70 units in
2009 and 151 units in 2008), with an average selling price
(ASP) in 2009 of EUR 16.8 million (EUR
21.1 million for new systems and
ASML ANNUAL REPORT 2009
6
EUR 7.9 million for used systems) and an ASP in 2008
of EUR 16.7 million (EUR 20.4 million for new
systems and EUR 4.8 million for used systems). As a
result, the timing of recognition of revenue from a small number
of product sales may have a significant impact on our net sales
and operating results for a particular reporting period.
Specifically, the failure to receive anticipated orders, or
delays in shipments near the end of a particular reporting
period, due, for example, to:
|
|
|
a downturn in the highly cyclical semiconductor industry;
|
|
unanticipated shipment rescheduling;
|
|
cancellation or order push-back by customers;
|
|
unexpected manufacturing difficulties; and
|
|
delays in deliveries by suppliers,
|
may cause net sales in a particular reporting period to fall
significantly below net sales in previous periods or our
expected net sales, and may have a material adverse effect on
our operating results for that period.
In particular our published quarterly earnings may vary
significantly from quarter to quarter and may vary in the future
for the reasons discussed above.
The Pace of
Introduction of Our New Products Is Accelerating and Is
Accompanied by Potential Design and Production Delays and by
Significant Costs
The development and initial production, installation and
enhancement of the systems we produce is often accompanied by
design and production delays and related costs of a nature
typically associated with the introduction and transition to
full-scale manufacturing of complex capital equipment. While we
expect and plan for a corresponding learning curve effect in our
product development cycle, we cannot predict with precision the
time and expense required to overcome these initial problems and
to ensure full performance to specifications. There is a risk
that we may not be able to introduce or bring to full-scale
production new products as quickly as we expected in our product
introduction plans, which could have a material adverse effect
on our business, financial condition and results of operations.
In order for the market to accept technology enhancements, our
customers, in many cases, must upgrade their existing technology
capabilities. Such upgrades from established technology may not
be available to our customers to enable volume production using
our new technology enhancements. This could result in our
customers not purchasing, or pushing back or cancelling orders
for our technology enhancements, which could negatively impact
our business, financial condition and results of operations.
Failure to
Adequately Protect the Intellectual Property Rights Upon Which
We Depend Could Harm Our Business
We rely on intellectual property rights such as patents,
copyrights and trade secrets to protect our proprietary
technology. However, we face the risk that such measures could
prove to be inadequate because:
|
|
|
intellectual property laws may not sufficiently support our
proprietary rights or may change in the future in a manner
adverse to us;
|
|
patent rights may not be granted or construed as we expect;
|
|
patents will expire which may result in key technology becoming
widely available which may hurt our competitive position;
|
|
the steps we take to prevent misappropriation or infringement of
our proprietary rights may not be successful; and
|
|
third parties may be able to develop or obtain patents for
similar competing technology.
|
In addition, litigation may be necessary to enforce our
intellectual property rights or to determine the validity and
scope of the proprietary rights of others. Any such litigation
may result in substantial costs and diversion of resources, and,
if decided unfavorably to us, could have a material adverse
effect on our business, financial condition and results of
operations.
Defending
Against Intellectual Property Claims Brought by Others Could
Harm Our Business
In the course of our business, we are subject to claims by third
parties alleging that our products or processes infringe upon
their intellectual property rights. If successful, such claims
could limit or prohibit us from developing our technology and
manufacturing our products, which could have a material adverse
effect on our business, financial condition and results of
operations.
In addition, our customers may be subject to claims of
infringement from third parties, alleging that our products used
by such customers in the manufacture of semiconductor products
and/or the
processes relating to the use of our products infringe one or
more patents issued to such parties. If such claims were
successful, we could be required to indemnify customers for some
or all of any losses incurred or damages assessed against them
as a result of such infringement, which could have a material
adverse effect on our business, financial condition and results
of operations.
We may also incur substantial licensing or settlement costs
where doing so would strengthen or expand our intellectual
property rights or limit our exposure to intellectual property
claims brought by others, which may have a material adverse
effect on our business, financial condition and results of
operations.
ASML ANNUAL REPORT 2009
7
We Are Subject
to Risks in Our International Operations
The majority of our sales are made to customers outside Europe.
There are a number of risks inherent in doing business in some
of those regions, including the following:
|
|
|
potentially adverse tax consequences;
|
|
unfavorable political or economic environments;
|
|
unexpected legal or regulatory changes; and
|
|
an inability to effectively protect intellectual property.
|
If we are unable to manage successfully the risks inherent in
our international activities, our business, financial condition
and results of operations could be materially and adversely
affected.
In particular, approximately 28 percent of our 2009
revenues and approximately 12 percent of our 2008 revenues
were derived from customers in Taiwan. Taiwan has a unique
international political status. The Peoples Republic of
China asserts sovereignty over Taiwan and does not recognize the
legitimacy of the Taiwan government. Changes in relations
between Taiwan and the Peoples Republic of China,
Taiwanese government policies and other factors affecting
Taiwans political, economic or social environment could
have a material adverse effect on our business, financial
condition and results of operations.
We Are
Dependent on the Continued Operation of a Limited Number of
Manufacturing Facilities
All of our manufacturing activities, including subassembly,
final assembly and system testing, take place in cleanroom
facilities located in Veldhoven, the Netherlands, in Wilton,
Connecticut, the United States and in Linkou, Taiwan. These
facilities are subject to disruption for a variety of reasons,
including work stoppages, fire, energy shortages, flooding or
other natural disasters. We cannot ensure that alternative
production capacity would be available if a major disruption
were to occur or that, if it were available, it could be
obtained on favorable terms. Such a disruption could have a
material adverse effect on our business, financial condition and
results of operations.
Because of
Labor Laws and Practices, Any Workforce Reductions That We May
Seek to Implement in Order to Reduce Costs Company-Wide May Be
Delayed or Suspended
The semiconductor market is highly cyclical and as a consequence
we may need to implement workforce reductions in case of a
downturn, in order to adapt to such market changes. In
accordance with labor laws and practices applicable in the
jurisdictions in which we operate, a reduction of any
significance may be subject to certain formal procedures, which
can delay, or may result in the modification of our planned
workforce reductions. For example, in the Netherlands, if our
Works Council renders adverse advice in connection with a
proposed workforce reduction in the Netherlands, but we
nonetheless determine to proceed, we must temporarily suspend
any action while the Works Council determines whether to appeal
to the Enterprise Chamber of the Amsterdam Court of Appeal. This
appeal process can cause a delay of several months and may
require us to address any procedural inadequacies identified by
the Court in the way we reached our decision. Such delays could
impair our ability to reduce costs company-wide to levels
comparable to those of our competitors. See Item 6.D.
Employees.
Fluctuations
in Foreign Exchange Rates Could Harm Our Results of
Operations
We are exposed to currency risks. We are particularly exposed to
fluctuations in the exchange rates between the U.S. dollar,
Japanese yen and the euro as we incur manufacturing costs for
our systems predominantly in euro while a portion of our net
sales and cost of sales is denominated in U.S. dollars and
Japanese yen.
In addition, a substantial portion of our assets and liabilities
and operating results are denominated in U.S. dollars, and
a small portion of our assets, liabilities and operating results
are denominated in currencies other than the euro and the
U.S. dollar. Our consolidated financial statements are
expressed in euro. Accordingly, our results of operations and
assets and liabilities are exposed to fluctuations in various
exchange rates. In general, our customers run their businesses
in U.S. dollars, and therefore a further weakening of the
U.S. dollar against the euro might impact the ability of
our customers to purchase our products.
Furthermore, a strengthening of the euro particularly against
the Japanese yen could further intensify price-based competition
in those regions that account for the majority of our sales,
resulting in lower prices and margins and a material adverse
effect on our business, financial condition and results of
operations.
Also see Item 5.A. Operating Results, Foreign
Exchange Management, Item 5.F. Tabular
Disclosure of Contractual Obligations, Item 11
Quantitative and Qualitative Disclosures About Market
Risk and Note 3 to our consolidated financial
statements.
We May Be
Unable to Make Desirable Acquisitions or to Integrate
Successfully Any Businesses We Acquire
Our future success may depend in part on the acquisition of
businesses or technologies intended to complement, enhance or
expand our current business or products or that might otherwise
offer us growth opportunities. Our ability to complete such
transactions may be hindered by a number of factors, including
potential difficulties in obtaining government approvals.
ASML ANNUAL REPORT 2009
8
Any acquisition that we do make would pose risks related to the
integration of the new business or technology with our business.
We cannot be certain that we will be able to achieve the
benefits we expect from a particular acquisition or investment.
Acquisitions may also strain our managerial and operational
resources, as the challenge of managing new operations may
divert our staff from monitoring and improving operations in our
existing business. Our business, financial condition and results
of operations may be materially and adversely affected if we
fail to coordinate our resources effectively to manage both our
existing operations and any businesses we acquire.
Our Business
and Future Success Depend on Our Ability to Attract and Retain a
Sufficient Number of Adequately Educated and Skilled
Employees
Our business and future success significantly depend upon our
employees, including a large number of highly qualified
professionals, as well as our ability to attract and retain
employees. Competition for such personnel is intense, and we may
not be able to continue to attract and retain such personnel,
which could adversely affect our business, financial condition
and results of operations.
In addition, the increasing complexity of our products results
in a longer learning curve for new and existing employees
leading to an inability to decrease cycle times and incurring
significant additional costs, which could adversely affect our
business, financial condition and results of operations.
Risks Related to
Our Ordinary Shares
The Price of
Our Ordinary Shares is Volatile
The current market price of our ordinary shares may not be
indicative of prices that will prevail in the future. In
particular, the market price of our ordinary shares has in the
past experienced significant fluctuation, including fluctuation
that is unrelated to our performance. This fluctuation may
continue in the future.
Restrictions
on Shareholder Rights May Dilute Voting Power
Our Articles of Association provide that we are subject to the
provisions of Netherlands law applicable to large corporations,
called structuurregime. These provisions have the
effect of concentrating control over certain corporate decisions
and transactions in the hands of our Supervisory Board. As a
result, holders of ordinary shares may have more difficulty in
protecting their interests in the face of actions by members of
our Supervisory Board than if we were incorporated in the United
States or another jurisdiction.
Our authorized share capital also includes a class of cumulative
preference shares and ASML has granted Stichting
Preferente Aandelen ASML, a Netherlands foundation, an
option to acquire, at their nominal value of EUR 0.02 per
share, such cumulative preference shares. Exercise of the
cumulative preference share option would effectively dilute the
voting power of our outstanding ordinary shares by one-half,
which may discourage or significantly impede a third party from
acquiring a majority of our voting shares.
See further Item 6.C. Board Practices and
Item 10.B. Memorandum and Articles of
Association.
Item 4
Information on the Company
A. History and
Development of the Company
We commenced business operations in 1984. ASM
Lithography Holding N.V. was incorporated in the Netherlands on
October 3, 1994 to serve as the holding company for our
worldwide operations, which include operating subsidiaries in
the Netherlands, the United States, Italy, France, Germany, the
United Kingdom, Ireland, Belgium, Korea, Taiwan, Singapore,
China (including Hong Kong), Japan, Malaysia and Israel. In
2001, we changed our name from ASM Lithography Holding N.V. to
ASML Holding N.V. Our registered office is located at De Run
6501, 5504 DR Veldhoven, the Netherlands, telephone +31 40 268
3000.
In May 2001, we merged with Silicon Valley Group
(SVG) (now part of ASML US, Inc.), a company that
was active in lithography, as well as in track and thermal
businesses, which we subsequently divested or discontinued.
From time to time, ASML pursues acquisitions of smaller
businesses that it believes will complement or enhance
ASMLs core lithography business. These have included the
acquisition of MaskTools in July 1999 and the acquisition of
Brion Technologies, Inc. (Brion) in March 2007.
Capital
Expenditures and Divestitures
Our capital expenditures (purchases of property, plant and
equipment) for 2009, 2008 and 2007 amounted to
EUR 105.0 million, EUR 259.8 million and
EUR 179.2 million, respectively. Our capital
expenditures in these years generally related to the
ASML ANNUAL REPORT 2009
9
construction of new facilities in Veldhoven for our latest
technologies such as EUV and double patterning (in 2007, 2008
and 2009) and in Taiwan for our ASML Center of Excellence
(ACE, in 2007 and 2008), purchases of machinery and
equipment, information technology investments, and leasehold
improvements to our facilities (in 2007, 2008 and 2009).
Divestitures mainly consisting of machinery and equipment (more
specifically prototypes, demonstration and training systems)
amounted to EUR 10.9 million for 2009,
EUR 4.3 million for 2008 and
EUR 19.2 million for 2007. See Note 11 to our
consolidated financial statements.
B. Business
Overview
We are one of the worlds leading providers of advanced
technology systems for the semiconductor industry. We offer an
integrated portfolio of lithography systems mainly for
manufacturing complex integrated circuits
(semiconductors, ICs or
chips). We supply lithography systems to IC
manufacturers throughout Asia, the United States and Europe and
also provide our customers with a full range of support services
from advanced process and product applications knowledge to
complete
round-the-clock
service support.
Our Business
Model
Our business model is derived from our Value of
Ownership concept which is based on the following
principles:
|
|
|
offering ongoing improvements in productivity, imaging and
overlay by introducing advanced technology based on modular
platforms and advanced applications outside the traditional
lithography business, each resulting in lower costs per product
for our customers;
|
|
providing customer services that ensure rapid, efficient
installation and superior
on-site
support and training to optimize manufacturing processes of our
customers and improve productivity;
|
|
maintaining appropriate levels of R&D to offer the most
advanced technology suitable for high-throughput and low-cost
volume production at the earliest possible date;
|
|
enhancing the capabilities of the installed base of our
customers through ongoing field upgrades of key value drivers
(productivity, imaging and overlay) based on further technology
developments;
|
|
reducing the cycle time between a customers order of a
system and the use of that system in volume production
on-site;
|
|
expanding operational flexibility in research and manufacturing
by reinforcing strategic alliances with world class partners,
including outsourcing companies;
|
|
improving the reliability and uptime of our installed system
base; and
|
|
providing refurbishing services that effectively increase
residual value by extending the life of equipment.
|
Market and
Technology Overview
Introduction
Chip making is all about shrink or reducing the size
of chip designs. The worldwide electronics and computer
industries have experienced significant growth since the
commercialization of ICs in the 1960s, largely due to the
continual reduction in the cost per function performed by ICs.
Improvement in the design and manufacture of ICs with higher
circuit or packing densities has resulted in smaller
and lower cost, ICs capable of performing a greater number of
functions at faster speeds and with reduced power consumption.
Despite the recent financial and economic crisis, we believe
that these long-term trends will continue for the foreseeable
future and will be accompanied by a continuing demand, subject
to ongoing cyclical variation, for production equipment that can
accurately produce advanced ICs in high volumes at the lowest
possible cost. Lithography is used to print complex circuit
patterns onto the wafers that are the primary raw material for
ICs and is one of the most critical and expensive steps in their
fabrication. It is therefore a significant focus of the IC
industrys demand for cost-efficient enhancements to
production technology.
We primarily design, manufacture, market and service
semiconductor processing equipment used in the fabrication of
ICs. Our lithography equipment includes Step & Scan
systems, which combine stepper technology with a photo-scanning
method.
Our systems use a mask to achieve the required chip pattern. A
mask is a flat, transparent quartz plate containing an opaque
microscopic pattern: an image of the electronic circuitry for
one layer of a chip. The mask is placed in a scanner where
intense light passing through it projects the pattern, via a
series of reducing lenses, onto part of the wafer. Before
exposure, the wafer is coated with photoresist and positioned so
that the projected pattern aligns with existing features on the
chip/wafer. After exposure and developing, the pattern left on
the wafer surface is used to selectively process and build up
the next layer.
Customer
Roadmaps
Supported by their technology roadmaps, IC manufacturers
continue to show interest in resolution shrink as a means to
lower manufacturing costs per unit. The leading IC manufacturers
for both volatile and non-volatile memory, as well as logic and
microprocessor units, have plans to migrate their production
capabilities in the foreseeable future to resolutions close to
or beyond 20 nm, for which they will require
state-of-the-art
lithography equipment.
ASML ANNUAL REPORT 2009
10
Products
We develop lithography systems and related products for the
semiconductor industry and related patterning applications. Our
product development strategy focuses on the development of
product families based on a modular, upgradeable design.
Our older PAS 2500 and PAS 5000 lithography systems, which we no
longer manufacture but continue to refurbish, are used for
g-line and i-line processing of wafers up to 150 mm in diameter
and are employed in manufacturing environments and in special
applications for which design resolutions no more precise than
0.5 microns are required.
Our PAS 5500 product family comprises advanced wafer steppers
and Step & Scan systems suitable for i-line, Krypton
Fluoride (KrF) and Argon Fluoride (ArF)
processing of wafers up to 200 mm in diameter and is employed in
volume manufacturing to achieve design nodes requiring
resolutions down to 90 nm. In 1997, we introduced the PAS 5500
Step & Scan systems with improved resolution and
overlay.
We offer TWINSCAN systems, based on i-line, KrF and ArF
processing of wafers up to 300 mm in diameter for manufacturing
environments for which design resolutions down to 38 nanometer
(nm) are required. The modular upgradeable design
philosophy of the
Step-and-Scan
product family has been further refined and applied in the
design of our most advanced product family. The TWINSCAN
platform, introduced in 2000, is the basis for our current and
next generation Step-and Scan systems, which are capable of
extending shrink technology down to 38 nm.
We are the leader in the innovation of immersion technologies
and we were the worlds first producer of dual-stage design
(TWINSCAN) systems. Wafer measurement, including focus and
alignment, is completed on the dry stage, while the imaging
process, using water applied between the wafer and the lens, is
completed on the wet stage. The dual-stage advantage of TWINSCAN
systems enables our customers to benefit from the process
enhancements of immersion while continuing to use familiar and
proven metrology technology.
Furthermore, we continuously develop and sell a range of product
options and enhancements designed to increase productivity and
improve imaging and overlay to optimize value of ownership over
the entire life of our systems.
Product
Development
In 2003, we introduced the second generation of TWINSCAN systems
based on the XT body with a 50 percent reduction in the
main production area occupied by our system.
In 2004, we shipped our first lithography systems based on
immersion technology. These shipments marked the delivery of the
industrys first high productivity immersion scanners for
mainstream production.
In 2006, we shipped the industrys first EUV Alpha Demo
Tools to two research institutions, which work closely with most
of the worlds major IC manufacturers in developing
manufacturing processes and materials. EUV combines a wavelength
of 13.5 nm and a lens system with a numerical aperture
(NA) of 0.25 to provide imaging at a resolution of
27 nm.
In 2006, we started volume production of the TWINSCAN XT:1700i,
a 193 nm immersion scanner capable of imaging at the 45 nm node
in volume production environments. With a new catadioptric lens
design, this system featured an NA of 1.2, substantially higher
than that of its predecessor, the XT:1400, which had an NA of
0.93, exceeding the non-immersion barrier of 1.0. The XT:1700i
has enabled chipmakers to improve resolution by 30 percent
and has been employed in the development and manufacturing of
the latest advanced generation of ICs.
The acquisition of Brion in 2007 enabled ASML to improve the
implementation of optical proximity correction (OPC)
technology and resolution enhancement techniques
(RET) such as Double Patterning Technology
(DPT) and Source-Mask Optimization (SMO)
for masks. These improvements are extending the practical
resolution limits of ASML ArF immersion products. Brions
computational lithography capabilities enable us to offer
products that further improve the
set-up and
control of ASML lithography systems.
Brions current computational lithography portfolio
comprises not only traditional products (such as
RET/OPC/DPT/SMO), but also solutions that directly interface
with the numerous calibration controls in an ASML scanner to
optimize performance. Our computational lithography products
capture detailed knowledge of scanner design and real
performance, which enables them to accurately predict real-life
manufacturing performance. Such predictions are essential in
addressing possible
ramp-up and
yield problems in advance, potentially avoiding months of delay
in
time-to-market
for our customers. The same prediction capabilities allow the
ASML scanners to be optimally calibrated for improved
performance in production, given specific chip designs or
reticles, thereby achieving improved yield.
ASML ANNUAL REPORT 2009
11
Once a scanner is optimally
set-up for a
given application, ASML also offers scanner control solutions
that ensure that the performance of the lithographic process
remains optimal and stable throughout production. These scanner
control solutions also leverage the scanner controls to
compensate for potential performance drifts in the scanner
itself, as well as in other steps of the device manufacturing
process, such as reticle deterioration, resist coating
fingerprints, etching fingerprints, or chemical-mechanical
planarization fingerprints. To ensure optimal control
performance, ASMLs scanner control solutions use
ASMLs own advanced wafer metrology technology, Yieldstar.
In the third quarter of 2007, ASML began volume shipment of the
XT:1900i, with a new industry benchmark of 1.35 NA, which is
close to the practical limit for water-based immersion
technology. This optical lithography system is capable of volume
production of ICs down to 40 nm and below and is used for high
volume IC manufacturing at multiple customers worldwide.
In 2008, we discontinued research into optical maskless
lithography due to the reduced market opportunity for this
technology. Research studies on alternative technologies
continue for both mask-based and maskless lithography.
In the third quarter of 2008, ASML announced an enhanced version
of the XT:1900i system, the XT:1950i, with improved throughput
of 148 wafers per hour, resolution of 38 nm and a scheduled
overlay of 4 nm. In the first quarter of 2009, we started
shipments of XT:1950i systems, which extend the performance,
imaging and overlay specifications of the successful XT:1900i
system.
Also in the third quarter of 2008, ASML commenced shipment of
the XT:1000, which uses the catadioptric lens technology
developed for the XT:1700i and XT:1900i to extend the maximum NA
of the previous generation of 248 nm wavelength, KrF, systems to
0.93 NA from the previous maximum available of 0.80 NA. The
XT:1000s high NA of 0.93 can resolve 80 nm device
features, far smaller than the 100 nm of other KrF systems. The
XT:1000 also improves value to customers, with an increased
throughput of 165 300 mm wafers per hour under volume
manufacturing conditions while maintaining the same
industry-leading 6 nm overlay as leading-edge ArF systems.
By the end of 2009, ASML had shipped more than 850 TWINSCAN
systems demonstrating the acceptance of the TWINSCAN platform as
the semiconductor industrys standard for 300 mm
lithography. We also announced an improved version of the
successful TWINSCAN platform called NXT featuring new stage and
position control technology, providing improved imaging and
overlay performance for immersion. Initial shipments started in
the third quarter of 2009 with volume production expected in
2010.
Also by the end of 2009, ASML had received five orders for next
generation EUV systems, the first of which is scheduled for
shipment in the second half of 2010. EUV will provide a large
process window and much greater shrink compared to
current approaches and we expect it to be a multi-generation
lithography solution. The first generation of these systems will
combine a wavelength of 13.5 nm and a lens system with a NA of
0.25 to provide imaging at a resolution of 27 nm. The EUV
platform is targeted for production of ICs down to 22 nm and
beyond.
In February 2009, Brion Technologies, a subsidiary of ASML,
announced Tachyon SMO, a new source-mask optimization (SMO)
product that allows full co-optimization of source and mask.
This product provides the industry with low k1 manufacturable
imaging solutions and is a major advancement of Brions
industry standard SMO technology, which was currently in use at
the leading logic and memory manufacturers.
In July 2009, ASML introduced
FlexRaytm
programmable illumination and
BaseLinertm
scanner matching technology. Together, they offer scanner
stability optimization and stabilize manufacturing process
windows.
ASML ANNUAL REPORT 2009
12
The table below outlines our current product portfolio of
Stepper and Scanner Systems by resolution and wavelength.
Current ASML
lithography product portfolio of Step & Scan
Systems1
|
|
|
|
|
|
|
|
|
|
|
|
|
Resolution
|
|
Wavelength
|
|
Lightsource
|
|
Numerical aperture
|
PAS 5500 SYSTEMS
|
|
|
|
|
|
|
|
|
PAS 5500/4X0
|
|
280 nm
|
|
365 nm
|
|
i-line
|
|
0.48-0.65
|
PAS 5500/750
|
|
130 nm
|
|
248 nm
|
|
KrF
|
|
0.50-0.70
|
PAS 5500/850
|
|
110 nm
|
|
248 nm
|
|
KrF
|
|
0.55-0.80
|
PAS 5500/1150
|
|
90 nm
|
|
193 nm
|
|
ArF
|
|
0.50-0.75
|
|
|
|
|
|
|
|
|
|
TWINSCAN SYSTEMS
|
|
|
|
|
|
|
|
|
TWINSCAN XT:400
|
|
350 nm
|
|
365 nm
|
|
i-line
|
|
0.48-0.65
|
TWINSCAN XT:450
|
|
220 nm
|
|
365 nm
|
|
i-line
|
|
0.48-0.65
|
TWINSCAN XT:8X0
|
|
110 nm
|
|
248 nm
|
|
KrF
|
|
0.55-0.80
|
TWINSCAN XT:875
|
|
90 nm
|
|
248 nm
|
|
KrF
|
|
0.55-0.80
|
TWINSCAN XT:1000
|
|
80 nm
|
|
248 nm
|
|
KrF
|
|
0.50-0.93
|
TWINSCAN XT:1450
|
|
57 nm
|
|
193 nm
|
|
ArF
|
|
0.65-0.93
|
TWINSCAN XT:1700 immersion
|
|
45 nm
|
|
193 nm
|
|
ArF
|
|
0.75-1.20
|
TWINSCAN XT:1900 immersion
|
|
40 nm
|
|
193 nm
|
|
ArF
|
|
0.85-1.35
|
TWINSCAN XT:1950 immersion
|
|
38 nm
|
|
193 nm
|
|
ArF
|
|
0.85-1.35
|
TWINSCAN NXT:1950 immersion
|
|
38 nm
|
|
193 nm
|
|
ArF
|
|
0.85-1.35
|
|
|
|
1
|
This table does not include the
older (including pre-used) products sold on the PAS 2500, PAS
5000 and PAS 5500 platforms
|
|
|
XT is a TWINSCAN system for 200 and
300 mm wafer sizes;
|
|
Wavelength refers to the frequency
of light going through projection lenses; the shorter the
wavelength, the smaller the line-width and the finer the pattern
on the IC;
|
|
1 nm is equal to one billionth of a
meter;
|
|
The X in the number represents
different models in the product portfolio within the same
resolution. For example XT:8X0 can either represent XT:800 or
XT:850;
|
|
NXT is an improved version of the
current TWINSCAN system, introducing new stages and stage
position control technology, which enable improved imaging and
overlay.
|
Sales, Customer
Support and Customers
We market and sell our products through our direct sales staff.
We support our customers with a broad range of applications,
services, and technical support products to maintain and
maximize the performance of our systems at customer sites. We
also offer refurbished and remanufactured tools, system upgrades
and enhancements, and technical training.
Our field engineers and applications, service and technical
support specialists are located throughout Asia, the United
States and Europe.
In 2006, ASML established the ASML Center of Excellence
(ACE) in Asia. The primary goal of ACE is to serve
as a supplementary engine to propel ASMLs long-term
growth. ACE features customer support, training, logistics,
refurbishment, technology and application development. ACE also
enables sourcing of selected equipment modules, components and
services in the region. Finally, ACE is used as a training
center to develop worldwide talent for ASMLs workforce. In
the fourth quarter of 2008, we completed construction of the
building and facility that houses ACE near Taipei, Taiwan and
into which the ACE organization was moved.
Customers and
Geographic Regions
In 2009, sales to our largest customer accounted for
EUR 349 million, or 21.9 percent of net sales,
compared to EUR 754 million, or 25.5 percent of
net sales, in 2008 (2007: EUR 818 million or
21.7 percent of net sales). We expect that sales to
relatively few customers will continue to account for a high
percentage of our net sales in any particular period for the
foreseeable future.
In 2009, we derived 72.6 percent of net sales from Asia,
23.1 percent from the United States and 4.3 percent
from Europe. In general, since ASMLs founding in 1984, the
percentage of our sales derived from Asia has increased and the
cumulative percentage of our sales derived from the United
States and Europe has decreased. See Note 19 to the
consolidated financial statements.
Manufacturing,
Logistics and Suppliers
Our business model is based on outsourcing production of a
significant part of the components and modules that comprise our
lithography systems, working in partnership with suppliers from
all over the world. Our manufacturing activities comprise the
subassembly and testing of certain modules and the final
assembly and fine tuning / testing of a finished
system from components
ASML ANNUAL REPORT 2009
13
and modules that are manufactured to our specifications by third
parties and by us. All of our manufacturing activities
(subassembly, final assembly and system fine
tuning / testing) are performed in cleanroom
facilities located in Veldhoven, the Netherlands, in Wilton,
Connecticut, the United States and in Linkou, Taiwan, Republic
of China. We procure stepper and scanner system components and
subassemblies from a single supplier or a limited group of
suppliers in order to ensure overall quality and timeliness of
delivery. We jointly operate a formal strategy with suppliers
known as value sourcing, which is based on
competitive performance in quality, logistics, technology and
total cost. The essence of value sourcing is to maintain a
supply base that is world class, globally competitive and
globally present.
Our value sourcing strategy is based on the following strategic
principles:
|
|
|
maintaining long-term relationships with our suppliers;
|
|
sharing risks and rewards with our suppliers;
|
|
dual sourcing of knowledge, globally, together with our
suppliers; and
|
|
single, dual or multiple sourcing of products, where possible or
required.
|
Value sourcing is intended to align the performance of our
suppliers with our requirements on quality, logistics,
technology and total costs.
Zeiss is our sole external supplier of main optical systems and
one of the suppliers of other components. In 2009, approximately
26 percent of our aggregate cost of sales was purchased
from Zeiss (2008: 32 percent; 2007: 40 percent).
Zeiss is highly dependent on its manufacturing and testing
facilities in Oberkochen and Wetzlar, Germany, and its
suppliers. Moreover, Zeiss has a finite capacity for production
of lenses and optical components for our stepper and scanner
systems. The expansion of this production capacity may require
significant lead-time. From time to time, the number of systems
we have been able to produce has been limited by the capacity of
Zeiss to provide us with lenses and optical components. During
2009, our sales were not limited by the deliveries from Zeiss.
If Zeiss is unable to maintain or increase production levels, we
might not be able to respond to customer demand. As a result,
our relationships with current and prospective customers could
be harmed, which would have a material adverse effect on our
business, financial condition and results of operations.
Our relationship with Zeiss is structured as a strategic
alliance pursuant to several agreements executed in 1997 and
later years. These agreements define a framework in all areas of
our business relationship. The partnership between ASML and
Zeiss is focused on continuous improvement of operational
excellence.
Pursuant to these agreements, ASML and Zeiss have agreed to
continue their strategic alliance until either party provides at
least three years notice of its intent to terminate.
Although we believe such an outcome is unlikely, if Zeiss were
to terminate its relationship with us, or if Zeiss were unable
to produce lenses and optical components over a prolonged
period, we would effectively cease to be able to conduct our
business.
In addition to Zeiss, we also rely on other outside vendors for
the components and subassemblies used in our systems, each of
which is obtained from a single supplier or a limited number of
suppliers. Our reliance on a limited group of suppliers involves
several risks, including a potential inability to obtain an
adequate supply of required components and the risk of untimely
delivery of these components and subassemblies.
Research and
Development
The semiconductor manufacturing industry is subject to rapid
technological changes and new product introductions and
enhancements. We believe that continued and timely development
and introduction of new and enhanced systems are essential for
us to maintain our competitive position. As a result, we have
historically devoted a significant portion of our financial
resources to R&D programs and we expect to continue to
allocate significant resources to these efforts. In addition, we
have established sophisticated development centers in the
Netherlands, the United States and Taiwan. We are also involved
in joint R&D programs with both public and private
partnerships and consortiums, involving independent research
centers, leading chip manufacturers and governmental programs.
We aim to own or license our jointly developed technology and
designs of critical components.
We apply for subsidy payments in connection with specific
development projects under programs sponsored by the Netherlands
government, the European Union, the United States government and
the Taiwanese government. Amounts received under these programs
generally are not required to be repaid.
We invested EUR 467 million in R&D (net of
credits) in 2009, compared to EUR 516 million in 2008
and EUR 486 million in 2007. In addition to these
R&D investments, in 2007 we recognized a one-off charge
related to the Brion acquisition of EUR 23 million
(amortization of in-process R&D).
ASML ANNUAL REPORT 2009
14
In 2009, our R&D efforts drove further development of the
several versions of the TWINSCAN platform along with
leading-edge technologies, including immersion, double
patterning and EUV. The continuous drive by our customers for
cost reductions has led us to increase significantly the
commonality of components across different TWINSCAN platform
versions and led to our announcement in 2009 of an improved
version of TWINSCAN platform called NXT, which provides improved
imaging and overlay performance. We continue to develop
technology to support applications of double
patterning. Double patterning is a resolution enhancement
technique that involves splitting a dense circuit pattern into
multiple, less-dense patterns. We also are putting increased
effort in holistic lithography, enabling further shrink by
integrating computational lithography, wafer lithography and
process control and optimizing process windows and lithography
system
set-up for
volume production.
In 2009, we increased our resources for development of EUV
technology. This technology promises a means for cost-effective
extendibility of our customers roadmaps. The EUV Alpha
Demo Tools (ADT) have provided us with sufficient
data to begin to finalize the planned pre-production tools. Our
key customers now have direct access to EUV technology, which we
expect will result in the acceptance of this technology as well
as drive the development of EUV infrastructure, including mask
fabrication and resist processes. These pre-production tools are
planned for shipment starting in the second half of 2010.
Intellectual
Property
We rely on intellectual property rights such as patents,
copyrights and trade secrets to protect our proprietary
technology. We aim to obtain ownership rights on technology
developed by or for us or, alternatively, to have license rights
in place with respect to such technology. However, we face the
risk that such measures will be inadequate. Intellectual
property laws may not sufficiently support our proprietary
rights, our patent applications may not be granted and our
patents may not be construed as we expect. Furthermore,
competitors may be able to develop or protect similar technology
earlier and independently.
Litigation may be necessary to enforce our intellectual property
rights, to determine the validity and scope of the proprietary
rights of others, or to defend against claims of infringement.
Any such litigation may result in substantial costs and
diversion of management resources, and, if decided unfavorably
to us, could have a material adverse effect on our business,
financial condition and results of operations. We also may incur
substantial licensing or settlement costs where doing so would
strengthen or expand our intellectual property rights or limit
our exposure to intellectual property claims of third parties.
In 2007, ASML and Zeiss signed an agreement with Canon for the
global cross-license of patents in their respective fields of
semiconductor lithography and optical components, used to
manufacture ICs. There was no transfer of technology and no
payment was made among the parties.
From 2001 through late 2004, we were party to a series of civil
litigations and administrative proceedings in which Nikon
alleged ASMLs infringement of Nikon patents relating to
lithography. ASML in turn filed claims against Nikon. Pursuant
to agreements executed on December 10, 2004, ASML, Zeiss
and Nikon agreed to settle all pending worldwide patent
litigation between the companies. The settlement included an
exchange of releases, a cross-license of patents related to
lithography equipment used to manufacture semiconductor devices
and payments to Nikon by ASML and Zeiss. In connection with the
settlement, ASML and Zeiss made settlement payments to Nikon
from 2004 to 2007.
Competition
The semiconductor equipment industry is highly competitive. The
principal elements of competition in our market segments are:
|
|
|
the technical performance characteristics of a lithography
system;
|
|
the value of ownership of that system based on its purchase
price, maintenance costs and productivity;
|
|
a strengthening of the euro particularly against the Japanese
yen which results in lower prices and margins;
|
|
the strength and breadth of our portfolio of patent and other
intellectual property rights; and
|
|
our customers desire to obtain lithography equipment from
more than one supplier.
|
We believe that the market segment for lithography systems and
the investments required to be a significant competitor in this
market segment have resulted in increased competition for market
share through the aggressive prosecution of patents. Our
competitiveness will increasingly depend upon our ability to
protect and defend our patents, as well as our ability to
develop new and enhanced semiconductor equipment that is
competitively priced and introduced on a timely basis.
Government
Regulation
Our business is subject to direct and indirect regulation in
each of the countries in which our customers or we do business.
As a result, changes in various types of regulations could
affect our business adversely. The implementation of new
technological, safety or legal requirements could impact our
products, or our manufacturing or distribution processes, and
could affect the timing of product introductions, the cost of
our production, and products as well as their commercial
success. Moreover, environmental and other regulations that
adversely affect the pricing of our products could adversely
affect our results of operation. The impact of these changes in
regulation could adversely affect our business even where the
specific regulations do not directly apply to us or to our
products.
ASML ANNUAL REPORT 2009
15
C. Organizational
Structure
ASML Holding N.V. is a holding company that operates through its
subsidiaries. Our major operating subsidiaries, each of which is
a wholly-owned subsidiary, are as follows:
See Exhibit 8.1 for a list of our subsidiaries.
D. Property,
Plant and Equipment
We principally obtain our facilities under operating leases.
However, we also own a limited number of buildings, mainly
consisting of the new production facilities in the Netherlands
and Taiwan. The book value of land and buildings owned by us
amounted to EUR 354 million as of December 31,
2009 compared to EUR 302 million as of
December 31, 2008. As a result of the decline in revenues
caused by the recent financial and economic crisis, we
experienced temporary underutilization of our facilities, mainly
in the first half of 2009.
Depending on market conditions, we expect that our capital
expenditures (purchases of property, plant and equipment) in
2010 will be approximately EUR 100 million, in line
with 2009 capital expenditures. Purchases of property, plant and
equipment in 2009 mainly include amounts spent to finalize the
first part of the construction of the production facilities in
Veldhoven for our latest technologies such as EUV and NXT
(double patterning). We intend to fund capital expenditures
primarily with cash on hand
and/or cash
generated through operations.
Facilities in
Europe
Our headquarters, applications laboratory and R&D
facilities are located at a single site in Veldhoven, the
Netherlands. This
state-of-the-art
facility includes 65 thousand square meters of office space and
30 thousand square meters of buildings used for manufacturing
and R&D activities. We lease the majority of these
facilities through long-term operating leases that contain
purchase options. Some of our office facilities at our
headquarters in Veldhoven are financed through a special purpose
vehicle that is a variable interest entity. See Item 5.E.
Off-Balance Sheet Arrangements and Note 15 to
our consolidated financial statements. We also lease several
sales and service facilities at locations across Europe.
Facilities in the
United States
Our main United States operations are located in a nine thousand
square meters office building in Tempe, Arizona. We maintain
lithography research, development and manufacturing operations
in a 27 thousand square meters facility in Wilton, Connecticut
and a six thousand square meters facility in Santa Clara,
California. We also lease several sales and service facilities
at locations across the United States.
Facilities in
Asia
Our Asian headquarters is located in a 425 square meters
office space in Hong Kong. Furthermore, our ACE facility,
located in Linkou, Taiwan comprises cleanroom (approximately two
thousand square meters) and office space (approximately six
thousand square meters). The ACE facility supports customers in
the Asia-Pacific region by focusing on technology and
applications development, equipment support, training, logistics
and refurbishment. ACE also enables local sourcing of equipment,
components and services. We also lease and own several sales and
service and training facilities at locations across Asia.
Item 4A
Unresolved Staff Comments
Not applicable.
Item 5
Operating and Financial Review and Prospects
Executive
Summary
Introduction
ASML is one of the worlds leading providers of lithography
equipment that is critical to the production of ICs or chips.
ASMLs market share based on revenue was approximately
68 percent in 2009 (2008: 65 percent; 2007:
65 percent). This is according to
ASML ANNUAL REPORT 2009
16
the latest available data up to and including November 2009 as
reported by SEMI, an independent semiconductor industry
organization. Headquartered in Veldhoven, the Netherlands, ASML
operates globally, with activities in Europe, the United States
and Asia. As of December 31, 2009 we employed approximately
6,500 payroll employees (2008: 6,900) and approximately 1,100
temporary employees (2008: 1,300), measured in full-time
employees, FTEs. ASML operated in 15 countries
through over 60 sales and service locations.
In 2009, we generated net sales of EUR 1,596 million
and loss from operations of EUR 165 million or
10.3 percent of net sales. Net loss in 2009 amounted to
EUR 151 million or 9.5 percent of net sales,
representing EUR 0.35 net loss per ordinary share.
In the executive summary below we provide an update of the
semiconductor equipment industry, followed by our business
strategy and a discussion of our key performance indicators.
Semiconductor
equipment industry conditions
Chip making is all about shrink or reducing the size
of chip designs. Historically the semiconductor industry has
experienced significant growth largely due to the continual
reduction of cost per function performed by ICs. Improvement in
the design and manufacture of ICs with higher circuit densities
resulted in smaller and cheaper ICs capable of performing a
larger number of functions at higher speeds with lower power
consumption. We believe that these long-term trends will
continue for the foreseeable future and will be accompanied by a
continuing demand for production equipment that is capable of
accurate production of advanced ICs in high volumes at the
lowest possible cost.
Lithography equipment is used to print complex circuit patterns
onto silicon wafers, which are the primary raw materials for
ICs. The printing process is one of the most critical and
expensive steps in wafer fabrication. Lithography equipment is
therefore a significant focus of the IC industrys demand
for cost-efficient enhancements to production technology.
The costs to develop new lithography equipment are high.
Accordingly, the lithography equipment industry is characterized
by the presence of only a few primary suppliers: ASML, Nikon and
Canon. ASML is one of the worlds leading providers of
lithography equipment with a market share based on revenue of
approximately 68 percent in 2009 (2008: 65 percent;
2007: 65 percent). This is according to the latest
available data up to and including November 2009 as reported by
SEMI, an independent semiconductor industry organization.
Total lithography equipment shipped by the industry as a whole
in the five years ended December 31, 2008 is set out in the
following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
2008
|
Total units shipped
|
|
694
|
|
536
|
|
633
|
|
604
|
|
344
|
Total value (in millions USD)
|
|
5,268
|
|
4,988
|
|
6,386
|
|
7,144
|
|
5,388
|
|
(Source: Gartner Dataquest)
For the year 2009, the latest indications of independent market
analysts show a drop in total lithography equipment shipped to
the market by the industry of 61 percent in unit volume and
49 percent in value. The year 2009 was characterized by the
financial and economic crisis which has led to lower overall
semiconductor end-demand. Against this background, in the first
half of 2009, our customers implemented inventory corrections,
production capacity adjustments and experienced a lack of
capital. In the second half of 2009, non-leading-edge production
capacity additions were still delayed. However, demand increased
compared to the first half of 2009 as our customers invested in
leading-edge immersion technology, with DRAM customers
introducing new memory devices and Foundry customers beginning
to ramp up 40 nm products.
Business
strategy
The long-term growth of the semiconductor industry is the result
of the principle that the power, cost and time required for
every computation on a digital electronic device can be reduced
by shrinking the size of transistors on chips. Todays
transistors are around 250 times smaller than they were in the
early 1970s. Using advanced semiconductors in industrial and
consumer products often provides economic benefits,
user-friendliness and increased safety. The technology
revolution powered by semiconductors has brought many
advantages: not only can information be more widely disseminated
than ever before, affordable chip intelligence has also enabled
industry and services sectors to create and distribute products
and ideas at lightning speed.
Smarter, smaller and more energy-efficient chips are made with
more sophisticated lithography systems like the ones produced by
ASML. Lithography systems are crucial to the roadmaps of
chipmakers to smaller transistors on chips. ASMLs business
strategy is based on achieving and further developing a position
as a technology leader in semiconductor lithography. When
ASML ANNUAL REPORT 2009
17
executed, this strategy results in the delivery of lithography
systems which enable customers to produce highest performance
and lowest cost chips. The superior value of ownership offered
to customers as a result of ASMLs strategy also maximizes
ASMLs own financial performance, aligning the interests of
ASML and our customers. We implement our strategy through
customer focus, strategic investment in R&D, and
operational excellence.
Customer
focus
We serve different types of chipmakers by ensuring that our
products provide premium value for customers in the various
semiconductor market segments, including Flash and DRAM memory
makers, integrated device manufacturers, and foundries or
made-to-order
chip contractors.
Through 2009, 18 of the top 20 chipmakers worldwide, in terms of
semiconductor capital expenditure, were our customers. We also
have a significant share of customers outside the top 20 and we
strive for continued business growth with all customers.
In 2009, we achieved a top three position in customer
satisfaction rankings amongst large suppliers of semiconductor
equipment, according to VLSI Research, an independent industry
research firm that surveyed customers representing
95 percent of the worlds total semiconductor market.
Our satisfaction ratings by customers surpassed every
lithography competitor for the seventh year in a row.
Strategic
investment in research and development
Our customer-base relies on ASML to deliver the right technology
at the right time to meet long-term roadmaps which often extend
many years into the future. In order to meet these demands, ASML
is committed to significant long-term investments into R&D
that are not significantly impacted by short-term cyclical
swings. In 2009, despite experiencing the impact of a severe
global economic downturn caused by the financial and economic
crisis, these investments (net of credits) amounted to
EUR 467 million (2008: EUR 516 million;
2007: EUR 486 million).
The foundation of our Lithography scanners is our dual-stage
wafer imaging platform the TWINSCAN
system which we introduced in 2000 and which allows
exposure of one wafer while simultaneously measuring the wafer
which will be exposed next. Our strong leadership in this
capability has allowed us to achieve the industrys highest
throughput, enabling reduced
cost-per-exposure
per wafer. ASML is the only lithography manufacturer that
enables volume production based on dual stage systems.
We have focused our R&D investments on three core programs:
immersion, double patterning and EUV.
Our innovative immersion lithography systems place a fluid
between the wafer and a systems projection lens, to
enhance focus and enabling circuit line-width to shrink to even
smaller dimensions than what is possible with dry
lithography systems. ASML pioneered this wet
technology and has experienced strong demand for immersion-based
systems, driven initially by NAND Flash solid state memory
chipmakers which have aggressive shrink roadmaps to reduce cost
per memory function. Shrinking the feature sizes on chips by
means of immersion systems has meanwhile been adopted by most of
our customers in all other semiconductor market segments,
including DRAM memory chip, as well as the Logic chip segment
including the Foundry contract chip manufacturers.
With immersion becoming the cornerstone of the modern chip
factory, we have developed different immersion systems for
different needs. We have optimized our TWINSCAN XT immersion
systems for cost-effective imaging down to 40 nm patterning,
while we have simultaneously developed a new dual wafer stage
system called TWINSCAN NXT with improved positioning
(overlay) and imaging. The NXT platform enables next
generations of semiconductors through the so-called Double
Patterning technique which requires two exposures per layer on a
chip. Imaging patterns and lines between one another without
creating contacts is very demanding on the exact placement of
lines and patterns and this overlay requirement is uniquely
served by our NXT planar wafer stage and breakthrough grid
metrology. Our first TWINSCAN NXT system was shipped in the
third quarter of 2009 and achieved overlay below the
specification of 3 nm, which is only 12 silicon atoms across, or
the length a human hair grows in just half a second.
We complement our scanner products with a rapidly expanding
portfolio of software and metrology products to help our
customers achieve better imaging at aggressive resolutions,
offering significant revenue-generating and cost-saving
opportunities to our customers. As customers optimize their
scanner performance by taking into account the entire chip
creation process, from design to volume manufacturing, we have
called this approach holistic lithography. During
the chip design phase ASMLs holistic lithography software
uses actual scanner profiles and tuning capabilities to create a
design with the maximum process window for a given node and
application. During manufacturing, ASMLs holistic
lithography leverages unique metrology techniques and feedback
loops to monitor overlay and Critical Dimension Uniformity (CDU)
performance to continuously maintain the system centered in the
process window. During 2009 we launched new products such as
FlexRaytm
programmable illumination, Source
ASML ANNUAL REPORT 2009
18
Mask Optimization (SMO) tools and
BaseLinertm
scanner stability, while announcing deals for sales of these
products with major chip manufacturers.
Also in 2009, we confirmed our roadmap for EUV lithography with
the first shipment of our pre-production system (for which we
have received five orders) scheduled for the second half of
2010. EUV derives its name from the light source it uses the
wavelength of which is 15 times shorter than the Deep
Ultraviolet ArF light source used in our most advanced immersion
systems. Despite the financial and economic crisis, assembly of
our first pre-production systems started in 2009 in the new EUV
cleanroom facility at our headquarters in Veldhoven, which was
opened on schedule in May 2009. The NXE (EUV) system, which will
be built on an evolved TWINSCAN platform, will enable our
customers to extend their roadmap with chip features down to 22
nm and smaller. Industry support for EUV was boosted by the
publication of excellent imaging results from many customers who
have been working on our Alpha Demo Tools located at two major
industry R&D centres (IMEC in Leuven, Belgium and CNSE
Albany NanoTech in New York State, U.S.). Also, there was
considerable progress reported publicly in EUV infrastructure
development, ranging from reticles and resists to source power
improvements. We have published a roadmap to develop a range of
EUV models, offering the greatest extendibility at the lowest
cost of ownership for the future of lithography.
Operational
excellence
We strive to sustain our business success based on our
technological leadership by continuing to execute our
fundamental operating strategy well, including reducing
lead-times while improving our cost competitiveness. Lead-time
is the time from a customers order to a tools
delivery.
Our business strategy includes outsourcing the majority of
components and subassemblies that make up our products. We work
in partnership with suppliers, collaborating on quality,
logistics, technology and total cost. By operating our strategy
of value sourcing, we strive to attain flexibility and cost
efficiencies from our suppliers through mutual commitment and
shared risk and reward. Value sourcing also allows the
flexibility to adapt to the cyclicality of the world market for
semiconductor lithography systems. As a result of an increase in
the number of orders in the second half of 2009, our suppliers
went from very low to very high levels of deliveries to ASML.
Our supply-base has been able to handle the volatility well, as
they have mirrored our flexible business model and have reduced
their exposure to ASML compared with the previous economic
downturn. ASML more than doubled the frequency of planning
communication with its supply chain during the financial and
economic crisis, in order to assist those suppliers and maintain
their viability throughout the crisis. Our supply-base proved to
be robust in coping with the volume swings.
ASML has a flexible labor model with a mix of fixed and flexible
contracted labor in its manufacturing and R&D facilities
located in Veldhoven. This reinforces our ability to adapt more
quickly to semiconductor market cycles, including support for
potential
24-hour,
seven
days-a-week
production activities. By maximizing the flexibility of our
high-tech workforce, we can shorten lead-times: a key driver of
added value for customers. Flexibility also reduces our working
capital requirements. The flexibility in our business model was
used in response to the sharp downturn. We reduced our workforce
by approximately 1,000 temporary employees, including 700 in
Veldhoven. We rehired approximately 400 temporary employees in
2009.
In view of the economic volatility of the semiconductor
industry, we continue to strive to improve efficiencies in our
operations: addressing our cost structure and strengthening our
capability to generate cash. We started cost reduction
initiatives in the second quarter of 2008 and by the end of 2009
we had cut our costs by more than EUR 200 million per
year, of which we expect approximately 75 percent is
sustainable during an economic upturn up to a sales level of
approximately EUR 800 million per quarter. If the
sales level increases above EUR 800 million per
quarter, cost levels are expected to increase. We maintained our
high R&D investments for our strategic R&D projects as
well as our machinery and equipment capacity at our productions
facilities, which is expected to give us a strong position for
the anticipated recovery in demand for our products.
ASML operations
update on key performance indicators
Significant
effects of the financial and economic crisis on ASML
In the fourth quarter of 2008, the financial and economic crisis
started to impact ASML severely and resulted in a sharp decrease
in customer demand. As part of the cost reduction program, and
in anticipation of a continued decrease in customer demand in
2009, ASML started to reduce costs through a restructuring
program (without impacting key R&D projects) and recognized
impairment charges of EUR 20.8 million on property,
plant and equipment, inventory obsolescence charges of
EUR 94.6 million and restructuring costs of
EUR 22.4 million in the fourth quarter of 2008.
The actions taken in 2008 resulted in cost savings of more than
EUR 200 million in 2009 and approximately
EUR 30 million in 2008. The cost savings in 2009 and
2008 mainly related to efficiency improvements in our operations
and the use of our flexible business model, reducing the cost of
temporary employees, consultancy and other
out-of-pocket
expenses.
ASML ANNUAL REPORT 2009
19
In addition, cost savings in 2009 also included the effects of
the Labor Time Reduction Program. From January 5, 2009
until June 21, 2009, ASML participated in the Labor Time
Reduction Program, a Netherlands government program that helped
companies to reduce working hours for employees without
impacting their salaries. On average 1,033 employees
participated in this program which reduced our loss from
operations of approximately EUR 6 million.
Finally, the cost savings in 2009 included the effects from the
restructuring measures taken by ASML in the fourth quarter of
2008 which resulted in a decrease in employee expenses of a
EUR 6.5 million and a decrease in rental expenses of
EUR 2.7 million.
We expect approximately 75 percent of all these savings to
be sustainable during an economic upturn up to a sales level of
EUR 800 million per quarter. If the sales level
increases above EUR 800 million, cost levels are
expected to increase. The actual savings are in line with the
savings that the Company anticipated at the end of 2008. These
actions resulted in an approximately similar positive effect on
cash flows from operating activities.
The following table presents the key performance indicators used
by our Board of Management and senior management to measure
performance in our monthly operational review meetings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
|
|
|
2008
|
|
|
|
|
|
2009
|
|
|
|
(in millions, except market share and systems)
|
|
EUR
|
|
|
|
|
|
EUR
|
|
|
|
|
|
EUR
|
|
|
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market share (based on revenue)
|
|
|
65
|
%
|
|
|
|
|
|
|
65
|
%
|
|
|
|
|
|
|
68
|
%1
|
|
|
|
Net sales
|
|
|
3,768
|
|
|
|
|
|
|
|
2,954
|
|
|
|
|
|
|
|
1,596
|
|
|
|
|
Increase (decrease) in net sales
|
|
|
5.2
|
%
|
|
|
|
|
|
|
(21.6)
|
%
|
|
|
|
|
|
|
(46.0
|
)%
|
|
|
|
Net system sales
|
|
|
3,351
|
|
|
|
|
|
|
|
2,517
|
|
|
|
|
|
|
|
1,175
|
|
|
|
|
Sales of systems (in units)
|
|
|
260
|
|
|
|
|
|
|
|
151
|
|
|
|
|
|
|
|
70
|
|
|
|
|
Average selling price of system sales
|
|
|
12.9
|
|
|
|
|
|
|
|
16.7
|
|
|
|
|
|
|
|
16.8
|
|
|
|
|
Value of systems backlog
|
|
|
1,697
|
|
|
|
|
|
|
|
755
|
|
|
|
|
|
|
|
1,853
|
|
|
|
|
Systems backlog (in units)
|
|
|
89
|
|
|
|
|
|
|
|
41
|
|
|
|
|
|
|
|
69
|
|
|
|
|
Average selling price of systems backlog
|
|
|
19.1
|
|
|
|
|
|
|
|
18.4
|
|
|
|
|
|
|
|
26.8
|
2
|
|
|
|
Immersion systems shipped (in units)
|
|
|
38
|
|
|
|
|
|
|
|
56
|
|
|
|
|
|
|
|
36
|
|
|
|
|
Profitability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
1,550
|
|
|
|
41.1%
|
|
|
|
1,016
|
|
|
|
34.4%
|
|
|
|
458
|
|
|
|
28.7%
|
Income (loss) from operations
|
|
|
8153
|
|
|
|
21.6%
|
|
|
|
287
|
|
|
|
9.7%
|
|
|
|
(165
|
)
|
|
|
(10.3)%
|
Net income (loss)
|
|
|
6713
|
|
|
|
17.8%
|
|
|
|
322
|
|
|
|
10.9%
|
|
|
|
(151
|
)
|
|
|
(9.5)%
|
Liquidity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
1,272
|
|
|
|
|
|
|
|
1,109
|
|
|
|
|
|
|
|
1,037
|
|
|
|
|
Operating cash flow
|
|
|
701
|
|
|
|
|
|
|
|
281
|
|
|
|
|
|
|
|
98
|
|
|
|
|
|
|
|
1
|
According to the latest available
data up to and including November 2009 as reported by SEMI, an
independent semiconductor industry organization.
|
|
|
2
|
In 2009, the ASP of the systems
backlog for new systems amounts to EUR 28.9 million,
and the ASP of the systems backlog for used systems amounts to
EUR 9.0 million.
|
|
|
3
|
The 2007 figures for income from
operations and net income include a one-off charge of
EUR 23 million relating to the Brion acquisition for
amortization of in-process R&D.
|
Sales
Notwithstanding the depth of the financial and economic crisis
in 2009, we expect our longer term sales level to grow based on
industry analysts IC growth forecasts. Based on these forecasts,
our general strategy is to seek to grow net sales to a
EUR 5 billion level. The timing of growth to such
level depends on three growth drivers: market growth, market
share growth and a broadening of our product and services scope.
In 2009, net sales decreased by 46.0 percent to
EUR 1,596 million from EUR 2,954 million in
2008 (2007: EUR 3,768 million). The decrease in net
sales was caused by the collapse in semiconductor equipment
demand. In the first half of 2009, our customers implemented
inventory corrections, production capacity adjustments and
experienced a lack of capital. In the second half of 2009,
non-leading-edge production capacity additions were still
delayed. However, demand increased compared to the first half of
2009 as our customers invested in leading-edge immersion
technology, with DRAM customers introducing new memory devices
and Foundry customers beginning to ramp up 40 nm products.
The ASP of our systems increased by 0.6 percent to
EUR 16.8 million in 2009 from
EUR 16.7 million in 2008 (2007:
EUR 12.9 million). This slight increase was mainly
driven by an increased ASP of our leading-edge technology
systems due to shipment of our new NXT: 1950i systems, partly
offset by the increased number of used systems sold as a
percentage of the
ASML ANNUAL REPORT 2009
20
total number of systems sold (2009: 33 percent; 2008:
24 percent; 2007: 10 percent) reflecting our
customers response to the financial and economic crisis.
As of December 31, 2009, our systems backlog was valued at
EUR 1,853 million and included 69 systems with an ASP
of EUR 26.8 million. As of December 31, 2008, the
systems backlog was valued at EUR 755 million and
included 41 systems with an ASP of EUR 18.4 million.
The significantly increased value and number of systems backlog
reflects the accelerated technology investments by our customers
in the DRAM memory segments and technology and capacity
investments by our customers in the Foundry segments after a
period of very low capital investment. The increase in ASP of
our systems in the systems backlog mainly results from a
relatively low proportion of used systems compared to
December 31, 2008 and a high number of new immersion
systems.
During 2009, we shipped our first TWINSCAN NXT systems with
improved overlay and imaging compared to the TWINSCAN XT
immersion systems. The NXT platform enables next generations of
semiconductors through the so-called Double Patterning technique
which requires two exposures per layer on a chip. The systems
were shipped on explicit request of our customers, although
these TWINSCAN NXT systems did not meet all specifications. For
the remaining performance obligations a portion of the sales
price has been deferred. Management expects to resolve the
remaining performance obligation in the course of 2010.
Profitability
Our general strategy is to seek to achieve income from
operations to net sales of
10-15 percent
at the downturn point and
20-25 percent
at the upturn point over the industrys business cycle.
However in exceptional circumstances, as evidenced by the
financial and economic crisis, we could see periods with results
from operations that are substantially below our minimum target
level.
Income from operations decreased from EUR 287 million
or 9.7 percent of net sales in 2008 to a loss from
operations of EUR 165 million or 10.3 percent of
net sales in 2009 (2007: EUR 815 million income from
operations or 21.6 percent of net sales). This
EUR 452 million decrease was substantially the result
of a decrease in sales and the resulting decrease in gross
profit of EUR 557 million which was partially offset
by a decrease in operating expenses of EUR 105 million.
Gross profit decreased from EUR 1,015.5 million or
34.4 percent of net sales in 2008 to 458.4 million or
28.7 percent of net sales in 2009 (2007:
EUR 1,549.6 gross profit or 41.1 percent of net
sales). The lower gross profit was mainly attributable to a
significant decrease in net sales as a result of the collapse of
demand for semiconductor equipment caused by the financial and
economic crisis. 2009 gross margin was favorably impacted
by the absence of restructuring and impairment charges that were
included in 2008 gross margin and the profit on the sale of
inventories that had been previously written down. However, this
was more than offset by the increased portion of used systems
sold, with a lower margin, as a percentage of total systems sold
in 2009 compared to 2008 and underutilization of our production
facilities, mainly in the first half of 2009.
At the end of 2008, customers in the market segment for Logic
technology underestimated the
ramp-up of
45 nm technology used in, among others, advanced internet
devices and smart phones, which unexpectedly increased demand
for our non-leading-edge immersion systems in 2009 (mainly
XT:1700i). As a result we made EUR 64.8 million profit
on the sale of inventories that had been previously written down.
Operating expenses showed a decrease of
EUR 105 million in 2009 compared to 2008 due to a
decrease of SG&A costs by EUR 56 million, or
26.2 percent and a decrease of R&D costs net of
credits by EUR 49 million, or 9.6 percent. The
SG&A and R&D costs were reduced as part of our cost
reduction program. While we implemented some operational savings
in R&D, these did not impact our spending on any of our
strategic programs, in particular immersion, double patterning
and EUV, which we believe are necessary to maintain and further
develop our position as technology leader.
ASML has a flexible labor model with a mix of payroll and
temporary employees, which enables the Company to quickly adapt
its costs to the semiconductor market cycles.
Net loss in 2009 amounted to EUR 151 million or
9.5 percent of net sales, representing
EUR 0.35 net loss per ordinary share compared with net
income in 2008 of EUR 322 million or 10.9 percent
of net sales, representing EUR 0.75 net income per
ordinary share (2007: net income of EUR 671 million or
17.8 percent of net sales, representing
EUR 1.45 net income per ordinary share).
Liquidity
Our general strategy is to seek to maintain our strategic target
level of cash and cash equivalents between EUR 1.0 and
1.5 billion. To the extent that our cash and cash
equivalents exceeds this target and there are no investment
opportunities that we wish to pursue, we will return excess cash
to our shareholders.
ASML ANNUAL REPORT 2009
21
As of December 31, 2009 our cash and cash equivalents
amounted to EUR 1.0 billion.
Our cash and cash equivalents decreased from
EUR 1,109 million as of December 31, 2008 to
EUR 1,037 million as of December 31, 2009. We
generated cash from operations of EUR 98 million in
2009, which was offset by a cash outflow of
EUR 73 million from financing activities, reflecting
our 2009 dividend payment (EUR 86 million), and
EUR 98 million cash used in investing activities
mainly related to the completion of the first part of the EUV
and NXT production facilities in Veldhoven.
In addition to its existing EUR 500 million credit
facility, the Company signed a EUR 200 million loan
facility with the European Investment Bank in April 2009 to
support the Companys EUV investment efforts. This loan can
be drawn in tranches before October 2010. It is repayable in
annual installments after four years, with a final repayment
seven years after drawdown. No amounts were outstanding under
the EUR 500 million credit facility and the
EUR 200 million loan facility as of December 31,
2009.
ASML did not repurchase any shares in 2009. The
cumulative amount returned to shareholders in the form of share
buybacks and capital repayment between May 2006 and December
2009 was EUR 2,137 million. In April 2009, the Company
paid a dividend of EUR 0.20 per ordinary share of
EUR 0.09 or EUR 86 million in total.
A proposal will be submitted to the Annual General Meeting of
Shareholders on March 24, 2010 to declare a dividend for
2009 of EUR 0.20 per ordinary share of EUR 0.09.
A. Operating
Results
Critical
accounting policies using significant estimates
Our discussion and analysis of our financial condition and
results of operations are based upon our consolidated financial
statements, which have been prepared in accordance with
U.S. GAAP. The preparation of our financial statements
requires us to make estimates and judgments that affect the
reported amounts of assets, liabilities, net sales and expenses,
and related disclosure of contingent assets and liabilities. On
an ongoing basis, we evaluate our estimates, including those
related to revenue recognition, warranty, long-lived assets,
inventories, accounts receivable, provisions, contingencies and
litigation, share-based compensation expenses and income tax. We
base our estimates on historical experience and on various other
assumptions that we believe to be reasonable under the
circumstances. While we regularly evaluate our estimates and
assumptions, actual results may differ from these estimates if
these assumptions prove incorrect. To the extent there are
material differences between actual results and these estimates,
our future results of operations could be materially and
adversely affected. We believe that the accounting policies
described below require us to make significant judgments and
estimates in the preparation of our consolidated financial
statements.
Revenue
recognition
ASML recognizes revenue when all four revenue recognition
criteria are met: persuasive evidence of an arrangement exists;
delivery has occurred or services have been rendered;
sellers price to buyer is fixed or determinable; and
collectability is reasonably assured. At ASML, this policy
generally results in revenue recognition from the sale of a
system upon shipment. The revenue from the installation of a
system is generally recognized upon completion of that
installation at the customer site. Each system undergoes, prior
to shipment, a Factory Acceptance Test in
ASMLs cleanroom facilities, effectively replicating the
operating conditions that will be present on the customers
site, in order to verify whether the system will meet its
standard specifications and any additional technical and
performance criteria agreed with the customer, if any. A system
is shipped, and revenue is recognized, only after all
specifications are met and customer sign-off is received or
waived. In case not all specifications are met and the remaining
performance obligation is not essential to the functionality of
the system but is substantive rather than inconsequential or
perfunctory a portion of the sales price is deferred. Although
each systems performance is re-tested upon installation at
the customers site, ASML has never failed to successfully
complete installation of a system at a customers premises.
In connection with future introductions of new technology, we
may initially defer revenue recognition until completion of
installation and acceptance of the new technology at customer
premises. This deferral would continue until we are able to
conclude that installation of the technology in question would
occur consistently within a predetermined time period and that
the performance of the new technology would not reasonably be
different from that exhibited in the pre-shipment Factory
Acceptance Test. Any such deferral of revenues, however, could
have a material effect on ASMLs results of operations for
the fiscal period in which the deferral occurred and on the
succeeding fiscal period. At December 31, 2009 and 2008 we
had no deferred revenue from shipments of new technology. During
the three years ended December 31, 2009 no revenue from new
technology was recorded that had been previously deferred. As
our systems are based largely on two product platforms that
permit incremental, modular upgrades, the introduction of
genuinely new technology occurs infrequently, and in
the past ten years, has occurred on only one occasion in 1999.
ASML ANNUAL REPORT 2009
22
ASML has no significant repurchase commitments in its general
sales terms and conditions. From time to time the Company
repurchases systems that it has manufactured and sold and,
following refurbishment, resells those systems to other
customers. This repurchase decision is driven by market demand
expressed by other customers and not by explicit or implicit
contractual arrangements relating to the initial sale. The
Company considers reasonable offers from any vendor, including
customers, to repurchase used systems so that it can refurbish,
resell and install these systems as part of its normal business
operations. Once repurchased, the repurchase price of the used
system is recorded in
work-in-process
inventory during the period it is being refurbished, following
which the refurbished system is reflected in finished products
inventory until it is sold to the customer. As of
December 31, 2009 and 2008 ASML had no repurchase
commitments.
A portion of our revenue is derived from contractual
arrangements with our customers that have multiple deliverables,
such as installation and training services and prepaid extended
and enhanced (optic) warranty contracts. The revenue relating to
the undelivered elements of the arrangements is deferred at fair
value until delivery of these elements. The fair value is
determined by vendor specific objective evidence
(VSOE) except the fair value of the prepaid extended
and enhanced (optic) warranty contracts which is based on the
list price. VSOE is determined based upon the prices that we
charge for installation and comparable services (such as
relocating a system to another customer site) on a stand-alone
basis, which are subject to normal price negotiations. Revenue
from installation and training services is recognized when the
services are completed. Revenue from prepaid extended and
enhanced (optic) warranty contracts is recognized over the term
of the contract.
The deferred revenue balance from installation and training
services as of December 31, 2009 amounted to approximately
EUR 3 million (2008: EUR 3 million) and
EUR 10 million (2008: EUR 15 million),
respectively.
The deferred revenue balance from prepaid extended and enhanced
(optic) warranty contracts as of December 31, 2009 amounted
to approximately EUR 126 million (2008:
EUR 173 million).
We offer customers discounts in the normal course of sales
negotiations. These discounts are directly deducted from the
gross sales price at the moment of revenue recognition. From
time to time, we offer volume discounts to a limited number of
customers. In some instances these volume discounts can be used
to purchase field options (system enhancements). The related
amount is recorded as a reduction in revenue at time of
shipment. From time to time, we offer free or discounted
products or services (award credits) to our customers as part of
a volume purchase agreement. The sales transaction that gives
rise to these award credits is accounted for as a multiple
element revenue transaction as the agreements involve the
delivery of multiple products. The consideration received from
the sales transaction is allocated between the award credits and
the other elements of the sales transaction. The consideration
allocated to the award credits is recognized as deferred revenue
until award credits are delivered to the customer.
Revenues are recognized excluding the taxes levied on revenues
(net basis).
Warranty
We provide standard warranty coverage on our systems for
12 months and on certain optic parts for 60 months,
providing labor and parts necessary to repair systems and optic
parts during the warranty period. The estimated warranty costs
are accounted for by accruing these costs for each system upon
recognition of the system sale. The estimated warranty costs are
based on historical product performance and field expenses.
Based upon historical service records, we calculate the charge
of average service hours and parts per system to determine the
estimated warranty charge. On a semi-annual basis, the Company
assesses, and updates if necessary, its accounting estimates
used to calculate the standard warranty reserve based on the
latest actual historical warranty costs and expected future
warranty costs. The actual product performance
and/or field
expense profiles may differ, and in those cases we adjust our
warranty reserves accordingly. Future warranty costs may exceed
our estimates, which could lead to an increase in our cost of
sales. In 2009, the reassessments of the warranty reserve, and
resulting change in accounting estimate, did not have a material
effect. For 2008, the impact of the change in accounting
estimate on the consolidated statements of operations and
per-share amounts was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
2008
|
|
|
|
|
(in thousands, except per share data)
|
|
EUR
|
|
|
%
|
|
Income from operations
|
|
|
33,409
|
|
|
|
11.6%
|
|
Net income
|
|
|
24,890
|
|
|
|
7.7%
|
|
Basic net income per ordinary share
|
|
|
0.06
|
|
|
|
8.0%
|
|
Diluted net income per ordinary share
|
|
|
0.06
|
|
|
|
8.1%
|
|
|
Evaluation of
long-lived assets for impairment and costs associated with exit
or disposal activities
Long-lived assets include goodwill, other intangible assets and
property, plant and equipment.
ASML ANNUAL REPORT 2009
23
Goodwill is tested for impairment annually on September 30 and
whenever events or changes in circumstances indicate that the
carrying amount of the goodwill may not be recoverable. Goodwill
is tested for impairment based on a two-step approach for each
reporting unit in which goodwill has been recorded. First,
recoverability is tested by comparing the carrying amount of the
reporting unit including goodwill with the fair value of the
reporting unit, being the sum of the discounted future cash
flows. If the carrying amount of the reporting unit is higher
than the fair value of the reporting unit, the second step
should be performed. Goodwill impairment is measured as the
excess of the carrying amount of the goodwill over its implied
fair value. The implied fair value of goodwill is determined by
calculating the fair value of the various assets and liabilities
included in the reporting unit in the same manner as goodwill is
determined in a business combination.
All of ASMLs goodwill as of December 31, 2009 relates
to the acquisition of Brion in March 2007. For the purpose of
impairment testing, goodwill is allocated to the reporting unit
Brion. The fair value of the reporting unit Brion is calculated
based on the discounted cash flow method (income approach).
These calculations use after-tax discounted cash flow
projections based on a strategic plan approved by management.
The material assumptions used by management for the fair value
calculation of the reporting unit are:
|
|
|
Cash flow projections for the first six years are based on a
significant growth scenario, reflecting the
start-up
nature of Brion. Projections are built
bottom-up,
using estimates for revenue, gross profit, R&D costs and
SG&A costs.
|
|
Brion would reach maturity in the final year of this six year
start-up
period and grow at a weighted average growth rate of three
percent, which Management believes is a reasonable estimate that
does not exceed the long-term historical average growth rate for
the lithography business in which Brion operates.
|
|
A discount rate of 14.7 percent representing Brions
weighted average cost of capital (WACC), was determined using an
adjusted version of the Capital Asset Pricing Model. Since Brion
is not financed with debt, WACC was assumed to equal
Brions cost of equity. The discount rate increased
compared to the prior year reflecting the increased market
uncertainty.
|
Management believes that the fair value calculated reflects the
amount a market participant would be willing to pay. Based on
this analysis management believes that the fair value of the
reporting unit substantially exceeded its carrying value and
that, therefore, goodwill was not impaired as of
December 31, 2009 and December 31, 2008.
ASML performed sensitivity analyses on each of these assumptions
and concluded that any reasonably likely change in these
assumptions would not have caused the carrying amount of Brion
to exceed its fair value. A discussion of the sensitivity
analysis is set out below:
|
|
|
Estimated cash flows associated with Brions initial six
year
start-up
period accounted for approximately 35 percent of the
reporting units estimated fair value. These estimated cash
flows could be reduced by up to 52 percent without causing
the fair value of Brion to decrease below its carrying amount of
EUR 155.5 million. Management does not believe that
such a decline is reasonably likely based on historical evidence
of the reliability of the estimated cash flows and
managements future expectations on the development of
these cash flows.
|
|
Estimated cash flows associated with Brions operations
after the initial six year period accounted for approximately
65 percent of the reporting units estimated fair
value, based on the assumed three percent growth rate. Assuming
Managements estimate of cash flows for the initial six
year period is unchanged; growth in subsequent years could
reduce to zero percent without Brions estimated fair value
falling below its carrying amount of
EUR 155.5 million. Management does not believe,
however, that such a long-term no growth scenario is reasonably
likely, given that the long-term historical growth rate of the
lithography industry exceeds three percent.
|
|
The discount rate used in the fair value calculation could
increase from 14.7 percent to 19.2 percent without
causing the fair value of Brion to decrease below its carrying
amount. Management does not believe such an increase is
reasonably likely.
|
Other intangible assets and property, plant and equipment are
reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of those assets
may not be recoverable. Other intangible assets and property,
plant and equipment are tested for impairment based on a
two-step approach. First the recoverability is tested by
comparing the carrying amount of the other intangible assets and
property, plant and equipment with the fair value being the sum
of the undiscounted future cash flows. Secondly, if the carrying
amount of the other intangible assets and property, plant and
equipment is lower than the fair value the assets are considered
to be impaired. The impairment to be recognized is measured by
the amount by which the carrying amount of the assets exceeds
the fair value of the asset.
In determining the fair value of a reporting unit or an asset,
the Company makes estimates about future cash flows. These
estimates are based on the financial plan updated with the
latest available projection of the semiconductor market
conditions and our sales and cost expectations which are
consistent with the plans and estimates that we use to manage
our business. We also make estimates and assumptions concerning
Weighted Average Cost of Capital (WACC) and future inflation
rates.
ASML ANNUAL REPORT 2009
24
It is possible that the outcome of the plans, estimates and
assumptions used may differ from our estimates, which may
require impairment of certain long-lived assets, including
goodwill. Future adverse changes in market conditions may also
require impairment of certain long-lived assets, including
goodwill.
During 2009, we recorded impairment charges of
EUR 15.9 million in property, plant and equipment of
which we recorded EUR 2.1 million in cost of sales,
EUR 9.1 million in R&D costs and
EUR 4.7 million in SG&A costs. We did not record
any impairment charges in other intangible assets. The
impairment charges of EUR 15.9 million mainly relate
to certain non-leading-edge systems and machinery and equipment
that have ceased to be used or will cease to be used during the
expected economic life, and which management no longer believes
can be sold because of lack of demand for these products. The
impairment charges were determined based on the difference
between the assets estimated fair value (being
EUR 7.0 million) and their carrying amount.
Inventories
Inventories, including spare parts and lenses, are stated at the
lower of cost
(first-in,
first-out method) or market value. Costs include net prices paid
for materials purchased, charges for freight and customs duties,
production labor cost and factory overhead. Allowances are made
for slow moving, obsolete or unsellable inventory and are
reviewed on a quarterly basis. Our methodology involves matching
our on-hand and on-order inventory with our requirements based
on the manufacturing forecast. In determining inventory
allowances, we evaluate inventory in excess of our forecasted
needs on both technological and economical criteria and make
appropriate provisions to reflect the risk of obsolescence. This
methodology is significantly affected by our forecasted needs
for inventory. If actual requirements were to be lower than
estimated, additional inventory allowances for excess or
obsolete inventory may be required, which could have a material
adverse effect on our business, financial condition and results
of operations. At the end of 2008, customers in the market
segment for Logic technology underestimated the
ramp-up of
45 nm technology used in, among others, advanced internet
devices and smart phones, which unexpectedly increased demand
for our non-leading-edge immersion systems in 2009 (mainly
XT:1700i). As a result we made EUR 64.8 million profit
on the sale of inventories that had been previously written down.
As of December 31, 2009, the allowance for inventory
obsolescence amounted to EUR 225.3 million (2008:
EUR 189.9 million). The increase in the allowance for
inventory obsolescence is mainly due to a reassessment by the
Company in 2009 of expected future demand based on the
unexpected customers response to the financial and
economic crisis. This resulted in an increase in allowance for
inventory obsolescence for different types of non-leading-edge
systems compared to prior year and additional parts which
management believes cannot be sold.
Accounts
receivable
A majority of our accounts receivable are derived from sales to
a limited number of large multinational semiconductor
manufacturers throughout the world. In order to monitor
potential credit losses, we perform ongoing credit evaluations
of our customers financial condition. An allowance for
doubtful accounts is maintained for potential credit losses
based upon managements assessment of the expected
collectability of all accounts receivable. The allowance for
doubtful accounts is reviewed periodically to assess the
adequacy of the allowance. In making this assessment, management
takes into consideration (i) any circumstances of which we
are aware regarding a customers inability to meet its
financial obligations; and (ii) our judgments as to
potential prevailing economic conditions in the industry and
their potential impact on the Companys customers. Where we
deem it prudent to do so, we may require some form of credit
enhancement, such as letters of credit, down payments and
retention of ownership, before shipping systems to certain
customers. Retention of ownership enables ASML to recover the
systems in the event a customer defaults on payment. We have not
incurred any material accounts receivable credit losses during
the past three years. Our three largest customers (based on net
sales) accounted for 44.0 percent of accounts receivable at
December 31, 2009, compared to 42.2 percent at
December 31, 2008. A business failure of one of our main
customers could result in a substantial credit loss in respect
to amounts owed to the Company by that customer, which could
adversely affect our business, financial condition and results
of operations.
Provisions
Employee contract termination benefits are payable when
employment is terminated before the normal retirement date, or
whenever an employee accepts voluntary redundancy in exchange
for these benefits. ASML recognizes employee contract
termination benefits when ASML is demonstrably committed to
either terminating the employment of current employees according
to a detailed formal plan where there is no possibility of
withdrawal, or when ASML provides termination benefits as a
result of an offer made to encourage voluntary redundancy. The
timing of recognition and measurement of the provision for
employee contract termination benefits depends on whether
employees are required to render service until their employment
is terminated in order to receive the termination benefits. If
this period of continued employment extends beyond the minimum
retention period, the provision shall be determined at the
communication date based on the fair value as of the termination
date and is recognized ratably over the future service period.
As of December 31, 2009, the provision for contract
termination benefits was fully utilized.
ASML ANNUAL REPORT 2009
25
Provisions for lease contract termination costs are recognized
when costs will continue to be incurred under a contract for its
remaining term without economic benefit to the Company and the
Company ceases using the rights conveyed by the contract. The
provisions are measured at fair value which is determined based
on the remaining lease payments reduced by the estimated
sublease payment that could be reasonably obtained for the
building.
As of December 31, 2009, the provision for lease contract
termination costs amounts to EUR 15.2 million (2008:
EUR 17.9 million) and relates to an operating lease
contract for a building for which no economic benefits are
expected.
The restructuring in 2008 resulted in cost savings of
EUR 9.2 million in 2009, consisting of a
EUR 2.7 million decrease in rental expenses and
EUR 6.5 million decrease in employee expenses. The
actual savings are in line with the savings that the Company
anticipated at the end of 2008. These actions resulted in an
approximately similar positive effect on cash flows from
operating activities.
Contingencies and
litigation
We are party to various legal proceedings generally incidental
to our business, as disclosed in Note 17 to the
consolidated financial statements. In connection with these
proceedings and claims, management evaluated, based on the
relevant facts and legal principles, the likelihood of an
unfavorable outcome and whether the amount of the loss could be
reasonably estimated. In each case, management determined that
either a loss was not probable or was not reasonably estimable.
As a result, no estimated losses were recorded as a charge to
our consolidated statements of operations in 2007, 2008 and
2009. Significant subjective judgments were required in these
evaluations, including judgments regarding the validity of
asserted claims and the likely outcome of legal and
administrative proceedings. The outcome of these proceedings,
however, is subject to a number of factors beyond our control,
most notably the uncertainty associated with predicting
decisions by courts and administrative agencies. In addition,
estimates of the potential costs associated with legal and
administrative proceedings frequently cannot be subjected to any
sensitivity analysis, as damage estimates or settlement offers
by claimants may bear little or no relation to the eventual
outcome. Finally, in any particular proceeding, even where we
believe that we would ultimately prevail, we may agree to settle
or to terminate a claim or proceeding where we believe that
doing so, when taken together with other relevant commercial
considerations, is more cost-effective than engaging in
expensive and protracted litigation, the outcome of which is
uncertain.
We accrue legal costs related to litigation in our consolidated
statements of operations at the time when the related legal
services are actually provided to us.
Share-based
compensation expenses
The cost of employee services received (compensation expenses)
in exchange for awards of equity instruments are recognized
based upon the grant date fair value of stock options and stock.
The grant date fair value of stock options is estimated using a
Black-Scholes option valuation model. This Black-Scholes model
requires the use of assumptions, including expected stock price
volatility, the estimated life of each award and the estimated
dividend yield. The risk-free interest rate used in the model is
determined, based on a Euro government bond with a life equal to
the expected life of the equity-settled share-based payments.
The fair value of stock is determined based on the closing price
of the Companys ordinary shares on Euronext Amsterdam by
NYSE Euronext (Euronext Amsterdam) on the grant date.
The fair value determined at the grant date of the
equity-settled share-based payments is expensed on a
straight-line basis over the vesting period, based on the
Companys estimate of equity instruments that will
eventually vest. At each balance sheet date, the Company revises
its estimate of the number of equity instruments expected to
vest. The impact of the revision of the original estimates, if
any, is recognized in the consolidated statements of operations
in the period in which the revision is determined, with a
corresponding adjustment to equity.
We make quarterly assessments of the adequacy of the
(hypothetical) tax pool to determine whether there are tax
deficiencies that require recognition in the consolidated
statements of operations. We have selected the alternative
transition method (under Accounting Standards Codification
(ASC) 718) in order to calculate the tax pool.
Our current share-based payment plans do not provide for cash
settlement of options and stock.
Income
taxes
We operate in various tax jurisdictions in Europe, Asia and the
United States and must comply with the tax laws and regulations
of each of these jurisdictions.
We use the asset and liability method in accounting for income
taxes. Under this method, deferred tax assets and liabilities
are recognized for tax consequences attributable to differences
between the balance sheet carrying amounts of existing assets
and liabilities and their respective tax bases. Furthermore tax
assets are recognized for the tax effect of incurred net
operating losses.
ASML ANNUAL REPORT 2009
26
If it is more likely than not that the carrying amounts of
deferred tax assets will not be realized, a valuation allowance
is recorded to reduce the carrying amounts of those assets.
We continuously assess our ability to realize our deferred tax
assets resulting, among others, from net operating loss
carry-forwards. The total amount of tax effect of the loss
carry-forwards as of December 31, 2009 was
EUR 107.1 million, which resides with ASML Holding
N.V. and Netherlands based subsidiaries of ASML Holding NV and
ASML US, Inc. and US based subsidiaries of ASML US Inc. We
believe that all losses will be offset by future taxable income
before our ability to utilize those losses expires. This
analysis takes into account our projected future taxable income
from operations and possible tax planning alternatives available
to us.
On January 1, 2007 the Company adopted the provisions of
FIN 48 Accounting for Uncertainty in Income
Taxes after codification included in ASC 740. ASC 740
clarifies the accounting for income taxes, by prescribing a
minimum recognition threshold a tax position is required to
meet, before being recognized in the financial statements. ASC
740 also provides guidance on derecognition, measurement,
classification, interest and penalties, accounting in interim
periods and disclosure regarding income taxes.
Consistent with the provisions of ASC 740, we classified the
liability for unrecognized tax benefits as of December 31,
2009, amounting to EUR 133.3 million (2008:
EUR 124.2 million) as non-current liabilities because
at year end payment of cash was uncertain within one year. These
non-current income tax liabilities are recorded in deferred tax
and other tax liabilities in the consolidated balance sheets.
The total liability for unrecognized tax benefits, if reversed,
would have a favorable effect on the Companys effective
tax rate.
Expected interest and penalties related to income tax
liabilities have been accrued for and are included in the
liability for unrecognized tax benefits and in the provision for
income taxes. The balance of accrued interest and penalties
recorded in the consolidated balance sheets of December 31,
2009, amounted to EUR 28.5 million (2008:
EUR 23.6 million). The balance of accrued interest and
penalties recorded in the consolidated statements of operations
of 2009 amounted to EUR 4.9 million (2008:
EUR 2.1 million; 2007: EUR 21.5 million) and
are included under (provision for) benefit from income taxes.
A reconciliation of the beginning and ending balance of the
liability for unrecognized tax benefits is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
(in millions)
|
|
EUR
|
|
|
EUR
|
|
Balance, January 1
|
|
|
110.3
|
|
|
|
124.2
|
|
Gross increases tax positions in prior period
|
|
|
13.0
|
|
|
|
6.4
|
|
Gross decreases tax positions in prior period
|
|
|
(6.5
|
)
|
|
|
(1.8
|
)
|
Gross increases tax positions in current period
|
|
|
15.2
|
|
|
|
10.6
|
|
Settlements
|
|
|
(5.0
|
)
|
|
|
(4.3
|
)
|
Lapse of statute of limitations
|
|
|
(2.8
|
)
|
|
|
(1.8
|
)
|
|
|
|
|
|
|
|
|
|
Balance, December 31
|
|
|
124.2
|
|
|
|
133.3
|
|
|
For the year ended December 31, 2009, there were no
material changes compared to 2008 related to the liability for
unrecognized tax benefits that impacted the Companys
effective tax rate.
The Company estimates that the total liability of unrecognized
tax benefits will decrease by EUR 8.5 million within
the next 12 months. The estimated changes to the liability
for unrecognized tax benefits within the next 12 months are
mainly due to expected settlements and expiration of statute of
limitations.
In the course of 2008, we reached agreement in principle with
the Netherlands tax authorities on determination of the tax
benefits resulting from application of the so-called
Royalty Box, a Netherlands tax measure intended to
stimulate innovation. The Royalty Box mechanism partly exempts
income attributable to research efforts and protected by patents
from taxation, resulting in taxation of so called patent income
at an effective corporate income tax rate of 10 percent
instead of a nominal tax rate of 25.5 percent. This
agreement in principle covered the Royalty Box for the year 2007
and the years thereafter. However, the Royalty Box benefit
calculation technique includes a benefits threshold to be
surpassed before the effective tax rate on these benefits is
reduced to 10 percent. The threshold is required to be
exceeded each financial year, and when not exceeded - the
remainder of the threshold rolls over to future
years resulting in a cumulating threshold. In a loss year, the
threshold will not be exceeded. In addition, a loss for the year
itself will increase the threshold for future years. As 2008 and
2009 are loss years for the relevant Netherlands entities, the
threshold for the years 2008 and 2009 will roll over to 2010 and
beyond. For 2010 and future years, the Royalty Box has been
replaced under Netherlands law by the Innovation Box, and the
effective tax rate on Innovation Box income
ASML ANNUAL REPORT 2009
27
has been reduced from 10 percent to 5 percent. Based
on our calculations, a clean start of the Innovation Box (which
under Netherlands law replaces the Royalty Box as of
January 1, 2010) in 2010 will result in a higher
cumulative benefit for ASML. In the light of this analysis, in
2009, the Company has decided to forego the 2007 Royalty Box
benefit in lieu of a fresh start of the Innovation Box as per
2010. The reversal of the 2007 Royalty Box benefit has resulted
in a tax charge of approximately EUR 43 million
including interest, which has an unfavorable impact on the tax
rate during 2009 of approximately 25 percent.
Results of
Operations
The following discussion and analysis of results of operations
should be viewed in the context of the risks affecting our
business strategy, described in Item 3.D. Risk
Factors.
Set out below our consolidated statements of operations data for
the three years ended December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in millions)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Total net sales
|
|
|
3,768.2
|
|
|
|
2,953.7
|
|
|
|
1,596.1
|
|
Cost of sales
|
|
|
2,218.5
|
|
|
|
1,938.2
|
|
|
|
1,137.7
|
|
Gross profit on sales
|
|
|
1,549.7
|
|
|
|
1,015.5
|
|
|
|
458.4
|
|
Research and development
costs1
|
|
|
486.1
|
|
|
|
516.1
|
|
|
|
466.8
|
|
Amortization of in-process research and development costs
|
|
|
23.2
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative costs
|
|
|
225.7
|
|
|
|
212.3
|
|
|
|
156.6
|
|
Income (loss) from operations
|
|
|
814.7
|
|
|
|
287.1
|
|
|
|
(165.0
|
)
|
Interest income (expense), net
|
|
|
33.5
|
|
|
|
22.6
|
|
|
|
(6.5
|
)
|
Income (loss) from operations before income taxes
|
|
|
848.2
|
|
|
|
309.7
|
|
|
|
(171.5
|
)
|
(Provision for) benefit from income taxes
|
|
|
(177.2
|
)
|
|
|
12.7
|
|
|
|
20.6
|
|
Net income (loss)
|
|
|
671.0
|
|
|
|
322.4
|
|
|
|
(150.9
|
)
|
|
|
|
1
|
As of January 1, 2009,
R&D credits are presented as part of R&D costs. The
comparative figures for 2007 and 2008 have been adjusted
accordingly.
|
Set out below are our consolidated statements of operations from
operations data for the three years ended December 31,
2009, expressed as a percentage of our total net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
|
|
|
|
|
|
|
|
(as percentage of net sales)
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Total net sales
|
|
|
100.0
|
|
|
|
100.0
|
|
|
|
100.0
|
|
Cost of sales
|
|
|
58.9
|
|
|
|
65.6
|
|
|
|
71.3
|
|
Gross profit on sales
|
|
|
41.1
|
|
|
|
34.4
|
|
|
|
28.7
|
|
Research and development
costs1
|
|
|
12.9
|
|
|
|
17.5
|
|
|
|
29.2
|
|
Amortization of in-process research and development costs
|
|
|
0.6
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative costs
|
|
|
6.0
|
|
|
|
7.2
|
|
|
|
9.8
|
|
Income (loss) from operations
|
|
|
21.6
|
|
|
|
9.7
|
|
|
|
(10.3
|
)
|
Interest income (expense), net
|
|
|
0.9
|
|
|
|
0.8
|
|
|
|
(0.4
|
)
|
Income (loss) from operations before income taxes
|
|
|
22.5
|
|
|
|
10.5
|
|
|
|
(10.7
|
)
|
(Provision for) benefit from income taxes
|
|
|
(4.7
|
)
|
|
|
0.4
|
|
|
|
1.2
|
|
Net income (loss)
|
|
|
17.8
|
|
|
|
10.9
|
|
|
|
(9.5
|
)
|
|
|
|
1
|
As of January 1, 2009,
R&D credits are presented as part of R&D costs. The
comparative figures for 2007 and 2008 have been adjusted
accordingly.
|
ASML ANNUAL REPORT 2009
28
Results of
operations 2009 compared with 2008
Net sales and
gross profit
The following table shows a summary of sales (revenue and units
sold), gross profit on sales and ASP data on an annual and
semi-annual basis for the years ended December 31, 2008 and
2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
First
|
|
|
Second
|
|
|
Full
|
|
|
First
|
|
|
Second
|
|
|
Full
|
|
|
|
half year
|
|
|
half year
|
|
|
year
|
|
|
half year
|
|
|
half year
|
|
|
year
|
|
Net sales (EUR million)
|
|
|
1,763
|
|
|
|
1,191
|
|
|
|
2,954
|
|
|
|
460
|
|
|
|
1,136
|
|
|
|
1,596
|
|
Net system sales (EUR million)
|
|
|
1,546
|
|
|
|
971
|
|
|
|
2,517
|
|
|
|
284
|
|
|
|
891
|
|
|
|
1,175
|
|
Net service and field option sales (EUR million)
|
|
|
217
|
|
|
|
220
|
|
|
|
437
|
|
|
|
176
|
|
|
|
245
|
|
|
|
421
|
|
Total sales of systems (in units)
|
|
|
89
|
|
|
|
62
|
|
|
|
151
|
|
|
|
21
|
|
|
|
49
|
|
|
|
70
|
|
Total sales of new systems (in units)
|
|
|
74
|
|
|
|
41
|
|
|
|
115
|
|
|
|
11
|
|
|
|
36
|
|
|
|
47
|
|
Total sales of used systems (in units)
|
|
|
15
|
|
|
|
21
|
|
|
|
36
|
|
|
|
10
|
|
|
|
13
|
|
|
|
23
|
|
Gross profit as a percentage of net sales
|
|
|
40.3
|
|
|
|
25.6
|
|
|
|
34.4
|
|
|
|
10.2
|
|
|
|
36.2
|
|
|
|
28.7
|
|
ASP of system sales (EUR million)
|
|
|
17.4
|
|
|
|
15.7
|
|
|
|
16.7
|
|
|
|
13.5
|
|
|
|
18.2
|
|
|
|
16.8
|
|
ASP of new system sales (EUR million)
|
|
|
20.0
|
|
|
|
21.2
|
|
|
|
20.4
|
|
|
|
20.1
|
|
|
|
21.5
|
|
|
|
21.1
|
|
ASP of used system sales (EUR million)
|
|
|
4.6
|
|
|
|
4.9
|
|
|
|
4.8
|
|
|
|
6.3
|
|
|
|
9.1
|
|
|
|
7.9
|
|
|
Net sales decreased by EUR 1,358 million or
46.0 percent from EUR 2,954 million in 2008 to
EUR 1,596 million in 2009. The decrease in net sales
mainly relates to a decrease in net system sales of
EUR 1,342 million or 53.3 percent from
EUR 2,517 million in 2008 to
EUR 1,175 million in 2009 mainly attributable to a
lower number of systems shipped. Net service and field option
sales decreased from EUR 437 million in 2008 to
EUR 421 million in 2009.
The number of systems shipped decreased by 53.6 percent
from 151 systems in 2008 to 70 systems in 2009. The year 2009
was characterized by the financial and economic crisis which has
led to lower overall semiconductor end-demand. Against this
background, in the first half of 2009, our customers implemented
inventory corrections, production capacity adjustments and
experienced a lack of capital. In the second half of 2009,
non-leading-edge production capacity additions were still
delayed. However, demand increased compared to the first half of
2009 as our customers invested in leading-edge immersion
technology, with DRAM customers introducing new memory devices
and Foundry customers beginning to ramp up 40 nm products.
The ASP of our systems increased by 0.6 percent to
EUR 16.8 million in 2009 from
EUR 16.7 million in 2008. This slight increase was
mainly driven by an increased ASP of our leading-edge technology
systems sold due to shipment of our new TWINSCAN NXT systems,
partly offset by the increased number of used systems sold
compared to total number of systems sold (2009: 33 percent;
2008: 24 percent) reflecting our customers response
to the financial and economic crisis.
From time to time, ASML repurchases systems that it has
manufactured and sold and, following factory-rebuild or
refurbishment, resells those systems to other customers. This
repurchase decision is mainly driven by market demand for
capacity expressed by other customers and not by explicit or
implicit contractual arrangements relating to the initial sale.
The number of used systems sold in 2009 decreased to 23 from 36
in 2008. The ASP for used systems increased from
EUR 4.8 million in 2008 to EUR 7.9 million
in 2009, reflecting a further shift from our older PAS family to
our newer TWINSCAN family.
Through 2009, 18 of the top 20 chipmakers worldwide, in terms of
semiconductor capital expenditure, were our customers. In 2009,
sales to our largest customer accounted for
EUR 349 million, or 21.9 percent of our net
sales. In 2008, sales to our largest customer accounted for
EUR 754 million, or 25.5 percent of our net sales.
Gross profit decreased from EUR 1,016 million or
34.4 percent of net sales in 2008 to 458 million or
28.7 percent of net sales in 2009. The lower gross profit
was mainly attributable to a significant decrease in net sales
as a result of the collapse of demand for semiconductor
equipment caused by the financial and economic crisis.
2009 gross margin was favorably impacted by the absence of
restructuring and impairment charges that were included in
2008 gross margin and the profit on the sale of inventories
that had been previously written down. However, this was more
than offset by the increased portion of used systems sold, with
a lower margin, as a percentage of total systems sold in 2009
compared to 2008 and underutilization of our production
facilities, mainly in the first half of 2009.
We started 2009 with a systems backlog of 41 systems. In 2009,
we booked orders for 108 systems, received order cancellations
or push-outs beyond 12 months for 10 systems and recognized
sales for 70 systems. This resulted in a systems backlog of 69
systems as of December 31, 2009. The total value of our
systems backlog as of December 31, 2009 amounted to
ASML ANNUAL REPORT 2009
29
EUR 1,853 million with an ASP of
EUR 26.8 million, compared with a systems backlog of
EUR 755 million with an ASP of
EUR 18.4 million as of December 31, 2008.
The significantly increased value and number of systems backlog
reflects the accelerated technology investments by our customers
in the DRAM memory segments and technology and capacity
investments by our customers in the Foundry segments after a
period of very low capital investment. The increase in ASP of
our systems in the systems backlog mainly results from a
relatively low proportion of used systems compared to
December 31, 2008 and a high number of new immersion
systems included.
Research and
development costs
R&D costs (net of credits) decreased by
EUR 49 million or 9.6 percent from
EUR 516 million in 2008, or 17.5 percent of net
sales, to EUR 467 million in 2009, or
29.2 percent of net sales. This decrease reflects the
operational savings in R&D, and is limited because we
continued strategic investment in technology leadership in 2009
through investments in the development and enhancement of the
next generation
TWINSCANtm
systems based on immersion, double patterning and EUV.
Selling,
general and administrative costs
SG&A costs decreased by EUR 55.7 million or
26.2 percent from EUR 212.3 million in 2008, or
7.2 percent of net sales, to EUR 156.6 million in
2009, or 9.8 percent of net sales, as a result of our cost
savings program.
Interest
income (expense), net
Net interest decreased from EUR 23 million income in
2008 to EUR 7 million expense in 2009. Our interest
income relates to interest earned on our cash and cash
equivalents. In 2009 interest income decreased as a result of a
lower average cash balance and significant lower interest rates.
Interest income was more than offset by net interest expense on
our outstanding debt. While operating cash flows remained
positive, the average cash balance decreased mainly as a result
of the dividend paid in 2009 and cash used for capital
expenditures.
Income
taxes
The effective tax rate was 12.0 percent of loss before
taxes in 2009, compared to -4.1 percent of income before
taxes in 2008. In 2008, ASML recognized tax income of
approximately EUR 70 million or approximately
22 percent of net income attributable to three main items
on which it reached agreement with the Netherlands tax
authorities. These items were the treatment of taxable income
related to ASMLs patent portfolio (application of the
Royalty Box) in 2007, the valuation of intellectual
property rights acquired in the past against historical exchange
rates, and the treatment of taxable income related to a
temporarily depreciated investment in ASMLs United States
subsidiary, all of which had a favorable impact on the effective
tax rate for 2008. In 2009, ASML recognized tax expense
including interest of approximately EUR 43 million or
approximately 25 percent of loss before taxes attributable
to the reversal of the 2007 Royalty Box benefit, which had an
unfavorable impact on the effective tax rate for 2009. In 2009,
based on a tax law change effective January 1, 2010, ASML
decided to reverse the Royalty Box benefits of 2007 as
management expects that a clean start of the Innovation Box
(which under Netherlands law replaces the Royalty Box as of
January 1, 2010) in 2010 and beyond will result in a
higher cumulative benefit for ASML.
Results of
operations 2008 compared with 2007
Net sales and
gross profit
The following table shows a summary of sales (revenue and units
sold), gross profit on sales and ASP data on an annual and
semi-annual basis for the years ended December 31, 2007 and
2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
First
|
|
|
Second
|
|
|
Full
|
|
|
First
|
|
|
Second
|
|
|
Full
|
|
|
|
half year
|
|
|
half year
|
|
|
year
|
|
|
half year
|
|
|
half year
|
|
|
year
|
|
Net sales (EUR million)
|
|
|
1,879
|
|
|
|
1,889
|
|
|
|
3,768
|
|
|
|
1,763
|
|
|
|
1,191
|
|
|
|
2,954
|
|
Net system sales (EUR million)
|
|
|
1,673
|
|
|
|
1,678
|
|
|
|
3,351
|
|
|
|
1,546
|
|
|
|
971
|
|
|
|
2,517
|
|
Net service and field option sales (EUR million)
|
|
|
206
|
|
|
|
211
|
|
|
|
417
|
|
|
|
217
|
|
|
|
220
|
|
|
|
437
|
|
Total sales of systems (in units)
|
|
|
146
|
|
|
|
114
|
|
|
|
260
|
|
|
|
89
|
|
|
|
62
|
|
|
|
151
|
|
Total sales of new systems (in units)
|
|
|
131
|
|
|
|
104
|
|
|
|
235
|
|
|
|
74
|
|
|
|
41
|
|
|
|
115
|
|
Total sales of used systems (in units)
|
|
|
15
|
|
|
|
10
|
|
|
|
25
|
|
|
|
15
|
|
|
|
21
|
|
|
|
36
|
|
Gross profit as a percentage of net sales
|
|
|
41.3
|
|
|
|
41.0
|
|
|
|
41.1
|
|
|
|
40.3
|
|
|
|
25.6
|
|
|
|
34.4
|
|
ASP of system sales (EUR million)
|
|
|
11.5
|
|
|
|
14.7
|
|
|
|
12.9
|
|
|
|
17.4
|
|
|
|
15.7
|
|
|
|
16.7
|
|
ASP of new system sales (EUR million)
|
|
|
12.5
|
|
|
|
15.6
|
|
|
|
13.8
|
|
|
|
20.0
|
|
|
|
21.2
|
|
|
|
20.4
|
|
ASP of used system sales (EUR million)
|
|
|
2.8
|
|
|
|
5.5
|
|
|
|
3.9
|
|
|
|
4.6
|
|
|
|
4.9
|
|
|
|
4.8
|
|
|
ASML ANNUAL REPORT 2009
30
Net sales decreased by EUR 814 million or
21.6 percent from EUR 3,768 million in 2007 to
EUR 2,954 million in 2008. The decrease in net sales
mainly relates to a decrease in net system sales of
EUR 834 million, from EUR 3,351 million in
2007 to EUR 2,517 million in 2008 mainly attributable
to a lower number of systems shipped (-41.9 percent),
partly offset by an increased ASP (+29.5 percent). Net
service and field option sales increased from
EUR 417 million in 2007 to EUR 437 million
in 2008.
The number of systems shipped decreased by 41.9 percent
from 260 systems in 2007 to 151 systems in 2008. The year 2008
was characterized by significant overall economic uncertainty
fuelled by the financial and economic crisis. This led to lower
overall semiconductor end-demand. Against this background our
customers started to re-assess their strategic alliances and
their investments to match production capacity to end-demand,
resulting in a delay of non-leading-edge production capacity
additions. While lithography equipment buyers reduced standard
production capacity, their willingness to invest in leading-edge
immersion technology, however, remained strong as this
technology enables lithography equipment buyers to reduce their
costs aggressively.
The ASP of our systems increased by 29.5 percent from
EUR 12.9 million in 2007 to EUR 16.7 million
in 2008. This increase was mainly driven by a change in product
mix reflecting the continued shift in market demand to our
leading-edge technology systems (as customers continued their
ramp-up of
volume manufacturing with our leading-edge immersion systems for
45 nm Flash and 55 nm DRAM) with higher ASPs driven by the
shrink roadmaps of our customers.
From time to time, ASML repurchases systems that it has
manufactured and sold and, following factory-rebuild or
refurbishment, resells those systems to other customers. This
repurchase decision is mainly driven by market demand for
capacity expressed by other customers and not by explicit or
implicit contractual arrangements relating to the initial sale.
The number of used systems sold in 2008 increased to 36 from 25
in 2007, reflecting increased demand for older systems to
produce less complex ICs following the lower overall
semiconductor end-demand than anticipated. The ASP for used
systems increased from EUR 3.9 million in 2007 to
EUR 4.8 million in 2008, reflecting a further shift
from our older PAS 2500 towards our newer PAS 5500 family and
TWINSCAN family.
Through 2008, 17 of the top 20 chipmakers worldwide, in terms of
semiconductor capital expenditure, were our customers. In 2008,
sales to the largest customer accounted for
EUR 754 million, or 25.5 percent of our net
sales. In 2007, sales to the largest customer accounted for
EUR 818 million, or 21.7 percent of our net sales.
Gross profit decreased from EUR 1,550 million or
41.1 percent of net sales in 2007 to 1,016 million or
34.4 percent of net sales in 2008. Gross margin was
negatively impacted by restructuring and impairment charges
(-4.6 percent), by capacity losses consistent with lower
production levels (-4.3 percent) and by a changed product
mix (-0.8 percent) partly offset by increased ASPs
(1.7 percent) and decreased cost of goods
(1.9 percent) reflecting the results of our continuous
cost-of-goods
reduction programs.
We started 2008 with a systems backlog of 89 systems. In 2008,
we booked orders for 115 systems, received order cancellations
or push-outs beyond 12 months of 12 systems and recognized
sales for 151 systems. This resulted in a systems backlog of 41
systems as of December 31, 2008. The total value of our
systems backlog as of December 31, 2008 amounted to
EUR 755 million with an ASP of
EUR 18.4 million, compared with a systems backlog of
EUR 1,697 million with an ASP of
EUR 19.1 million as of December 31, 2007.
Research and
development costs
R&D costs (net of credits) increased by
EUR 30 million or 6.2 percent from
EUR 486 million in 2007 to EUR 516 million
in 2008. This increase reflects continued investment in
technology in 2008 through investments in the development of
enhancements of the next generation TWINSCAN systems based on
immersion, double patterning and EUV.
Amortization of in-process R&D costs of
EUR 23 million in 2007 relates to a one-off charge
related to the Brion acquisition.
Selling,
general and administrative costs
SG&A costs decreased by 5.9 percent from
EUR 226 million in 2007 to EUR 212 million
in 2008. In anticipation of the lower sales level we reduced
SG&A costs.
Net interest
income
Net interest income decreased from EUR 33 million in
2007 to EUR 23 million in 2008. Our interest income
relates to interest earned on our cash and cash equivalents. In
2008 interest income decreased mainly as a result of a lower
average cash balance and slightly lower interest rates. While
operating cash flows remained positive, the average cash balance
decreased mainly as a result of the share buyback programs
implemented in the fourth quarter of 2007 and in the first
quarter of 2008, the dividend paid in 2008 and cash used for
capital expenditures.
ASML ANNUAL REPORT 2009
31
Income
taxes
Income taxes represented -4.1 percent of income before
taxes in 2008, compared to 20.9 percent in 2007. The
decrease in income taxes in 2008 is mainly related to three main
items on which we reached agreement with the Netherlands tax
authorities. These items are the treatment of taxable income
related to ASMLs patent portfolio, the valuation of
intellectual property rights acquired in the past against
historical exchange rates, and the treatment of taxable income
related to a temporarily depreciated investment in ASMLs
United States subsidiary, all of which had a favorable impact on
the Companys effective tax rate. As a result of these
three items, ASML recognized exceptional tax income of
approximately EUR 70 million in 2008.
Foreign Exchange
Management
See Item 3.D. Risk Factors, Fluctuations in Foreign
Exchange Rates Could Harm Our Results of Operations,
Item 11 Quantitative and Qualitative Disclosures
About Market Risk and Note 3 to our consolidated
financial statements.
New U.S.
GAAP Accounting Pronouncements
In June 2009, the FASB issued ASC 105 Generally Accepted
Accounting Principles. ASC 105 establishes the FASB
Accounting Standards Codification (Codification) as the single
source of authoritative generally accepted accounting principles
recognized by the FASB to be applied by nongovernmental
entities. All of its content carries the same level of
authority, effectively superseding FASB Statement 162 and
modifying the GAAP hierarchy to include only two levels of GAAP:
authoritative and non-authoritative. The Codification is
effective for financial statements issued for interim and annual
periods ending after September 15, 2009. The adoption of
ASC 105 did not have any impact on our consolidated financial
statements, but resulted in the update of all references to
accounting guidance in this
Form 20-F
to refer to the new Codification.
In 2009 ASML has adopted ASC 820, Fair Value
Measurements. The ASC defines fair value, provides
guidance on how to measure assets and liabilities using fair
value and expands disclosures about fair value measurements. The
adoption of ASC 820 did not have any impact on our consolidated
statements of operations, but resulted in additional disclosures
to the Companys consolidated financial statements; see
Note 2, Fair Value Measurements for more
information.
In April 2009, the FASB issued ASC
820-10-65-4,
Determining Fair Value When the Volume and Level of
Activity for the Asset or Liability Have Significantly Decreased
and Identifying Transactions That Are Not Orderly. This
ASC provides guidelines for making fair value measurements more
consistent with the principles presented in ASC 820, Fair
Value Measurements. The ASC relates to determining fair
values when there is no active market or where the price inputs
being used represent distressed sales. It reaffirms the
objective of fair value measurement to reflect how
much an asset would be sold for in an orderly transaction (as
opposed to a distressed or forced transaction) at the date of
the financial statements under current market conditions.
Specifically, it reaffirms the need to use judgment to ascertain
if a formerly active market has become inactive and in
determining fair values when markets have become inactive. The
ASC is effective for financial statements issued for fiscal
years and interim periods beginning after June 15, 2009 and
should be applied prospectively. We are currently assessing the
impact that this ASC may have on the Companys consolidated
financial statements.
In June 2009, the FASB issued ASC 810 (Statement 167,
Amendments to FASB Interpretation No. 46(R)).
This ASC changes the way in which a company determines whether
or not an entity that is insufficiently capitalized or is not
controlled through voting (or similar rights) should be
consolidated. The determination of whether a company is required
to consolidate an entity is based on, among other things, an
entitys purpose and design and its ability to direct the
activities of the entity that most significantly impact the
entitys economic performance. This ASC is effective for
fiscal years and interim periods beginning after
November 15, 2009. We are currently assessing the impact
that this ASC may have on the Companys consolidated
financial statements.
In September 2009, the EITF reached final consensus on
Accounting Standards Update (ASU)
2009-13,
Revenue Arrangements with Multiple Deliverables. ASU
2009-13
amends the current guidance on arrangements with multiple
deliverables (ASC
605-25) to
(1) eliminate the separation criterion that requires
entities to establish objective and reliable evidence of fair
value for undelivered elements, (2) establish a selling
price hierarchy to help entities allocate arrangement
consideration to the separate units of account (i.e. separate
elements of the sales agreement), (3) require the relative
selling price allocation method for all arrangements (i.e.,
eliminate the residual method), and (4) significantly
expand required disclosures. The final consensus is effective
for financial years beginning after June 15, 2010. We are
currently assessing the impact that ASU
2009-13 will
have on the Companys consolidated financial statements.
In September 2009, the EITF reached final consensus on ASU
2009-14,
Certain Revenue Arrangements that include Software elements. ASU
2009-14
amends the scoping guidance for software arrangements (ASC
985-605) to
exclude tangible products that contain software elements and
non-software elements that function together to interdependently
deliver the products essential functionality. ASU
2009-14 also
provides considerations and examples for entities applying this
guidance.
ASML ANNUAL REPORT 2009
32
This issue will be effective prospectively for new or materially
modified agreements entered into in financial years beginning on
or after June 15, 2010. We are currently assessing the
impact that ASU
2009-14 will
have on the Companys consolidated financial statements.
B. Liquidity
and Capital Resources
ASML generated cash from operating activities of
EUR 701 million, EUR 281 million and
EUR 98 million in 2007, 2008 and 2009, respectively.
The primary components of cash provided by operating activities
in 2009 were cash inflows reflecting the net loss of
EUR 151 million which was more than offset by non-cash
expense items such as depreciation (EUR 140 million),
inventory obsolescence (EUR 87 million) and cash inflows as
a result of changes in assets and liabilities (EUR
36 million). The changes in assets and liabilities relate
to higher income taxes payable of EUR 71 million,
lower accounts receivable of EUR 98 million, lower
other assets of EUR 5 million, higher accounts payable
of EUR 10 million and higher accrued liabilities of
EUR 10 million, which are partly offset by higher
inventories of EUR 158 million.
ASML used EUR 98 million for investing activities in
2009 and EUR 260 million in 2008 (2007:
EUR 362 million). The majority of the 2009 and 2008
expenditures were attributable to the finalization of the first
part of the construction of the new production facilities in
Veldhoven. Further, the 2008 expenditures also included the
finalization of the construction of ACE. The 2007 expenditures
included EUR 188 million for the Brion acquisition.
Net cash used in financing activities was
EUR 73 million in 2009 compared to
EUR 184 million in 2008 (2007:
EUR 715 million). In 2009 net cash used in
financing activities included EUR 86 million as a
result of the dividend payment and EUR 11 million cash
inflow from the issuance of shares in connection with the
exercise and purchase of employee stock options. In 2008, cash
used by financing activities mainly included
EUR 108 million for our dividend payment,
EUR 88 million for share buyback programs and
EUR 11 million cash inflow from the issuance of shares
in connection with the exercise and purchase of employee stock
options. In 2007, cash used in financing activities included
EUR 1,372 for share buyback programs, partly offset by
EUR 594 million of net proceeds from the issuance in
June 2007 of a Eurobond.
ASMLs principal sources of liquidity consist of
EUR 1,037 million of cash and cash equivalents as of
December 31, 2009, EUR 700 million of available
credit facilities as of December 31, 2009 and expected
future cash-flows from operations.
The EUR 700 million of available credit facilities
consist of two separate facilities: a EUR 500 million
credit facility and a EUR 200 million loan facility.
The EUR 500 million credit facility contains a
restrictive covenant that the Company maintains a minimum
financial condition ratio, calculated in accordance with a
contractually agreed formula. ASML was in compliance with the
covenant as of December 31, 2009 and December 31,
2008. The EUR 200 million loan facility is related to
the Companys EUV investment efforts, and was entered into
in 2009 with the European Investment Bank. This loan can be
drawn in tranches until October 2010. It is repayable in annual
installments four years after drawdown, with final repayment
seven years after drawdown. This facility contains a covenant
that restricts the maximum indebtedness. ASML was in compliance
with the covenant as of December 31, 2009. ASML does not
expect any difficulty in continuing to meet these covenant
requirements. For further details of our credit facilities, see
Note 14 to our consolidated financial statements.
In addition to cash and available credit facilities, from time
to time we may raise additional capital in debt and equity
markets. Our liquidity needs are affected by many factors, some
of which are based on the normal ongoing operations of the
business, and others that relate to the uncertainties of the
global economy and the semiconductor industry. Although our cash
requirements fluctuate based on the timing and extent of these
factors, we believe that cash generated from operations,
together with the liquidity provided by existing cash balances,
are sufficient to satisfy our requirements in the foreseeable
future.
We expect that our capital expenditures (purchases of property,
plant and equipment) in 2010 could be approximately
EUR 100 million, in line with 2009 capital
expenditures. Capital expenditures in 2010 will mainly consist
of investments in capacity expansions. We expect to finance 2010
capital expenditures out of our cash flow from operations and
available cash and cash equivalents.
As general strategy we seek to maintain our strategic target
level of cash and cash equivalents between EUR 1.0 and
1.5 billion. To the extent that our cash and cash
equivalents exceed this target and there are no investments
opportunities that we wish to pursue, we will consider returning
excess cash to our shareholders, through share buybacks,
dividends or capital repayment.
We have repayment obligations in 2017, amounting to
EUR 600 million, on our 5.75 percent senior notes
due 2017. We currently intend to fund any future repayment
obligations primarily with cash on hand and cash generated
through operations. A description of our senior bond and lines
of credit is provided in Note 14 to our consolidated
financial statements.
See Notes 3 and 14 to our consolidated financial statements
for discussion of our funding, treasury policies and our
long-term debt.
ASML ANNUAL REPORT 2009
33
C. Research
and Development, Patents and Licenses, etc.
Research and
Development
See Item 4.B. Business Overview, Research and
Development and Item 5.A. Operating
Results.
Intellectual
Property Matters
See Item 3.D. Risk Factors, Defending Against
Intellectual Property Claims by Others Could Harm Our
Business and Item 4.B. Business Overview,
Intellectual Property.
D. Trend
Information
Despite the financial and economic crisis, which has led to
lower overall semiconductor end-demand, 2009 ended with improved
sales and strong bookings, as the semiconductor business
recovers, driven by technology buys from the DRAM memory market
segments and technology and capacity buys from major Foundry
customers.
The following table sets forth our systems backlog as of
December 31, 2008 and 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2008
|
|
|
2009
|
|
New systems backlog (in units)
|
|
|
33
|
|
|
|
62
|
|
Used systems backlog (in units)
|
|
|
8
|
|
|
|
7
|
|
Total systems backlog (in units)
|
|
|
41
|
|
|
|
69
|
|
Value of new systems backlog (EUR million)
|
|
|
719
|
|
|
|
1,790
|
|
Value of used systems backlog (EUR million)
|
|
|
36
|
|
|
|
63
|
|
Total value of systems backlog (EUR million)
|
|
|
755
|
|
|
|
1,853
|
|
ASP of new systems backlog (EUR million)
|
|
|
21.8
|
|
|
|
28.9
|
|
ASP of used systems backlog (EUR million)
|
|
|
4.5
|
|
|
|
9.0
|
|
ASP of total systems backlog (EUR million)
|
|
|
18.4
|
|
|
|
26.8
|
|
|
Our systems backlog includes only system orders for which
written authorizations have been accepted and shipment dates
within 12 months have been assigned. Historically, orders
have been subject to cancellation or delay by the customer. Due
to possible customer changes in delivery schedules and to
cancellation of orders, our systems backlog at any particular
date is not necessarily indicative of actual sales for any
succeeding period.
The significant increase in the total value of the systems
backlog reflects accelerated technology investments in the DRAM
memory and Foundry segments after a nine month period ended
June 28, 2009 of very low capital spending. This recovery
mainly supports new IC product introductions instead of an
overall significant wafer capacity increase. Of our backlog,
49 units are for new immersion systems, including 17
advanced NXT:1950i scanners.
We expect that shipments will continue to grow in the first half
of 2010, with the first quarter somewhat restricted, due to long
equipment industry production lead times and new product
introduction challenges, followed by a much higher second
quarter. ASML expects first quarter 2010 net sales of
approximately EUR 700 million, and gross margin of
approximately 40 percent. R&D expenditures are
expected to be approximately EUR 120 million net of
credits and SG&A costs are expected to be approximately
EUR 40 million.
As a result of our continued investments in R&D, we have
been able to ramp up our new mid- and top-range platforms,
respectively the XT:1950Hi and the NXT:1950i scanners. In
parallel, we are progressing with our next generation EUV
technology, as system integration and source performance
development confirms shipments of the first pre-production
systems in the second half of 2010.
We ended a challenging year, having generated cash from
operations, set up a more efficient cost structure and built a
strong product portfolio.
The trends discussed in this Item 5.D. Trend
information are subject to risks and uncertainties. See
Part I Special Note Regarding Forward
Looking Statements.
ASML ANNUAL REPORT 2009
34
E. Off-Balance
Sheet Arrangements
We have various contractual obligations, some of which are
required to be recorded as liabilities in our consolidated
financial statements, including long- and short-term debt. Other
contractual arrangements, namely operating lease commitments and
purchase obligations, are not generally required to be
recognized as liabilities on our consolidated balance sheets but
are required to be disclosed.
Variable interest
entities
In December 2003, the FASB issued ASC 810 Consolidation of
Variable Interest Entities. Under this ASC, an enterprise
must consolidate a variable interest entity if that enterprise
has a variable interest (or combination of variable interests)
that will either absorb a majority of the entitys expected
losses if they occur, or receive a majority of the entitys
expected residual returns if they occur.
In 2003, ASML moved to its current Veldhoven headquarters. We
lease these headquarters for a period of 15 years from an
entity (the lessor) that was incorporated by a
syndicate of three banks (shareholders) solely for
the purpose of leasing this building. The lessors
shareholders equity amounts to EUR 1.9 million. The
shareholders each granted a loan of EUR 11.6 million
and a fourth bank granted a loan of EUR 12.3 million
to the lessor. ASML provided the lessor with a subordinated loan
of EUR 5.4 million and has a purchase option that is
exercisable either at the end of the lease in 2018, at a
pre-determined price of EUR 24.5 million, or during
the lease at the book value of the assets. The total assets of
the lessor entity amounted to approximately
EUR 54 million at inception of the lease.
ASML believes that it holds a variable interest in this entity
and that the entity is a variable interest entity
(VIE) because it is subject to consolidation in
accordance with the provisions of paragraph 5 of ASC 810.
The total equity investment at risk is approximately
3.6 percent of the lessors total assets and is not
considered and cannot be demonstrated, qualitatively or
quantitatively, to be sufficient to permit the lessor to finance
its activities without additional subordinated financial support
provided by any parties, including the shareholders.
ASML has determined that it is not appropriate to consolidate
the VIE as it is not the primary beneficiary. To make this
determination, the expected losses and expected residual returns
of the lessor were allocated to each variable interest holder
based on their contractual right to absorb expected losses and
residual returns. The analysis of expected losses and expected
residual returns involved determining the expected negative and
positive variability in the fair value of the lessors net
assets exclusive of variable interests through various cash flow
scenarios based upon the expected market value of the
lessors net assets. Based on this analysis, ASML
determined that other variable interest holders will absorb the
majority of the lessors expected losses, and as a result,
ASML is not the primary beneficiary.
ASMLs maximum exposure to the lessors expected
losses is estimated to be approximately
EUR 5.4 million.
The resulting lease obligation is included in the line
Operational Lease Obligations in the table of
Item 5.F. Tabular Disclosure of Contractual
Obligations.
F. Tabular
Disclosure of Contractual Obligations
Our contractual obligations as of December 31, 2009 can be
summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than
|
|
|
|
|
|
|
|
|
After
|
|
Payments due by period
|
|
Total
|
|
|
1 year
|
|
|
1-3 years
|
|
|
3-5 years
|
|
|
5 years
|
|
(In thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Long Term Debt Obligations, including interest
expenses1
|
|
|
939,102
|
|
|
|
34,514
|
|
|
|
69,000
|
|
|
|
69,000
|
|
|
|
766,588
|
|
Operating Lease Obligations
|
|
|
130,374
|
|
|
|
33,077
|
|
|
|
43,150
|
|
|
|
27,912
|
|
|
|
26,235
|
|
Purchase Obligations
|
|
|
1,431,247
|
|
|
|
1,388,902
|
|
|
|
40,985
|
|
|
|
788
|
|
|
|
572
|
|
Unrecognized Tax Benefits
|
|
|
133,270
|
|
|
|
8,535
|
|
|
|
41,544
|
|
|
|
35,699
|
|
|
|
47,492
|
|
|
Total Contractual Obligations
|
|
|
2,633,993
|
|
|
|
1,465,028
|
|
|
|
194,679
|
|
|
|
133,399
|
|
|
|
840,887
|
|
|
|
|
1
|
See Note 14 to the
consolidated financial statements for the amounts excluding
interest expenses.
|
Long-term debt obligations relate to interest payments and the
redemption of the principal amount of the Eurobond. See
Note 14 to the consolidated financial statements.
ASML ANNUAL REPORT 2009
35
Operating lease obligations include leases of equipment and
facilities. Lease payments recognized as an expense were
EUR 46 million, EUR 43 million and
EUR 39 million for the years ended December 31,
2007, 2008 and 2009, respectively.
Several operating leases for our buildings contain purchase
options, exercisable at the option of the Company at the end of
the lease, and in some cases, during the term of the lease. The
amounts to be paid if ASML should exercise these purchase
options at the end of the lease can be summarized as of
December 31, 2009 as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase options
|
|
|
|
|
Less than
|
|
|
|
|
|
|
|
|
After
|
|
due by period
|
|
Total
|
|
|
1 year
|
|
|
1-3 years
|
|
|
3-5 years
|
|
|
5 years
|
|
(In thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Purchase options
|
|
|
55,736
|
|
|
|
|
|
|
|
8,250
|
|
|
|
8,999
|
|
|
|
38,487
|
|
|
Purchase obligations include purchase commitments with vendors
in the ordinary course of business. ASML expects that it will
honor these purchase obligations to fulfill future sales, in
line with the timing of those future sales. If not, the general
terms and conditions of the agreements relating to the major
part of the Companys purchase commitments as of
December 31, 2009 contain clauses that enable ASML to delay
or cancel delivery of ordered goods and services up to the dates
specified in the corresponding purchase contracts. These terms
and conditions that ASML has agreed with its supply chain
partners give ASML additional flexibility to adapt its purchase
obligations to its requirements in light of the inherent
cyclicality of the industry in which the Company operates. The
Company establishes a provision for cancellation fees when it is
probable that the liability has been incurred and the amount of
cancellation fees is reasonably estimable.
Unrecognized tax benefits relate to a liability for uncertain
tax positions. See Note 18 to the consolidated financial
statements.
G. Safe
Harbor
See Part I Special Note Regarding Forward-Looking
Statements.
Item 6
Directors, Senior Management and Employees
A. Directors and
Senior Management
The members of our Supervisory Board and our Board of Management
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Year of Birth
|
|
|
Term Expires
|
|
Arthur P.M. van der
Poel1,3,4
|
|
Chairman of the Supervisory Board
|
|
|
1948
|
|
|
|
2012
|
|
Jos W.B.
Westerburgen2,
3
|
|
Member of the Supervisory Board
|
|
|
1942
|
|
|
|
2011
|
|
Fritz W.
Fröhlich1
|
|
Member of the Supervisory Board
|
|
|
1942
|
|
|
|
2012
|
|
Ieke C.J. van den
Burg2
|
|
Member of the Supervisory Board
|
|
|
1952
|
|
|
|
2013
|
|
OB
Bilous3,4
|
|
Member of the Supervisory Board
|
|
|
1938
|
|
|
|
2012
|
|
William T.
Siegle4
|
|
Member of the Supervisory Board
|
|
|
1939
|
|
|
|
2011
|
|
Pauline F.M. van der Meer
Mohr2
|
|
Member of the Supervisory Board
|
|
|
1960
|
|
|
|
2013
|
|
Wolfgang H. Ziebart
1,4
|
|
Member of the Supervisory Board
|
|
|
1950
|
|
|
|
2013
|
|
Eric Meurice
|
|
President, Chief Executive Officer and Chairman of Management
|
|
|
1956
|
|
|
|
2012
|
|
Peter T.F.M. Wennink
|
|
Executive Vice President, Chief Financial Officer and Member of
the Board of Management
|
|
|
1957
|
|
|
|
N/A 5
|
|
Martin A. van den Brink
|
|
Executive Vice President, Chief Product and Technology Officer
and Member of the Board of Management
|
|
|
1957
|
|
|
|
N/A 5
|
|
Frits J. van Hout
|
|
Executive Vice President, Chief Marketing Officer and Member of
the Board of Management
|
|
|
1960
|
|
|
|
2013
|
|
Frederic
Schneider-Maunoury6
|
|
Executive Vice President, Chief Operating Officer and Member of
the Board of Management
|
|
|
1961
|
|
|
|
2014
|
|
|
|
|
1
|
Member of the Audit Committee.
|
2
|
Member of the Remuneration
Committee.
|
3
|
Member of the Selection and
Nomination Committee.
|
4
|
Member of the Technology and
Strategy Committee.
|
5
|
There are no specified terms for
members of the Board of Management appointed prior to March 2004.
|
6
|
Mr. Schneider-Maunourys
appointment to ASMLs Board of Management is subject to
notification of the General Meeting of Shareholders, scheduled
to be held on March 24, 2010.
|
ASML ANNUAL REPORT 2009
36
Effective March 26, 2009, Ms. Van den Burg,
Mr. Bilous, Mr. Jan A. Dekker and
Mr. Westerburgen retired by rotation from the Supervisory
Board and Ms. Van den Burg, Mr. Bilous and
Mr. Westerburgen were reappointed as members of the
Supervisory Board. Also effective March 26, 2009,
Ms. Van der Meer Mohr and Mr. Ziebart were appointed
as members of the Supervisory Board.
There are no family relationships among the members of our
Supervisory Board and Board of Management.
Since 2005, the Works Council of ASML Netherlands B.V. has an
enhanced right to make recommendations (which recommendation may
be rejected by the Supervisory Board in limited circumstances)
for nomination of one-third of the members of the Supervisory
Board. See Item 6.C. Board Practices, Supervisory
Board. At the 2005 General Meeting of Shareholders,
Ms. Van den Burg was appointed pursuant to this
recommendation right. At the 2009 General Meeting of
Shareholders, Ms. Van der Meer Mohr was appointed pursuant
to this recommendation right.
Director and
Officer Biographies
Arthur P.M.
van der Poel
Mr. Van der Poel was appointed to our Supervisory Board in
March 2004 and was appointed as Chairman in 2007. Until 2001 he
was the Chief Executive Officer of Philips Semiconductors.
Mr. Van der Poel is a former member of the Board of
Management (until April 2003) and a former member of the
Group Management Committee of Royal Philips Electronics.
Mr. Van der Poel is a member of the Board of Directors of
Gemalto Holding N.V. and serves as a member of the Supervisory
Boards of PSV N.V. and DHV Holding B.V.
Jos W.B.
Westerburgen
Mr. Westerburgen was appointed to our Supervisory Board in
March 2002. Mr. Westerburgen has extensive experience in
the field of corporate law and tax. Mr. Westerburgen is
former Company Secretary and Head of Tax of Unilever N.V. and
Plc. Mr. Westerburgen currently serves as a member of the
Supervisory Board of Unibail-Rodamco S.E. and is also
Vice-Chairman of the Board of the Association Aegon.
Fritz W.
Fröhlich
Mr. Fröhlich was appointed to our Supervisory Board in
March 2004. He is the former Deputy Chairman and Chief Financial
Officer of Akzo Nobel N.V. Mr. Fröhlich is the
Chairman of the Supervisory Boards of Randstad Holding N.V.,
Draka Holding N.V. and Altana A.G. and serves as a member of the
Supervisory Boards of Allianz Nederland N.V. and Rexel S.A.
Ieke C.J. van
den Burg
Ms. Van den Burg was appointed to our Supervisory Board in
March 2005. She is a former member of the Dutch Social and
Economic Council and of the EU Economic and Social Committee.
Ms. Van den Burg also held various positions in Dutch and
international trade union and labor organizations. Ms. Van
den Burg is a former member of the European Parliament
(EP) and served on the EPs Committee on
Economic and Monetary Affairs and on the Committee on Budget
Control. Ms. Van den Burg is a member of the Supervisory
Board of APG Group N.V. and serves as a member of the Dutch
Monitoring Committee Corporate Governance and member of the
Advisory Board of College Bescherming Persoonsgegevens (Dutch
Data Protection Authority).
OB
Bilous
Mr. Bilous was appointed to our Supervisory Board in March
2005. From 1960 until 2000 Mr. Bilous held various
management positions at IBM, including General Manager and VP
Worldwide Manufacturing of IBMs Microelectronics Division.
He also served on the Boards of SMST, ALTIS Semiconductor and
Dominion Semiconductor. Mr. Bilous currently serves as
Board member of Nantero, Inc.
William T.
Siegle
Mr. Siegle was appointed to our Supervisory Board in March
2007. From 1964 until 1990 Mr. Siegle held various
technical, management and executive positions at IBM, including
Director of the Advanced Technology Center. From 1990 until 2005
Mr. Siegle served as SVP and Chief Scientist at AMD,
responsible for the development of technology platforms and
manufacturing operations worldwide. He was also chairman of the
Board of Directors of SRC, member of the Board of Directors of
Sematech and Director of Etec, Inc. and DuPont Photomask, Inc.
Currently, Mr. Siegle is a member of the Advisory Board of
Acorn Technologies, Inc.
Pauline P.M.
van der Meer Mohr
Ms. Van der Meer Mohr was appointed to our Supervisory
Board in March 2009. As of January 1, 2010 Ms. Van der
Meer Mohr serves as President of the Executive Board of the
Erasmus University Rotterdam. Ms. van der Meer Mohr is the
founder of the Amstelbridge Group, a global network of human
capital professionals, of which she was managing partner until
December 31, 2009. Prior thereto, she was Senior Executive
Vice President at ABN AMRO Bank, Head of Group Human Resources
at TNT,
ASML ANNUAL REPORT 2009
37
and held several senior executive roles at the Royal/Dutch Shell
Group of Companies in various areas. Ms. Van der Meer Mohr
was a member of the Supervisory Boards of Océ Technologies
B.V. and the Amsterdam Medical Centre until December 31,
2009.
Wolfgang H.
Ziebart
Mr. Ziebart was appointed to our Supervisory Board in March
2009. Since December 2009 he is Chief Executive Officer of the
German specialty car manufacturer Artega Automobile GmbH&Co
KG. Until May 2008 he was President and CEO of Infineon
Technologies AG Before Infineon, Mr. Ziebart was on the
boards of management of car components manufacturer Continental
AG and automobile producer BMW AG. Mr. Ziebart is a member
of the Board of Autoliv, Inc. and of Nordex AG.
Eric
Meurice
Mr. Meurice joined ASML on October 1, 2004 as
President, Chief Executive Officer and Chairman of the Board of
Management. Prior to joining ASML, and since March 2001, he was
Executive Vice President Thomson Television
Worldwide. Between 1995 and 2001, Mr. Meurice served as
Vice President for Dell Computer, where he ran the Western,
Eastern Europe and Dells Emerging Markets business within
EMEA. Before 1995, he gained extensive technology experience in
the semiconductor industry at ITT Semiconductors Group and Intel
Corporation, in the micro-controller group. Mr. Meurice is
currently a member of the Board of Directors of Verigy Inc.
Peter T.F.M.
Wennink
Mr. Wennink joined ASML on January 1, 1999 and was
appointed as Executive Vice President, Chief Financial Officer
of ASML and member of our Board of Management on July 1,
1999. Mr. Wennink has an extensive background in finance
and accounting. Prior to his employment with ASML,
Mr. Wennink worked as a partner at Deloitte Accountants,
specializing in the high technology industry with an emphasis on
the semiconductor equipment industry. Mr. Wennink is a
member of the Netherlands Institute of Registered Accountants.
Mr. Wennink is currently a member of the Supervisory Board
of Bank Insinger de Beaufort N.V.
Martin A. van
den Brink
Mr. Van den Brink was appointed as member of our Board of
Management in 1999 and currently is ASMLs Executive Vice
President Products & Technology. Mr. Van den
Brink joined ASML when the company was founded in early 1984. He
held several positions in engineering and from 1995 he served as
Vice President Technology.
Frits J. van
Hout
Mr. Van Hout was appointed as Executive Vice President,
Chief Marketing Officer and Member of our Board of Management in
2009. In 2008, Mr. Van Hout was appointed Executive Vice
President Integral Efficiency. After rejoining ASML in 2001, he
served as Senior Vice President Customer Support and two
Business Units. Mr. Van Hout was previously an ASML
employee from its founding in 1984 to 1992, in various roles in
engineering and sales. From 1998 to 2001, Mr. Van Hout
served as Chief Executive Officer of the Beyeler Group, based in
the Netherlands and Germany.
Frederic
Schneider-Maunoury
Mr. Schneider-Maunoury joined ASML on December 1, 2009
and was appointed as Executive Vice President and Chief
Operating Officer. His appointment to ASMLs Board of
Management will be effective as per the notification of the
General Meeting of Shareholders, scheduled on March 24,
2010. Before joining ASML, Mr. Schneider-Maunoury served as
Vice President Thermal Products Manufacturing of the power
generation and rail transport equipment group Alstom.
Previously, he ran the worldwide Hydro Business of Alstom as
general manager. Before joining Alstom in 1996,
Mr. Schneider-Maunoury held various positions at the French
Ministry of Trade and Industry.
B.
Compensation
For details on Board of Management and Supervisory Board
remuneration as well as benefits upon termination, see
Note 20 to our consolidated financial statements.
ASML has not established in the past and does not intend to
establish in the future any stock option or purchase plans or
other equity compensation arrangements for members of our
Supervisory Board.
Bonus and
Profit-sharing plans
For details of employee bonus and profit-sharing plans, see
Note 16 to our consolidated financial statements.
Pension
plans
For details of employee pension plans, see Note 16 to our
consolidated financial statements.
ASML ANNUAL REPORT 2009
38
C. Board
Practices
General
We endorse the importance of good corporate governance, in which
independent oversight, accountability and transparency are the
most significant elements. Within the framework of corporate
governance, it is important that a relationship of trust exists
between the Board of Management, the Supervisory Board, our
employees and our shareholders.
We pursue a policy of active communication with our
shareholders. In addition to the exchange of ideas at the
General Meeting of Shareholders, other important forms of
communication include the publication of our annual and
quarterly financial results as well as press releases and
publications posted on our website.
Our corporate governance structure is intended to:
|
|
|
provide shareholders with regular, reliable, relevant and
transparent information regarding our activities, structure,
financial condition, performance and other information,
including information on our social, ethical and environmental
records and policies;
|
|
apply high quality standards for disclosure, accounting and
auditing; and
|
|
apply stringent rules with regard to insider securities trading.
|
Two-tier
structure
ASML is incorporated under Netherlands law and has a two-tier
board structure. Responsibility for the management of ASML lies
with the Board of Management. Independent, non-executive members
serve on the Supervisory Board, which supervises and advises the
members of the Board of Management in performing their
management tasks. The Board of Management has the duty to keep
the Supervisory Board informed, consult with the Supervisory
Board on important matters and submit certain important
decisions to the Supervisory Board for its approval. The
Supervisory Board is responsible for supervising, monitoring and
advising the Board of Management on: (i) the achievement of
ASMLs objectives, (ii) the corporate strategy and
management of risks inherent to ASMLs business activities,
(iii) the structure and operation of internal risk
management and control systems, (iv) the financial
reporting process and (v) compliance with applicable
legislation and regulations.
Supervisory Board members are prohibited from serving as
officers or employees of ASML, and members of the Board of
Management cannot serve on the Supervisory Board.
Board of
Management
The Board of Management consists of at least two members or such
larger number of members as determined by the Supervisory Board.
Members of the Board of Management are appointed by the
Supervisory Board. The Supervisory Board must notify the General
Meeting of Shareholders of the intended appointment of a member
of the Board of Management. As a result of our compliance with
the Netherlands Corporate Governance Code, members of the Board
of Management that are appointed in 2004 or later shall be
appointed for a maximum period of four years, but may be
re-appointed. Members of the Board of Management serve until the
end of the term of their appointment, voluntary retirement, or
suspension or dismissal by the Supervisory Board. In the case of
dismissal, the Supervisory Board must first inform the General
Meeting of Shareholders of the intended removal.
The Supervisory Board determines the remuneration of the
individual members of the Board of Management, in line with the
remuneration policy adopted by the General Meeting of
Shareholders, upon a proposal of the Supervisory Board.
ASMLs remuneration policy is posted on its website.
Supervisory
Board
The Supervisory Board consists of at least three members or such
larger number as determined by the Supervisory Board. The
Supervisory Board prepares a profile in relation to its size and
composition; ASMLs Supervisory Board profile is posted on
ASMLs website.
Members of the Supervisory Board are appointed by the General
Meeting of Shareholders from nominations of the Supervisory
Board. Nominations must be reasoned and must be made available
to the General Meeting of Shareholders and the Works Council
simultaneously. Before the Supervisory Board presents its
nominations, both the General Meeting of Shareholders and the
Works Council may make recommendations (which the Supervisory
Board may reject). In addition, the Works Council has an
enhanced right to make recommendations for nomination of at
least one-third of the members of the Supervisory Board, which
recommendation may only be rejected by the Supervisory Board:
(i) if the relevant person is unsuitable or (ii) if
the Supervisory Board would not be duly composed if the
recommended person were appointed as a Supervisory Board member.
If no agreement can be reached between the Supervisory Board and
the Works Council on these recommendations, the Supervisory
Board may request the Enterprise Chamber of the Amsterdam Court
to declare its objection legitimate. Any decision of the
Enterprise Chamber on this matter is non-appealable.
ASML ANNUAL REPORT 2009
39
Nominations of the Supervisory Board may be overruled by the
General Meeting of Shareholders by an absolute majority of the
votes representing at least one-third of the total outstanding
capital. If the votes cast in favor of such resolution do not
represent at least one-third of the total outstanding capital, a
new meeting can be convened at which the nomination can be
overruled by an absolute majority. If a nomination is overruled,
the Supervisory Board must make a new nomination. If a
nomination is not overruled and the General Meeting of
Shareholders does not appoint the nominated person, the
Supervisory Board will appoint the nominated person.
Members of the Supervisory Board serve for a maximum term of
four years from the date of their appointment, or a shorter
period as set out in the rotation schedule as adopted by the
Supervisory Board, and may be re-appointed, provided that their
entire term of office does not exceed twelve years. The General
Meeting of Shareholders may, with an absolute majority of the
votes representing at least one-third of the total outstanding
capital, dismiss the Supervisory Board in its entirety for lack
of confidence. In such event, the Enterprise Chamber of the
Amsterdam Court shall appoint one or more members of the
Supervisory Board at the request of the Board of Management.
Upon the proposal of the Supervisory Board, the General Meeting
of Shareholders determines the remuneration of the members of
the Supervisory Board. A member of the Supervisory Board shall
not be granted any shares or option rights by way of
remuneration.
Approval of
Board of Management Decisions
The Board of Management requires prior approval of the General
Meeting of Shareholders for resolutions concerning an important
change in the identity or character of ASML or its business,
including in any case:
|
|
|
a transfer of all or substantially all of the business of ASML
to a third party;
|
|
entering into or the termination of a long-term material joint
venture between ASML and a third party; and
|
|
an acquisition or divestment by ASML of an interest in the
capital of a company with a value of at least one-third of
ASMLs assets (determined by reference to ASMLs most
recently adopted annual accounts).
|
Rules of
Procedure
The Board of Management and the Supervisory Board have adopted
Rules of Procedure for each of the Board of Management,
Supervisory Board and the four Committees of the Supervisory
Board. These Rules of Procedure are posted on ASMLs
website.
Directors and
Officers Insurance and Indemnification
Members of the Board of Management and Supervisory Board, as
well as certain senior management members, are insured under
ASMLs Directors and Officers Insurance Policy. Although
the insurance policy provides for a wide coverage, our directors
and officers may incur uninsured liabilities. ASML has agreed to
indemnify its Board of Management and Supervisory Board against
any claims arising in connection with their position as director
and officer of the Company, provided that such claim is not
attributable to willful misconduct or intentional recklessness
of such officer or director.
Corporate
Governance Developments
ASML continuously monitors and assesses applicable corporate
governance rules, including recommendations and initiatives
regarding principles of corporate governance. These include
rules that have been promulgated in the United States both by
the NASDAQ Stock Market LLC (NASDAQ) and by the SEC
pursuant to the Sarbanes-Oxley Act of 2002.
The Netherlands Corporate Governance Code (the Code)
came into effect on January 1, 2004. A full report on
ASMLs compliance with the Code is required to be included
in the Companys statutory annual report. Netherlands
listed companies are required to either comply with the
principles and the best practice provisions of the Code, or to
explain on which points they deviate from these best practice
provisions and why. On December 10, 2008 the Netherlands
Corporate Governance Code Monitoring Committee presented an
amended Code to the groups that have requested the changes and
to the Ministers of Finance, Justice and Economic Affairs. The
amended Code is effective from the financial year starting on
January 1, 2009 and ASML will report on its compliance with
the amended Code in its statutory annual report for the year
ended December 31, 2009.
Pursuant to the Codes recommendations, ASML has included a
separate chapter on corporate governance in its statutory annual
report.
Committees of
ASMLs Supervisory Board
While retaining overall responsibility, the Supervisory Board
assigns certain of its tasks to its four committees: the Audit
Committee, the Remuneration Committee, the Selection and
Nomination Committee and the Technology and Strategy Committee.
Members of these committees are appointed from among the
Supervisory Board members.
ASML ANNUAL REPORT 2009
40
The chairman of each committee reports to the Supervisory Board
verbally and when deemed necessary in writing, the issues and
items discussed in each meeting. In addition, the minutes of
each committee are distributed to all members of the Supervisory
Board.
Audit
Committee
ASMLs Audit Committee is composed of three members of the
Supervisory Board. The current members of our Audit Committee
are Fritz Fröhlich (chairman), Arthur van der Poel and
Wolfgang Ziebart, each of whom is an independent, non-executive
member of our Supervisory Board. The Supervisory Board has
determined that Fritz Fröhlich qualifies as the Audit
Committee financial expert pursuant to Section 407 of the
Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder.
Our external auditor, our Chief Executive Officer, our Chief
Financial Officer, our Corporate Controller, our Chief
Accountant, our Director Internal Audit, as well as other ASML
employees invited by the chairman of the Audit Committee will
also attend the meetings of the Audit Committee.
The Audit Committee assists the Supervisory Board in:
|
|
|
overseeing the integrity of our financial statements and related
(non)financial disclosure;
|
|
overseeing the qualifications, independence and performance of
the external auditor; and
|
|
overseeing the integrity of our systems of disclosure controls
and procedures and the system of internal controls over
financial reporting.
|
In 2009, the Audit Committee met five times and held five
conference calls.
Remuneration
Committee
ASMLs Remuneration Committee is currently composed of
three members of the Supervisory Board. The current members of
our Remuneration Committee are Jos Westerburgen (chairman), Ieke
van den Burg and Pauline van der Meer Mohr. The Remuneration
Committee is responsible for the preparation of the remuneration
policy for the Board of Management.
The Remuneration Committee prepares and the Supervisory Board
establishes ASMLs general compensation philosophy for
members of the Board of Management, and oversees the development
and implementation of compensation programs for members of the
Board of Management. The Remuneration Committee reviews and
proposes to the Supervisory Board corporate goals and objectives
relevant to the compensation of members of the Board of
Management. The Committee further evaluates the performance of
members of the Board of Management in view of those goals and
objectives, and makes recommendations to the Supervisory Board
on the compensation levels of the members of the Board of
Management based on this evaluation.
In proposing to the Supervisory Board the actual remuneration
elements and levels applicable to the members of the Board of
Management, the Remuneration Committee considers, among other
factors, the remuneration policy, the desired levels of and
emphasis on particular aspects of ASMLs short and
long-term performance, as well as current compensation and
benefits structures and levels benchmarked against relevant
peers. External compensation survey data and, where necessary,
external consultants are used to benchmark ASMLs
remuneration levels and structures.
In 2009, the Remuneration Committee held six formal meetings and
several ad hoc meetings.
Selection and
Nomination Committee
ASMLs Selection and Nomination Committee is composed of
three members of the Supervisory Board. The current members of
our Selection and Nomination Committee are Jos Westerburgen
(chairman), Arthur van der Poel and OB Bilous.
The Selection and Nomination Committee assists the Supervisory
Board in:
|
|
|
preparing the selection criteria and appointment procedures for
members of the Companys Supervisory Board and Board of
Management;
|
|
periodically evaluating the scope and composition of the Board
of Management and the Supervisory Board, and proposing the
profile of the Supervisory Board in relation thereto;
|
|
periodically evaluating the functioning of the Board of
Management and the Supervisory Board and the individual members
of those boards and reporting the results thereof to the
Supervisory Board; and
|
|
proposing (re-)appointments of members of the Board of
Management and the Supervisory Board, and supervising the policy
of the Board of Management in relation to the selection and
appointment criteria for senior management.
|
The Selection and Nomination Committee held three scheduled
meetings and several ad hoc meetings in 2009.
Technology and
Strategy Committee
ASMLs Technology and Strategy Committee is composed of
four members of the Supervisory Board. The current members of
our Technology and Strategy Committee are William Siegle
(chairman), Arthur van der Poel, OB Bilous and Wolfgang Ziebart.
In
ASML ANNUAL REPORT 2009
41
addition, the Technology and Strategy Committee may appoint one
or more advisors from within the Company
and/or from
outside the Company. The advisors to the Technology and Strategy
Committee may be invited as guests to the meetings, or parts
thereof, of the Committee, but are not entitled to vote in the
meetings.
The Technology and Strategy Committee advises the Supervisory
Board in relation to the following responsibilities and may
prepare resolutions of the Supervisory Board related thereto:
|
|
|
familiarization with and risk assessment and study of potential
strategies, required technical resources, technology roadmaps
and product roadmaps; and
|
|
providing advice to the Supervisory Board with respect to
matters related thereto.
|
The Technology and Strategy Committee held three meetings in
2009.
Disclosure
Committee
ASML has a Disclosure Committee to ensure compliance with
applicable disclosure requirements arising under US and
Netherlands law and applicable stock exchange rules. The
Disclosure Committee is composed of various members of senior
management, and reports to the Chief Executive Officer and Chief
Financial Officer. The Disclosure Committee informs the Audit
Committee about the outcome of the Disclosure Committee
meetings. Furthermore, members of the Disclosure Committee are
in close contact with our external legal counsel and our
external auditor.
The Disclosure Committee gathers all relevant financial and
non-financial information and assesses materiality, timeliness
and necessity for disclosure of such information. In addition
the Disclosure Committee assists the Chief Executive Officer and
Chief Financial Officer in the maintenance and evaluation of
disclosure controls and procedures.
During 2009, the Disclosure Committee reviewed the quarterly
earnings announcements and the audited annual report including
the consolidated financial statements and other public
announcements containing financial information and advised the
Chief Executive Officer and Chief Financial Officer on the
assessment of ASMLs disclosure controls and procedures.
Variations from
Certain NASDAQ Corporate Governance Rules
NASDAQ rules provide that foreign private issuers may follow
home country practice in lieu of the NASDAQ corporate governance
standards subject to certain exceptions and except to the extent
that such exemptions would be contrary to US federal securities
laws. The practices followed by ASML in lieu of NASDAQ rules are
described below:
|
|
|
ASML does not follow NASDAQs quorum requirements
applicable to meetings of ordinary shareholders. In accordance
with Netherlands law and Netherlands generally accepted business
practice, ASMLs Articles of Association provide that there
are no quorum requirements generally applicable to General
Meetings of Shareholders.
|
|
ASML does not follow NASDAQs requirements regarding the
provision of proxy statements for General Meetings of
Shareholders. Netherlands law does not have a regulatory regime
for the solicitation of proxies: the solicitation of proxies is
not a generally accepted business practice in the Netherlands.
ASML does provide shareholders with an agenda and other relevant
documents for the General Meeting of Shareholders.
|
|
ASML does not follow NASDAQs requirement regarding
distribution to shareholders of copies of an annual report
containing audited financial statements prior to the
Companys Annual General Meeting of Shareholders. The
distribution of annual reports to shareholders is not required
under Netherlands corporate law or Netherlands securities laws,
or by Euronext Amsterdam. Furthermore, it is generally accepted
business practice for Netherlands companies not to distribute
annual reports. In part, this is because the Netherlands system
of bearer shares has made it impractical to keep a current list
of holders of the bearer shares in order to distribute the
annual reports. Instead, we make our annual report available at
our corporate head office in the Netherlands (and at the offices
of our Netherlands listing agent as stated in the convening
notice for the meeting) as from the day of convocation of the
Annual General Meeting of Shareholders. In addition, we post a
copy of our annual report on our website prior to the Annual
General Meeting of Shareholders.
|
NASDAQ rules require shareholder approval of stock option plans
available to officers, directors or employees. However, NASDAQ
has granted ASML an exemption from this requirement (foreign
private issuers are no longer required to obtain an exemption,
but may follow home country practice in lieu of NASDAQ corporate
governance rules, subject to exceptions).
ASML ANNUAL REPORT 2009
42
D.
Employees
The following table presents the total numbers of payroll
employees and temporary employees for the years ended
December 31, 2007, 2008 and 2009 (in FTEs) employed by
ASML, primarily in manufacturing, product development and
customer support activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
|
|
|
|
|
|
December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Payroll Employees
|
|
|
6,582
|
|
|
|
6,930
|
|
|
|
6,548
|
|
Temporary Employees
|
|
|
1,725
|
|
|
|
1,329
|
|
|
|
1,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
8,307
|
|
|
|
8,259
|
|
|
|
7,685
|
|
|
For a more detailed description of payroll employee information,
including a breakdown of our employees in FTEs by sector, see
Notes 16 and 21 to our consolidated financial statements,
which are incorporated herein by reference. We rely on our
ability to vary the number of temporary employees to respond to
fluctuating market demand for our products.
Our future success will depend on our ability to attract, train,
retain and motivate highly qualified, skilled and educated
employees, who are in great demand. We are particularly reliant
for our continued success on the services of several key
employees, including a number of systems development specialists
with advanced university qualifications in engineering, optics
and computing.
ASML Netherlands B.V., our operating subsidiary in the
Netherlands, has a Works Council, as required by Netherlands
law. A Works Council is a representative body of the employees
of a Netherlands company elected by the employees. The Board of
Management of any Netherlands company that runs an enterprise
with a Works Council must seek the non-binding advice of the
Works Council before taking certain decisions with respect to
the company, such as those related to a major restructuring, a
change of control, or the appointment or dismissal of a member
of the Board of Management. Other decisions directly involving
employment matters that apply either to all employees, or
certain groups of employees, may only be taken with the Works
Councils approval. Such a decision may be taken without
the prior approval of the Works Council only with the approval
of the District Court.
E. Share
Ownership
Information with respect to share ownership of members of our
Supervisory Board and Board of Management is included in
Item 7 Major Shareholders and Related Party
Transactions and Note 20 to our consolidated
financial statements, which are incorporated herein by
reference. Information with respect to the grant of shares and
stock options to employees is included in Note 16 to our
consolidated financial statements which are incorporated herein
by reference.
Item 7 Major
Shareholders and Related Party Transactions
A. Major
Shareholders
The following table sets forth the total number of ordinary
shares owned by each shareholder whose beneficial ownership of
ordinary shares exceeds 5 percent of the ordinary shares
issued and outstanding, as well as the ordinary shares
(including options) owned by the members of the Supervisory
Board and members of the Board of Management (which includes
those persons specified in Item 6 Directors, Senior
Management and Employees), as a group, as of
December 31, 2009. The information set out below is solely
based on public filings with the SEC and AFM (Autoriteit
Financiële Markten) on December 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Percent of
|
|
Identity of Person or Group
|
|
Owned
|
|
|
Class
|
|
FMR LLC1
|
|
|
65,359,636
|
|
|
|
15.1%
|
|
Capital World
Investors2
|
|
|
37,869,170
|
|
|
|
8.8%
|
|
PRIMECAP Management
Company3
|
|
|
25,198,365
|
|
|
|
5.8%
|
|
Members of ASMLs Supervisory Board and Board of
Management, as a group
(4 persons)4
|
|
|
1,579,616
|
|
|
|
*
|
|
|
|
|
1
|
Based solely on the
Schedule 13-G/A
filed by FMR LLC with the Commission on February 17, 2009.
|
2
|
Based solely on the
Schedule 13-G/A
filed by Capital World Investors with the Commission on
February 13, 2009.
|
3
|
Based solely on the
Schedule 13-G/A
filed by PRIMECAP Management Company with the Commission on
February 12, 2009.
|
4
|
For further information, please
refer to Note 20, Board of Management and Supervisory Board
Remuneration, of the consolidated financial statements.
|
ASML ANNUAL REPORT 2009
43
According to SEC filings, (i) FMR LLC decreased its
shareholding from 57,681,794 as of December 31, 2006 to
28,506,903 as of September 30, 2007, and to 6,429,585 as of
December 31, 2007 and increased its shareholding to
56,750,236 as of October 31, 2008, and to 65,359,636 as of
December 31, 2008, (ii) Capital World Investors held a
shareholding of 25,882,170 as of December 31, 2007, and
increased its shareholding to 37,869,170 as of December 31,
2008, (iii) PRIMECAP Management Company decreased its
shareholding from 26,144,000 as of February 28, 2007,
decreased its shareholding to 23,383,824 as of December 31,
2007, and increased its shareholding to 25,198,365 as of
December 31, 2008.
Our major shareholders do not have voting rights different from
other shareholders. We do not issue share certificates, except
for registered New York Shares. For more information see
Item 10.B. Memorandum and Articles of
Association.
As of December 31, 2009, 116.8 million ordinary shares
were held by 407 registered holders with a registered address in
the United States. Since certain of our ordinary shares were
held by brokers and nominees, the number of record holders in
the United States may not be representative of the number of
beneficial holders or of where the beneficial holders are
resident.
Obligations of
Shareholders to Disclose Holdings under Netherlands
Law
Holders of our shares may be subject to reporting obligations
under the Act on the supervision of financial markets (Wet op
het financieel toezicht, the Act).
The disclosure obligations under the Act apply to any person or
entity that acquires, holds or disposes of an interest in the
voting rights
and/or the
capital of a public limited company incorporated under the laws
of the Netherlands whose shares are admitted to trading on a
regulated market within the European Union, such as ASML.
Disclosure is required when the percentage of voting rights or
capital interest of a person or an entity reaches, exceeds or
falls below 5, 10, 15, 20, 25, 30, 40, 50, 60, 75 or
95 percent (as a result of an acquisition or disposal by
such person, or as a result of a change in our total number of
voting rights or capital issued). With respect to ASML, the Act
requires any person or entity whose interest in the voting
rights
and/or
capital of ASML reached, exceeded or fell below those percentage
interests to notify the Netherlands Authority for the Financial
Markets (AFM) immediately.
ASML is required to notify the AFM immediately if the
Companys voting rights
and/or
capital have changed by one percent or more since its previous
notification on outstanding voting rights and capital. In
addition, ASML must notify the AFM of changes of less than one
percent in ASMLs outstanding voting rights and capital at
least once per calendar quarter, within eight days after the end
of the quarter. Any person whose direct or indirect voting
rights
and/or
capital interest meets or passes the thresholds referred to in
the previous paragraph as a result of a change in the
outstanding voting rights or capital must notify the AFM no
later than the fourth trading day after the AFM has published
such a change.
Once every calendar year, within four weeks after the end of the
calendar year, holders of an interest of five percent or more in
ASMLs voting rights or capital must notify the AFM of any
changes in the composition of their interest resulting from
certain acts (including, but not limited to, the exchange of
shares for depositary receipts and vice versa, and the exercise
of rights to acquire shares).
Subsidiaries, as defined in the Act, do not have independent
reporting obligations under the Act, as interests held by them
are attributed to their (ultimate) parents. Any person may
qualify as a parent for purposes of the Act, including an
individual. A person who disposes of an interest of five percent
or more in ASMLs voting rights or capital and who ceases
to be a subsidiary must immediately notify the AFM. As of that
moment, all notification obligations under the Act become
applicable to the former subsidiary.
For the purpose of calculating the percentage of capital
interest or voting rights, the following interests must, among
other arrangements, be taken into account: shares and votes
(i) directly held by any person, (ii) held by such
persons subsidiaries, (iii) held by a third party for
such persons account, (iv) held by a third party with
whom such person has concluded an oral or written voting
agreement (including on the basis of an unrestricted power of
attorney) and (v) held by a third party with whom such
person has agreed to temporarily transfer voting rights against
payment. Interests held jointly by multiple persons are
attributed to those persons in accordance with their
entitlement. A holder of a pledge or right of usufruct in
respect of shares can also be subject to these reporting
obligations if such person has, or can acquire, the right to
vote on the shares or, in case of depositary receipts, the
underlying shares. The managers of certain investment funds are
deemed to hold the capital interests and voting rights in the
funds managed by them.
For the same purpose, the following instruments qualify as
shares: (i) shares, (ii) depositary
receipts for shares (or negotiable instruments similar to such
receipts), (iii) negotiable instruments for acquiring the
instruments under (i) or (ii) (such as convertible bonds),
and (iv) options for acquiring the instruments under
(i) or (ii).
The AFM keeps a public registry of and publishes all
notifications made pursuant to the Act.
ASML ANNUAL REPORT 2009
44
Non-compliance with the reporting obligations under the Act
could lead to criminal fines, administrative fines, imprisonment
or other sanctions. In addition, non-compliance with the
reporting obligations under the Act may lead to civil sanctions,
including (i) suspension of the voting rights relating to
the shares held by the offender, for a period of not more than
three years, (ii) nullification of any resolution of the
General Meeting of Shareholders of the Company to the extent
that such resolution would not have been approved if the votes
at the disposal of the person or entity in violation of a duty
under the Act had not been exercised and (iii) a
prohibition on the acquisition by the offender of our shares or
the voting on our ordinary shares for a period of not more than
five years.
B. Related Party
Transactions
There have been no transactions during our most recent fiscal
year, nor are there presently any proposed transactions, which
are material to ASML or any transactions that are unusual in
their nature or conditions, involving goods, services, or
tangible or intangible assets between ASML or any of its
subsidiaries and any significant shareholder and any director or
officer or any relative or spouse thereof. During our most
recent fiscal year, there has been no, and at present there is
no, outstanding indebtedness to ASML owed or owing by any
director or officer of ASML or any associate thereof, other than
the virtual financing arrangement with respect to stock options
described under Note 16 to our consolidated financial
statements.
C. Interests of
Experts & Counsel
Not applicable.
Item 8
Financial Information
A. Consolidated
Statements and Other Financial Information
Consolidated
Statements
See Item 18 Financial Statements.
Export
Sales
See Note 19 to our consolidated financial statements
included in Item 18 Financial Statements, which
is incorporated herein by reference.
Legal
Proceedings
See Item 4.B. Business Overview, Intellectual
Property and Note 17 to our consolidated financial
statements included in Item 18 Financial
Statements, which are incorporated herein by reference.
Dividend
Policy
Annually, the Supervisory Board, upon proposal of the Board of
Management, will assess the amount of dividend that will be
proposed to the Annual General Meeting of Shareholders. A
proposal will be submitted to the Annual General Meeting of
Shareholders on March 24, 2010 to declare a dividend for
2009 of EUR 0.20 per ordinary share of EUR 0.09.
For more information see Item 10.B. Memorandum and
Articles of Association and Item 10.D. Exchange
Controls and Note 25 to our consolidated financial
statements included in Item 18 Financial Statements,
which are incorporated herein by reference.
B. Significant
Changes
No significant changes have occurred since the date of our
consolidated financial statements. See Item 5.D.
Trend Information.
Item 9 The
Offer and Listing
A. Offer and
Listing Details
Our ordinary shares are listed for trading in the form of
registered shares on NASDAQ (New York shares) and in
the form of registered shares on Euronext Amsterdam
(Amsterdam Shares). The principal trading market of
our ordinary shares is Euronext Amsterdam. For more information
see Item 10.B. Memorandum and Articles of
Association.
New York shares are registered with J.P. Morgan Chase Bank,
N.A. (the New York Transfer Agent), 4 New York
Plaza, New York, New York, pursuant to the terms of a transfer,
registrar and dividend disbursing agreement (the Transfer
Agent Agreement) between the Company and the New York
Transfer Agent. Amsterdam shares are held in dematerialized form
through the facilities of Nederlands Centraal Instituut voor
Giraal Effectenverkeer B.V. (Euroclear Nederland),
the Netherlands centralised securities custody and
administration system. The New York Transfer Agent charges
shareholders a fee of USD 5.00 per 100 shares for the
exchange of New York shares for Amsterdam shares and vice versa.
ASML ANNUAL REPORT 2009
45
Dividends payable on New York shares are declared in euro and
converted by the Company to dollars at the rate of exchange on
Euronext Amsterdam at the close of business on the date
determined and announced by the Board of Management. The
resulting amounts are distributed through the New York Transfer
Agent and no charge is payable by holders of New York shares in
connection with this conversion or distribution.
Pursuant to the terms of the Transfer Agent Agreement, the
Company has agreed to reimburse the New York Transfer Agent for
certain out of pocket expenses, including in connection with any
mailing of notices, reports or other communications made
generally available by the Company to holders of ordinary shares
and the New York Transfer Agent has waived its fees associated
with routine services to the Company associated with the New
York shares. In addition, the New York Transfer Agent has agreed
to reimburse certain reasonable expenses incurred by the Company
in connection with the issuance and transfer of New York shares.
In the year ended December 31, 2009, the Transfer Agent
reimbursed USD 468,795 of expenses incurred by ASML, which
mainly comprised legal, audit and accounting fees incurred due
to the existence of the New York shares.
The following table sets forth, for the periods indicated, the
high and low closing prices of our ordinary shares on NASDAQ, as
well as on Euronext Amsterdam.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NASDAQ
|
|
|
Euronext Amsterdam
|
|
|
|
USD
|
|
|
EUR
|
|
|
|
High
|
|
|
Low
|
|
|
High
|
|
|
Low
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
20.13
|
|
|
|
14.44
|
|
|
|
17.12
|
|
|
|
11.11
|
|
2006
|
|
|
25.83
|
|
|
|
18.46
|
|
|
|
19.90
|
|
|
|
14.49
|
|
2007
|
|
|
35.79
|
|
|
|
22.89
|
|
|
|
24.99
|
|
|
|
17.15
|
|
2008
|
|
|
30.47
|
|
|
|
12.66
|
|
|
|
20.97
|
|
|
|
10.68
|
|
2009
|
|
|
34.67
|
|
|
|
14.28
|
|
|
|
24.24
|
|
|
|
11.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1st quarter 2008
|
|
|
30.47
|
|
|
|
22.23
|
|
|
|
20.97
|
|
|
|
13.92
|
|
2nd quarter 2008
|
|
|
30.30
|
|
|
|
23.98
|
|
|
|
19.59
|
|
|
|
15.19
|
|
3rd quarter 2008
|
|
|
25.20
|
|
|
|
16.29
|
|
|
|
16.81
|
|
|
|
11.72
|
|
4th quarter 2008
|
|
|
18.84
|
|
|
|
12.66
|
|
|
|
14.60
|
|
|
|
10.68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1st quarter 2009
|
|
|
18.58
|
|
|
|
14.28
|
|
|
|
14.20
|
|
|
|
11.35
|
|
2nd quarter 2009
|
|
|
22.12
|
|
|
|
17.77
|
|
|
|
16.22
|
|
|
|
13.42
|
|
3rd quarter 2009
|
|
|
30.31
|
|
|
|
21.21
|
|
|
|
20.55
|
|
|
|
15.11
|
|
4th quarter 2009
|
|
|
34.67
|
|
|
|
26.67
|
|
|
|
24.24
|
|
|
|
18.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Monthly Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 2009
|
|
|
26.01
|
|
|
|
21.21
|
|
|
|
18.37
|
|
|
|
15.11
|
|
August 2009
|
|
|
27.97
|
|
|
|
25.00
|
|
|
|
19.58
|
|
|
|
17.58
|
|
September 2009
|
|
|
30.31
|
|
|
|
26.33
|
|
|
|
20.55
|
|
|
|
18.43
|
|
October 2009
|
|
|
31.65
|
|
|
|
26.67
|
|
|
|
21.61
|
|
|
|
18.38
|
|
November 2009
|
|
|
32.02
|
|
|
|
27.16
|
|
|
|
21.40
|
|
|
|
18.51
|
|
December 2009
|
|
|
34.67
|
|
|
|
31.96
|
|
|
|
24.24
|
|
|
|
21.20
|
|
January (through Jan. 25) 2010
|
|
|
35.25
|
|
|
|
31.73
|
|
|
|
24.57
|
|
|
|
22.43
|
|
|
(Source: Bloomberg Finance LP)
B. Plan of
Distribution
Not applicable.
C.
Markets
See Item 9. A. Offer and listing Details.
D. Selling
Shareholders
Not applicable.
E.
Dilution
Not applicable.
F. Expenses of
the Issue
Not applicable.
ASML ANNUAL REPORT 2009
46
Item 10
Additional Information
A. Share
Capital
Not applicable.
B. Memorandum and
Articles of Association
The information required by Item 10.B. is incorporated by
reference in ASMLs Report on
Form 6-K,
filed with the Commission on November 2, 2007.
Current
Authorizations to Issue and Repurchase Ordinary Shares
Our Board of Management has the power to issue ordinary shares
and cumulative preference shares insofar as the Board of
Management has been authorized to do so by the General Meeting
of Shareholders (either by means of a resolution or by an
amendment to our Articles of Association). The Board of
Management requires approval of the Supervisory Board for such
an issue.
At our annual General Meeting of Shareholders, held on
March 26, 2009, the Board of Management was authorized for
a period of 18 months, subject to the approval of the
Supervisory Board, to issue shares
and/or
rights thereto representing up to a maximum of 5 percent of
our issued share capital as of the date of authorization, plus
an additional 5 percent of our issued share capital as of
the date of authorization that may be issued in connection with
mergers and acquisitions. At our annual General Meeting of
Shareholders to be held on March 24, 2010, our shareholders
will be asked to authorize the Board of Management (subject to
the approval of the Supervisory Board) to issue shares
and/or
rights thereto through September 24, 2011.
Holders of our ordinary shares have a preemptive right of
subscription, in proportion to the aggregate nominal amount of
the ordinary shares held by them, to any issuance of ordinary
shares for cash, which right may be restricted or excluded.
Ordinary shareholders have no pro rata preemptive right of
subscription to any ordinary shares issued for consideration
other than cash or ordinary shares issued to employees. If
authorized for this purpose by the General Meeting of
Shareholders (either by means of a resolution or by an amendment
to our Articles of Association), the Board of Management has the
power subject to approval of the Supervisory Board, to restrict
or exclude the preemptive rights of holders of ordinary shares.
At our annual General Meeting of Shareholders held on
March 26, 2009, the Board of Management was authorized,
subject to approval of the Supervisory Board, to restrict or
exclude preemptive rights of holders of ordinary shares. At our
annual General Meeting of Shareholders to be held on
March 24, 2010, our shareholders will be asked to grant
this authority through September 24, 2011. At this annual
General Meeting of Shareholders, the shareholders will be asked
to grant authority to the Board of Management to issue shares or
options separately. These authorizations will each be requested
to be granted for a period of 18 months.
We may repurchase our issued ordinary shares at any time,
subject to compliance with the requirements of Netherlands law
and our Articles of Association. Although Netherlands law
provides since June 11, 2008 that after such repurchases
the aggregate nominal value of the ordinary shares held by ASML
or a subsidiary must not be more than 50 percent of the
issued share capital, our current Articles of Association
provide that after such repurchases the aggregate nominal value
of the ordinary shares held by ASML or a subsidiary must not be
more than 10 percent of the issued share capital. Any such
purchases are subject to the approval of the Supervisory Board
and the authorization (whether by means of a resolution or by an
amendment to our Articles of Association) of shareholders at our
General Meeting of Shareholders, which authorization may not be
for more than 18 months. The Board of Management is
currently authorized, subject to Supervisory Board approval, to
repurchase through September 26, 2010 up to a maximum of
approximately 27 percent of the issued share capital as of
the date of authorization (March 26, 2009) at a price
between the nominal value of the ordinary shares purchased and
110 percent of the market price of these securities on
Euronext Amsterdam or NASDAQ. At our annual General Meeting of
Shareholders to be held on March 24, 2010, our shareholders
will be asked to extend this authority through
September 24, 2011.
C. Material
Contracts
Not applicable.
D. Exchange
Controls
There are currently no limitations, either under the laws of the
Netherlands or in the Articles of Association of ASML, to the
rights of non-residents to hold or vote ordinary shares. Cash
distributions, if any, payable in Euros on Amsterdam Shares may
be officially transferred by bank from the Netherlands and
converted into any other currency without being subject to any
Netherlands legal restrictions. However, for statistical
purposes, such payments and transactions must be reported by
ASML to the Netherlands Central Bank. Furthermore, no payments,
including dividend payments, may be made to jurisdictions
subject to certain sanctions, adopted by the government of the
Netherlands, implementing resolutions of the Security Council of
the United Nations. Cash distributions, if any, on New York
Shares shall be paid in U.S. dollars, converted at the rate
of exchange on Euronext Amsterdam at the close of business on
the date fixed for that purpose by the Board of Management in
accordance with the Articles of Association.
ASML ANNUAL REPORT 2009
47
E.
Taxation
Netherlands
Taxation
The statements below represent a summary of current Netherlands
tax laws, regulations and judicial interpretations thereof. The
description is limited to the material tax implications for a
holder of ordinary shares who is not, or is not deemed to be, a
resident of the Netherlands for Netherlands tax purposes (a
Non-resident Holder). This summary does not address
special rules that may apply to special classes of holders of
ordinary shares and should not be read as extending by
implication to matters not specifically referred to herein. As
to individual tax consequences, each investor in ordinary shares
should consult his or her tax counsel.
General
The acquisition of ordinary shares by a non-resident of the
Netherlands should not be treated as a taxable event for
Netherlands tax purposes. The income consequences in connection
with owning and disposing of our ordinary shares are discussed
below.
Substantial
Interest
A person that, directly or indirectly, owns five percent or more
of our share capital, or who is entitled to five percent of the
voting power in the shareholders meeting, or holds options to
purchase five percent or more of our share capital, is deemed to
have a substantial interest in our shares, respectively, our
options, as applicable. A deemed substantial interest also
exists if (part of) a substantial interest has been disposed of,
or is deemed to be disposed of, in a transaction where no
taxable gain has been recognized. Special attribution rules
exist in determining the presence of a substantial interest.
Income Tax
Consequences for Individual Non-resident Holders on Owning and
Disposing of the Ordinary Shares
An individual who is a Non-resident Holder will not be subject
to Netherlands income tax on received income in respect of our
ordinary shares or capital gains derived from the sale, exchange
or other disposition of our ordinary shares, provided that such
holder:
|
|
|
does not carry on and has not carried on a business in the
Netherlands through a permanent establishment or a permanent
representative to which the ordinary shares are attributable;
|
|
does not hold and has not held a (deemed) substantial interest
in our share capital or, in the event the Non-resident Holder
holds or has held a (deemed) substantial interest in our share
capital, such interest is, respectively was, a business asset in
the hands of the holder;
|
|
does not share and has not shared directly (through the
beneficial ownership of ordinary shares or similar securities)
in the profits of an enterprise managed and controlled in the
Netherlands which (is deemed to) own(s), respectively (is deemed
to have) has owned, our ordinary shares;
|
|
does not carry out and has not carried out any activities which
generate taxable profit or taxable wages to which the holding of
our ordinary shares was connected;
|
|
does not carry out and has not carried out employment activities
in the Netherlands, does not serve and has not served as a
director or board member of any entity resident in the
Netherlands, and does not serve and has not served as a civil
servant of a Netherlands public entity with which the holding of
our ordinary shares is or was connected; and
|
|
is not an individual that has elected to be taxed as a resident
of the Netherlands.
|
Corporate
Income Tax Consequences for Corporate Non-resident
Holders
Income derived from ordinary shares or capital gains derived
from the sale, exchange or disposition of ordinary shares by a
corporate Non-resident Holder is taxable if:
|
|
|
the holder carries on a business in the Netherlands through a
permanent establishment or a permanent agent in the Netherlands
(Netherlands enterprise) and the ordinary shares are
attributable to this permanent establishment or permanent agent,
unless the participation exemption (discussed below) applies; or
|
|
the holder has a substantial interest in our share capital,
which is not attributable to his enterprise; or
|
|
certain assets of the holder are deemed to be treated as a
Netherlands enterprise under Netherlands tax law and the
ordinary shares are attributable to this Netherlands enterprise.
|
To qualify for the Netherlands participation exemption, the
holder must generally hold at least five percent of our nominal
paid-in capital and meet certain other requirements.
Dividend
Withholding Tax
In general, a dividend distributed by us in respect of our
ordinary shares will be subject to a withholding tax imposed by
the Netherlands at the statutory rate of 15 percent.
Dividends include:
|
|
|
dividends in cash and in kind;
|
|
deemed and constructive dividends;
|
ASML ANNUAL REPORT 2009
48
|
|
|
consideration for the repurchase or redemption of ordinary
shares (including a purchase by a direct or indirect ASML
subsidiary) in excess of qualifying average paid-in capital
unless such repurchase is made for temporary investment purposes
or is exempt by law;
|
|
stock dividends up to their nominal value (unless distributed
out of qualifying paid-in capital);
|
|
any (partial) repayment of paid-in capital not qualifying as
capital for Netherlands dividend withholding tax purposes; and
|
|
liquidation proceeds in excess of qualifying average paid-in
capital for Netherlands dividend withholding tax purposes.
|
A reduction of Netherlands dividend withholding tax can be
obtained if:
|
|
|
the participation exemption applies and the ordinary shares are
attributable to a business carried out in the Netherlands;
|
|
the dividends are distributed to a qualifying EU corporate
holder satisfying the conditions of the EU Parent-Subsidiary
Directive; or
|
|
the rate is reduced by a Tax Treaty.
|
A Non-resident Holder of ordinary shares can be eligible for a
partial or complete exemption or refund of all or a portion of
the above withholding tax under a Tax Treaty that is in effect
between the Netherlands and the Non-resident Holders
country of residence. The Netherlands has concluded such
treaties with the United States, Canada, Switzerland, Japan,
most European Union member states, as well as many other
countries. Under the Treaty between the United States and the
Netherlands for the Avoidance of Double Taxation and the
Prevention of Fiscal Evasion with Respect to Taxes on Income
(the Tax Treaty), dividends paid by us to a
Non-resident Holder that is a resident of the United States as
defined in the Tax Treaty (other than an exempt organization or
exempt pension trust, as discussed below) are generally liable
to 15 percent Netherlands withholding tax or, in the case
of certain United States corporate shareholders owning at least
10 percent of our voting power, a reduction to five
percent, provided that it does not have an enterprise or an
interest in an enterprise that is, in whole or in part, carried
on through a permanent establishment or permanent representative
in the Netherlands to which the dividends are attributable. The
Tax Treaty provides for a complete exemption from tax on
dividends received by exempt pension trusts and exempt
organizations, as defined therein. Except in the case of exempt
organizations, the reduced dividend withholding tax rate (or
exemption from withholding) can be applied at the source upon
payment of the dividends, provided that the proper forms have
been filed in advance of the payment. Exempt organizations
remain subject to the statutory withholding rate of
15 percent and are required to file for a refund of such
withholding.
A Non-resident Holder may not claim the benefits of the Tax
Treaty unless (i) it is a resident of the United States as
defined therein, or (ii) it is deemed to be a resident on
the basis of the provisions of article 24(4) of the Tax
Treaty, and (iii) its entitlement to those benefits is not
limited by the provisions of article 26 (limitation on
benefits) of the Tax Treaty.
In this respect it is noted that the United States and the
Netherlands have agreed on a protocol to the Tax Treaty. It
provides for (among others) a 0 percent dividend
withholding tax rate on dividends, provided certain requirements
are met. One of these requirements is that the shareholder is a
company which directly owns shares representing 80 percent
of the voting power in our company. In addition, above mentioned
article 26 (limitation on benefits) has been adjusted. Some
requirements to the various tests mentioned in article 26
will become more severe and others will be moderated.
Dividend
Stripping Rules
Under Netherlands tax legislation regarding anti-dividend
stripping, no exemption from, or refund of, Netherlands dividend
withholding tax is granted if the recipient of dividends paid by
us is not considered the beneficial owner of such dividends.
Gift or
Inheritance Taxes
Netherlands gift or inheritance taxes will not be levied on the
transfer of ordinary shares by way of gift, or upon the death of
a Non-resident Holder, unless:
(1) the transfer is construed as an inheritance or as a
gift made by or on behalf of a person who, at the time of the
gift or death, is deemed to be, resident of the Netherlands; or
(2) the ordinary shares are attributable to an enterprise
or part thereof that is carried on through a permanent
establishment or a permanent representative in the Netherlands.
For purposes of Netherlands gift and inheritance tax, an
individual of Netherlands nationality is deemed to be a resident
of the Netherlands if he has been a resident thereof at any time
during the ten years preceding the time of the gift or death.
For purposes of Netherlands gift tax, a person not possessing
Netherlands nationality is deemed to be a resident of the
Netherlands if he has resided therein at any time in the twelve
months preceding the gift.
Value Added
Tax
No Netherlands value added tax is imposed on dividends in
respect of our ordinary shares or on the transfer of our shares.
ASML ANNUAL REPORT 2009
49
Residence
A Non-resident Holder will not become resident, or be deemed to
be resident, in the Netherlands solely as a result of holding
our ordinary shares or of the execution, performance, delivery
and/or
enforcement of rights in respect of our ordinary shares.
United States
Taxation
The following is a discussion of the material United States
federal income tax consequences relating to the acquisition,
ownership and disposition of ordinary shares by a United States
Holder acting in the capacity of a beneficial owner (as defined
below) who is not a tax resident of the Netherlands. This
discussion deals only with ordinary shares held as capital
assets and does not deal with the tax consequences applicable to
all categories of investors, some of which (such as tax-exempt
entities, financial institutions, regulated investment
companies, dealers in securities/traders in securities that
elect a
mark-to-market
method of accounting for securities holdings, insurance
companies, investors owning directly, indirectly or
constructively 10 percent or more of our outstanding voting
shares, investors who hold ordinary shares as part of hedging or
conversion transactions and investors whose functional currency
is not the U.S. dollar) may be subject to special rules. In
addition, the discussion does not address any alternative
minimum tax or any state, local, FIRPTA related United States
federal income tax consequences, or
non-United
States tax consequences.
This discussion is based on the
U.S.-Netherlands
Income Tax Treaty (Treaty) and the Internal Revenue
Code of 1986, as amended to the date hereof, final, temporary
and proposed Treasury Department regulations promulgated, and
administrative and judicial interpretations thereof, changes to
any of which subsequent to the date hereof, possibly with
retroactive effect, may affect the tax consequences described
herein. In addition, there can be no assurance that the Internal
Revenue Service (IRS) will not challenge one or more
of the tax consequences described herein, and we have not
obtained, nor do we intend to obtain, a ruling from the IRS or
an opinion of counsel with respect to the United States federal
income tax consequences of acquiring or holding shares.
Prospective purchasers of ordinary shares are advised to consult
their tax advisers with respect to their particular
circumstances and with respect to the effects of United States
federal, state, local or
non-United
States tax laws to which they may be subject.
As used herein, the term United States Holder means
a beneficial owner of ordinary shares that for United States
federal income tax purposes whose holding of ordinary shares
does not form part of the business property or assets of a
permanent establishment or fixed base in the Netherlands; who is
fully entitled to the benefits of the Treaty in respect of such
ordinary shares; and is:
|
|
|
an individual citizen or tax resident of the United States;
|
|
a corporation or other entity treated as a corporation for
United States federal income tax purposes created or organized
in or under the laws of the United States or of any political
subdivision thereof;
|
|
an estate of which the income is subject to United States
federal income taxation regardless of its source; or
|
|
a trust whose administration is subject to the primary
supervision of a court within the United States and which has
one or more United States persons who have the authority to
control all of its substantial decisions.
|
If an entity treated as a partnership for United States federal
income tax purposes owns ordinary shares, the United States
federal income tax treatment of a partner in such partnership
will generally depend upon the status and tax residency of the
partner and the activities of the partnership. A partnership
that owns ordinary shares and the partners in such partnership
should consult their tax advisors about the United States
federal income tax consequences of holding and disposing of the
ordinary shares.
Taxation of
Dividends
ASML believes it was not a Passive Foreign Investment Company
(PFIC) for U.S. federal income tax purposes in
2008 and that it will not be a PFIC in 2009. However, as PFIC
status is a factual matter that must be determined annually at
the close of each taxable year, there can be no certainty as to
our actual PFIC status in any particular year until the close of
the taxable year in question. ASML has not conducted a detailed
study at this time to confirm its non-PFIC status.
United States Holders should generally include in gross income
as foreign-source dividend income the gross amount of any
non-liquidating distribution (before reduction for Netherlands
withholding taxes) ASML makes out of its current or accumulated
earnings and profits (as determined for United States federal
income tax purposes) when the distribution is actually or
constructively received by the United States Holder.
Distributions will not be eligible for the dividends-received
deduction generally allowed to United States corporations in
respect of dividends received from other United States
corporations. The amount of the dividend distribution includible
in income of a United States Holder should be the
U.S. dollar value of the foreign currency (e.g. Euros)
paid, determined by the spot rate of exchange on the date of the
distribution, regardless of whether the payment is in fact
converted into U.S. dollars. Distributions in excess of
current and accumulated earnings and profits, as determined for
United States federal income tax purposes, will be treated as a
non-taxable return of capital to the extent of the United States
Holders U.S. tax basis in the ordinary shares and
thereafter as taxable capital gain. ASML presently does not
maintain calculations of its earnings and profits under United
States federal income tax principles. If ASML does not report to
a United States Holder the
ASML ANNUAL REPORT 2009
50
portion of a distribution that exceeds earnings and profits, the
distribution will generally be taxable as a dividend even if
that distribution would otherwise be treated as a non-taxable
return of capital or as capital gain under the rules described
above.
Subject to limitations provided in the United States Internal
Revenue Code, a United States Holder may generally deduct from
its United States federal taxable income, or credit against its
United States federal income tax liability, the amount of
qualified Netherlands withholding taxes. However, Netherlands
withholding tax may be credited only if the United States Holder
does not claim a deduction for any Netherlands or other
non-United
States taxes paid or accrued in that year. In addition,
Netherlands dividend withholding taxes will likely not be
creditable against the United States Holders United States
tax liability to the extent ASML is not required to pay over the
amount withheld to the Netherlands Tax Administration.
Currently, a Netherlands corporation that receives dividends
from qualifying
non-Netherlands
subsidiaries may credit source country tax withheld from those
dividends against Netherlands withholding tax imposed on a
dividend paid by a Netherlands corporation, up to a maximum of
three percent of the dividend paid by the Netherlands
corporation. The credit reduces the amount of dividend
withholding that ASML is required to pay to the Netherlands Tax
Administration but does not reduce the amount of tax ASML is
required to withhold from dividends.
For U.S. foreign tax credit purposes, dividends paid by
ASML generally will be treated as foreign-source income and as
passive category income (or in the case of certain
holders, as general category income). Gains or
losses realized by a United States Holder on the sale or
exchange of ordinary shares generally will be treated as
U.S.-source
gain or loss. The rules governing foreign tax credit are complex
and we suggest each United States Holder to consult its own tax
advisor to determine whether, and to what extent, a foreign tax
credit will be available.
Dividends received by a United States Holder will generally be
taxed at ordinary income tax rates. However, the Jobs and Growth
Tax Reconciliation Act of 2003,(the 2003 Tax Act)
and subsequently the Tax Increase and Prevention Act of 2006
reduces to 15 percent the maximum tax rate for certain
dividends received by individuals through taxable years
beginning on or before December 31, 2010, so long as the
stock has been held for more than 60 days during the
120 day period beginning 60 days before the
ex-dividend date. Dividends received from qualified
foreign corporations generally qualify for the reduced
rate. A
non-United
States corporation (other than a foreign personal holding
company, foreign investment company, or passive foreign
investment company) generally will be considered to be a
qualified foreign corporation if (i) the shares of the
non-United
States corporation are readily tradable on an established
securities market in the United States or (ii) the
non-United
States corporation is eligible with respect to substantially all
of its income for the benefits of a comprehensive income tax
treaty with the United States which contains an exchange of
information program and the Tax Treaty has been identified as a
qualifying treaty. Individual United States Holders should
consult their tax advisors regarding the impact of the
provisions of the 2003 Tax Act on their particular situations.
Dividends paid by ASML generally will constitute portfolio
income for purposes of the limitations on the use of
passive activity losses (and, therefore, generally may not be
offset by passive activity losses) and as investment
income for purposes of the limitation on the deduction of
investment interest expense.
Taxation on Sale
or Other Disposition of Ordinary Shares
Upon a sale or other disposition of ordinary shares, a United
States Holder will generally recognize capital gain or loss for
United States federal income tax purposes in an amount equal to
the difference between the amount realized, if paid in
U.S. dollars, or the U.S. dollar value of the amount
realized (determined at the spot rate on the settlement date of
the sale) if proceeds are paid in currency other than the
U.S. dollar, as the case may be, and the United States
Holders U.S. tax basis (determined in
U.S. dollars) in such ordinary shares. Generally, the
capital gain or loss will be long-term capital gain or loss if
the holding period of the United States Holder in the ordinary
shares exceeds one year at the time of the sale or other
disposition. The deductibility of capital losses is subject to
limitations for United States federal income tax purposes. Gain
or loss from the sale or other disposition of ordinary shares
generally will be treated as United States source income or loss
for United States foreign tax credit purposes. Generally, any
gain or loss resulting from currency fluctuations during the
period between the date of the sale of the ordinary shares and
the date the sale proceeds are converted into U.S. dollars
will be treated as ordinary income or loss from sources within
the United States. Each United States Holder should consult its
tax advisor with regard to the translation rules of its adjusted
U.S. tax basis and the amount realized upon a sale or other
disposition of its ordinary shares if purchased in, or sold or
disposed of for, a currency other than U.S. dollar.
Information
Reporting and Backup Withholding
Information returns may be filed with the IRS in connection with
payments on the ordinary shares or proceeds from a sale,
redemption or other disposition of the ordinary shares. A
backup withholding tax may apply to these payments
if the beneficial owner fails to provide a correct taxpayer
identification number to the paying agent and to comply with
certain certification procedures or otherwise establish an
exemption from backup withholding. Any amounts withheld under
the backup withholding rules might be refunded (or credited
against the beneficial owners United States federal income
tax liability, if any) depending on the facts and provided that
the required information is furnished to the IRS.
ASML ANNUAL REPORT 2009
51
The discussion set out above is included for general information
only and may not be applicable depending upon a holders
particular situation. Holders should consult their tax advisors
with respect to the tax consequences to them of the purchase,
ownership and disposition of shares including the tax
consequences under state, local and other tax laws and the
possible effects of changes in United States federal and other
tax laws.
F. Dividends and
Paying Agents
Not applicable.
G. Statement by
Experts
Not applicable.
H. Documents on
Display
We are subject to certain reporting requirements of the US
Securities Exchange Act of 1934 (the Exchange Act).
As a foreign private issuer, we are exempt from the
rules under the Exchange Act prescribing certain disclosure and
procedural requirements for proxy solicitations, and our
officers, directors and principal shareholders are exempt from
the reporting and short-swing profit recovery
provisions contained in Section 16 of the Exchange Act,
with respect to their purchases and sales of shares. In
addition, we are not required to file reports and financial
statements with the Commission as frequently or as promptly as
companies that are not foreign private issuers whose securities
are registered under the Exchange Act. However, we are required
to file with the Commission, within six months after the end of
each fiscal year, an annual report on
Form 20-F
containing financial statements audited by an independent
accounting firm and interactive data comprising financial
statements in extensible business reporting language within
30 days of filing our annual report on
Form 20-F.
We publish unaudited interim financial information after the end
of each quarter. We furnish this quarterly financial information
to the Commission under cover of a
Form 6-K.
Documents we file with the Commission are publicly available at
its public reference facilities at 450 Fifth Street, N.W.,
Washington, DC 20549, Woolworth Building, 233 Broadway, New
York, New York 10048 and Citicorp Center, 500 West Madison
Street, Suite 1400, Chicago, Illinois
60661-2511.
Copies of the documents are available at prescribed rates by
writing to the Public Reference Section of the Commission at
450 Fifth Street, N.W., Washington DC 20549. The Commission
also maintains a website that contains reports and other
information regarding registrants that are required to file
electronically with the Commission. The address of this website
is
http://www.sec.gov.
Please call the Commission at
1-800-SEC-0330
for further information on the operation of the public reference
facilities.
I. Subsidiary
Information
See Item 4.C. Organizational Structure.
Item 11
Quantitative and Qualitative Disclosures About Market
Risk
ASML is exposed to a variety of financial risks: market risks
(including foreign currency exchange risk and interest rate
risk), credit risk, liquidity risk and capital risk. The overall
risk management program focuses on the unpredictability of
financial markets and seeks to minimize potentially adverse
effects on the Companys financial performance. The Company
uses derivative instruments to hedge certain risk exposures.
None of the transactions are entered into for trading or
speculative purposes.
We believe that market information is the most reliable and
transparent means of measurement for our derivative instruments
that are measured at fair value.
Foreign currency
risk management
The Company uses the euro as its invoicing currency in order to
limit the exposure to foreign currency movements. Exceptions may
occur on a customer by customer basis. To the extent that
invoicing is done in a currency other than the euro, the Company
is exposed to foreign currency risk.
It is the Companys policy to hedge material transaction
exposures, such as forecasted sales and purchase transactions
and accounts receivable and payable. The Company hedges these
exposures through the use of currency contracts (foreign
exchange options and forward contracts). In 2009, we identified
four ineffective cash flow hedges related to forecasted sales
transactions. This resulted in a loss recognized in sales for an
amount of EUR 10.7 million (2008: loss of
EUR 18.0 million). The effectiveness of all
outstanding hedge contracts is monitored on a quarterly basis
throughout the life of the hedges.
As of December 31, 2009 other comprehensive income includes
EUR 56.1 million loss (net of taxes:
EUR 41.8 million loss; 2008:
EUR 49.2 million loss) representing the total
anticipated loss to be released to sales, and
EUR 0.7 million gain (net of taxes:
EUR 0.5 million gain; 2008: EUR 1.4 million
gain) to be charged to cost of sales, which will offset the
higher EUR equivalent of foreign currency denominated forecasted
sales and purchase transactions. It is anticipated that an
amount of EUR 34.7 million
ASML ANNUAL REPORT 2009
52
loss will be charged to sales and EUR 0.7 million gain
will be released to cost of sales over the next twelve months,
as the forecasted sales and purchase transactions occur. The
remainder of the loss is anticipated to be charged to sales
between one and two years, as the forecasted sales transactions
occur.
It is the Companys policy to hedge material remeasurement
exposures. These net exposures from certain monetary assets and
liabilities in non-functional currencies are hedged with forward
contracts.
In 2009, the Company decided to change its hedging policy of
managing material currency translation exposures resulting
predominantly from ASMLs U.S. dollar net investments
by hedging these partly with forward contracts. The Company
decided to no longer hedge these U.S. dollar translation
exposures. The related foreign currency translation amounts
included in cumulative translation adjustment for the years 2008
and 2009 were EUR 12.7 million gain and
EUR 13.1 million loss, respectively. The cumulative
gain included in cumulative translation adjustment relating to
the net investment hedge would be reclassified from equity to
the consolidated statements of operations only in the event the
Companys U.S. subsidiary is (partially) disposed or
sold.
Interest rate
risk management
The Company has both assets and liabilities that bear interest,
which expose the Company to fluctuations in the prevailing
market rate of interest. The Company uses interest rate swaps to
align the interest typical terms of interest-bearing assets with
the interest typical terms of interest-bearing liabilities.
There might be some residual interest rate risks to the extent
that the asset and liability positions do not fully offset.
Furthermore, the Company uses interest rate swaps to hedge
changes in market value of fixed loan coupons payable on our
Eurobond due to changes in market interest rates and to hedge
the variability of future interest receipts as a result of
changes in market interest rates on part of our cash and cash
equivalents.
Financial
instruments
The Company uses currency contracts to manage its currency risk
and interest rate swaps to manage its interest rate risk. Most
derivatives will mature in one year or less after the balance
sheet date. The following table summarizes the notional amounts
and estimated fair values of the Companys financial
instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
Notional
|
|
|
|
|
|
Notional
|
|
|
|
|
As of December 31
|
|
Amount
|
|
|
Fair Value
|
|
|
Amount
|
|
|
Fair Value
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Currency
contracts1
|
|
|
896,642
|
|
|
|
(38,521
|
)
|
|
|
527,816
|
|
|
|
7,428
|
|
Interest rate
swaps2
|
|
|
641,500
|
|
|
|
63,173
|
|
|
|
641,500
|
|
|
|
78,485
|
|
|
(Source: Bloomberg Finance LP)
|
|
1
|
Relates to forward contracts
assigned as a hedge to forecasted sales and purchase
transactions, to monetary assets and liabilities and to net
investments in foreign operations (only 2008), mainly in U.S.
dollar and Japanese Yen
|
2
|
Relates to interest rate swaps
assigned as a hedge to interest bearing assets and liabilities
mainly related to the EUR 600 million Eurobond; the fair
value of the interest rate swaps includes accrued interest
|
The fair value of forward contracts (used for hedging purposes)
is the estimated amount that a bank would receive or pay to
terminate the forward contracts at the reporting date, taking
into account current interest rates and current exchange rates.
The valuation technique used to determine the fair value of
forward contracts approximates the net present value of future
cash flows.
The fair value of interest rate swaps (used for hedging
purposes) is the estimated amount that a bank would receive or
pay to terminate the swap agreements at the reporting date,
taking into account current interest rates. The valuation
technique used to determine the fair value of interest rate
swaps approximates the net present value of future cash flows.
Credit risk
management
Financial instruments that potentially subject ASML to
significant concentrations of credit risk consist principally of
cash and cash equivalents, accounts receivable and derivative
instruments used in hedging activities.
Cash and cash equivalents and derivative instruments contain an
element of risk of the counterparties being unable to meet their
obligations. This financial credit risk is monitored and
minimized per type of financial instrument by limiting
ASMLs counterparties to a sufficient number of major
financial institutions. Furthermore, in view of the continuing
higher volatility of the financial markets, the cash and cash
equivalents have mainly been placed on short term deposits with
highly rated financial institutions and have partly been
invested in AAAm-rated money market funds that invest in highly
rated short term debt securities of financial institutions and
governments. ASML does not expect the counterparties to default
given their high credit quality.
ASML ANNUAL REPORT 2009
53
ASMLs customers consist of IC manufacturers located
throughout the world. ASML performs ongoing credit evaluations
of its customers financial condition. ASML regularly
reviews if an allowance for doubtful debts is needed by
considering factors such as historical payment experience,
credit quality, age of the accounts receivable balances, and
current economic conditions that may affect a customers
ability to pay. In response to the increased volatility of the
financial markets, ASML has taken additional measures to
mitigate credit risk when considered appropriate by means of
e.g. down payments, letters of credit, and retention of
ownership. Retention of ownership enables ASML to recover the
systems in the event a customer defaults on payment.
Liquidity and
Capital risk management
Prudent liquidity risk management includes maintaining
sufficient cash and cash equivalents and the availability of
funding through an adequate amount of committed credit
facilities. Our general strategy is to seek to maintain our
strategic target level of cash and cash equivalents between
EUR 1.0 and 1.5 billion. The Company regularly reviews
the efficiency of its capital structure. To the extent that our
cash and cash equivalents exceeds this target and there are no
investment opportunities that we wish to pursue, we will
consider returning excess cash to our shareholders, including
through share buybacks, dividends and capital repayment.
As of December 31, 2009 the cash and cash equivalents
amounted to EUR 1.0 billion and the Company has
available credit facilities for a total amount of
EUR 700 million (2008: EUR 500 million). The
EUR 700 million of available credit facilities consist
of two separate facilities: a EUR 500 million credit
facility and a EUR 200 million loan facility.
The EUR 500 million credit facility, which will expire
in May 2012, contains a covenant that requires the Company to
maintain a minimum financial condition ratio, calculated in
accordance with a contractually agreed formula. ASML was in
compliance with the covenant at the end of 2009 and 2008.
Outstanding amounts under this credit facility will bear
interest at EURIBOR or LIBOR plus a margin that is dependent on
the Companys liquidity position. No amounts were
outstanding under this credit facility at the end of 2009 and
2008.
The EUR 200 million loan facility is related to the
Companys EUV investment efforts and was entered into in
2009 with the European Investment Bank. This loan can be drawn
in tranches until October 2010. It is repayable in annual
installments four years after drawdown, with final repayment
seven years after drawdown. This facility contains a covenant
that restricts the maximum indebtedness. ASML was in compliance
with the covenant at the end of 2009. Outstanding amounts under
this loan facility will bear interest at EURIBOR or LIBOR plus a
margin. No amounts were outstanding under this loan facility at
the end of 2009.
Sensitivity
analysis financial instruments
Foreign
currency sensitivity
ASML is mainly exposed to the U.S. dollar and Japanese yen.
The following table details the Companys sensitivity to a
10 percent strengthening of foreign currencies against the
euro. The sensitivity analysis includes foreign currency
denominated monetary items outstanding and adjusts their
translation at the period end for a 10 percent
strengthening in foreign currency rates. A positive amount
indicates an increase in income from operations before income
taxes and equity.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
Impact on
|
|
|
|
|
|
Impact on
|
|
|
|
|
|
|
income from
|
|
|
|
|
|
income from
|
|
|
|
|
|
|
operations
|
|
|
|
|
|
operations
|
|
|
|
|
|
|
before income
|
|
|
Impact on
|
|
|
before income
|
|
|
Impact on
|
|
|
|
taxes
|
|
|
equity
|
|
|
taxes
|
|
|
equity
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
U.S. dollar
|
|
|
(2,915
|
)
|
|
|
14,118
|
|
|
|
(3,689
|
)
|
|
|
24,903
|
|
Japanese yen
|
|
|
(14,501
|
)
|
|
|
(38,886
|
)
|
|
|
(1,711
|
)
|
|
|
(32,416
|
)
|
Other currencies
|
|
|
(1,285
|
)
|
|
|
8,482
|
|
|
|
(1,620
|
)
|
|
|
12,080
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
(18,701
|
)
|
|
|
(16,286
|
)
|
|
|
(7,020
|
)
|
|
|
4,567
|
|
|
It is the Companys policy to limit the currency effects
through the consolidated statements of operations. The negative
effect on income from operations before income taxes as
presented in the table above for 2009 and 2008 is mainly
attributable to timing differences between the arising of
exposures and the hedging thereof.
ASML ANNUAL REPORT 2009
54
The increase in the U.S. dollar effect on income from
operations before income taxes in 2009 compared to 2008 is
caused by a higher U.S. dollar liability position at year
end. The large negative Japanese yen effect in 2008 was mainly
caused by ineffective system sales hedges.
The revaluation effects of investments in foreign entities are
recognized in other comprehensive income, within equity. The
movements of currency rates therefore might have a significant
effect on other comprehensive income. The increased
U.S. dollar effect on other comprehensive income in 2009
compared to 2008 is caused by the fact that early 2009 the
Company decided to no longer hedge its U.S. dollar net
investments exposures. The effect on other comprehensive income
for other currencies mainly relates to investments in foreign
entities in Taiwan dollar, Korean won and Singapore dollar.
Fair value movements of cash flow hedges, entered into for
U.S. dollar and Japanese yen transactions, are recognized
in other comprehensive income.
For a 10 percent weakening of the foreign currencies
against the euro, there would be approximately an equal and
opposite effect on the income from operations before income
taxes and other comprehensive income. For the sensitivity for a
10 percent weakening of both the U.S. dollar and
Japanese yen against the euro, there would be a lower opposite
effect than presented in the table shown above of
EUR 4.5 million and EUR 5.9 million on other
comprehensive income, respectively.
Interest rate
sensitivity
The sensitivity analysis below has been determined based on the
exposure to interest rates for both derivatives and
non-derivative instruments at the balance sheet date and the
stipulated change taking place at the beginning of the financial
year and held constant throughout the reporting period. The
table below shows the effect of a one percent increase in
interest rates on the Companys income from operations
before income taxes and other comprehensive income. As a result
of the current low market interest rates, a one percent decrease
in interest rates is not possible, therefore there would be a
smaller and opposite effect on other comprehensive income and
income from operations before income taxes. A positive amount
indicates an increase in income from operations before income
taxes and other comprehensive income.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
Impact on
|
|
|
|
|
|
Impact on
|
|
|
|
|
|
|
income from
|
|
|
|
|
|
income from
|
|
|
|
|
|
|
operations
|
|
|
|
|
|
operations
|
|
|
|
|
|
|
before income
|
|
|
Impact on
|
|
|
before income
|
|
|
Impact on
|
|
|
|
taxes
|
|
|
equity
|
|
|
taxes
|
|
|
equity
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
|
|
6,018
|
|
|
|
2,465
|
|
|
|
4,425
|
|
|
|
2,336
|
|
|
The positive effect on other comprehensive income, within
equity, is mainly attributable to the fair value movements of
the interest rate swaps designated as cash flow hedges. The
effect on income from operations before income taxes has
decreased, mainly due to a decrease in cash and cash equivalents
in 2009 compared to 2008.
Item 12
Description of Securities Other Than Equity Securities
Not applicable.
ASML ANNUAL REPORT 2009
55
Part II
Item 13
Defaults, Dividend Arrearages and Delinquencies
None.
Item 14
Material Modifications to the Rights of Security Holders and Use
of Proceeds
None.
Item 15
Controls and Procedures
Disclosure
Controls and Procedures
As of the end of the period covered by this report, the
management of ASML conducted an evaluation, under the
supervision and with the participation of ASMLs Chief
Executive Officer and Chief Financial Officer, of the
effectiveness of the design and operation of ASMLs
disclosure controls and procedures (as defined in
Rule 13a-15(e)
under the Exchange Act). Based on such evaluation, ASMLs
Chief Executive Officer and Chief Financial Officer have
concluded that, as of December 31, 2009, ASMLs
disclosure controls and procedures are effective in recording,
processing, summarizing and reporting, on a timely basis,
information required to be disclosed by ASML in the reports that
it files or submits under the Exchange Act and are effective in
ensuring that information required to be disclosed by ASML in
the reports that it files or submits under the Exchange Act is
accumulated and communicated to ASMLs management,
including ASMLs Chief Executive Officer and Chief
Financial Officer, as appropriate to allow timely decisions
regarding required disclosure.
Managements
Report on Internal Control over Financial Reporting
ASMLs management is responsible for establishing and
maintaining adequate internal control over financial reporting,
as defined in
Rule 13a-15(f)
under the Exchange Act, for ASML. Under the supervision and with
the participation of ASMLs Chief Executive Officer and
Chief Financial Officer, ASMLs management conducted an
evaluation of the effectiveness of ASMLs internal control
over financial reporting based upon the framework in
Internal Control Integrated Framework
issued by the Committee of Sponsoring Organizations of the
Treadway Commission as of the end of the period covered by this
report. Based on that evaluation, management has concluded that
ASMLs internal control over financial reporting was
effective as of December 31, 2009 at providing reasonable
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in
accordance with accounting principles generally accepted in the
United States of America.
Deloitte Accountants B.V., an independent registered public
accounting firm, has audited the consolidated financial
statements included in Item 18 of this annual report on
Form 20-F
and, as part of the audit, has issued a report, included herein,
on the effectiveness of ASMLs internal control over
financial reporting.
Changes in
Internal Control over Financial Reporting
During the year ended December 31, 2009 there have been no
changes in our internal control over financial reporting that
have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.
Inherent
Limitations of Disclosure Controls and Procedures in Internal
Control over Financial Reporting
It should be noted that any system of controls, however
well-designed and operated, can provide only reasonable, and not
absolute, assurance that the objectives of the system will be
met. In addition, the design of any control system is based in
part upon certain assumptions about the likelihood of future
events.
Item 16
A. Audit
Committee Financial Expert
Our Supervisory Board has determined that effective
March 18, 2004, Mr. Fritz Fröhlich, an
independent member of the Supervisory Board, qualifies as the
Audit Committee Financial Expert.
ASML ANNUAL REPORT 2009
56
ASML has adopted its Principles of Ethical Business
Conduct, which contain ASMLs ethical principles in
relation to various subjects. These Principles have been
developed into
day-to-day
guidelines (the Internal Guidelines on Ethical Business
Conduct). The Internal Guidelines on Ethical Business
Conduct apply to ASML employees worldwide, as well as
ASMLs Supervisory Board and Board of Management. Our
Principles of Ethical Business Conduct and Internal Guidelines
on Ethical Business Conduct are posted on our website
(www.asml.com).
The Internal Guidelines on Ethical Business Conduct contain,
among others, written standards that are reasonably designed to
deter wrongdoing and to promote:
|
|
|
honest and ethical conduct, including the ethical handling of
actual or apparent conflicts of interest between personal and
professional relationships;
|
|
full, fair, accurate, timely, and understandable disclosure in
reports and documents that ASML files with, or submits to, the
SEC and in other public communications made by ASML;
|
|
compliance with applicable governmental laws, rules and
regulations;
|
|
prompt internal reporting of violations of the Internal
Guidelines on Ethical Business Conduct to an appropriate person
or persons identified in these guidelines; and
|
|
accountability for adherence to the guidelines.
|
C. Principal
Accountant Fees and Services
Deloitte Accountants B.V. has served as our independent
registered public accounting firm for each of the three
financial years up to December 31, 2009. The following
table sets out the aggregate fees for professional audit
services and other services rendered by Deloitte Accountants
B.V. and its members firms
and/or
affiliates in 2008 and 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Audit fees
|
|
|
1,377
|
|
|
|
1,191
|
|
Audit-related fees
|
|
|
52
|
|
|
|
75
|
|
Tax fees
|
|
|
536
|
|
|
|
723
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,965
|
|
|
|
1,989
|
|
|
Audit
fees
Audit fees primarily relate to the audit of our annual
consolidated financial statements set out in our Annual Report
on
Form 20-F,
agreed upon procedures work on our quarterly financial results,
services related to statutory and regulatory filings of ASML
Holding N.V. and its subsidiaries and services in connection
with accounting consultations on U.S. GAAP.
Audit-related
fees
Audit-related fees mainly related to various audit services not
related to the Companys consolidated financial statements.
Tax
fees
Tax fees can be detailed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Corporate Income Tax compliance services
|
|
|
160
|
|
|
|
113
|
|
Tax assistance for expatriate employees
|
|
|
152
|
|
|
|
172
|
|
Other tax advisory and compliance
|
|
|
224
|
|
|
|
438
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
536
|
|
|
|
723
|
|
|
The Audit Committee has approved the external audit plan and
related audit fees for the year 2009. The Audit Committee has
adopted a policy regarding audit and non-audit services, in
consultation with Deloitte Accountants B.V. This policy ensures
the independence of our auditors by expressly setting forth all
services that the auditors may not perform and reinforcing the
principle of independence regardless of the type of work
performed. Certain non-audit services, such as certain
tax-related services and acquisition advisory services, are
permitted. The Audit Committee pre-approves all audit and
non-audit services not specifically prohibited under this policy
and reviews the annual external audit plan and any subsequent
engagements.
ASML ANNUAL REPORT 2009
57
D. Exemptions
from the Listing Standards for Audit Committees
Not applicable.
E. Purchases of
Equity Securities by the Issuer and Affiliated
Purchasers
The following table provides a summary of shares repurchased by
the Company between 2006 and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total value
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number
|
|
|
|
|
|
of Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
of Shares
|
|
|
Maximum
|
|
|
Purchased as
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Purchased as
|
|
|
Number of
|
|
|
Part of Publicly
|
|
|
|
|
|
|
|
|
|
Price
|
|
|
Part of Publicly
|
|
|
Shares That May
|
|
|
Announced
|
|
|
|
|
|
|
|
|
|
Paid per
|
|
|
Announced
|
|
|
Yet be Purchased
|
|
|
Plans or
|
|
|
|
|
|
|
Total Number of
|
|
|
Share
|
|
|
Plans or
|
|
|
Under the
|
|
|
Programs (in
|
|
Program
|
|
Period
|
|
|
Shares purchased
|
|
|
(EUR)
|
|
|
Programs
|
|
|
Programs
|
|
|
EUR million)
|
|
2006-2007 Share
program
|
|
|
May 17-26, 2006
|
|
|
|
6,412,920
|
|
|
|
15.59
|
|
|
|
6,412,920
|
|
|
|
19,037,376
|
|
|
|
100
|
|
2006-2007 Share
program
|
|
|
June 7-30, 2006
|
|
|
|
13,517,078
|
|
|
|
15.81
|
|
|
|
19,929,998
|
|
|
|
5,520,298
|
|
|
|
314
|
|
2006-2007 Share
program
|
|
|
July 3-13, 2006
|
|
|
|
5,520,298
|
|
|
|
15.62
|
|
|
|
25,450,296
|
|
|
|
|
|
|
|
400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006-2007 Share
program
|
|
|
October 12, 2006
|
|
|
|
14,934,843
|
|
|
|
18.55
|
|
|
|
14,934,843
|
|
|
|
|
|
|
|
277
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006-2007 Share
program
|
|
|
February 14-23, 2007
|
|
|
|
8,000,000
|
|
|
|
19.53
|
|
|
|
8,000,000
|
|
|
|
|
|
|
|
156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital repayment program 2007
|
|
|
September - October 2007
|
|
|
|
55,093,409
|
|
|
|
18.36
|
|
|
|
55,093,409
|
|
|
|
|
|
|
|
1,012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007-2008 Share
program
|
|
|
November 14-26, 2007
|
|
|
|
9,000,000
|
|
|
|
22.62
|
|
|
|
9,000,000
|
|
|
|
5,000,000
|
|
|
|
204
|
|
2007-2008 Share
program
|
|
|
January 17-22, 2008
|
|
|
|
5,000,000
|
|
|
|
17.52
|
|
|
|
14,000,000
|
|
|
|
|
|
|
|
292
|
|
|
2006-2007 Share
program
On March 23, 2006, the General Meeting of Shareholders
authorized the repurchase of up to a maximum of 10 percent
of our issued shares through September 23, 2007. The number
of shares bought back in the initial phase of this Repurchase
Program was 25,450,296 shares, representing
100 percent of the announced objective for the initial
phase of the Repurchase Program of maximum
EUR 400 million and 5.25 percent of outstanding
shares. This 2006 Repurchase Program was completed in the third
quarter of 2006. Shares repurchased were recorded at cost and
classified within shareholders equity. ASML cancelled
these repurchased shares in 2007.
In the second phase of the Repurchase Program, ASML repurchased
14,934,843 additional shares pursuant to a call option
transaction announced on October 9, 2006. These repurchased
shares represented 100 percent of the announced objective
of the second phase of the Repurchase Program. In order to
mitigate the dilution due to the issuance of shares upon
conversion of its convertible bond due October 2006, these
shares were subsequently used to satisfy the conversion rights
of holders of ASMLs 5.75 percent Convertible
Subordinated Notes. The Company paid an aggregate of
EUR 277 million in cash for these shares. This
repurchase program was completed in the fourth quarter of 2006.
These shares were purchased from a third party who issued the
call option.
In February 2007, ASML repurchased the final phase of shares
under the Repurchase Program of the remaining 1.7 percent
of outstanding shares, being 8,000,000 shares. The share
program was announced on February 14, 2007 and was
completed in the first quarter of 2007. Shares repurchased have
been used to cover outstanding stock options and to satisfy
partly the conversion rights of holders of ASMLs
5.50 percent Convertible Subordinated Notes.
Capital repayment
program 2007
On July 17, 2007 the Extraordinary General Meeting of
Shareholders approved three proposals to amend the
Companys Articles of Association. The first amendment
involved an increase of share capital by an increase in the
nominal value per ordinary share from EUR 0.02 to
EUR 2.12 and a corresponding reduction in share premium.
The second amendment was a reduction of the nominal value per
ordinary share from EUR 2.12 to EUR 0.08 resulting in
the payment to shareholders of EUR 2.04 per ordinary share.
The third amendment involved a reduction in stock, whereby 9
ordinary shares with a nominal value of EUR 0.08 each were
consolidated into 8 ordinary shares with a nominal value of
EUR 0.09 each. As a result of these amendments, which in
substance constitute a synthetic share buyback,
EUR 1,012 million has been repaid to our shareholders
and the outstanding number of ordinary shares was reduced by
55,093,409 shares or 11 percent. The capital repayment
program was completed in October 2007.
2007-2008 Share
program
On March 28, 2007, the General Meeting of Shareholders
authorized the repurchase of up to a maximum of three times
10 percent of our issued shares through September 28,
2008.
ASML ANNUAL REPORT 2009
58
In 2007, the aggregate number of shares bought back under the
2007-2008 share
program was 9,000,000, representing 64.3 percent of the
announced objective of 14,000,000 shares to be repurchased
during a period ending on September 28, 2008. The share
program was announced on October 17, 2007. Shares
repurchased will be used to cover outstanding stock options.
In January 2008, ASML bought back 5,000,000 shares. The
aggregate number of shares bought back up to and including
January 2008, represents 100 percent of the announced
objective of 14,000,000 shares.
Authorization of
share repurchases
On March 26, 2009, the General Meeting of Shareholders
authorized the repurchase of up to a maximum of approximately
27 percent of our issued share capital as of the date of
authorization (March 26, 2009) through
September 26, 2010. The Company did not buyback any shares
in 2009.
F. Change in
Registrants Certifying Accountant
Not applicable.
G. Corporate
governance
See Item 6.C. Variations from Certain NASDAQ
Corporate Governance Rules.
ASML ANNUAL REPORT 2009
59
Part III
Item 17
Financial Statements
Not applicable.
Item 18
Financial Statements
In response to this item, the Company incorporates herein by
reference the consolidated financial statements of the Company
set out on pages F-2 through F-47 hereto.
Item 19
Exhibits
|
|
|
|
|
Exhibit No.
|
|
Description
|
1
|
|
Articles of Association of ASML Holding N.V. (English
translation) (Incorporated by reference to Amendment No. 11
to the Registrants Registration Statement on
Form 8-A/A,
filed with the Commission on November 2, 2007)
|
2.1
|
|
Fiscal Agency Agreement between ASML Holding N.V., Deutsche Bank
AG, London Branch and Deutsche Bank Luxembourg S.A. relating to
the Registrants 5.75 percent Notes due 2017
(Incorporated by reference to the Registrants Annual
Report for the year ended December 31, 2008)
|
4.1
|
|
Agreement between ASML Lithography B.V. and Carl Zeiss, dated
March 17, 2000 (Incorporated by reference to the
Registrants Annual Report on
Form 20-F
for the fiscal year ended December 31, 2000) #
|
4.2
|
|
Agreement between ASML Holding N.V. and Carl Zeiss, dated
October 24, 2003 (Incorporated by reference to the
Registrants Annual Report on
Form 20-F
for the year ended December 31, 2003) #
|
4.3
|
|
Form of Indemnity Agreement between ASML Holding N.V. and
members of its Board of Management (Incorporated by reference to
the Registrants Annual Report on
Form 20-F
for the year ended December 31, 2003)
|
4.4
|
|
Form of Indemnity Agreement between ASML Holding N.V. and
members of its Supervisory Board (Incorporated by reference to
the Registrants Annual Report on
Form 20-F
for the year ended December 31, 2003)
|
4.5
|
|
Form of Employment Agreement for members of the Board of
Management (Incorporated by reference to the Registrants
Annual Report on
Form 20-F
for the fiscal year ended December 31, 2003)
|
4.6
|
|
Nikon-ASML Patent Cross-License Agreement, dated
December 10, 2004, between ASML Holding N.V. and Nikon
Corporation (Incorporated by reference to the Registrants
Annual Report on
Form 20-F
for the fiscal year ended December 31, 2004) #
|
4.7
|
|
ASML/Zeiss Sublicense Agreement, 2004, dated December 10,
2004, between Carl Zeiss SMT AG and ASML Holding N.V.
(Incorporated by reference to the Registrants Annual
Report on
Form 20-F
for the fiscal year ended December 31, 2004) #
|
4.8
|
|
ASML New Hires and Incentive Stock Option Plan For Management
(Version 2003) (Incorporated by reference to the
Registrants Statement on
Form S-8,
filed with the Commission on September 2, 2003 (File
No. 333-109154))
|
4.9
|
|
ASML Incentive and New Hire Option Plan for Board of Management
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8,
filed with the Commission on June 9, 2004 (File
No. 333-116337))
|
4.10
|
|
ASML Option Plan for Management of ASML Holding Group Companies
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on June 30, 2005 (file
No. 333-126340))
|
4.11
|
|
ASML Stock Option Plan for New Hire Options granted to Members
of the Board of Management (Version April 2006) (Incorporated by
reference to the Registrants Registration Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.12
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version April 2006)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.13
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version July 2006)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.14
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version October 2006)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.15
|
|
ASML Restricted Stock Plan (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on March 7, 2007 (file
No. 333-141125))
|
4.16
|
|
Brion Technologies, Inc., 2002 Stock Option Plan (as amended on
March 25, 2005; March 24, 2006; and November 17,
2006) (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on April 20, 2007 (file
No. 333-142254))
|
4.17
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version January 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
ASML ANNUAL REPORT 2009
60
|
|
|
|
|
Exhibit No.
|
|
Description
|
4.18
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version April 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.19
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version July 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.20
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version October 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.21
|
|
ASML Performance Stock Plan for Members of the Board of
Management (Version 1) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.22
|
|
ASML Performance Stock Option Plan for Members of the Board of
Management (Version 2) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.23
|
|
ASML Stock Option Plan from Base Salary for Senior &
Executive Management (Version October 2007) (Incorporated by
reference to the Registrants Registration Statement on
Form S-8
filed with the Commission on November 2, 2007 (file
No. 333-147128))
|
4.24
|
|
ASML Performance Stock Option Plan for Senior and Executive
Management (version 1) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on August 29, 2008 (file
No. 333-153277))
|
4.25
|
|
ASML Performance Share Plan for Senior and Executive Management
(version 1) (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on August 29, 2008 (file
No. 333-153277))
|
4.26
|
|
ASML Restricted Stock Plan (version 2) (Incorporated by
reference to the Registrants Registration Statement on
Form S-8
filed with the Commission on August 29, 2008 (file
No. 333-153277))
|
4.27
|
|
ASML Performance Stock Plan for Members of the Board of
Management (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on October 13, 2009 (file
No. 333-162439))
|
4.28
|
|
ASML Performance Stock Option Plan for Senior and Executive
Management (version 1) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on October 13, 2009 (file
No. 333-162439))
|
4.29
|
|
ASML Performance Share Plan for Senior and Executive Management
(version 1) (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on October 13, 2009 (file
No. 333-162439))
|
8.1
|
|
List of Material Subsidiaries*
|
12.1
|
|
Certification of CEO and CFO Pursuant to
Rule 13a-14(a)
of the Securities Exchange Act of 1934*
|
13.1
|
|
Certification of CEO and CFO Pursuant to
Rule 13a-14(b)
of the Securities Exchange Act of 1934 and 18 U.S.C.
Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002*
|
15.1
|
|
Consent of Deloitte Accountants B.V.*
|
|
|
|
*
|
Filed at the Commission herewith
|
#
|
Certain information omitted
pursuant to a request for confidential treatment filed
separately with the Securities and Exchange Commission
|
ASML Holding N.V. hereby certifies that it meets all of the
requirements for filing on
Form 20-F
and that it has duly caused and authorized the undersigned to
sign this annual report on its behalf.
(Registrant)
Eric Meurice
President, Chief Executive Officer and Chairman of the Board of
Management
Dated: January 29, 2010
Peter T.F.M. Wennink
Executive Vice President, Chief Financial Officer and Member of
the Board of Management
Dated: January 29, 2010
ASML ANNUAL REPORT 2009
61
Index to Financial
Statements
ASML ANNUAL REPORT 2009
F-1
Consolidated
Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Notes
|
|
(in thousands, except per share data)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
Net system sales
|
|
|
3,351,281
|
|
|
|
2,516,762
|
|
|
|
1,174,858
|
|
|
|
Net service and field option sales
|
|
|
416,904
|
|
|
|
436,916
|
|
|
|
421,205
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
Total net sales
|
|
|
3,768,185
|
|
|
|
2,953,678
|
|
|
|
1,596,063
|
|
|
|
Cost of system sales
|
|
|
1,943,779
|
|
|
|
1,631,069
|
|
|
|
852,417
|
|
|
|
Cost of service and field option sales
|
|
|
274,747
|
|
|
|
307,095
|
|
|
|
285,254
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21
|
|
Total cost of sales
|
|
|
2,218,526
|
|
|
|
1,938,164
|
|
|
|
1,137,671
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit on sales
|
|
|
1,549,659
|
|
|
|
1,015,514
|
|
|
|
458,392
|
|
21, 22
|
|
Research and development
costs1
|
|
|
486,141
|
|
|
|
516,128
|
|
|
|
466,761
|
|
10
|
|
Amortization of in-process research and development costs
|
|
|
23,148
|
|
|
|
|
|
|
|
|
|
21
|
|
Selling, general and administrative costs
|
|
|
225,668
|
|
|
|
212,341
|
|
|
|
156,644
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
814,702
|
|
|
|
287,045
|
|
|
|
(165,013
|
)
|
23
|
|
Interest income
|
|
|
78,165
|
|
|
|
72,497
|
|
|
|
42,766
|
|
23
|
|
Interest expense
|
|
|
(44,714
|
)
|
|
|
(49,898
|
)
|
|
|
(49,303
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations before income taxes
|
|
|
848,153
|
|
|
|
309,644
|
|
|
|
(171,550
|
)
|
18
|
|
(Provision for) benefit from income taxes
|
|
|
(177,152
|
)
|
|
|
12,726
|
|
|
|
20,625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
671,001
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
|
|
Basic net income (loss) per ordinary share
|
|
|
1.45
|
|
|
|
0.75
|
|
|
|
(0.35
|
)
|
|
|
Diluted net income (loss) per ordinary share
|
|
|
1.41
|
|
|
|
0.74
|
|
|
|
(0.35
|
)
|
|
|
Number of ordinary shares used in computing per share amounts
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
462,406
|
|
|
|
431,620
|
|
|
|
432,615
|
|
|
|
Diluted
|
|
|
485,643
|
|
|
|
434,205
|
|
|
|
432,615
|
|
|
Consolidated
Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
671,001
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
Loss on foreign currency translation, net of taxes
|
|
|
(23,294
|
)
|
|
|
(12,734
|
)
|
|
|
(8,592
|
)
|
Gain (loss) on derivative instruments, net of taxes
|
|
|
(3,450
|
)
|
|
|
(43,579
|
)
|
|
|
6,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
644,257
|
|
|
|
266,057
|
|
|
|
(153,023
|
)
|
|
|
|
1
|
As of January 1, 2009,
R&D credits are presented as part of R&D costs. The
comparative figures for 2007 and 2008 have been adjusted
accordingly.
|
ASML ANNUAL REPORT 2009
F-2
Consolidated
Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
Notes
|
|
(in thousands, except share and per share data)
|
|
EUR
|
|
|
EUR
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
4
|
|
Cash and cash equivalents
|
|
|
1,109,184
|
|
|
|
1,037,074
|
|
5
|
|
Accounts receivable, net
|
|
|
463,273
|
|
|
|
377,439
|
|
6
|
|
Finance receivables, net
|
|
|
6,225
|
|
|
|
21,553
|
|
18
|
|
Current tax assets
|
|
|
87,560
|
|
|
|
11,286
|
|
7
|
|
Inventories, net
|
|
|
999,150
|
|
|
|
963,382
|
|
18
|
|
Deferred tax assets
|
|
|
71,780
|
|
|
|
119,404
|
|
8
|
|
Other assets
|
|
|
236,077
|
|
|
|
218,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
2,973,249
|
|
|
|
2,748,884
|
|
|
|
|
|
|
|
|
|
|
|
|
6
|
|
Finance receivables, net
|
|
|
31,030
|
|
|
|
|
|
18
|
|
Deferred tax assets
|
|
|
148,133
|
|
|
|
133,263
|
|
8
|
|
Other assets
|
|
|
88,197
|
|
|
|
77,054
|
|
9
|
|
Goodwill
|
|
|
131,453
|
|
|
|
131,462
|
|
10
|
|
Other intangible assets, net
|
|
|
26,692
|
|
|
|
18,128
|
|
11
|
|
Property, plant and equipment, net
|
|
|
540,640
|
|
|
|
618,706
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total non-current assets
|
|
|
966,145
|
|
|
|
978,613
|
|
|
|
Total assets
|
|
|
3,939,394
|
|
|
|
3,727,497
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
193,690
|
|
|
|
206,226
|
|
12
|
|
Accrued and other liabilities
|
|
|
789,788
|
|
|
|
817,361
|
|
18
|
|
Current tax liabilities
|
|
|
20,039
|
|
|
|
15,032
|
|
13
|
|
Provisions
|
|
|
4,678
|
|
|
|
2,504
|
|
18
|
|
Deferred tax liabilities
|
|
|
148
|
|
|
|
3,047
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
1,008,343
|
|
|
|
1,044,170
|
|
|
|
|
|
|
|
|
|
|
|
|
14
|
|
Long-term debt
|
|
|
647,050
|
|
|
|
663,102
|
|
18
|
|
Deferred and other tax liabilities
|
|
|
209,699
|
|
|
|
188,404
|
|
13
|
|
Provisions
|
|
|
15,495
|
|
|
|
12,694
|
|
12
|
|
Accrued and other liabilities
|
|
|
70,038
|
|
|
|
44,359
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total non-current liabilities
|
|
|
942,282
|
|
|
|
908,559
|
|
|
|
Total liabilities
|
|
|
1,950,625
|
|
|
|
1,952,729
|
|
|
|
|
|
|
|
|
|
|
|
|
15, 17
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
Cumulative Preference Shares; EUR 0.02 nominal value;
3,150,005,000 shares authorized;
|
|
|
|
|
|
|
|
|
|
|
none issued and outstanding at December 31, 2008 and 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares; EUR 0.09 and EUR 0.01 nominal value;
respectively 700,000,000 and 10,000 shares authorized;
respectively 432,073,534 and none issued and outstanding at
December 31, 2008; respectively 433,638,976 and none issued
and outstanding at December 31, 2009
|
|
|
38,887
|
|
|
|
39,028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share premium
|
|
|
474,765
|
|
|
|
476,261
|
|
|
|
Treasury shares at cost
|
|
|
(253,436
|
)
|
|
|
(218,203
|
)
|
|
|
Retained earnings
|
|
|
1,698,929
|
|
|
|
1,450,156
|
|
|
|
Accumulated other comprehensive income
|
|
|
29,624
|
|
|
|
27,526
|
|
|
|
|
|
|
|
|
|
|
|
|
25
|
|
Total shareholders equity
|
|
|
1,988,769
|
|
|
|
1,774,768
|
|
|
|
Total liabilities and shareholders equity
|
|
|
3,939,394
|
|
|
|
3,727,497
|
|
|
ASML ANNUAL REPORT 2009
F-3
Consolidated
Statements of Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued and outstanding
|
|
|
|
|
|
|
|
|
Treasury
|
|
|
Accumulated
|
|
|
|
|
|
|
Shares
|
|
|
Share
|
|
|
Retained
|
|
|
Shares
|
|
|
Other Comprehensive
|
|
|
|
|
|
|
|
|
|
Amount
|
|
|
Premium
|
|
|
Earnings
|
|
|
at cost
|
|
|
Income
|
|
|
Total
|
|
(in thousands)
|
|
Number1
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Balance at January 1, 2007
|
|
|
477,099
|
|
|
|
10,051
|
|
|
|
1,195,034
|
|
|
|
1,231,237
|
|
|
|
(401,000
|
)
|
|
|
112,681
|
|
|
|
2,148,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of
comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
671,001
|
|
|
|
|
|
|
|
|
|
|
|
671,001
|
|
Foreign Currency Translation, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(23,294
|
)
|
|
|
(23,294
|
)
|
Gain (loss) on derivative instruments, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,450
|
)
|
|
|
(3,450
|
)
|
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
16,506
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,506
|
|
Cumulative effect of applying the provisions of ASC 740
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,648
|
)
|
|
|
|
|
|
|
|
|
|
|
(7,648
|
)
|
Purchase of shares in conjunction with conversion rights of
bond holders and share-based payment
plans2
|
|
|
(17,000
|
)
|
|
|
(970
|
)
|
|
|
|
|
|
|
|
|
|
|
(358,886
|
)
|
|
|
|
|
|
|
(359,856
|
)
|
Issuance of shares in conjunction with convertible bonds
|
|
|
26,232
|
|
|
|
718
|
|
|
|
288,360
|
|
|
|
(35,366
|
)
|
|
|
130,317
|
|
|
|
|
|
|
|
384,029
|
|
Capital
repayment3
|
|
|
(55,093
|
)
|
|
|
29,748
|
|
|
|
(1,041,605
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,011,857
|
)
|
Cancellation of treasury shares
|
|
|
|
|
|
|
(509
|
)
|
|
|
(48,563
|
)
|
|
|
(351,928
|
)
|
|
|
401,000
|
|
|
|
|
|
|
|
|
|
Tax benefit from stock options
|
|
|
|
|
|
|
|
|
|
|
9,006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,006
|
|
Issuance of shares and stock options
|
|
|
4,388
|
|
|
|
168
|
|
|
|
45,108
|
|
|
|
(6,388
|
)
|
|
|
29,676
|
|
|
|
|
|
|
|
68,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
435,626
|
|
|
|
39,206
|
|
|
|
463,846
|
|
|
|
1,500,908
|
|
|
|
(198,893
|
)
|
|
|
85,937
|
|
|
|
1,891,004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
322,370
|
|
|
|
|
|
|
|
|
|
|
|
322,370
|
|
Foreign Currency Translation, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,734
|
)
|
|
|
(12,734
|
)
|
Gain (loss) on derivative instruments, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(43,579
|
)
|
|
|
(43,579
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
13,535
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,535
|
|
Purchase of shares in conjunction with share-based payment
plans
|
|
|
(5,000
|
)
|
|
|
(450
|
)
|
|
|
|
|
|
|
|
|
|
|
(87,155
|
)
|
|
|
|
|
|
|
(87,605
|
)
|
Dividend paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(107,841
|
)
|
|
|
|
|
|
|
|
|
|
|
(107,841
|
)
|
Tax benefit from stock options
|
|
|
|
|
|
|
|
|
|
|
2,144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,144
|
|
Issuance of shares and stock options
|
|
|
1,448
|
|
|
|
131
|
|
|
|
(4,760
|
)
|
|
|
(16,508
|
)
|
|
|
32,612
|
|
|
|
|
|
|
|
11,475
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
432,074
|
|
|
|
38,887
|
|
|
|
474,765
|
|
|
|
1,698,929
|
|
|
|
(253,436
|
)
|
|
|
29,624
|
|
|
|
1,988,769
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(150,925
|
)
|
|
|
|
|
|
|
|
|
|
|
(150,925
|
)
|
Foreign Currency Translation, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,592
|
)
|
|
|
(8,592
|
)
|
Gain (loss) on derivative instruments, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,494
|
|
|
|
6,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
13,394
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,394
|
|
Dividend
paid4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(86,486
|
)
|
|
|
|
|
|
|
|
|
|
|
(86,486
|
)
|
Tax benefit from stock options
|
|
|
|
|
|
|
|
|
|
|
1,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,954
|
|
Issuance of shares and stock options
|
|
|
1,565
|
|
|
|
141
|
|
|
|
(13,852
|
)
|
|
|
(11,362
|
)
|
|
|
35,233
|
|
|
|
|
|
|
|
10,160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
433,639
|
|
|
|
39,028
|
|
|
|
476,261
|
|
|
|
1,450,156
|
|
|
|
(218,203
|
)
|
|
|
27,526
|
|
|
|
1,774,768
|
|
|
ASML ANNUAL REPORT 2009
F-4
|
|
1
|
As of December 31, 2009, the
number of issued shares was 444,480,095. This includes the
number of issued and outstanding shares of 433,638,976 and the
number of treasury shares of 10,841,119. As of December 31,
2008, the number of issued shares was 444,480,095. This includes
the number of issued and outstanding shares of 432,073,534 and
the number of treasury shares of 12,406,561.
|
2
|
In 2007, 17,000,000 shares
were repurchased, some of which were re-issued in order to cover
exercised stock options and to satisfy the conversion rights of
holders of our 5.50 percent Convertible Subordinated Notes.
See Note 26 for further information.
|
3
|
In 2007, as part of a capital
repayment program, EUR 1,012 million of equity was repaid
to our shareholders and the number of outstanding ordinary
shares was reduced by 11 percent. See Note 26 for
further information.
|
4
|
In 2009, ASML paid out a dividend
of EUR 86 million to its shareholders, see Note 25 for
further information.
|
ASML ANNUAL REPORT 2009
F-5
Consolidated
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Cash Flows from Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
671,001
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile net income (loss) to net cash flows
from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
126,344
|
|
|
|
119,190
|
|
|
|
140,201
|
|
Impairment
|
|
|
9,022
|
|
|
|
25,109
|
|
|
|
15,896
|
|
Loss on disposals of property, plant and equipment
|
|
|
14,210
|
|
|
|
4,257
|
|
|
|
4,053
|
|
Share-based payments
|
|
|
16,506
|
|
|
|
13,535
|
|
|
|
13,394
|
|
Allowance for doubtful debts
|
|
|
(178
|
)
|
|
|
188
|
|
|
|
1,889
|
|
Allowance for obsolete inventory
|
|
|
79,592
|
|
|
|
139,628
|
|
|
|
86,636
|
|
Deferred income taxes
|
|
|
106,403
|
|
|
|
(34,155
|
)
|
|
|
(49,423
|
)
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
42,410
|
|
|
|
132,147
|
|
|
|
97,540
|
|
Inventories
|
|
|
(438,746
|
)
|
|
|
(87,804
|
)
|
|
|
(158,024
|
)
|
Other assets
|
|
|
(86,053
|
)
|
|
|
(76,342
|
)
|
|
|
4,893
|
|
Accounts payable
|
|
|
(38,944
|
)
|
|
|
(94,375
|
)
|
|
|
10,430
|
|
Current income taxes
|
|
|
(74,428
|
)
|
|
|
(158,277
|
)
|
|
|
71,267
|
|
Other liabilities
|
|
|
273,872
|
|
|
|
(24,725
|
)
|
|
|
9,937
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
701,011
|
|
|
|
280,746
|
|
|
|
97,764
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
|
(179,152
|
)
|
|
|
(259,770
|
)
|
|
|
(104,959
|
)
|
Proceeds from sale of property, plant and equipment
|
|
|
5,011
|
|
|
|
|
|
|
|
6,877
|
|
Purchases of intangible assets
|
|
|
|
|
|
|
(35
|
)
|
|
|
|
|
Acquisition of subsidiary (net of cash acquired)
|
|
|
(188,011
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(362,152
|
)
|
|
|
(259,805
|
)
|
|
|
(98,082
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital repayment
|
|
|
(1,011,857
|
)
|
|
|
|
|
|
|
|
|
Purchase of shares in conjunction with conversion rights of
bondholders and
share-based payments
|
|
|
(359,856
|
)
|
|
|
(87,605
|
)
|
|
|
|
|
Net proceeds from issuance of shares and stock options
|
|
|
63,307
|
|
|
|
11,475
|
|
|
|
11,073
|
|
Dividend paid
|
|
|
|
|
|
|
(107,841
|
)
|
|
|
(86,486
|
)
|
Net proceeds from issuance of bond
|
|
|
593,755
|
|
|
|
|
|
|
|
|
|
Net proceeds from other long-term debt
|
|
|
|
|
|
|
|
|
|
|
32
|
|
Repayment of debt
|
|
|
(9,718
|
)
|
|
|
(2,411
|
)
|
|
|
(17
|
)
|
Tax benefits from stock options
|
|
|
9,006
|
|
|
|
2,144
|
|
|
|
1,954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
(715,363
|
)
|
|
|
(184,238
|
)
|
|
|
(73,444
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows
|
|
|
(376,504
|
)
|
|
|
(163,297
|
)
|
|
|
(73,762
|
)
|
Effect of changes in exchange rates on cash
|
|
|
(7,717
|
)
|
|
|
845
|
|
|
|
1,652
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents
|
|
|
(384,221
|
)
|
|
|
(162,452
|
)
|
|
|
(72,110
|
)
|
Cash and cash equivalents at beginning of the year
|
|
|
1,655,857
|
|
|
|
1,271,636
|
|
|
|
1,109,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of the year
|
|
|
1,271,636
|
|
|
|
1,109,184
|
|
|
|
1,037,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Cash Flow Information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid
|
|
|
38,936
|
|
|
|
40,247
|
|
|
|
40,235
|
|
Taxes paid (received)
|
|
|
167,268
|
|
|
|
167,360
|
|
|
|
(36,705
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of bonds into 26,232,275, 0 and 0 ordinary shares
respectively
in 2007, 2008 and 2009
|
|
|
378,413
|
|
|
|
|
|
|
|
|
|
|
ASML ANNUAL REPORT 2009
F-6
Notes
to the Consolidated Financial Statements
1. General
information / Summary of significant accounting
policies
ASML Holding N.V., with its corporate headquarters in Veldhoven,
the Netherlands, is engaged in the development, production,
marketing, sale and servicing of advanced semiconductor
equipment systems exclusively consisting of lithography systems.
ASMLs principal operations are in the Netherlands, the
United States of America and Asia.
The Companys shares are listed for trading in the form of
registered shares on NASDAQ Global Select Market (New York
shares) and in the form of registered shares on Euronext
Amsterdam (Amsterdam Shares). The principal trading
market of the Companys ordinary shares is Euronext
Amsterdam.
The accompanying consolidated financial statements include the
financial statements of ASML Holding N.V. headquartered in
Veldhoven, the Netherlands, and its consolidated subsidiaries
(together referred to as ASML or the
Company).
Basis of
preparation
The accompanying consolidated financial statements are stated in
thousands of Euros (EUR) unless indicated otherwise.
ASML follows accounting principles generally accepted in the
United States of America (U.S. GAAP).
ASMLs reporting currency is the euro.
Use of
estimates
The preparation of ASMLs consolidated financial statements
in conformity with U.S. GAAP requires management to make
estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets
and liabilities on the balance sheet dates, and the reported
amounts of revenue and expenses during the reported periods.
Actual results could differ from those estimates.
Principles of
consolidation
The consolidated financial statements include the accounts of
ASML Holding N.V. and all of its majority-owned subsidiaries.
All intercompany profits, balances and transactions have been
eliminated in the consolidation.
Subsidiaries
Subsidiaries are all entities over which ASML has the power to
govern financial and operating policies generally accompanying a
shareholding of more than one-half of the voting rights. As from
the date that these criteria are met, the financial data of the
relevant company are included in the consolidation.
Acquisitions of subsidiaries are included on the basis of the
purchase accounting method. The cost of acquisition
is measured as the cash payment made, the fair value of other
assets distributed and the fair value of liabilities incurred or
assumed at the date of exchange, plus the costs that can be
allocated directly to the acquisition. The excess of the costs
of an acquired subsidiary over the net of the amounts assigned
to assets acquired and liabilities incurred or assumed is
capitalized as goodwill.
Foreign currency
translation
The financial information for subsidiaries outside the euro-zone
is generally measured using local currencies as the functional
currency. The financial statements of those foreign subsidiaries
are translated into Euros in the preparation of ASMLs
consolidated financial statements. Assets and liabilities are
translated into Euros at the exchange rate in effect on the
respective balance sheet dates. Income and expenses are
translated into Euros based on the average exchange rate for the
corresponding period. The resulting translation adjustments are
recorded directly in shareholders equity. Currency
differences on intercompany loans that have the nature of a
long-term investment are also accounted for directly in
shareholders equity.
Derivative
instruments
The Company principally uses derivative hedging instruments for
the management of foreign currency risks and interest rate
risks. The Company measures all derivative hedging instruments
based on fair values derived from market prices of the
instruments. The Company adopts hedge accounting for hedges that
are highly effective in offsetting the identified hedged risks
taking into account required effectiveness criteria.
Derivatives are initially recognized at fair value on the date a
derivative contract is entered into and are subsequently
remeasured at their fair value. The method of recognizing the
resulting gain or loss depends on whether the derivative is
designated as a hedging instrument, and if so, the nature of the
item being hedged. The Company designates certain derivatives as
either:
|
|
|
A hedge of the exposure to changes in the fair value of a
recognized asset or liability, or of an unrecognized firm
commitment, that are attributable to a particular risk (fair
value hedge);
|
ASML ANNUAL REPORT 2009
F-7
|
|
|
A hedge of the exposure to variability in the cash flows of a
recognized asset or liability, or of a forecasted transaction,
that is attributable to a particular risk (cash flow
hedge); or
|
|
A hedge of the foreign currency exposure of a net investment in
a foreign operation (net investment hedge);
|
The Company documents at the inception of the transaction the
relationship between hedging instruments and hedged items, as
well as its risk management objectives and strategy for
undertaking various hedging transactions. The Company also
documents its assessment, both at hedge inception and on an
ongoing basis, of whether derivatives that are used in hedging
transactions are highly effective in offsetting changes in fair
values or cash flows of hedged items.
Fair value
hedge
Changes in the fair value of a derivative that is designated and
qualifies as a fair value hedge, along with the gain or loss on
the hedged asset or liability, that is attributable to the
hedged risk, are recorded in the consolidated statements of
operations. The Company designates foreign currency hedging
instruments as a hedge of the fair value of a recognized asset
or liability in non-functional currencies.
The gain or loss relating to the ineffective portion of foreign
currency hedging instruments is recognized in the consolidated
statements of operations as net sales or cost
of sales.
Interest rate swaps that are being used to hedge the fair value
of fixed loan coupons payable are designated as fair value
hedges. The change in fair value is intended to offset the
change in the fair value of the underlying fixed loan coupons,
which is recorded accordingly.
The gain or loss relating to the ineffective portion of interest
rate swaps hedging fixed loan coupons payable is recognized in
the consolidated statements of operations as interest
income or interest expense.
Cash flow
hedge
Changes in the fair value of a derivative that is designated and
qualifies as a cash flow hedge are recorded in other
comprehensive income, net of taxes, until the underlying hedged
transaction is recognized in the consolidated statements of
operations. In the event that the underlying hedge transaction
will not occur within the specified time period, the gain or
loss on the related cash flow hedge is released from other
comprehensive income and included in the consolidated statements
of operations, unless, extenuating circumstances exist that are
related to the nature of the forecasted transaction and are
outside the control or influence of the Company and which cause
the forecasted transaction to be probable of occurring on a date
that is beyond the specified time period.
Foreign currency hedging instruments that are being used to
hedge cash flows related to forecasted sales or purchase
transactions in non-functional currencies are designated as cash
flow hedges. The gain or loss relating to the ineffective
portion of the foreign currency hedging instruments is
recognized in the consolidated statements of operations in
sales or cost of sales.
Interest rate swaps that are being used to hedge changes in the
variability of future interest receipts are designated as cash
flow hedges. The changes in fair value of the derivatives are
intended to offset changes in future interest cash flows on the
assets. The gain or loss relating to the ineffective portion of
interest rate swaps hedging the variability of future interest
receipts is recognized in the consolidated statements of
operations as interest income or interest
expense.
Net investment
hedge
Foreign currency hedging instruments that are being used to
hedge changes in the value of a net investment are designated as
net investment hedges. Changes in the fair value of a derivative
that is designated and qualifies as a net investment hedge are
recorded in other comprehensive income, net of taxes. The gain
or loss relating to the ineffective portion is recognized in the
consolidated statements of operations as interest
income or interest expense. Gains and losses
accumulated in other comprehensive income are recognized in the
consolidated statements of operations when the foreign operation
is (partially) disposed or sold. In 2009, the Company decided to
change its policy to manage material currency translation
exposures resulting predominantly from ASMLs
U.S. dollar net investments by hedging these partly with
forward contracts. The Company decided to no longer hedge these
U.S. dollar net investments exposures.
Cash and cash
equivalents
Cash and cash equivalents consist primarily of highly liquid
investments, such as bank deposits and money market funds with
insignificant interest rate risk and remaining maturities of
three months or less at the date of acquisition.
ASML ANNUAL REPORT 2009
F-8
Inventories
Inventories are stated at the lower of cost
(first-in,
first-out method) or market value. Cost includes net prices paid
for materials purchased, charges for freight and customs duties,
production labor cost and factory overhead. Allowances are made
for slow-moving, obsolete or unsellable inventory.
Allowances for inventory are determined based on the expected
demand which is derived from the sales forecasts as well as the
expected market value of the inventory.
Goodwill
Goodwill represents the excess of the costs of an acquisition
over the fair value of Companys share of the identifiable
net assets of the acquired subsidiary at the date of
acquisition. Goodwill on acquisition of subsidiaries is
allocated to reporting units for the purpose of impairment
testing. The allocation is made to those reporting units that
are expected to benefit from the business combination in which
the goodwill arose. Goodwill is tested for impairment annually
on September 30 and whenever events or changes in circumstances
indicate that the carrying amount of the goodwill may not be
recoverable. Goodwill is stated at cost less accumulated
impairment losses.
Other intangible
assets
Other intangible assets include acquired intellectual property
rights, developed technology, customer relationships and other
intangible assets. Other intangible assets are stated at cost,
less accumulated amortization and any accumulated impairment
losses. Amortization is calculated using the straight-line
method based on the estimated useful lives of the assets. The
following table presents the estimated useful lives of
ASMLs other intangible assets:
|
|
|
|
|
|
|
|
|
Category
|
|
Estimated useful life
|
|
Intellectual property rights
|
|
|
3 10 years
|
|
Developed technology
|
|
|
6 years
|
|
Customer relationships
|
|
|
8 years
|
|
Other intangible assets
|
|
|
2 6 years
|
|
|
Property, plant
and equipment
Property, plant and equipment are stated at cost, less
accumulated depreciation and any accumulated impairment losses.
Costs of assets manufactured by ASML include direct
manufacturing costs, production overhead and interest costs
incurred for qualifying assets during the construction period.
Depreciation is calculated using the straight-line method based
on the estimated useful lives of the related assets. In the case
of leasehold improvements, the estimated useful lives of the
related assets do not exceed the remaining term of the
corresponding lease.
The following table presents the estimated useful lives of
ASMLs property, plant and equipment:
|
|
|
|
|
|
|
|
|
Category
|
|
Estimated useful life
|
|
Buildings and constructions
|
|
|
5 40 years
|
|
Machinery and equipment
|
|
|
2 5 years
|
|
Furniture, fixtures and other equipment
|
|
|
3 5 years
|
|
Leasehold improvements
|
|
|
5 10 years
|
|
|
Land is not depreciated.
Certain internal and external costs associated with the purchase
and/or
development of internally used software are capitalized when
both the preliminary project stage is completed and management
has authorized further funding for the project, which it has
deemed probable to be completed and to be usable for the
intended function. These costs are amortized on a straight-line
basis over the period of related benefit, which ranges primarily
from three to five years.
Evaluation of
long-lived assets for impairment
Long-lived assets include goodwill, other intangible assets and
property, plant and equipment.
Goodwill is tested for impairment annually on September 30 and
whenever events or changes in circumstances indicate that the
carrying amount of the goodwill may not be recoverable. Goodwill
is tested for impairment based on a two-step approach. First the
recoverability is tested by comparing the carrying amount of the
goodwill with the fair value being the sum of the discounted
ASML ANNUAL REPORT 2009
F-9
future cash flows. If the carrying amount of the goodwill at
reporting unit level is higher than the fair value of the
goodwill, the second step should be performed. The goodwill
impairment is measured as the excess of the carrying amount of
the goodwill over its implied fair value. The implied fair value
of goodwill is determined by calculating the fair value of the
various assets and liabilities included in the reporting unit in
the same manner as goodwill is determined in a business
combination.
Other intangible assets and property, plant and equipment are
reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of those assets
may not be recoverable. Other intangible assets and property,
plant and equipment are tested for impairment based on a
two-step approach. First, the recoverability is tested by
comparing the carrying amount of the other intangible assets and
property, plant and equipment with the fair value being the sum
of the undiscounted future cash flows. Secondly, if the carrying
amount of the other intangible assets and property, plant and
equipment is higher than the fair value the assets are
considered to be impaired. An impairment expense is recognized
as the difference between the carrying amount and the fair value
of the other intangible assets and property, plant and equipment.
Provisions
Provisions include employee contract termination benefits and
lease contract termination costs.
Provisions for employee contract termination benefits are
recognized when ASML is demonstrably committed to either
terminating the employment of current employees according to a
detailed formal plan where there is no possibility of
withdrawal, or when ASML provides termination benefits as a
result of an offer made to encourage voluntary redundancy. The
timing of recognition and measurement of the provision for
employee termination benefits depends on whether employees are
required to render service until their employment is terminated
in order to receive the termination benefits. If employees are
not required to render services beyond the minimum retention
period, the provision will be recognized at the communication
date. If employees are required to render services beyond the
minimum retention period the provision will be recognized
ratably over the future service period. The provisions are
measured at fair value.
Provisions for lease contract termination costs are recognized
when costs will continue to be incurred under a contract for its
remaining term without economic benefit to the Company and the
Company ceases using the rights conveyed by the contract. The
provisions are measured at fair value which for an operating
lease contract is determined based on the remaining lease
payments reduced by the estimated sublease payments that could
be reasonably obtained for the building.
Revenue
recognition
ASML recognizes revenue when all four revenue recognition
criteria are met: persuasive evidence of an arrangement exists;
delivery has occurred or services have been rendered;
sellers price to buyer is fixed or determinable; and
collectability is reasonably assured. At ASML, this policy
generally results in revenue recognition from the sale of a
system upon shipment. The revenue from the installation of a
system is generally recognized upon completion of that
installation at the customer site. Each system undergoes, prior
to shipment, a Factory Acceptance Test in
ASMLs cleanroom facilities, effectively replicating the
operating conditions that will be present on the customers
site, in order to verify whether the system will meet its
standard specifications and any additional technical and
performance criteria agreed with the customer, if any. A system
is shipped, and revenue is recognized, only after all
specifications are met and customer sign-off is received or
waived. In case not all specifications are met and the remaining
performance obligation is not essential to the functionality of
the system but substantive rather than inconsequential or
perfunctory a portion of the sales price is deferred. Although
each systems performance is re-tested upon installation at
the customers site, ASML has never failed to successfully
complete installation of a system at a customers premises.
In connection with future introductions of new technology, the
Company may initially defer revenue recognition until completion
of installation and acceptance of the new technology at customer
premises. This deferral would continue until the Company is able
to conclude that installation of the technology in question
would occur consistently within a predetermined time period and
that the performance of the new technology would not reasonably
be different from that exhibited in the pre-shipment Factory
Acceptance Test. Any such deferral of revenues, however, could
have a material effect on ASMLs results of operations for
the fiscal period in which the deferral occurred and on the
succeeding fiscal period. At December 31, 2009 and 2008
ASML had no deferred revenue from shipments of new technology.
During the three years ended December 31, 2009 no revenue
from new technology was recorded that had been previously
deferred. As ASMLs systems are based largely on two
product platforms that permit incremental, modular upgrades, the
introduction of genuinely new technology occurs
infrequently, and in the past ten years, has occurred on only
one occasion in 1999.
ASML has no significant repurchase commitments in its general
sales terms and conditions. From time to time the Company
repurchases systems that it has manufactured and sold and,
following refurbishment, resells those systems to other
customers. This repurchase decision is driven by market demand
expressed by other customers and not by explicit or implicit
contractual arrangements relating to the initial sale. The
Company considers reasonable offers from any vendor, including
customers, to repurchase used systems so that it can refurbish,
resell and install these systems as part of its normal business
operations. Once
ASML ANNUAL REPORT 2009
F-10
repurchased, the repurchase price of the used system is recorded
in
work-in-process
inventory during the period it is being refurbished, following
which the refurbished system is reflected in finished products
inventory until it is sold to the customer. As of
December 31, 2009 and December 31, 2008 ASML had no
repurchase commitments.
A portion of ASMLs revenue is derived from contractual
arrangements with its customers that have multiple deliverables,
such as installation and training services and prepaid extended
and enhanced (optic) warranty contracts. The revenue relating to
the undelivered elements of the arrangements is deferred at fair
value until delivery of these elements. The fair value is
determined by vendor specific objective evidence
(VSOE) except the fair value of the prepaid extended
and enhanced (optic) warranty contracts which is based on the
list price. VSOE is determined based upon the prices that the
Company charges for installation and comparable services (such
as relocating a system to another customer site) on a
stand-alone basis, which are subject to normal price
negotiations. Revenue from installation and training services is
recognized when the services are completed. Revenue from prepaid
extended and enhanced (optic) warranty contracts is recognized
over the term of the contract.
The deferred revenue balance from installation and training
services as of December 31, 2009 amounted to approximately
EUR 3 million (2008: EUR 3 million) and
EUR 10 million (2008: EUR 15 million),
respectively.
The deferred revenue balance from prepaid extended and enhanced
(optic) warranty contracts as of December 31, 2009 amounted
to approximately EUR 126 million (2008:
EUR 173 million).
ASML offers customers discounts in the normal course of sales
negotiations. These discounts are directly deducted from the
gross sales price at the moment of revenue recognition. From
time to time, the Company offers volume discounts to a limited
number of customers. In some instances these volume discounts
can be used to purchase field options (system enhancements). The
related amount is recorded as a reduction in revenue at time of
shipment. From time to time, the Company offers free or
discounted products or services (award credits) to its customers
as part of a volume purchase agreement. The sales transaction
that gives rise to these award credits is accounted for as a
multiple element revenue transaction as the agreements involve
the delivery of multiple products. The consideration received
from the sales transaction is allocated between the award
credits and the other elements of the sales transaction. The
consideration allocated to the award credits is recognized as
deferred revenue until award credits are delivered to the
customer.
Revenues are recognized excluding the taxes levied on revenues
(net basis).
Warranty
The Company provides standard warranty coverage on its systems
for 12 months and on certain optic parts for
60 months, providing labor and parts necessary to repair
systems and optic parts during the warranty period. The
estimated warranty costs for a standard warranty are accounted
for by accruing these costs for each system upon recognition of
the system sale. Based upon historical service records, the
Company calculates the charge of average service hours and parts
per system to determine the estimated warranty costs. On a
semi-annual basis, the Company assesses, and updates if
necessary, its accounting estimates used to calculate the
standard warranty reserve based on the latest actual historical
warranty costs and expected future warranty costs.
The extended and enhanced (optic) warranty on the Companys
systems is accounted for as a separate element of multiple
element revenue recognition transactions.
Accounting for
shipping and handling fees and costs
ASML bills the customer for, and recognizes as revenue, any
charges for shipping and handling costs. The related costs are
recognized as cost of sales.
Cost of
sales
Cost of system sales comprise direct product costs such as
materials, labor, cost of warranty, depreciation, shipping and
handling costs and related overhead costs. ASML accrues for the
estimated cost of the warranty on its systems, which includes
the cost of labor and parts necessary to repair systems during
the warranty period. The amounts recorded in the warranty
accrual are estimated based on actual historical expenses
incurred and on estimated probable future expenses related to
current sales. Actual warranty costs are charged against the
accrued warranty reserve.
Costs of service sales comprise direct service costs such as
materials, labor, depreciation and overhead costs.
Cost of field option sales comprise direct product costs such as
materials, labor, cost of warranty, shipping and handling costs
and related overhead costs.
ASML ANNUAL REPORT 2009
F-11
Research and
development costs and credits
Costs relating to R&D are charged to operating expenses as
incurred. ASML receives subsidies and other credits from several
Netherlands and international (inter)governmental institutes.
These subsidies and other governmental credits to cover R&D
costs relating to approved projects are recorded as R&D
costs in the consolidated statements of operations in the period
when such costs occur.
Share-based
payments
The cost of employee services received (compensation expenses)
in exchange for awards of equity instruments are recognized
based upon the grant date fair value of stock options and stock.
The grant date fair value of stock options is estimated using a
Black-Scholes option valuation model. This Black-Scholes model
requires the use of assumptions, including expected stock price
volatility, the estimated life of each award and the estimated
dividend yield. The risk-free interest rate used in the model is
determined, based on a Euro government bond with a life equal to
the expected life of the equity-settled share-based payments.
The grant date fair value of stock is determined based on the
closing price of the Companys ordinary shares on the
Euronext Amsterdam.
The grant date fair value of the equity-settled share-based
payments is expensed on a straight-line basis over the vesting
period, based on the Companys estimate of equity
instruments that will eventually vest. At each balance sheet
date, the Company revises its estimate of the number of equity
instruments expected to vest. The impact of the revision of the
original estimates, if any, is recognized in the consolidated
statements of operations in the period in which the revision is
determined, with a corresponding adjustment to equity.
The Company makes quarterly assessments of the adequacy of the
(hypothetical) tax pool to determine whether there are tax
deficiencies that require recognition in the consolidated
statements of operations. The Company has selected the
alternative transition method (under ASC 718) in order to
calculate the tax pool.
The Companys current share-based payment plans do not
provide for cash settlement of options and stock.
Income
taxes
The asset and liability method is used in accounting for income
taxes. Under this method, deferred tax assets and liabilities
are recognized for the tax effect of incurred net operating
losses and for tax consequences attributable to differences
between the balance sheet carrying amounts of existing assets
and liabilities and their respective tax bases. If it is more
likely than not that the carrying amounts of deferred tax assets
will not be realized, a valuation allowance is recorded to
reduce the carrying amounts of those assets.
Deferred tax assets and liabilities are measured using enacted
tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of
a change in tax rates is recognized in the consolidated
statements of operations in the period that includes the
enactment date.
On January 1, 2007 the Company adopted the provisions of
FIN 48 Accounting for Uncertainty in Income
Taxes after codification included in ASC 740. ASC 740
clarifies the accounting for income taxes by prescribing a
minimum recognition threshold a tax position is required to meet
before being recognized in the financial statements. ASC 740
also provides guidance on derecognition, measurement,
classification, interest and penalties, accounting in interim
periods, disclosure and transition.
Contingencies and
litigation
The Company is party to various legal proceedings generally
incidental to its business, as disclosed in Note 17 to the
consolidated financial statements. In connection with these
proceedings and claims the Companys management evaluated,
based on the relevant facts and legal principles, the likelihood
of an unfavorable outcome and whether the amount of the loss
could be reasonably estimated. In each case, management
determined that either a loss was not probable or was not
reasonably estimable. As a result, no estimated losses were
recorded as a charge to the Companys consolidated
statements of operations in 2007, 2008 and 2009. Significant
subjective judgments were required in these evaluations,
including judgments regarding the validity of asserted claims
and the likely outcome of legal and administrative proceedings.
The outcome of these proceedings, however, is subject to a
number of factors beyond the Companys control, most
notably the uncertainty associated with predicting decisions by
courts and administrative agencies. In addition, estimates of
the potential costs associated with legal and administrative
proceedings frequently cannot be subjected to any sensitivity
analysis, as damage estimates or settlement offers by claimants
may bear little or no relation to the eventual outcome. Finally,
in any particular proceeding, the Company may agree to settle or
to terminate a claim or proceeding in which it believes that it
would ultimately prevail where it believes that doing so, when
taken together with other relevant commercial considerations, is
more cost-effective than engaging in an expensive and protracted
litigation, the outcome of which is uncertain.
ASML ANNUAL REPORT 2009
F-12
The Company accrues for legal costs related to litigation in its
consolidated statements of operations at the time when the
related legal services are actually provided to it.
Net income (loss)
per ordinary share
Basic net income (loss) per ordinary share is computed by
dividing net income (loss) by the weighted average ordinary
shares outstanding for that period. Diluted net income (loss)
per ordinary share reflects the potential dilution that could
occur if options issued under ASMLs share-based payment
plan were exercised, and if ASMLs convertible notes were
converted, unless the exercise of the stock options or
conversion of the convertible notes would have an anti-dilutive
effect. The dilutive effect is calculated using the if-converted
method. Following this method, ASMLs convertible notes
were considered dilutive in 2007. In the second half of 2007,
these notes were converted or redeemed. Excluded from the
diluted weighted average number of shares outstanding
calculation are cumulative preference shares contingently
issuable to the preference share foundation, since they
represent a different class of stock than the ordinary shares.
See further discussion in Note 25.
The earnings per share (EPS) data have been
calculated in accordance with the following schedule:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands, except per share data)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Basic EPS computation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to holders of common shares
|
|
|
671,001
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding (after
deduction of treasury stock) during the year
|
|
|
462,406
|
|
|
|
431,620
|
|
|
|
432,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
|
1.45
|
|
|
|
0.75
|
|
|
|
(0.35
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS computation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to holders of common shares
|
|
|
671,001
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
Plus interest on assumed conversion of convertible subordinated
notes, net of taxes
|
|
|
11,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to holders of common shares plus
effect of assumed conversions
|
|
|
682,851
|
|
|
|
322,370
|
|
|
|
(150,925
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares:
|
|
|
462,406
|
|
|
|
431,620
|
|
|
|
432,615
|
|
Plus shares applicable to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
4,569
|
|
|
|
2,585
|
|
|
|
|
|
Convertible subordinated notes
|
|
|
18,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive potential common shares
|
|
|
23,237
|
|
|
|
2,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted weighted average number of
shares1
|
|
|
485,643
|
|
|
|
434,205
|
|
|
|
432,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share1
|
|
|
1.41
|
|
|
|
0.74
|
|
|
|
(0.35
|
)
|
|
|
|
1
|
The calculation of diluted net
income (loss) per ordinary share assumes the exercise of options
issued under ASML stock option plans for periods in which
exercises would have a dilutive effect. The calculation of
diluted net income (loss) per ordinary share does not assume
exercise of such options when such exercises would be
anti-dilutive.
|
Comprehensive
income
Comprehensive income consists of net income (loss) and other
comprehensive income.
Other comprehensive income refers to revenues, expenses, gains
and losses that are not included in net income (loss), but
recorded directly in shareholders equity. For the years
ended December 31, 2007, 2008 and 2009, comprehensive
income consists of net income (loss), unrealized gains and
losses on derivative instruments, net of taxes, and unrealized
gains and losses on foreign currency translation, net of taxes.
New U.S.
GAAP Accounting Pronouncements
In June 2009, the FASB issued ASC 105 Generally Accepted
Accounting Principles. ASC 105 establishes the FASB
Accounting Standards Codification (Codification) as the single
source of authoritative generally accepted accounting principles
recognized by the FASB to be applied by nongovernmental
entities. All of its content carries the same level of
authority, effectively superseding FASB Statement 162 and
modifying the GAAP hierarchy to include only two levels of GAAP:
authoritative and non-authoritative. The Codification is
effective for financial statements issued for interim and annual
periods ending after September 15, 2009. The adoption of
ASC 105 did not have any impact on our consolidated financial
statements, but resulted in the update of all references to
accounting guidance in this
Form 20-F
to refer to the new Codification.
ASML ANNUAL REPORT 2009
F-13
In 2009 ASML has adopted ASC 820, Fair Value
Measurements. The ASC defines fair value, provides
guidance on how to measure assets and liabilities using fair
value and expands disclosures about fair value measurements. The
adoption of ASC 820 did not have any impact on the
Companys consolidated financial statements, but resulted
in additional disclosures to the Companys consolidated
financial statements; See Note 2, Fair Value
Measurements for more information.
In April 2009, the FASB issued ASC
820-10-65-4,
Determining Fair Value When the Volume and Level of
Activity for the Asset or Liability Have Significantly Decreased
and Identifying Transactions That Are Not Orderly. This
ASC provides guidelines for making fair value measurements more
consistent with the principles presented in ASC 820, Fair
Value Measurements. The ASC relates to determining fair
values when there is no active market or where the price inputs
being used represent distressed sales. It reaffirms the
objective of fair value measurement to reflect how
much an asset would be sold for in an orderly transaction (as
opposed to a distressed or forced transaction) at the date of
the financial statements under current market conditions.
Specifically, it reaffirms the need to use judgment to ascertain
if a formerly active market has become inactive and in
determining fair values when markets have become inactive. The
ASC is effective for financial statements issued for fiscal
years and interim periods beginning after June 15, 2009 and
should be applied prospectively. The Company is currently
assessing the impact that this ASC may have on its consolidated
financial statements.
In June 2009, the FASB issued ASC 810 (Statement 167,
Amendments to FASB Interpretation No. 46(R)).
This ASC changes the way in which a company determines whether
or not an entity that is insufficiently capitalized or is not
controlled through voting (or similar rights) should be
consolidated. The determination of whether a company is required
to consolidate an entity is based on, among other things, an
entitys purpose and design and its ability to direct the
activities of the entity that most significantly impact the
entitys economic performance. This ASC is effective for
fiscal years and interim periods beginning after
November 15, 2009. The Company is currently assessing the
impact that this ASC may have on the its consolidated financial
statements.
In September 2009, the EITF reached final consensus on ASU
2009-13,
Revenue Arrangements with Multiple Deliverables. ASU
2009-13
amends the current guidance on arrangements with multiple
deliverables (ASC
605-25) to
(1) eliminate the separation criterion that requires
entities to establish objective and reliable evidence of fair
value for undelivered elements, (2) establish a selling
price hierarchy to help entities allocate arrangement
consideration to the separate units of account (i.e. separate
elements of the sales agreement), (3) require the relative
selling price allocation method for all arrangements (i.e.,
eliminate the residual method), and (4) significantly
expand required disclosures. The final consensus is effective
for financial years beginning after June 15, 2010. The
Company is currently assessing the impact that ASU
2009-13 will
have on its consolidated financial statements.
In September 2009, the EITF reached final consensus on ASU
2009-14,
Certain Revenue Arrangements that include Software elements. ASU
2009-14
amends the scoping guidance for software arrangements (ASC
985-605) to
exclude tangible products that contain software elements and
non-software elements that function together to interdependently
deliver the products essential functionality. ASU
2009-14 also
provides considerations and examples for entities applying this
guidance.
This issue will be effective prospectively for new or materially
modified agreements entered into in financial years beginning on
or after June 15, 2010. The Company is currently assessing
the impact that ASU
2009-14 will
have on its consolidated financial statements.
2. Fair value
measurements
Fair value is the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. The fair
value measurement hierarchy prioritizes the inputs to valuation
techniques used to measure fair value as follows:
|
|
|
Level 1: Valuations based on inputs such
as quoted prices for identical assets or liabilities in active
markets that the entity has the ability to access.
|
|
|
Level 2: Valuations based on inputs other
than level 1 inputs such as quoted prices for similar
assets or liabilities, quoted prices in markets that are not
active, or other inputs that are observable or can be
corroborated by observable data for substantially the full term
of the assets or liabilities.
|
|
|
Level 3: Valuations based on inputs that
are supported by little or no market activity and that are
significant to the fair value of the assets or liabilities.
|
The fair value hierarchy gives the highest priority to quoted
prices (unadjusted) in active markets for identical assets or
liabilities (Level 1) and the lowest priority to
unobservable inputs (Level 3). A financial
instruments fair value is based on the lowest level of any
input that is significant in the fair value measurement
hierarchy.
ASML ANNUAL REPORT 2009
F-14
Financial assets
and financial liabilities measured at fair value on a recurring
basis
Cash and cash equivalents include short-term deposits,
investments in money market funds and interest-bearing bank
accounts for which fair value measurements are all based on
quoted prices for similar assets or liabilities.
The principal market in which ASML executes its derivative
contracts is the institutional market in an
over-the-counter
environment with a high level of price transparency. The market
participants usually are large commercial banks. The valuation
inputs for ASMLs derivative contracts are based on quoted
prices and quoting pricing intervals from public data sources;
they do not involve management judgment.
The valuation technique used to determine the fair value of
forward contracts (used for hedging purposes) is the Net Present
Value technique which is the estimated amount that a bank would
receive or pay to terminate the forward contracts at the
reporting date, taking into account current interest rates and
current exchange rates. The valuation technique used to
determine the fair value of forward contracts approximates the
net present value of future cash flows.
The valuation technique used to determine the fair value of
interest rate swaps (used for hedging purposes) is the Net
Present Value technique which is the estimated amount that a
bank would receive or pay to terminate the swap agreements at
the reporting date, taking into account current interest rates.
The valuation technique used to determine the fair value of
interest rate swaps approximates the net present value of future
cash flows.
The carrying amount of the Eurobond consists of its principal
amount adjusted for fair value changes in interest rate swaps.
The Eurobond serves as a hedged item in a fair value hedge
relationship in which ASML hedges the variability of changes in
the market value of fixed loan coupons payable on the
Companys Eurobond due to changes in market interest rates;
the fair value changes of the interest rate swaps are recorded
on the balance sheet under derivative financial instruments
(within other current and non-current assets). Therefore, the
value disclosed in the table below is only adjusted for fair
value changes in interest rate swaps. For the actual fair value,
including credit risk considerations, we refer to Note 14.
The following table presents the Companys financial assets
and financial liabilities that are measured at fair value on a
recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
(In thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative financial
instruments1
|
|
|
|
|
|
|
92,446
|
|
|
|
|
|
|
|
92,446
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
1,109,184
|
|
|
|
|
|
|
|
1,109,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
1,201,630
|
|
|
|
|
|
|
|
1,201,630
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term
debt2
|
|
|
|
|
|
|
647,050
|
|
|
|
|
|
|
|
647,050
|
|
Derivative financial
instruments1
|
|
|
|
|
|
|
67,794
|
|
|
|
|
|
|
|
67,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
714,844
|
|
|
|
|
|
|
|
714,844
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2009
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
(In thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative financial
instruments1
|
|
|
|
|
|
|
103,384
|
|
|
|
|
|
|
|
103,384
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
1,037,074
|
|
|
|
|
|
|
|
1,037,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
1,140,458
|
|
|
|
|
|
|
|
1,140,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term
debt2
|
|
|
|
|
|
|
663,102
|
|
|
|
|
|
|
|
663,102
|
|
Derivative financial
instruments1
|
|
|
|
|
|
|
17,471
|
|
|
|
|
|
|
|
17,471
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
680,573
|
|
|
|
|
|
|
|
680,573
|
|
|
|
|
1
|
The derivative financial
instruments consist of forward contracts and interest rate
swaps. See Note 3, Market risks and derivatives.
|
2
|
The long-term debt mainly relates
to the Companys EUR 600 million Eurobond and
excludes accrued interest. For further details see Note 14,
Long-term debt.
|
As of December 31, 2009, the Company did not have any
assets or liabilities measured at fair value on a recurring
basis using significant unobservable inputs
(Level 3) in its consolidated balance sheets.
ASML ANNUAL REPORT 2009
F-15
Assets and
liabilities measured at fair value on a nonrecurring
basis
In 2009, the Company recognized impairment charges of
EUR 15.9 million on its property, plant and equipment,
mainly relating to machinery and equipment. Valuation of these
assets are classified as Level 3 in the fair value
hierarchy since their fair values were determined based on
unobservable inputs. The impairment charge is determined based
on the difference between the assets estimated fair value
(being EUR 7.0 million) and their carrying amount. In
determining the fair value of an asset, the Company makes
estimates about future cash flows. These estimates are based on
the financial plan updated with the latest available projection
of semiconductor market conditions and ASMLs sales and
cost expectations which are consistent with the plans and
estimates that the Company uses to manage the business. For
further information, see Note 11, Property, plant and
equipment.
The Company did not recognize any impairment charges for
goodwill and other intangible assets during 2009. See
Notes 9 and 10 for more information.
3. Market risks
and derivatives
The Company is exposed to a variety of financial risks: market
risks (including foreign currency exchange risk and interest
rate risk), credit risk, liquidity and capital risk. The overall
risk management program focuses on the unpredictability of
financial markets and seeks to minimize potentially adverse
effects on the Companys financial performance. The Company
uses derivative instruments to hedge certain risk exposures:
None of the transactions are entered into for trading or
speculative purposes.
ASML believes that market information is the most reliable and
transparent means of measurement for its derivative instruments
that are measured at fair value.
Foreign currency
risk management
The Company uses the euro as its invoicing currency in order to
limit the exposure to foreign currency movements. Exceptions may
occur on a customer by customer basis. To the extent that
invoicing is done in a currency other than the euro, the Company
is exposed to foreign currency risk.
It is the Companys policy to hedge material transaction
exposures, such as forecasted sales and purchase transactions
and accounts receivable and payable. The Company hedges these
exposures through the use of currency contracts (foreign
exchange options and forward contracts). In 2009, the Company
identified four ineffective cash flow hedges related to
forecasted sales transactions. This resulted in a loss
recognized in sales for an amount of EUR 10.7 million
(2008: loss of EUR 18.0 million). The effectiveness of
all outstanding hedge contracts is monitored on a quarterly
basis throughout the life of the hedges.
As of December 31, 2009 other comprehensive income includes
EUR 56.1 million loss (net of taxes:
EUR 41.8 million loss; 2008:
EUR 49.2 million loss) representing the total
anticipated loss to be released to sales, and
EUR 0.7 million gain (net of taxes:
EUR 0.5 million gain; 2008: EUR 1.4 million
gain) to be charged to cost of sales, which will offset the
higher EUR equivalent of foreign currency denominated forecasted
sales and purchase transactions. It is anticipated that an
amount of EUR 34.7 million loss will be charged to
sales and EUR 0.7 million gain will be released to
cost of sales over the next twelve months, as the forecasted
sales and purchase transactions occur. The remainder of the loss
is anticipated to be charged to sales between one and two years,
as the forecasted sales transactions occur.
It is the Companys policy to hedge material remeasurement
exposures. These net exposures from certain monetary assets and
liabilities in non-functional currencies are hedged with forward
contracts.
In 2009, the Company decided to change its hedging policy of
managing material currency translation exposures resulting
predominantly from ASMLs U.S. dollar net investments
by hedging these partly with forward contracts. The Company
decided to no longer hedge these U.S. dollar translation
exposures. The related foreign currency translation amounts
included in cumulative translation adjustment for the year 2009
was EUR 13.1 million loss (2008:
EUR 12.7 million gain). The cumulative gain included
in cumulative translation adjustment relating to the net
investment hedge would be reclassified from equity to the
consolidated statements of operations only in the event the
Companys U.S. subsidiary is (partially) disposed or
sold.
Interest rate
risk management
The Company has both assets and liabilities that bear interest,
which expose the Company to fluctuations in the prevailing
market rate of interest. The Company uses interest rate swaps to
align the interest typical terms of interest-bearing assets with
the interest typical terms of interest-bearing liabilities.
There might be some residual interest rate risks to the extent
that the asset and liability positions do not fully offset.
ASML ANNUAL REPORT 2009
F-16
Furthermore, the Company uses interest rate swaps to hedge
changes in market value of fixed loan coupons payable on its
Eurobond due to changes in market interest rates and to hedge
the variability of future interest receipts as a result of
changes in market interest rates on part of its cash and cash
equivalents.
Financial
instruments
The Company uses currency contracts to manage its currency risk
and interest rate swaps to manage its interest rate risk. Most
derivatives will mature in one year or less after the balance
sheet date. The following table summarizes the notional amounts
and estimated fair values of the Companys financial
instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
Notional
|
|
|
|
|
|
Notional
|
|
|
|
|
As of December 31
|
|
Amount
|
|
|
Fair Value
|
|
|
Amount
|
|
|
Fair Value
|
|
(In thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Currency
contracts1
|
|
|
896,642
|
|
|
|
(38,521
|
)
|
|
|
527,816
|
|
|
|
7,428
|
|
Interest rate
swaps2
|
|
|
641,500
|
|
|
|
63,173
|
|
|
|
641,500
|
|
|
|
78,485
|
|
|
(Source:
Bloomberg Finance LP)
|
|
1
|
Relates to forward contracts
assigned as a hedge to forecasted sales and purchase
transactions, to monetary assets and liabilities and to net
investments in foreign operations (only 2008), mainly in
U.S. dollar and Japanese Yen
|
2
|
Relates to interest rate swaps
assigned as a hedge to interest bearing assets and liabilities
mainly related to the EUR 600 million Eurobond; the
fair value of the interest rate swaps includes accrued interest
|
Credit risk
management
Financial instruments that potentially subject ASML to
significant concentrations of credit risk consist principally of
cash and cash equivalents, accounts receivable and derivative
instruments used in hedging activities.
Cash and cash equivalents and derivative instruments contain an
element of risk of the counterparties being unable to meet their
obligations. This financial credit risk is monitored and
minimized per type of financial instrument by limiting
ASMLs counterparties to a sufficient number of major
financial institutions. Furthermore, in view of the continuing
higher volatility of the financial markets, ASMLs cash and
cash equivalents have mainly been placed on short term deposits
with highly rated financial institutions and have partly been
invested in AAAm-rated money market funds that invest in highly
rated short term debt securities of financial institutions and
governments. ASML does not expect the counterparties to default
given their high credit quality.
ASMLs customers consist of IC manufacturers located
throughout the world. ASML performs ongoing credit evaluations
of its customers financial condition. ASML regularly
reviews if an allowance for doubtful debts is needed by
considering factors such as historical payment experience,
credit quality, and age of the accounts receivable balances, and
current economic conditions that may affect a customers
ability to pay. In response to the increased volatility of the
financial markets, ASML has taken additional measures to
mitigate credit risk when considered appropriate by means of
e.g. down payments, letters of credit, and retention of
ownership. Retention of ownership enables ASML to recover the
systems in the event a customer defaults on payment.
Liquidity and
Capital risk management
Prudent liquidity risk management implies maintaining sufficient
cash and cash equivalents and the availability of funding
through an adequate amount of committed credit facilities.
ASMLs general strategy is to seek to maintain its
strategic target level of cash and cash equivalents between
EUR 1.0 and 1.5 billion. The Company regularly reviews
the efficiency of its capital structure. To the extent that the
Companys cash and cash equivalents exceeds this target and
there are no investment opportunities that it wishes to pursue,
it will consider returning excess cash to its shareholders,
including through share buybacks, dividends and capital
repayment.
As of December 31, 2009 the cash and cash equivalents
amounted to EUR 1.0 billion and the Company has
available credit facilities for a total amount of
EUR 700 million (2008: EUR 500 million). The
EUR 700 million of available credit facilities consist
of two separate facilities: a EUR 500 million credit
facility and a EUR 200 million loan facility.
The EUR 500 million credit facility, which will expire
in May 2012, contains a covenant that requires the Company to
maintain a minimum financial condition ratio, calculated in
accordance with a contractually agreed formula. ASML was in
compliance with the covenant at the end of 2009 and 2008.
Outstanding amounts under this credit facility will bear
interest at EURIBOR or LIBOR plus a margin that is dependent on
the Companys liquidity position. No amounts were
outstanding under this credit facility at the end of 2009 and
2008.
The EUR 200 million loan facility is related to the
Companys EUV investment efforts and was entered into in
2009 with the European Investment Bank. This loan can be drawn
in tranches until October 2010. It is repayable in annual
installments four years after drawdown, with final repayment
seven years after drawdown. This facility contains a covenant
that restricts the
ASML ANNUAL REPORT 2009
F-17
maximum indebtedness. ASML was in compliance with the covenant
at the end of 2009. Outstanding amounts under this loan facility
will bear interest at EURIBOR or LIBOR plus a margin. No amounts
were outstanding under this loan facility at the end of 2009.
4. Cash and cash
equivalents
Cash and cash equivalents at December 31, 2009 include
short-term deposits of EUR 652 million (2008:
EUR 833 million), investments in money market funds of
EUR 303 million (2008: EUR 201 million) and
interest-bearing bank accounts of EUR 82 million
(2008: EUR 75 million).
Cash and cash equivalents have insignificant interest rate risk
and remaining maturities of three months or less at the date of
acquisition. No further restrictions on usage of cash and cash
equivalents exist. The carrying amount of these assets
approximates their fair value.
5. Accounts
receivable
Accounts receivable consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Accounts receivable, gross
|
|
|
464,703
|
|
|
|
380,678
|
|
Allowance for doubtful receivables
|
|
|
(1,430
|
)
|
|
|
(3,239
|
)
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
463,273
|
|
|
|
377,439
|
|
|
The carrying amount of the accounts receivable approximates the
fair value. The maximum exposure to credit risk at
December 31, 2009 is the fair value of the accounts
receivable mentioned above. ASML has taken additional measures
to mitigate credit risk when considered appropriate by means of
e.g. letters of credit, down payments and retention of
ownership, which is intended to enable ASML to recover the
systems in the event a customer defaults on payment.
Movements of the allowance for doubtful receivables are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Balance at beginning of year
|
|
|
(1,385
|
)
|
|
|
(1,430
|
)
|
Utilization of the provision
|
|
|
143
|
|
|
|
80
|
|
Addition for the
year1
|
|
|
(188
|
)
|
|
|
(1,889
|
)
|
|
|
|
|
|
|
|
|
|
Balance at end of year
|
|
|
(1,430
|
)
|
|
|
(3,239
|
)
|
|
|
|
1
|
Addition for the year is recorded
in cost of sales.
|
ASML ANNUAL REPORT 2009
F-18
6. Finance
receivables
Finance receivables consist of the net investment in sales-type
leases. The sales-type leases transfer ownership of the systems
to the lessee by the end of the lease term. The average lease
term is two years. The following table lists the components of
the finance receivables as of December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Finance receivables, gross
|
|
|
40,866
|
|
|
|
22,444
|
|
Unearned interest
|
|
|
(3,611
|
)
|
|
|
(891
|
)
|
|
|
|
|
|
|
|
|
|
Finance receivables, net
|
|
|
37,255
|
|
|
|
21,553
|
|
Current portion of finance receivables, gross
|
|
|
6,781
|
|
|
|
22,444
|
|
Current portion of unearned interest
|
|
|
(556
|
)
|
|
|
(891
|
)
|
|
|
|
|
|
|
|
|
|
Non-current portion of finance receivables, net
|
|
|
31,030
|
|
|
|
|
|
|
At December 31, 2009, the finance receivables due for
payment in each of the next five years and thereafter are as
follows:
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
EUR
|
|
2010
|
|
|
22,444
|
|
2011
|
|
|
|
|
2012
|
|
|
|
|
2013
|
|
|
|
|
2014
|
|
|
|
|
Thereafter
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
22,444
|
|
|
7.
Inventories
Inventories consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Raw materials
|
|
|
140,615
|
|
|
|
175,045
|
|
Work-in-process
|
|
|
655,505
|
|
|
|
799,390
|
|
Finished products
|
|
|
392,910
|
|
|
|
214,248
|
|
|
|
|
|
|
|
|
|
|
Total inventories, gross
|
|
|
1,189,030
|
|
|
|
1,188,683
|
|
Allowance for obsolescence and/or lower market value
|
|
|
(189,880
|
)
|
|
|
(225,301
|
)
|
|
|
|
|
|
|
|
|
|
Total inventories, net
|
|
|
999,150
|
|
|
|
963,382
|
|
|
A summary of activity in the allowance for obsolescence is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Balance at beginning of year
|
|
|
(129,045
|
)
|
|
|
(189,880
|
)
|
Addition for the year
|
|
|
(139,628
|
)
|
|
|
(86,636
|
)
|
Effect of exchange rates
|
|
|
(17
|
)
|
|
|
(260
|
)
|
Release of the provision
|
|
|
2,113
|
|
|
|
|
|
Utilization of the provision
|
|
|
76,697
|
|
|
|
51,475
|
|
|
|
|
|
|
|
|
|
|
Balance at end of year
|
|
|
(189,880
|
)
|
|
|
(225,301
|
)
|
|
ASML ANNUAL REPORT 2009
F-19
In 2009, the addition for the year is recorded in cost of sales
for an amount of EUR 68.1 million and R&D costs
for an amount of EUR 18.5 million (2008: cost of sales
EUR 139.6 million).
As of December 31, 2009, the allowance for inventory
obsolescence amounted to EUR 225.3 million (2008:
EUR 189.9 million). The increase in the allowance for
inventory obsolescence is mainly due to a reassessment by the
Company in 2009 of expected future demand based on the
unexpected customers response to the financial and
economic crisis. This resulted in an increase in allowance for
inventory obsolescence for different types of non-leading-edge
systems compared to prior year and additional parts which
management believes cannot be sold.
Utilization of the provision mainly relates to sale and scrap of
impaired inventories. At the end of 2008, customers in the
market segment for Logic technology underestimated the
ramp-up of
45 nm technology used in, among others, advanced internet
devices and smart phones, which unexpectedly increased demand
for our non-leading-edge immersion systems in 2009 (mainly
XT:1700i). As a result we made EUR 64.8 million profit
on the sale of inventories that had been previously written down.
8. Other
assets
Other current assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Advance payments to Zeiss
|
|
|
103,798
|
|
|
|
73,759
|
|
Prepaid expenses
|
|
|
57,471
|
|
|
|
46,808
|
|
Derivative instruments
|
|
|
39,240
|
|
|
|
47,436
|
|
VAT
|
|
|
18,693
|
|
|
|
25,211
|
|
Other
|
|
|
16,875
|
|
|
|
25,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other current assets
|
|
|
236,077
|
|
|
|
218,746
|
|
|
Zeiss is the Companys sole supplier of lenses and, from
time to time, receives non-interest bearing advance payments
from the Company that assist in financing Zeiss
work-in-process
and thereby secure lens deliveries to the Company. Amounts owed
under these advance payments are repaid through lens deliveries.
Prepaid expenses include a tax prepayment on intercompany
profit, not realized by the group of EUR 25.4 million
in 2009 (2008: EUR 26.2 million).
Derivative financial instruments consist of currency contracts
and the current part of the fair value of interest rate swaps
which includes accrued interest.
Other non-current assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Derivative instruments
|
|
|
53,206
|
|
|
|
55,948
|
|
Loan to Micronic
|
|
|
13,000
|
|
|
|
|
|
Compensation plan
assets1
|
|
|
7,103
|
|
|
|
8,520
|
|
Prepaid expenses
|
|
|
5,542
|
|
|
|
5,893
|
|
Subordinated loan granted to lessor
|
|
|
|
|
|
|
|
|
in respect of Veldhoven
headquarters2
|
|
|
5,445
|
|
|
|
5,445
|
|
Other
|
|
|
3,901
|
|
|
|
1,248
|
|
|
|
|
|
|
|
|
|
|
Total other non-current assets
|
|
|
88,197
|
|
|
|
77,054
|
|
|
|
|
1
|
For further details on compensation
plan see Note 16.
|
2
|
For further details on loan granted
to lessor in respect of Veldhoven headquarters see Note 15.
|
Derivative instruments consist of the non-current part of the
fair value of interest rate swaps which includes accrued
interest.
The loan to Micronic related to a license agreement between
Micronic Laser Systems AB and ASML, which was fully repaid in
2009.
ASML ANNUAL REPORT 2009
F-20
9.
Goodwill
Changes in goodwill are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Cost
|
|
|
|
|
|
|
|
|
Balance, January 1
|
|
|
128,271
|
|
|
|
131,453
|
|
Effect of exchange rates
|
|
|
3,182
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31
|
|
|
131,453
|
|
|
|
131,462
|
|
Carrying amount, December 31
|
|
|
131,453
|
|
|
|
131,462
|
|
|
The goodwill relates to the acquisition of Brion in March 2007.
Goodwill is tested for impairment annually on September 30 and
whenever events or changes in circumstances indicate that the
carrying amount of the goodwill may not be recoverable. For the
purpose of impairment testing, goodwill is allocated to the
reporting unit Brion. The fair value of the reporting unit Brion
is calculated based on the discounted cash flow method (income
approach). These calculations use after-tax discounted cash flow
projections based on the strategic plan approved by management.
The material assumptions used by management for the fair value
calculation of the reporting unit are:
|
|
|
Cash flow projections for the first six years are based on a
significant growth scenario, reflecting the
start-up
nature of Brion. The projections are built
bottom-up,
using estimates for revenue, gross profit, R&D costs and
SG&A costs.
|
|
Brion would reach maturity in the final year of this six year
start-up
period and grow at a weighted average growth rate of three
percent, which Management believes is a reasonable estimate that
does not exceed the long-term historical average growth rate for
the lithography business in which Brion operates.
|
|
A discount rate of 14.7 percent representing Brions
weighted average cost of capital (WACC) is determined using an
adjusted version of the Capital Asset Pricing Model. Since Brion
is not financed with debt, WACC is assumed to equal Brions
cost of equity. The discount rate increased compared to the
prior year reflecting the increased market uncertainty.
|
Management believes that the fair value calculated reflects the
amount a market participant would be willing to pay. Based on
this analysis management believes that the fair value of the
reporting unit substantially exceeded its carrying value and
that, therefore, goodwill was not impaired as of
December 31, 2009 and December 31, 2008.
ASML ANNUAL REPORT 2009
F-21
10. Other
intangible assets
Other intangible assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intellectual
|
|
|
Developed
|
|
|
Customer
|
|
|
In-process
|
|
|
|
|
|
|
|
|
|
property
|
|
|
technology
|
|
|
relationships
|
|
|
R&D
|
|
|
Other
|
|
|
Total
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2008
|
|
|
47,215
|
|
|
|
23,901
|
|
|
|
8,063
|
|
|
|
23,148
|
|
|
|
2,141
|
|
|
|
104,468
|
|
Additions
|
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
Effect of exchange rates
|
|
|
|
|
|
|
593
|
|
|
|
200
|
|
|
|
|
|
|
|
54
|
|
|
|
847
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008
|
|
|
47,250
|
|
|
|
24,494
|
|
|
|
8,263
|
|
|
|
23,148
|
|
|
|
2,195
|
|
|
|
105,350
|
|
Additions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rates
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009
|
|
|
47,250
|
|
|
|
24,495
|
|
|
|
8,263
|
|
|
|
23,148
|
|
|
|
2,196
|
|
|
|
105,352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated amortization and impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2008
|
|
|
37,797
|
|
|
|
3,765
|
|
|
|
839
|
|
|
|
23,148
|
|
|
|
724
|
|
|
|
66,273
|
|
Amortization
|
|
|
5,780
|
|
|
|
3,840
|
|
|
|
1,005
|
|
|
|
|
|
|
|
867
|
|
|
|
11,492
|
|
Impairment charges
|
|
|
|
|
|
|
552
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
552
|
|
Effect of exchange rates
|
|
|
|
|
|
|
249
|
|
|
|
50
|
|
|
|
|
|
|
|
42
|
|
|
|
341
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008
|
|
|
43,577
|
|
|
|
8,406
|
|
|
|
1,894
|
|
|
|
23,148
|
|
|
|
1,633
|
|
|
|
78,658
|
|
Amortization
|
|
|
3,436
|
|
|
|
4,019
|
|
|
|
1,075
|
|
|
|
|
|
|
|
254
|
|
|
|
8,784
|
|
Impairment charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rates
|
|
|
|
|
|
|
(157
|
)
|
|
|
(42
|
)
|
|
|
|
|
|
|
(19
|
)
|
|
|
(218
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009
|
|
|
47,013
|
|
|
|
12,268
|
|
|
|
2,927
|
|
|
|
23,148
|
|
|
|
1,868
|
|
|
|
87,224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
3,673
|
|
|
|
16,088
|
|
|
|
6,369
|
|
|
|
|
|
|
|
562
|
|
|
|
26,692
|
|
December 31, 2009
|
|
|
237
|
|
|
|
12,227
|
|
|
|
5,336
|
|
|
|
|
|
|
|
328
|
|
|
|
18,128
|
|
|
Developed technology, customer relationships, in-process
R&D and other were obtained from the acquisition of Brion.
During 2009, the Company recorded amortization charges of
EUR 8.8 million (2008: EUR 11.5 million;
2007: EUR 36.4 million) which were fully recorded in
cost of sales (2008: cost of sales EUR 11.5 million;
2007: cost of sales EUR 13.0 million and R&D
costs EUR 23.4 million).
During 2009, the Company did not record any impairment charges
for other intangible assets (2008: EUR 0.6 million;
2007: EUR 1.0 million).
Estimated amortization expenses relating to other intangible
assets for the next five years and thereafter are as follows:
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
EUR
|
|
2010
|
|
|
5,208
|
|
2011
|
|
|
5,001
|
|
2012
|
|
|
5,001
|
|
2013
|
|
|
1,698
|
|
2014
|
|
|
1,037
|
|
Thereafter
|
|
|
183
|
|
|
|
|
|
|
Total
|
|
|
18,128
|
|
|
ASML ANNUAL REPORT 2009
F-22
11. Property,
plant and equipment
Property, plant and equipment consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Land,
|
|
|
Machinery
|
|
|
|
|
|
Furniture,
|
|
|
|
|
|
|
buildings and
|
|
|
and
|
|
|
Leasehold
|
|
|
fixtures and other
|
|
|
|
|
|
|
constructions
|
|
|
equipment
|
|
|
improvements
|
|
|
equipment
|
|
|
Total
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2008
|
|
|
183,159
|
|
|
|
466,930
|
|
|
|
149,117
|
|
|
|
257,102
|
|
|
|
1,056,308
|
|
Additions
|
|
|
172,002
|
|
|
|
107,093
|
|
|
|
12,319
|
|
|
|
30,625
|
|
|
|
322,039
|
|
Disposals
|
|
|
(382
|
)
|
|
|
(91,024
|
)
|
|
|
(8,037
|
)
|
|
|
|
|
|
|
(99,443
|
)
|
Effect of exchange rates
|
|
|
752
|
|
|
|
399
|
|
|
|
425
|
|
|
|
570
|
|
|
|
2,146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008
|
|
|
355,531
|
|
|
|
483,398
|
|
|
|
153,824
|
|
|
|
288,297
|
|
|
|
1,281,050
|
|
Additions
|
|
|
74,135
|
|
|
|
179,050
|
|
|
|
3,484
|
|
|
|
7,258
|
|
|
|
263,927
|
|
Disposals
|
|
|
(2,247
|
)
|
|
|
(127,152
|
)
|
|
|
(2,403
|
)
|
|
|
(9,457
|
)
|
|
|
(141,259
|
)
|
Effect of exchange rates
|
|
|
360
|
|
|
|
(2,162
|
)
|
|
|
61
|
|
|
|
386
|
|
|
|
(1,355
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009
|
|
|
427,779
|
|
|
|
533,134
|
|
|
|
154,966
|
|
|
|
286,484
|
|
|
|
1,402,363
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2008
|
|
|
47,049
|
|
|
|
336,989
|
|
|
|
92,839
|
|
|
|
198,537
|
|
|
|
675,414
|
|
Depreciation
|
|
|
6,604
|
|
|
|
54,081
|
|
|
|
14,961
|
|
|
|
31,918
|
|
|
|
107,564
|
|
Impairment charges
|
|
|
266
|
|
|
|
22,324
|
|
|
|
423
|
|
|
|
1,544
|
|
|
|
24,557
|
|
Disposals
|
|
|
(558
|
)
|
|
|
(59,671
|
)
|
|
|
(7,201
|
)
|
|
|
|
|
|
|
(67,430
|
)
|
Effect of exchange rates
|
|
|
548
|
|
|
|
(255
|
)
|
|
|
80
|
|
|
|
(68
|
)
|
|
|
305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008
|
|
|
53,909
|
|
|
|
353,468
|
|
|
|
101,102
|
|
|
|
231,931
|
|
|
|
740,410
|
|
Depreciation
|
|
|
22,611
|
|
|
|
63,614
|
|
|
|
15,851
|
|
|
|
27,568
|
|
|
|
129,644
|
|
Impairment charges
|
|
|
|
|
|
|
11,185
|
|
|
|
155
|
|
|
|
4,556
|
|
|
|
15,896
|
|
Disposals
|
|
|
(2,247
|
)
|
|
|
(88,815
|
)
|
|
|
(2,191
|
)
|
|
|
(9,298
|
)
|
|
|
(102,551
|
)
|
Effect of exchange rates
|
|
|
(30
|
)
|
|
|
41
|
|
|
|
12
|
|
|
|
235
|
|
|
|
258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009
|
|
|
74,243
|
|
|
|
339,493
|
|
|
|
114,929
|
|
|
|
254,992
|
|
|
|
783,657
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
301,622
|
|
|
|
129,930
|
|
|
|
52,722
|
|
|
|
56,366
|
|
|
|
540,640
|
|
December 31, 2009
|
|
|
353,536
|
|
|
|
193,641
|
|
|
|
40,037
|
|
|
|
31,492
|
|
|
|
618,706
|
|
|
As of December 31, 2009, the carrying amount includes
assets under construction for land, buildings and constructions
of EUR 5.9 million (2008:
EUR 122.1 million), machinery and equipment of
EUR 30.4 million (2008: EUR 4.6 million),
leasehold improvements of EUR 0.5 million (2008:
EUR 2.4 million) and furniture, fixtures and other
equipment of EUR 1.9 million (2008:
EUR 8.6 million).
As of December 31, 2009, the carrying amount of land
amounts to EUR 34.5 million (2008:
EUR 34.0 million).
As of December 31, 2009, the carrying amount of machinery
and equipment includes an amount of EUR 73.9 million
with respect to evaluation and rental systems (2008: nil).
Additions to land, buildings and constructions mainly relate to
the finalization of the first part of the new production
facilities in Veldhoven.
The majority of the Companys disposals in 2008 and 2009
relate to machinery and equipment, primarily consisting of
prototypes, demonstration, evaluation and training systems.
These systems are similar to those that ASML sells in its
ordinary course of business. The systems are capitalized under
property, plant and equipment because they are held for own use,
for rental and for evaluation purposes and, at the time they are
placed in service, expected to be used for a period longer than
one year. These systems are recorded at cost and depreciated
over their useful life. From the time that these assets are no
longer held for own use but intended for sale, they are
reclassified from property, plant and equipment to inventory at
the lower of their carrying value or fair market value. When
sold, the proceeds and cost of these systems are recorded as net
sales and cost of sales, respectively, identical to the
treatment of other sales transactions. The cost of sales for
these systems includes the inventory value and the additional
costs of refurbishing (materials and labor).
ASML ANNUAL REPORT 2009
F-23
During 2009, the Company recorded impairment charges of
EUR 15.9 million (2008: EUR 24.6 million;
2007: EUR 8.0 million) of which it recorded
EUR 2.1 million (2008: EUR 20.8 million;
2007: EUR 7.6 million) in cost of sales,
EUR 9.1 million (2008: EUR 2.2 million;
2007: EUR 0.2 million) in R&D costs and
EUR 4.7 million (2008: EUR 1.6 million;
2007: EUR 0.2 million) in SG&A costs.
The impairment charges recorded in 2009 mainly related to
machinery and equipment (EUR 11.2 million). The Company
impaired certain non-leading-edge systems and machinery and
equipment that have ceased to be used or will cease to be used
during the expected economic life, and which management no
longer believes can be sold because of lack of demand for these
products. The impairment charges were determined based on the
difference between the assets estimated fair value (being
EUR 7.0 million) and their carrying amount. In
determining the fair value of an asset, the Company makes
estimates about future cash flows. These estimates are based on
the financial plan updated with the latest available projection
of semiconductor market conditions and the Companys sales
and cost expectations which are consistent with the plans and
estimates that it uses to manage its business.
The impairment charges recorded in 2008 mainly related to
machinery and equipment (EUR 22.3 million). The Company
impaired certain non-leading-edge machinery and equipment that
have ceased to be used during the expected economic life, and
which management no longer believes can be sold for two reasons,
both relating to the financial and economic crisis. The first
reason relates to ASMLs customers decision to delay
non-leading-edge capacity additions which increases the risk
that certain systems will become technologically obsolete. The
second reason has to do with the expected plant closures by
ASMLs high-tech customers to reduce certain
non-leading-edge capacity, which management believes will result
in a high supply of used systems and a downward pressure on
sales prices. The impairment charges were determined based on
the difference between the assets estimated fair value
(being EUR 5.4 million) and their carrying amount.
During 2009, the Company recorded depreciation charges of
EUR 129.6 million (2008: EUR 107.6 million;
2007: EUR 88.5 million) of which it recorded
EUR 83.6 million (2008: EUR 50.3 million;
2007: EUR 48.6 million) in cost of sales,
EUR 21.9 million (2008 EUR 25.5 million;
2007: EUR 21.5 million) in R&D costs and
EUR 24.1 million (2008: EUR 31.8 million;
2007: EUR 18.4 million) in SG&A costs.
12. Accrued and
other liabilities
Accrued and other liabilities consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Deferred revenue
|
|
|
262,209
|
|
|
|
219,378
|
|
Costs to be paid
|
|
|
190,225
|
|
|
|
208,684
|
|
Advances from customers
|
|
|
169,250
|
|
|
|
274,074
|
|
Personnel related items
|
|
|
130,651
|
|
|
|
114,255
|
|
Derivative instruments
|
|
|
67,794
|
|
|
|
17,471
|
|
Standard warranty reserve
|
|
|
35,225
|
|
|
|
23,208
|
|
Other
|
|
|
4,472
|
|
|
|
4,650
|
|
|
|
|
|
|
|
|
|
|
Total accrued and other liabilities
|
|
|
859,826
|
|
|
|
861,720
|
|
Less: long-term portion of accrued and other liabilities
|
|
|
70,038
|
|
|
|
44,359
|
|
|
|
|
|
|
|
|
|
|
Short-term portion of accrued and other liabilities
|
|
|
789,788
|
|
|
|
817,361
|
|
|
Deferred revenue mainly consists of prepaid extended and
enhanced (optic) warranty contracts and award credits regarding
free or discounted products or services.
Cost to be paid mainly relate to accrued cost for unbilled
services provided by vendors including contracted labor,
outsourced services and consultancy.
Advances from customers consist of down payments made by
customers prior to shipment for systems included in ASMLs
current product portfolio or systems currently under development.
Personnel related items mainly consist of accrued management
bonuses, accrued vacation days, accrued vacation allowance,
accrued wage tax, social securities and accrued pension premiums.
ASML ANNUAL REPORT 2009
F-24
Derivative financial instruments consist of currency contracts
and the fair value of interest rate swaps which includes accrued
interest.
Changes in standard warranty reserve for the years 2008 and 2009
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Balance, January 1
|
|
|
73,198
|
|
|
|
35,225
|
|
Additions of the year
|
|
|
30,322
|
|
|
|
15,047
|
|
Utilization of the reserve
|
|
|
(35,233
|
)
|
|
|
(19,360
|
)
|
Release of the reserve
|
|
|
(33,409
|
)
|
|
|
(7,666
|
)
|
Effect of exchange rates
|
|
|
347
|
|
|
|
(38
|
)
|
|
|
|
|
|
|
|
|
|
Balance, December 31
|
|
|
35,225
|
|
|
|
23,208
|
|
|
The release of the reserve is due to a change in accounting
estimate based on lower than expected historical warranty
expenses as a result of an improved learning curve concerning
ASMLs systems. The release has been included in cost of
sales.
In 2009, the reassessments of the warranty reserve, and
resulting change in accounting estimate, did not have a material
impact. For 2008, the impact of the change in accounting
estimate on the consolidated statements of operations and
per-share amounts was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2008
|
|
|
|
|
(in thousands, except per share data)
|
|
EUR
|
|
|
%
|
|
Income from operations
|
|
|
33,409
|
|
|
|
11.6%
|
|
Net income
|
|
|
24,890
|
|
|
|
7.7%
|
|
Basic net income per ordinary share
|
|
|
0.06
|
|
|
|
8.0%
|
|
Diluted net income per ordinary share
|
|
|
0.06
|
|
|
|
8.1%
|
|
|
13.
Provisions
Provisions consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee contract
|
|
|
Lease contract
|
|
|
|
|
|
|
termination benefits
|
|
|
termination costs
|
|
|
Total
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Balance at January 1, 2009
|
|
|
2,265
|
|
|
|
17,908
|
|
|
|
20,173
|
|
Utilization of the provision
|
|
|
(2,244
|
)
|
|
|
(2,747
|
)
|
|
|
(4,991
|
)
|
Unwinding of discount
|
|
|
|
|
|
|
136
|
|
|
|
136
|
|
Effect of exchange rates
|
|
|
(21
|
)
|
|
|
(99
|
)
|
|
|
(120
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
|
|
|
|
15,198
|
|
|
|
15,198
|
|
Less: current portion of provisions
|
|
|
|
|
|
|
2,504
|
|
|
|
2,504
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current portion of provisions
|
|
|
|
|
|
|
12,694
|
|
|
|
12,694
|
|
|
In December 2008, ASML announced a restructuring that resulted
in the discontinuation of its training center in the United
States, downsizing of the United States headquarters and closure
of several other locations, reflecting the continuous migration
of the semiconductor manufacturing activities to Asia which was
accelerated by the financial and economic crisis. The total
restructuring costs consisted of employee contract termination
benefits and lease contract termination costs.
Provision for employee contract termination benefits relates
mainly to the reduction of approximately 105 jobs and comprises
only personnel costs. The provision for employee contract
termination benefits was fully utilized in 2009.
Provision for lease contract termination costs relates to an
operating lease contract for a building for which no economic
benefits are expected. The provision for lease contract
termination costs is expected to be utilized by 2017.
ASML ANNUAL REPORT 2009
F-25
The restructuring in 2008 resulted in cost savings of
EUR 9.2 million in 2009, consisting of a
EUR 2.7 million decrease in rental expenses and
EUR 6.5 million decrease in employee expenses. The
actual savings are in line with the savings that the Company
anticipated at the end of 2008. These actions resulted in an
approximately similar positive effect on cash flows from
operating activities.
14. Long-term
debt
The Companys obligations to make principal repayments
under the Eurobond and other borrowing arrangements as of
December 31, 2009, for the next five years and thereafter
and excluding interest expense, are as follows:
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
EUR
|
|
2010
|
|
|
14
|
|
2011
|
|
|
|
|
2012
|
|
|
|
|
2013
|
|
|
|
|
2014
|
|
|
|
|
Thereafter
|
|
|
600,000
|
|
|
|
|
|
|
Total
|
|
|
600,014
|
|
Less: current portion of long-term debt
|
|
|
14
|
|
|
|
|
|
|
Non-current portion of long-term debt
|
|
|
600,000
|
|
|
Eurobond
The following table summarizes the carrying amount of the
Companys outstanding Eurobond, including fair value of
interest rate swaps used to hedge the change in the fair value
of the Eurobond:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
5.75 percent Eurobond
|
|
|
|
|
|
|
|
|
Principal amount
|
|
|
600,000
|
|
|
|
600,000
|
|
Fair value interest rate
swaps1
|
|
|
47,050
|
|
|
|
63,088
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
647,050
|
|
|
|
663,088
|
|
|
|
|
1
|
The fair value of the interest rate
swaps excludes accrued interest.
|
In June 2007, ASML completed an offering of
EUR 600 million principal amount of its
5.75 percent notes due 2017, with interest payable annually
on June 13 of each year. The notes are redeemable at the option
of ASML, in whole or in part, at any time by paying a make whole
premium, and unless previously redeemed, will be redeemed at
100 percent of their principal amount on June 13, 2017.
The Eurobond serves as a hedged item in a fair value hedge
relationship in which ASML hedges the variability of changes in
the market value of fixed loan coupons payable on the
Companys Eurobond due to changes in market interest rates;
the fair value changes of the interest rate swaps are recorded
on the balance sheet under derivative financial instruments
(within other current and non-current assets). Therefore, the
carrying amount is only adjusted for fair value changes in
interest rate swaps. The following table summarizes estimated
fair value of ASMLs Eurobond:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
Principal
|
|
|
Carrying
|
|
|
|
|
|
Principal
|
|
|
Carrying
|
|
|
|
|
As of December 31
|
|
Amount
|
|
|
Amount
|
|
|
Fair Value
|
|
|
Amount
|
|
|
Amount
|
|
|
Fair Value
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
5.75 percent Eurobond
|
|
|
600,000
|
|
|
|
647,050
|
|
|
|
345,585
|
|
|
|
600,000
|
|
|
|
663,088
|
|
|
|
599,232
|
|
|
(Source: Bloomberg Finance LP)
The fair value of the Companys Eurobond is estimated based
on the quoted market prices as of December 31, 2009. The
fair value of the Eurobond is lower than the principal amount as
a result of an increased implied credit spread.
ASML ANNUAL REPORT 2009
F-26
Lines of
credit
As of December 31, 2009, the Company has available credit
facilities for a total amount of EUR 700 million
(2008: EUR 500 million). The EUR 700 million
of available credit facilities consist of two separate
facilities: a EUR 500 million credit facility and a
EUR 200 million loan facility. The
EUR 500 million credit facility, which will expire in
May 2012, contains a covenant that requires the Company to
maintain a minimum financial condition ratio, calculated in
accordance with a contractually agreed formula. ASML was in
compliance with the covenant at the end of 2009 and 2008.
Outstanding amounts under this credit facility will bear
interest at EURIBOR or LIBOR plus a margin that is dependent on
the Companys liquidity position. No amounts were
outstanding under this credit facility at the end of 2009 and
2008.
The EUR 200 million loan facility is related to the
Companys EUV investment efforts and was entered into in
2009 with the European Investment Bank. This loan can be drawn
in tranches up until October 2010. It is repayable in annual
installments four years after drawdown, with a final repayment
seven years after drawdown. This facility contains a covenant
that restricts the maximum indebtedness. ASML was in compliance
with the covenant at the end of 2009. Outstanding amounts under
this loan facility will bear interest at EURIBOR or LIBOR plus a
margin. No amounts were outstanding under this loan facility at
the end of 2009.
15. Commitments,
contingencies and guarantees
The Company has various contractual obligations, some of which
are required to be recorded as liabilities in the Companys
consolidated financial statements, including long- and
short-term debt. Others, namely operating lease commitments,
purchase obligations and guarantees, are generally not required
to be recognized as liabilities on the Companys balance
sheet but are required to be disclosed.
Lease Commitments
and Variable Interests
The Company leases equipment and buildings under various
operating leases. Operating leases are charged to expense on a
straight-line basis. See the Tabular Disclosure of Contractual
Obligations below.
In December 2003, the FASB issued ASC 810, Consolidation
of Variable Interest Entities. Under ASC 810, an
enterprise must consolidate a variable interest entity if that
enterprise has a variable interest (or a combination of variable
interests) that will absorb a majority of the entitys
expected losses if they occur, receive a majority of the
entitys expected residual returns if they occur, or both.
In 2003, ASML moved to its current Veldhoven headquarters. The
Company is leasing these headquarters for a period of
15 years from an entity (the lessor) that was
incorporated by a syndicate of three banks
(shareholders) solely for the purpose of leasing
this building. The lessors shareholders equity amounts to
EUR 1.9 million.
The shareholders each granted a loan of
EUR 11.6 million and a fourth bank granted a loan of
EUR 12.3 million. ASML provided the lessor with a
subordinated loan of EUR 5.4 million and has a
purchase option that is exercisable either at the end of the
lease in 2018, at a pre-determined price of
EUR 24.5 million, or during the lease at the book
value of the assets. The total assets of the lessor entity
amounted to approximately EUR 54 million at inception
of the lease.
ASML believes that it holds a variable interest in this entity
and that the entity is a variable interest entity
(VIE) because it is subject to consolidation in
accordance with the provisions of ASC
810-10-15-14.
The total equity investment at risk is approximately
3.6 percent of the lessors total assets and is not
considered and cannot be demonstrated, qualitatively or
quantitatively, to be sufficient to permit the lessor to finance
its activities without additional subordinated financial support
provided by any parties, including the shareholders.
ASML determined that it is not appropriate to consolidate the
VIE as it is not the primary beneficiary. To make this
determination, the expected losses and expected residual returns
of the lessor were allocated to each variable interest holder
based on their contractual right to absorb expected losses and
residual returns. The analysis of expected losses and expected
residual returns involved determining the expected negative and
positive variability in the fair value of the lessors net
assets exclusive of variable interests through various cash flow
scenarios based upon the expected market value of the
lessors net assets. Based on this analysis, ASML
determined that other variable interest holders will absorb the
majority of the lessors expected losses, and as a result,
ASML is not the primary beneficiary.
ASMLs maximum exposure to the lessors expected
losses is estimated to be approximately
EUR 5.4 million. The resulting lease obligation is
included in the line Operational Lease Obligations; refer to the
table Tabular Disclosure of Contractual Obligations
below.
ASML ANNUAL REPORT 2009
F-27
Tabular
Disclosure of Contractual Obligations
The Companys contractual obligations as of
December 31, 2009 can be summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than
|
|
|
1-3
|
|
|
3-5
|
|
|
After 5
|
|
Payments due by period
|
|
Total
|
|
|
1 year
|
|
|
years
|
|
|
years
|
|
|
years
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Long Term Debt Obligations, including
interest
expenses1
|
|
|
939,102
|
|
|
|
34,514
|
|
|
|
69,000
|
|
|
|
69,000
|
|
|
|
766,588
|
|
Operating Lease Obligations
|
|
|
130,374
|
|
|
|
33,077
|
|
|
|
43,150
|
|
|
|
27,912
|
|
|
|
26,235
|
|
Purchase Obligations
|
|
|
1,431,247
|
|
|
|
1,388,902
|
|
|
|
40,985
|
|
|
|
788
|
|
|
|
572
|
|
Unrecognized Tax Benefits
|
|
|
133,270
|
|
|
|
8,535
|
|
|
|
41,544
|
|
|
|
35,699
|
|
|
|
47,492
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Contractual Obligations
|
|
|
2,633,993
|
|
|
|
1,465,028
|
|
|
|
194,679
|
|
|
|
133,399
|
|
|
|
840,887
|
|
|
|
|
1
|
See Note 14 to the
consolidated financial statements for the amounts excluding
interest expense.
|
Long-term debt obligations relate to interest payments and the
redemption of the principal amount of the Eurobond. See
Note 14 to the consolidated financial statements.
Operating lease obligations include leases of equipment and
facilities. Lease payments recognized as an expense were
EUR 46 million, EUR 43 million and
EUR 39 million for the years ended December 31,
2007, 2008 and 2009, respectively.
Several operating leases for the Companys buildings
contain purchase options, exercisable at the option of the
Company at the end of the lease, and in some cases, during the
term of the lease. The amounts to be paid if ASML should
exercise these purchase options at the end of the lease as of
December 31, 2009 can be summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than
|
|
|
1-3
|
|
|
3-5
|
|
|
After 5
|
|
Purchase options due by period
|
|
Total
|
|
|
1 year
|
|
|
years
|
|
|
years
|
|
|
years
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Purchase options
|
|
|
55,736
|
|
|
|
|
|
|
|
8,250
|
|
|
|
8,999
|
|
|
|
38,487
|
|
|
Purchase obligations include purchase commitments with vendors
in the ordinary course of business. ASML expects that it will
honor these purchase obligations to fulfill future sales, in
line with the timing of those future sales. If not, the general
terms and conditions of the agreements relating to the major
part of the Companys purchase commitments as of
December 31, 2009 contain clauses that enable ASML to delay
or cancel delivery of ordered goods and services up to the dates
specified in the corresponding purchase contracts. These terms
and conditions that ASML has agreed with its supply chain
partners give ASML additional flexibility to adapt its purchase
obligations to its requirements in light of the inherent
cyclicality of the industry in which the Company operates. The
Company establishes a provision for cancellation fees when it is
probable that the liability has been incurred and the amount of
cancellation fees is reasonably estimable.
Unrecognized tax benefits relate to a liability for uncertain
tax positions. See Note 18 to the consolidated financial
statements.
16. Employee
benefits
Deferred
compensation plans
In February 1997, SVG (a company that merged with ASML in May
2001) adopted a non-qualified deferred compensation plan
that allowed a select group of management and highly compensated
employees and directors to defer a portion of their salary,
bonus and directors fees. The plan allowed SVG to credit
additional amounts to participants account balances,
depending on the amount of the employees contribution, up
to a maximum of 5.0 percent of an employees annual
salary and bonus. In addition, interest is credited to the
participants account balances at 120 percent of the
average Moodys corporate bond rate. For calendar years
2007, 2008 and 2009, participants accounts were credited
at 7.16 percent, 7.34 percent and 9.07 percent
respectively. SVGs contributions and related interest
became 100 percent vested in May 2001 with the merger of
SVG and ASML. During fiscal years 2007, 2008 and 2009, the
expense incurred under this plan was EUR 0.1 million,
EUR 0.2 million and 0.2 million, respectively. As
of December 31, 2008 and 2009 the Companys liability
under the deferred compensation plan was EUR 2 million
and EUR 2 million respectively.
ASML ANNUAL REPORT 2009
F-28
In July 2002, ASML adopted a non-qualified deferred compensation
plan for its United States employees that allows a select group
of management or highly compensated employees to defer a portion
of their salary, bonus, and commissions. The plan allows ASML to
credit additional amounts to the participants account
balances. The participants divide their funds among the
investments available in the plan. Participants elect to receive
their funds in future periods after the earlier of their
employment termination or their withdrawal election, at least
three years after deferral. There were minor plan expenses in
2007, 2008 and 2009. On December 31, 2008 and 2009, the
Companys liability under the deferred compensation plan
was EUR 5 million and EUR 7 million,
respectively.
Pension
plans
ASML maintains various pension plans covering substantially all
of its employees. The Companys approximately 3,600 payroll
employees in FTEs in the Netherlands participate in a
multi-employer union plan (Bedrijfstakpensioenfonds
Metalektro) determined in accordance with the collective
bargaining agreements effective for the industry in which ASML
operates. This multi-employer plan spans approximately
1,250 companies and 156,000 contributing members. The plan
monitors its risks on a global basis, not by company or
employee, and is subject to regulation by Netherlands
governmental authorities. By law (the Netherlands Pension Act),
a multi-employer union plan must be monitored against specific
criteria, including the coverage ratio of the plans assets
to its obligations. This coverage ratio must exceed
100 percent for the total plan. Every company participating
in a Netherlands multi-employer union plan contributes a premium
calculated as a percentage of its total pensionable salaries,
with each company subject to the same percentage contribution
rate. The pension rights of each employee are based upon the
employees average salary during employment.
ASMLs net periodic pension cost for this multi-employer
plan for any fiscal period is the amount of the required
contribution for that period. A contingent liability may arise
from, for example, possible actuarial losses relating to other
participating entities because each entity that participates in
a multi-employer plan shares in the actuarial risks of every
other participating entity or any responsibility under the terms
of a plan to finance any shortfall in the plan if other entities
cease to participate.
The coverage ratio of the multi-employer plan increased to
100 percent as of November 30, 2009 (November 30,
2008: 91 percent). For 2010, the pension premium will not
increase. The current premium level, which is 23 percent of
the total pensionable salaries, is the maximum premium
determined in the articles of association of the Pension
Company. The coverage ratio is calculated by dividing the
funds capital by the total sum of pension liabilities and
is based on actual market interest.
ASML also participates in several defined contribution pension
plans, with ASMLs expenses for these plans equaling the
contributions made in the relevant fiscal period.
The Companys pension costs for all employees for the three
years ended December 31, 2009 were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Pension plan based on multi-employer union plan
|
|
|
26,485
|
|
|
|
30,579
|
|
|
|
30,930
|
|
Pension plans based on defined contribution
|
|
|
6,993
|
|
|
|
8,466
|
|
|
|
8,895
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
33,478
|
|
|
|
39,045
|
|
|
|
39,825
|
|
|
Bonus
plan
ASML has a performance-related bonus plan for senior management,
who are not members of the Board of Management. Under this plan,
the bonus amount is dependent on the actual performance on
corporate, departmental and personal targets. The bonus for
members of senior management can range between 0 percent
and 40 percent, or 0 percent and 70 percent of
their annual salaries, depending upon their seniority. The
performance targets for 2009 are set per half year. The bonus of
the first half of 2009 has been paid in the second half of 2009,
partly in shares and partly in cash. The bonus of the second
half is accrued for in the consolidated balance sheets as of
December 31, 2009 and is expected to be paid in the first
quarter of 2010. The Companys bonus expenses for all
participants under this plan were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Bonus expenses
|
|
|
8,934
|
|
|
|
7,756
|
|
|
|
9,167
|
|
|
ASML ANNUAL REPORT 2009
F-29
ASML has a retention bonus plan for employees and executives of
Brion including three retention bonuses. The first retention
bonus was conditional on the first year of employment after the
acquisition date and was paid in March 2008. The second
retention bonus is conditional on the second year of employment
after the acquisition date and was paid in March 2009. The third
retention bonus is conditional on the third year of employment
after the acquisition date and is payable in March 2010. The
Companys bonus expenses for all participants under this
plan were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Bonus expenses
|
|
|
5,335
|
|
|
|
5,031
|
|
|
|
5,222
|
|
|
Profit-sharing
plan
ASML has a profit-sharing plan covering all employees who are
not members of the Board of Management or senior management.
Under the plan, eligible employees receive an annual
profit-sharing bonus, based on a percentage of net income
relative to sales ranging from 0 to 20 percent of annual
salary. The profit-sharing percentage for the years 2007, 2008
and 2009 was 14 percent, 6 percent and 0 percent,
respectively.
Share-based
payments
ASML has adopted various share-based payment plans for its
employees, which are described below. The total gross amount of
recognized expenses associated with share- based payments was
EUR 16.5 million in 2007, EUR 13.5 million
in 2008 and EUR 13.4 million in 2009.
Total compensation expenses related to non-vested awards to be
recognized in future periods amount to
EUR 15.4 million as per December 31, 2009 (2008:
EUR 17.5 million; 2007: EUR 26.2 million).
The weighted average period over which these costs are expected
to be recognized is calculated at 1.2 years (2008:
1.5 years; 2007: 1.4 years).
Stock option transactions are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
|
|
|
|
Number of
|
|
|
exercise price per
|
|
|
|
options
|
|
|
share (EUR)
|
|
Outstanding, January 1, 2007
|
|
|
23,423,350
|
|
|
|
23.40
|
|
Granted
|
|
|
1,438,100
|
|
|
|
8.59
|
|
Exercised
|
|
|
(4,345,322
|
)
|
|
|
15.29
|
|
Forfeited
|
|
|
(172,560
|
)
|
|
|
13.33
|
|
Expired
|
|
|
(5,293,469
|
)
|
|
|
33.40
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2007
|
|
|
15,050,099
|
|
|
|
20.89
|
|
Granted
|
|
|
990,526
|
|
|
|
14.38
|
|
Exercised
|
|
|
(1,119,426
|
)
|
|
|
12.03
|
|
Forfeited
|
|
|
(984,832
|
)
|
|
|
11.99
|
|
Expired
|
|
|
(2,008,620
|
)
|
|
|
17.02
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2008
|
|
|
11,927,747
|
|
|
|
22.53
|
|
Granted
|
|
|
65,300
|
|
|
|
19.39
|
|
Exercised
|
|
|
(1,014,287
|
)
|
|
|
10.73
|
|
Forfeited
|
|
|
(162,313
|
)
|
|
|
14.93
|
|
Expired
|
|
|
|
|
|
|
|
|
Transfer to/from Board of
Management1
|
|
|
79,536
|
|
|
|
23.40
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2009
|
|
|
10,895,983
|
|
|
|
23.74
|
|
Exercisable, December 31, 2009
|
|
|
9,688,912
|
|
|
|
24.81
|
|
Exercisable, December 31, 2008
|
|
|
9,731,391
|
|
|
|
24.29
|
|
Exercisable, December 31, 2007
|
|
|
10,696,587
|
|
|
|
24.37
|
|
|
|
|
1
|
In 2009, as a result of a change in
the Board of Management stock options were transferred between
employee benefits and Board of Management remuneration.
|
The estimated weighted average fair value of options granted
during 2007, 2008 and 2009 was EUR 12.95, EUR 6.56 and
EUR 8.75, respectively, on the date of grant.
ASML ANNUAL REPORT 2009
F-30
The weighted average share price at the date of exercise for
stock options was EUR 20.31 (2008: EUR 17.91; 2007:
EUR 23.46).
Details with respect to the outstanding stock options are set
out in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
Weighted average
|
|
|
Weighted average
|
|
|
|
outstanding
|
|
|
Number exercisable
|
|
|
remaining
|
|
|
exercise price of
|
|
Range of exercise
|
|
December 31,
|
|
|
December 31,
|
|
|
contractual life
|
|
|
outstanding options
|
|
prices (EUR)
|
|
2009
|
|
|
2009
|
|
|
(years)
|
|
|
(EUR)
|
|
0.15 - 7.94
|
|
|
622,674
|
|
|
|
569,468
|
|
|
|
0.34
|
|
|
|
1.56
|
|
8.17 - 12.62
|
|
|
4,465,707
|
|
|
|
3,901,134
|
|
|
|
5.19
|
|
|
|
11.42
|
|
12.75 - 19.13
|
|
|
1,652,408
|
|
|
|
1,403,235
|
|
|
|
6.30
|
|
|
|
17.21
|
|
19.45 - 29.18
|
|
|
564,264
|
|
|
|
224,145
|
|
|
|
8.02
|
|
|
|
23.30
|
|
29.65 - 44.48
|
|
|
21,000
|
|
|
|
21,000
|
|
|
|
2.07
|
|
|
|
36.89
|
|
45.02 - 67.53
|
|
|
3,569,930
|
|
|
|
3,569,930
|
|
|
|
2.07
|
|
|
|
46.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
10,895,983
|
|
|
|
9,688,912
|
|
|
|
4.51
|
|
|
|
23.74
|
|
|
Details with respect to stock options and stock are set out in
the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
|
|
|
|
|
|
|
|
(in thousands, except for contractual term)
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Aggregate intrinsic value of stock options exercised (EUR)
|
|
|
33,273
|
|
|
|
5,894
|
|
|
|
10,140
|
|
Total fair value at vesting date of shares vested during the
year (EUR)
|
|
|
127
|
|
|
|
4,288
|
|
|
|
8,465
|
|
Aggregate remaining contractual term of currently exercisable
options (years)
|
|
|
3.72
|
|
|
|
4.83
|
|
|
|
4.03
|
|
Aggregate intrinsic value of exercisable stock options (EUR)
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate intrinsic value of outstanding stock options (EUR)
|
|
|
|
|
|
|
|
|
|
|
7,398
|
|
|
Stock transactions are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conditionally
|
|
|
|
|
|
|
|
|
|
Conditionally
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
outstanding
|
|
|
|
|
|
|
|
|
|
outstanding stock
|
|
|
conditionally
|
|
|
Stock
|
|
|
|
|
|
|
|
|
stock at
|
|
|
End of
|
|
|
|
|
|
|
at January 1,
|
|
|
stock
|
|
|
price
|
|
|
Forfeited/
|
|
|
|
|
|
December 31,
|
|
|
vesting
|
|
Share plan
|
|
Year
|
|
|
2009
|
|
|
granted
|
|
|
(EUR)
|
|
|
expired
|
|
|
Vested
|
|
|
2009
|
|
|
period
|
|
Employee plan
|
|
|
2007
|
|
|
|
45,151
|
|
|
|
|
|
|
|
24.26
|
|
|
|
(1,385
|
)
|
|
|
|
|
|
|
43,766
|
|
|
|
19-10-2010
|
|
Brion stock plan
|
|
|
2007
|
|
|
|
221,349
|
|
|
|
|
|
|
|
17.50
|
|
|
|
|
|
|
|
(110,675
|
)
|
|
|
110,674
|
|
|
|
07-03-2010
|
|
Brion performance stock plan
|
|
|
2007
|
|
|
|
81,490
|
|
|
|
|
|
|
|
23.12
|
|
|
|
|
|
|
|
(40,822
|
)
|
|
|
40,668
|
|
|
|
31-12-2010
|
|
New hire performance stock plan
|
|
|
2007
|
|
|
|
24,546
|
|
|
|
|
|
|
|
22.00
|
|
|
|
|
|
|
|
|
|
|
|
24,546
|
|
|
|
31-12-2010
|
|
Senior management
plan1
|
|
|
2007
|
|
|
|
69,074
|
|
|
|
|
|
|
|
17.80
|
|
|
|
(35,101
|
)
|
|
|
|
|
|
|
33,973
|
|
|
|
19-10-2010
|
|
Employee plan
|
|
|
2008
|
|
|
|
35,761
|
|
|
|
|
|
|
|
14.87
|
|
|
|
(719
|
)
|
|
|
|
|
|
|
35,042
|
|
|
|
18-07-2011
|
|
Brion performance stock plan
|
|
|
2008
|
|
|
|
200,032
|
|
|
|
|
|
|
|
12.95
|
|
|
|
|
|
|
|
(67,376
|
)
|
|
|
132,656
|
|
|
|
31-12-2011
|
|
New hire performance stock plan
|
|
|
2008
|
|
|
|
39,408
|
|
|
|
|
|
|
|
14.83
|
|
|
|
|
|
|
|
|
|
|
|
39,408
|
|
|
|
31-12-2010
|
|
Senior management plan
|
|
|
2008
|
|
|
|
|
|
|
|
88,072
|
|
|
|
13.05
|
|
|
|
|
|
|
|
|
|
|
|
88,072
|
|
|
|
18-07-2011
|
|
Employee plan
|
|
|
2009
|
|
|
|
|
|
|
|
93,050
|
|
|
|
19.85
|
|
|
|
|
|
|
|
|
|
|
|
93,050
|
|
|
|
16-10-2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
716,811
|
|
|
|
181,122
|
|
|
|
|
|
|
|
(37,205
|
)
|
|
|
(218,873
|
)
|
|
|
641,855
|
|
|
|
|
|
|
|
|
1
|
In 2009, as a result of a change in
the Board of Management stock was transferred between employee
benefits and Board of Management remuneration.
|
The Company has adopted various stock (option) plans for its
employees. Each year, the Board of Management determines, by
category of ASML personnel, the total available number of stock
options and maximum number of shares that can be granted in that
year. The determination is subject to the approval of the
Supervisory Board of the Company. Options granted under
ASMLs stock option plans have fixed exercise prices equal
to the closing price of the Companys ordinary shares on
Euronext Amsterdam on the applicable grant dates. Granted stock
options generally vest over a three-year period with any
unexercised stock options expiring ten years after the grant
date.
ASML ANNUAL REPORT 2009
F-31
The fair value of the stock options is determined using a
Black-Scholes option valuation model.
The Black-Scholes option valuation of the fair value of the
Companys stock options is based on the following
assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Weighted average share price (in EUR)
|
|
|
24.0
|
|
|
|
12.5
|
|
|
|
16.7
|
|
Volatility (in percentage)
|
|
|
29.0
|
|
|
|
54.5
|
|
|
|
51.7
|
|
Expected life (in years)
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
4.6
|
|
Risk free interest rate
|
|
|
4.4
|
|
|
|
4.4
|
|
|
|
3.2
|
|
Expected dividend yield (in EUR)
|
|
|
|
|
|
|
1.15
|
|
|
|
1.06
|
|
Forfeiture
rate1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
As of the three years ended
December 31, 2009 forfeitures are estimated to be nil.
|
When establishing the expected life assumption the Company
annually takes into account the contractual terms of the options
as well as historical employee exercise behavior.
Share-based
payment plans
In 2007 ASML launched new share-based payment plans providing
employees the choice between stock, stock options or a
combination of both. The new share-based payment plans divide
the employees in two categories, senior management excluding the
Board of Management and other employees who are not part of the
Board of Management or senior management. Each year, the Board
of Management determines the total number of awards that can be
granted in that year. The determination is subject to the
approval of the Supervisory Board of the Company.
The fair value of the stock options is determined using a
Black-Scholes option valuation model. For the assumptions on
which the Black-Scholes option valuation model is used see the
disclosure above under the caption Stock Option
Plans.
Senior management
plan
The senior management plan consists of two parts, both including
a half year performance condition based on a targeted Return On
Average Invested Capital (ROAIC) and a three-year
service condition. ROAIC is determined by dividing the average
income (loss) from operations less provision for (benefit from)
income taxes by the average invested capital. The average
invested capital is determined by total assets less cash and
cash equivalents, less current liabilities.
Stock and stock options are granted two times per year under the
senior management plan. Stock options granted under the senior
management plan have fixed exercise prices equal to the closing
price of the Companys ordinary shares on Euronext
Amsterdam on the date the plan was communicated to senior
management (announcement date). The fair value of stock is
determined based on the closing price of the Companys
ordinary shares on Euronext Amsterdam on the announcement date.
The announcement date may differ from the grant date for reason
of later approval and mutual understanding of the performance
condition. Granted awards generally vest over a two to
three-year period with any unexercised stock options expiring
ten years after the announcement date.
Employee
plan
The employee plan includes a three-year service condition. Stock
options granted under the employee plan have fixed exercise
prices equal to the closing price of the Companys ordinary
shares on Euronext Amsterdam on the grant date. The fair value
of stock is determined based on the closing price of the
Companys ordinary shares on Euronext Amsterdam on the
grant date. Granted awards generally vest over a three-year
period with any unexercised stock options expiring ten years
after the grant date.
New hire
performance stock plan
Some new hires are eligible to conditional performance stock
awards, under the conditions set out in the general terms and
conditions. The maximum number of performance stock will be
determined on the day of conditional grant and will be based
upon the market fair value of an ASML share per that day. The
ultimately awarded number of shares of performance stock will be
determined on yearly targets over a three-year period of
achievement. These targets are financial parameters relating to
ROAIC parameters of a benchmark group.
Brion share-based
payment plans
In March, 2007 ASML acquired Brion. As part of a retention
package employees and executives of Brion have been granted
stock awards, performance stock awards and the Brion stock
options outstanding at the acquisition date have been converted
to ASML stock options.
ASML ANNUAL REPORT 2009
F-32
Brion stock
plan
The Brion stock plan includes a three-year service condition.
The fair value of the stock is determined based on the closing
price of the Companys ordinary shares on the NASDAQ on the
grant date. Granted awards generally vest over a three-year
period.
Brion performance
stock plan
The performance stock awards are conditional on the executive
completing a three to four-year requisite service period and on
achievement of the performance conditions. The performance
target is based on multiple metrics, each with its own weight.
The fair value of the stock is determined based on the closing
price of the Companys ordinary shares on the NASDAQ on the
grant date.
Brion stock
option plan
At the effective date of the acquisition the existing stock
options of Brion have been converted to ASML stock options
leaving the vesting terms and conditions unchanged. The fair
value of the stock options was determined using a Black-Scholes
option valuation model. The fair value of the stock options
relating to past services is part of the total purchase
consideration. The fair value of the stock options relating to
future services will be part of future compensation expenses.
Granted awards generally vest over a four-year period.
Stock Option
Extension Plans and Financing
In 2002, employees were offered an extension of the option
period for options granted in 2000. As a result the option
period was extended until 2012. Employees who accepted the
extension became subject to additional exercise periods in
respect of their options. At the modification date, there was no
intrinsic value of the modified award because the exercise price
under each plan still exceeded ASMLs stock price on the
modification date. As a result, these stock option extensions
did not result in recognition of any compensation expense in
accordance with ASC 718.
Stock option plans that were issued before 2001 were constructed
with a virtual financing arrangement in compliance with the
applicable laws and after obtaining the necessary corporate
approvals, whereby ASML loaned the tax value of the options
granted to employees subject to the Netherlands tax-regime. The
interest-free loans issued under this arrangement are repayable
to ASML on the exercise date of the respective option, provided
that the option is actually exercised. If the options expire
unexercised, the loans are forgiven. ASMLs Supervisory
Board approved the Stock Option Plans 2000 at the time,
including the loans, as these were part of the Stock Option Plan.
In 2006, the Company launched a stock option plan for
Netherlands employees holding stock options granted in 2000
(option A), which expire in 2012. In this plan the
Company granted options (option B) which only become
effective after option A expires unexercised in
2012. The virtual employee loan in conjunction with option
A will then be transferred to option B
and consequentially gets the status of a perpetual loan. In
total 932 employees chose to join this plan. Under the plan
ASML granted 1,515,643 stock options and recognized additional
compensation expenses of EUR 0.8 million for the year
ended December 31, 2006.
Policy for
issuing shares upon exercise
Until 2006, ASML issued new shares to satisfy the option rights
of option holders upon exercise. In 2007, both new shares as
well as repurchased shares were used to satisfy the option
rights upon exercise. In 2008 and 2009, only repurchased shares
were used to satisfy the option rights upon exercise.
17. Legal
contingencies
ASML is party to various legal proceedings generally incidental
to its business. ASML also faces exposure from other actual or
potential claims and legal proceedings. In addition, ASML
customers may be subject to claims of infringement from third
parties alleging that the ASML equipment used by those customers
in the manufacture of semiconductor products,
and/or the
methods relating to use of the ASML equipment, infringes one or
more patents issued to those third parties. If these claims were
successful, ASML could be required to indemnify such customers
for some or all of any losses incurred or damages assessed
against them as a result of that infringement.
The Company accrues for legal costs related to litigation in its
statement of operations at the time when the related legal
services are actually provided to ASML.
From 2001 through late 2004, the Company was party to a series
of civil litigations and administrative proceedings in which
Nikon alleged ASMLs infringement of Nikon patents relating
to lithography. ASML in turn filed claims against Nikon.
Pursuant to agreements executed on December 10, 2004, ASML,
Zeiss and Nikon agreed to settle all pending worldwide patent
litigation between the companies. The settlement included an
exchange of releases, a cross-license of patents related to
lithography
ASML ANNUAL REPORT 2009
F-33
equipment used to manufacture semiconductor devices and payments
to Nikon by ASML and Zeiss. In connection with the settlement,
ASML and Zeiss made settlement payments to Nikon from 2004 to
2007.
18. Income
taxes
The components of income (loss) before income taxes are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
|
|
Netherlands
|
|
|
461,682
|
|
|
|
141,418
|
|
|
|
(269,374
|
)
|
|
|
|
|
Non-Netherlands
|
|
|
386,471
|
|
|
|
168,226
|
|
|
|
97,824
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
848,153
|
|
|
|
309,644
|
|
|
|
(171,550
|
)
|
|
|
|
|
|
In addition to the income tax benefit recognized in the
consolidated statements of operations, income tax benefits of
EUR 1.1 million have been recognized in equity in the
year 2009 related to share-based payment plans and derivative
financial instruments (2008: EUR 18.2 million benefit;
2007: EUR 4.5 million benefit).
The Netherlands statutory tax rate amounted to 25.5 percent
in 2009, 2008 and 2007. Taxation for other jurisdictions is
calculated at the rates prevailing in the relevant jurisdictions.
The reconciliation between the (provision for) benefit from
income taxes shown in the consolidated statements of operations,
based on the effective tax rate, and expense based on the
Netherlands tax rate, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
2007
|
|
|
|
|
|
2008
|
|
|
|
|
|
2009
|
|
|
|
|
(in thousands)
|
|
EUR
|
|
|
%
|
|
|
EUR
|
|
|
%
|
|
|
EUR
|
|
|
%
|
|
Income (loss) from operations before income taxes
|
|
|
848,153
|
|
|
|
100.0
|
|
|
|
309,644
|
|
|
|
100.0
|
|
|
|
(171,550
|
)
|
|
|
100.0
|
|
Income tax (expense) benefit based on Netherlands rate
|
|
|
(216,279
|
)
|
|
|
25.5
|
|
|
|
(78,959
|
)
|
|
|
25.5
|
|
|
|
43,745
|
|
|
|
25.5
|
|
Change in statutory tax rate
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Different tax rates
|
|
|
16,538
|
|
|
|
(1.9
|
)
|
|
|
26,764
|
|
|
|
(8.6
|
)
|
|
|
18,482
|
|
|
|
10.8
|
|
Other credits and non-taxable items
|
|
|
22,583
|
|
|
|
(2.7
|
)
|
|
|
64,921
|
|
|
|
(21.0
|
)
|
|
|
(41,602
|
)
|
|
|
(24.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Provision for) benefit from income taxes shown in the
consolidated statements of operations
|
|
|
(177,152
|
)
|
|
|
20.9
|
|
|
|
12,726
|
|
|
|
(4.1
|
)
|
|
|
20,625
|
|
|
|
12.0
|
|
|
Income tax (expense) benefit based on Netherlands rate reflects
the tax (expense) benefit that would have been applicable if all
of the Companys income (loss) was derived from its
Netherlands operations and there were no permanent book tax
differences.
A portion of ASMLs results are realized in countries other
than the Netherlands where different tax rates are applicable.
Different tax rates mainly reflect the adjustment necessary to
give effect to the different tax rates applicable in these
non-Netherlands
jurisdictions.
Other credits and non-taxable items reflect the impact on
statutory rates of permanent non-deductible and non-taxable
items such as non-deductible taxes, non-deductible interest
expense, and non-deductible meals and entertainment, as well as
the impact of (the reversal of) various tax credits on the
Companys provision for income taxes.
The effective tax rate was 12.0 percent of loss before
taxes in 2009, compared to -4.1 percent of income before
taxes in 2008 (2007; 20.9 percent of income before taxes).
In 2008, ASML recognized tax income of approximately
EUR 70 million or approximately 22 percent of
income before tax attributable to three main items on which the
Company reached agreement with the Netherlands tax authorities.
These items were the treatment of taxable income related to
ASMLs patent portfolio (application of the Royalty
Box) in 2007, the valuation of intellectual property
rights acquired in the past against historical exchange rates,
and the treatment of taxable income related to a temporarily
depreciated investment in ASMLs United States subsidiary,
all of which had a favorable impact on the effective tax rate
for 2008.
In 2009, ASML recognized tax expense including interest of
approximately EUR 43 million or approximately
25 percent of loss before taxes attributable to the
reversal of the 2007 Royalty Box benefit which had an
unfavorable impact on the effective tax rate for 2009. In 2009,
based on a tax law change effective January 1, 2010, ASML
decided to reverse the Royalty Box benefits of
ASML ANNUAL REPORT 2009
F-34
2007 as management expects that a clean start of the Innovation
Box (which under Netherlands law replaces the Royalty Box as of
January 1, 2010) in 2010 will result in a higher
cumulative benefit for ASML.
The benefit from (provision for) income taxes consists of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Current
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands
|
|
|
(96,751
|
)
|
|
|
45,165
|
|
|
|
7,886
|
|
Non-Netherlands
|
|
|
(86,962
|
)
|
|
|
(16,502
|
)
|
|
|
(21,426
|
)
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands
|
|
|
9,213
|
|
|
|
(15,614
|
)
|
|
|
41,196
|
|
Non-Netherlands
|
|
|
(2,652
|
)
|
|
|
(323
|
)
|
|
|
(7,031
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
(177,152
|
)
|
|
|
12,726
|
|
|
|
20,625
|
|
|
The deferred tax position and liability for unrecognized tax
benefits recorded on the balance sheet are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Deferred tax position
|
|
|
134,268
|
|
|
|
194,486
|
|
Liability for unrecognized tax benefits
|
|
|
(124,202
|
)
|
|
|
(133,270
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
10,066
|
|
|
|
61,216
|
|
|
The calculation of the Companys liability for unrecognized
tax benefits involves uncertainties in the application of
complex tax laws. The Companys estimate for the potential
outcome of any uncertain tax issue is highly judgmental. The
Company believes that it has adequately provided for uncertain
tax positions. However, settlement of these uncertain tax
positions in a manner inconsistent with its expectations could
have a material impact on its consolidated financial statements.
On January 1, 2007 the Company adopted the provisions of
FIN 48 Accounting for Uncertainty in Income
Taxes after codification included in ASC 740. Consistent
with the provisions of ASC 740, as of December 31, 2009,
ASML classified EUR 133.3 million (2008:
EUR 124.2 million) of the liability for unrecognized
tax benefits as non-current liabilities because payment of cash
was uncertain within one year. These non-current income tax
liabilities are recorded in deferred and other tax liabilities
in the consolidated balance sheets. The total liability for
unrecognized tax benefits, if recognized, would have a favorable
effect on the Companys effective tax rate.
Expected interest and penalties related to income tax
liabilities have been accrued for and are included in the
liability for unrecognized tax benefits and in the (provision
for) benefit from income taxes. The balance of accrued interest
and penalties recorded in the consolidated balance sheets of
December 31, 2009 amounted to EUR 28.5 million
(2008: EUR 23.6 million). Accrued interest and
penalties recorded in the consolidated statements of operations
of 2009 amounted to EUR 4.9 million (2008:
EUR 2.1 million; 2007: EUR 21.5 million) and
are included under (provision for) benefit from income taxes.
A reconciliation of the beginning and ending balance of the
liability for unrecognized tax benefits is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
(In millions)
|
|
EUR
|
|
|
EUR
|
|
Balance, January 1
|
|
|
110.3
|
|
|
|
124.2
|
|
Gross increases tax positions in prior period
|
|
|
13.0
|
|
|
|
6.4
|
|
Gross decreases tax positions in prior period
|
|
|
(6.5
|
)
|
|
|
(1.8
|
)
|
Gross increases tax positions in current period
|
|
|
15.2
|
|
|
|
10.6
|
|
Settlements
|
|
|
(5.0
|
)
|
|
|
(4.3
|
)
|
Lapse of statute of limitations
|
|
|
(2.8
|
)
|
|
|
(1.8
|
)
|
|
|
|
|
|
|
|
|
|
Balance, December 31
|
|
|
124.2
|
|
|
|
133.3
|
|
|
ASML ANNUAL REPORT 2009
F-35
For the year ended December 31, 2009, there were no
material changes related to the liability for unrecognized tax
benefits that impacted the Companys effective tax rate.
The Company estimates that the total liability for unrecognized
tax benefits will decrease by EUR 8.5 million within
the next 12 months. The estimated changes to the liability
for unrecognized tax benefits within the next 12 months are
mainly due to expected settlements and expiration of statute of
limitations.
The deferred tax position is classified in the consolidated
financial statements as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Deferred tax assets short term
|
|
|
71,780
|
|
|
|
119,404
|
|
Deferred tax assets long-term
|
|
|
148,133
|
|
|
|
133,263
|
|
Deferred tax liabilities short term
|
|
|
(148
|
)
|
|
|
(3,047
|
)
|
Deferred tax liabilities long-term
|
|
|
(85,497
|
)
|
|
|
(55,134
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
134,268
|
|
|
|
194,486
|
|
|
Short-term deferred tax assets increased as a result of the
current loss situation of the Company in certain tax
jurisdictions, as these losses are expected to be offset by
future profits. Long-term deferred tax assets decreased as a
result of a decrease in R&D costs which are tax deductible
in future years. Long-term deferred tax liabilities decreased,
because part of the tax refund relating to a temporarily
depreciated investment was partly repaid in 2009.
The deferred tax position in the consolidated financial
statements is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
Tax effect carry-forward losses
|
|
|
57,832
|
|
|
|
107,060
|
|
Bilateral Advance Pricing Agreement
|
|
|
20,856
|
|
|
|
14,390
|
|
Research and Development Costs
|
|
|
43,522
|
|
|
|
21,982
|
|
Inventories and
work-in-progress
|
|
|
33,298
|
|
|
|
30,515
|
|
Restructuring and impairment
|
|
|
12,840
|
|
|
|
8,004
|
|
Temporary depreciation investments
|
|
|
(72,587
|
)
|
|
|
(36,293
|
)
|
Other temporary differences
|
|
|
38,507
|
|
|
|
48,828
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
134,268
|
|
|
|
194,486
|
|
|
Deferred tax assets from carry-forward losses result
predominantly from net operating loss carry-forwards incurred in
the Netherlands and the United States.
Net operating losses qualified as tax losses under Netherlands
tax laws incurred by Netherlands subsidiaries can in general be
offset against future profits realized in the nine years
following the year in which the losses are incurred, and can be
offset with profits of (carried back to) the year prior to the
loss year. Certain specific 2009 losses incurred by Netherlands
ASML entities related to the financial and economic crisis can
be carried back partly for a limited amount of
EUR 10 million per year to two additional
prior years 2006 and 2007 at the expense of three future offset
years. These carry-back losses are reflected in the
Companys current tax assets as of December 31, 2009.
The total amount of losses carried forward under Netherlands tax
laws as of December 31, 2009 is EUR 188.9 million
tax basis or EUR 48.2 million tax effect. Management
believes that all qualified tax losses will be offset by future
taxable income before the Companys ability to utilize
those losses expires.
Net operating losses qualified as tax losses under United States
federal tax laws incurred by United States group companies can
in general be offset against future profits realized in the
20 years following the year in which the losses are
incurred. The Companys ability to carry forward its United
States federal tax losses in existence at December 31, 2009
will expire in the period 2021 through 2023. Net operating
losses qualified as tax losses under United States state tax
laws incurred by United States group companies can in general be
offset against future profits realized in the 5 to 20 years
following the year in which the losses are incurred. The period
of net operating loss carry forward for United States state tax
purposes depends on the state in which the tax loss arose. The
Companys ability to carry forward United States state tax
losses in existence at December 31, 2009 will expire in the
period 2010 through 2023. The total amount of losses carried
forward under United States federal tax laws as of
ASML ANNUAL REPORT 2009
F-36
December 31, 2009 is EUR 147.5 million tax basis
or EUR 58.9 million tax effect. Management believes
that all qualified tax losses will be offset by future taxable
income before the Companys ability to utilize those losses
expires. This analysis takes into account the Companys
projected future taxable income from operations and possible tax
planning alternatives available to the Company.
The deferred tax assets for R&D costs relate to costs which
are tax deductible in future years.
The deferred tax assets for inventories relate to temporary
differences on timing of allowance for obsolete inventory in the
United States. Temporary differences on timing of allowance for
obsolete inventory result from tax laws that defer deduction for
an allowance for obsolete inventory until the moment the related
inventory is actually disposed of or scrapped, rather than when
the allowance is recorded for accounting purposes. The deferred
tax assets related to
work-in-progress
relate to a 2007 tax law change in The Netherlands requiring
accelerated profit recognition on
work-in-process.
The deferred tax assets for restructuring and impairment relate
to costs that are tax deductible in future years.
Pursuant to Netherlands tax laws, the Company has temporarily
depreciated part of its investment in its United States group
companies in the period 2001 through 2005. This depreciation has
been deducted from the taxable base in the Netherlands, which
resulted in temporary (cash) tax refunds in prior years. This
tax refund will be repaid in the period 2006 through 2010 in
five equal installments. As of December 31, 2009, this
repayment obligation amounted to EUR 36.3 million,
which is recorded as a long-term deferred tax liability in the
Companys consolidated financial statements.
The Company is subject to tax audits in its major tax
jurisdictions for years as from 2007 for the Netherlands, for
years as from 2004 for Hong Kong and for years as from 2001 for
the United States. During such audits, local tax authorities may
challenge the positions taken by the Company.
19. Segment
disclosure
Segment information has been prepared in accordance with ASC
280, Segment Reporting (ASC 280).
ASML operates in one reportable segment for the development,
manufacturing, marketing and servicing of lithography equipment.
In accordance with ASC 280, ASMLs Chief Executive Officer
has been identified as the chief operating decision-maker, who
reviews operating results to make decisions about allocating
resources and assessing performance for the entire Company.
Management reporting includes net system sales figures of new
and used systems. Net sales for new and used systems were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
New systems
|
|
|
3,254,198
|
|
|
|
2,346,337
|
|
|
|
993,260
|
|
Used systems
|
|
|
97,083
|
|
|
|
170,425
|
|
|
|
181,598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net system sales
|
|
|
3,351,281
|
|
|
|
2,516,762
|
|
|
|
1,174,858
|
|
|
ASML ANNUAL REPORT 2009
F-37
For geographical reporting, net sales are attributed to the
geographic location in which the customers facilities are
located. Identifiable assets are attributed to the geographic
location in which these assets are located. Net sales and
identifiable assets (total assets excluding goodwill and other
intangible assets) by geographic region were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31
|
|
Net sales
|
|
|
Identifiable assets
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
2007
|
|
|
|
|
|
|
|
|
Japan
|
|
|
270,068
|
|
|
|
39,666
|
|
Korea
|
|
|
1,019,733
|
|
|
|
21,888
|
|
Singapore
|
|
|
204,673
|
|
|
|
4,989
|
|
Taiwan
|
|
|
794,113
|
|
|
|
53,534
|
|
Rest of Asia
|
|
|
283,076
|
|
|
|
824,524
|
|
Europe
|
|
|
344,013
|
|
|
|
2,602,672
|
|
United States
|
|
|
852,509
|
|
|
|
359,389
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
3,768,185
|
|
|
|
3,906,662
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
Japan
|
|
|
437,202
|
|
|
|
239,746
|
|
Korea
|
|
|
909,941
|
|
|
|
12,204
|
|
Singapore
|
|
|
72,245
|
|
|
|
5,174
|
|
Taiwan
|
|
|
361,808
|
|
|
|
62,509
|
|
Rest of Asia
|
|
|
252,713
|
|
|
|
374,285
|
|
Europe
|
|
|
280,040
|
|
|
|
2,750,007
|
|
United States
|
|
|
639,729
|
|
|
|
337,324
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,953,678
|
|
|
|
3,781,249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
Japan
|
|
|
41,075
|
|
|
|
103,399
|
|
Korea
|
|
|
377,677
|
|
|
|
24,931
|
|
Singapore
|
|
|
155,825
|
|
|
|
7,987
|
|
Taiwan
|
|
|
440,222
|
|
|
|
63,502
|
|
Rest of Asia
|
|
|
144,004
|
|
|
|
398,959
|
|
Europe
|
|
|
68,652
|
|
|
|
2,572,665
|
|
United States
|
|
|
368,608
|
|
|
|
406,464
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,596,063
|
|
|
|
3,577,907
|
|
|
In 2009, sales to the largest customer accounted for
EUR 349 million or 21.9 percent of net sales
(2008: EUR 754 million or 25.5 percent of net
sales; 2007: EUR 818 million or 21.7 percent of
net sales). ASMLs three largest customers (based on net
sales) accounted for 44.0 percent of accounts receivable at
December 31, 2009, 42.2 percent of accounts receivable
at December 31, 2008, and 40.1 percent of accounts
receivable at December 31, 2007.
Substantially all of ASMLs sales were export sales in
2007, 2008 and 2009.
20. Board of
Management and Supervisory Board remuneration
The remuneration of the members of the Board of Management is
determined by the Supervisory Board on the advice of the
Remuneration Committee, in cooperation with the Audit Committee
and the Technology & Strategy Committee of the
Supervisory Board. The 2008 remuneration policy was adopted by
the General Meeting of Shareholders on April 3, 2008.
ASMLs aim with the remuneration policy is to continue to
attract, reward and retain qualified industry professionals in
an international labor market. The remuneration structure and
levels are determined by referencing to the median level of the
appropriate top executive pay market practices by benchmarking
positions. The total remuneration consists of base salary and
benefits, short-term performance cash bonus and short-term
performance stock options and long-term performance stock.
ASML ANNUAL REPORT 2009
F-38
Base salary,
benefits and short-term performance cash bonus
The remuneration of the members of the Board of Management was
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Year Ended December 31
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Salaries
|
|
|
2,010,000
|
|
|
|
2,073,000
|
|
|
|
2,106,333
|
|
Bonuses
|
|
|
940,781
|
|
|
|
988,236
|
1
|
|
|
1,303,821
|
2
|
Pension cost
|
|
|
221,958
|
|
|
|
249,072
|
|
|
|
253,683
|
|
Other
benefits3
|
|
|
245,968
|
|
|
|
266,625
|
|
|
|
269,617
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
3,418,707
|
|
|
|
3,576,933
|
|
|
|
3,933,454
|
|
|
|
|
1
|
The bonuses relate for an amount of
EUR 629,255 to the first half of 2008 and for an amount of EUR
358,981 for the second half of 2008, which was partly paid in
cash, partly in shares.
|
2
|
As a response to the financial and
economic crisis in 2009, the Company decided to postpone the
Board of Managements payment of the 2009 cash bonus
(variable pay). Payment will be postponed until the cumulative
income from operations after two consecutive quarters, after
December 31, 2009, is at least EUR 100 million.
|
3
|
Other benefits include housing
costs, company car costs, social security costs, health and
disability insurance costs and representation allowances.
|
The 2009 remuneration of the individual members of the Board of
Management was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash bonus to
|
|
|
|
|
|
|
|
|
|
|
|
|
be paid in
|
|
|
Other
|
|
|
|
|
|
|
Base Salary
|
|
|
future
years1
|
|
|
benefits2
|
|
|
Total
|
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
E. Meurice
|
|
|
735,000
|
|
|
|
507,150
|
|
|
|
141,377
|
|
|
|
1,383,527
|
|
P.T.F.M. Wennink
|
|
|
455,000
|
|
|
|
251,160
|
|
|
|
44,886
|
|
|
|
751,046
|
|
M.A. van den Brink
|
|
|
483,000
|
|
|
|
266,616
|
|
|
|
44,992
|
|
|
|
794,608
|
|
F.J. van Hout
|
|
|
400,000
|
|
|
|
220,800
|
|
|
|
35,199
|
|
|
|
655,999
|
|
F.
Schneider-Maunoury3
|
|
|
33,333
|
|
|
|
58,095
|
|
|
|
3,163
|
|
|
|
94,591
|
|
|
|
|
1
|
As a response to the financial and
economic crisis in 2009, the Company decided to postpone the
Board of Managements payment of the 2009 cash bonus
(variable pay). Payment will be postponed until the cumulative
income from operations after two consecutive quarters, after
December 31, 2009, is at least EUR 100 million.
|
2
|
Other benefits include housing
costs, company car costs, social security costs, health and
disability insurance costs and representation allowances.
|
3
|
Base salary and other benefits
relate to December 2009. Mr. Schneider-Maunourys base
salary for a full year amounts to EUR 400,000.
Mr. Schneider-Maunourys appointment to ASMLs
Board of Management is subject to notification of the General
Meeting of Shareholders, scheduled to be held on March 24,
2010.
|
Under the 2008 Remuneration Policy, the annual short-term
performance bonus ranges between 0 and 75 percent of base
salary for the chairman of the Board of Management and between 0
and 60 percent of base salary for the other members of the
Board of Management. Under this plan the ultimate bonus amount
is dependent on the actual achievement of corporate targets.
These targets include targets related to market, financial,
operational and technology, as well as qualitative performance
targets based on agreed key objectives. As a result of the
economic and financial crisis and the accompanying downturn in
demand for the Companys products, the performance
parameters for 2009 were adjusted in order to reflect the
specific challenges of the downturn.
The 2009 vested pension
benefits1
of individual members of the Board of Management were as follows:
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
EUR
|
|
E. Meurice
|
|
|
91,950
|
|
P.T.F.M. Wennink
|
|
|
56,317
|
|
M.A. van den Brink
|
|
|
59,880
|
|
F.J. van Hout
|
|
|
40,800
|
|
F.
Schneider-Manoury2
|
|
|
4,736
|
|
|
|
|
1
|
Since the pension arrangement for
members of the Board of Management is a defined contribution
plan, the Company does not have additional pension obligations
beyond the annual premium contribution.
|
2
|
Pension benefits relate to December
2009. Mr. Schneider-Maunourys appointment to
ASMLs Board of Management is subject to notification of
the General Meeting of Shareholders, scheduled to be held on
March 24, 2010.
|
ASML ANNUAL REPORT 2009
F-39
Performance Stock
Options
Members of the Board of Management are eligible for a maximum
performance stock option grant, under the conditions of the 2008
Remuneration Policy, with a value equal to 50 percent of
their base salary (whereas the value at target performance
equals 25 percent of their base salary). In 2008 the
Supervisory Board decided that the maximum number of performance
stock options to be granted conditionally in 2009 would be equal
to the maximum number of stock options determined for 2008. The
ultimately awarded number of performance stock options is
calculated semi-annually upon achievement of the target for the
first and second half of 2009. Based on the Black-Scholes option
valuation model, the fair value of the options granted in 2008
and 2009 was EUR 5.66 and EUR 5.73, respectively. The
compensation expenses recorded in the consolidated statements of
operations for the year ended December 31, 2009 amount to
EUR 1.4 million (2008: EUR 0.9 million and
2007: EUR 1.8 million).
The actual numbers of performance stock options which were
awarded in 2009 and will be awarded in 2010 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual number of performance stock
|
|
|
Maximum number of performance stock
|
|
|
|
options which were awarded in 2009
|
|
|
options which will be awarded in 2010
|
|
|
|
for 2008 actual achievement
|
|
|
for 2009 actual
achievement1
|
|
E. Meurice
|
|
|
42,448
|
|
|
|
84,895
|
|
P.T.F.M. Wennink
|
|
|
26,277
|
|
|
|
52,554
|
|
M.A. van den Brink
|
|
|
27,894
|
|
|
|
55,788
|
|
F.J. van Hout
|
|
|
|
|
|
|
46,201
|
|
|
|
|
1
|
The numbers are based on a latest
estimate. The actual numbers of performance stock options will
be determined by the remuneration committee in February 2010.
|
Details of options held by members of the Board of Management to
purchase ordinary shares of ASML Holding N.V. are set out below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share price
|
|
|
|
|
|
|
Jan. 1,
|
|
|
Exercised
|
|
|
Expired
|
|
|
Dec. 31,
|
|
|
Exercise
|
|
|
on exercise
|
|
|
Expiration
|
|
|
|
2009
|
|
|
during 2009
|
|
|
during 2009
|
|
|
2009
|
|
|
price
|
|
|
date
|
|
|
date
|
|
E. Meurice
|
|
|
125,000
|
|
|
|
|
|
|
|
|
|
|
|
125,000
|
|
|
|
10.62
|
|
|
|
|
|
|
|
15-10-2014
|
|
|
|
|
12,500
|
|
|
|
|
|
|
|
|
|
|
|
12,500
|
|
|
|
11.52
|
|
|
|
|
|
|
|
21-01-2015
|
|
|
|
|
57,770
|
|
|
|
|
|
|
|
|
|
|
|
57,770
|
|
|
|
11.53
|
|
|
|
|
|
|
|
19-01-2015
|
|
|
|
|
88,371
|
|
|
|
|
|
|
|
|
|
|
|
88,371
|
|
|
|
17.90
|
|
|
|
|
|
|
|
18-01-2016
|
|
|
|
|
95,146
|
|
|
|
|
|
|
|
|
|
|
|
95,146
|
|
|
|
20.39
|
|
|
|
|
|
|
|
17-01-2017
|
|
|
|
|
42,448
|
|
|
|
|
|
|
|
|
|
|
|
42,448
|
|
|
|
17.20
|
|
|
|
|
|
|
|
04-02-2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
P.T.F.M. Wennink
|
|
|
31,500
|
|
|
|
|
|
|
|
|
|
|
|
31,500
|
|
|
|
58.00
|
|
|
|
|
|
|
|
20-01-2012
|
|
|
|
|
32,379
|
|
|
|
|
|
|
|
|
|
|
|
32,379
|
|
|
|
11.53
|
|
|
|
|
|
|
|
19-01-2015
|
|
|
|
|
56,236
|
|
|
|
|
|
|
|
|
|
|
|
56,236
|
|
|
|
17.90
|
|
|
|
|
|
|
|
18-01-2016
|
|
|
|
|
58,964
|
|
|
|
|
|
|
|
|
|
|
|
58,964
|
|
|
|
20.39
|
|
|
|
|
|
|
|
17-01-2017
|
|
|
|
|
26,277
|
|
|
|
|
|
|
|
|
|
|
|
26,277
|
|
|
|
17.20
|
|
|
|
|
|
|
|
04-02-2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M.A. van den Brink
|
|
|
31,500
|
|
|
|
|
|
|
|
|
|
|
|
31,500
|
|
|
|
58.00
|
|
|
|
|
|
|
|
20-01-2012
|
|
|
|
|
40,473
|
|
|
|
40,473
|
|
|
|
|
|
|
|
|
|
|
|
11.53
|
|
|
|
17.90
|
|
|
|
19-01-2015
|
|
|
|
|
59,098
|
|
|
|
|
|
|
|
|
|
|
|
59,098
|
|
|
|
17.90
|
|
|
|
|
|
|
|
18-01-2016
|
|
|
|
|
61,644
|
|
|
|
|
|
|
|
|
|
|
|
61,644
|
|
|
|
20.39
|
|
|
|
|
|
|
|
17-01-2017
|
|
|
|
|
27,894
|
|
|
|
|
|
|
|
|
|
|
|
27,894
|
|
|
|
17.20
|
|
|
|
|
|
|
|
04-02-2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F.J. van Hout
|
|
|
4,100
|
|
|
|
|
|
|
|
|
|
|
|
4,100
|
|
|
|
7.88
|
|
|
|
|
|
|
|
20-01-2013
|
|
|
|
|
16,365
|
|
|
|
|
|
|
|
|
|
|
|
16,365
|
|
|
|
10.11
|
|
|
|
|
|
|
|
18-07-2013
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
17.34
|
|
|
|
|
|
|
|
19-01-2014
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
12.02
|
|
|
|
|
|
|
|
16-07-2014
|
|
|
|
|
9,000
|
|
|
|
|
|
|
|
|
|
|
|
9,000
|
|
|
|
11.56
|
|
|
|
|
|
|
|
15-04-2015
|
|
|
|
|
14,000
|
|
|
|
|
|
|
|
|
|
|
|
14,000
|
|
|
|
17.90
|
|
|
|
|
|
|
|
20-10-2016
|
|
|
|
|
1,388
|
|
|
|
|
|
|
|
|
|
|
|
1,388
|
|
|
|
24.26
|
|
|
|
|
|
|
|
19-10-2017
|
|
|
|
|
8,000
|
|
|
|
|
|
|
|
|
|
|
|
8,000
|
|
|
|
14.87
|
|
|
|
|
|
|
|
18-07-2018
|
|
|
|
|
3,987
|
|
|
|
|
|
|
|
|
|
|
|
3,987
|
|
|
|
11.43
|
|
|
|
|
|
|
|
17-10-2018
|
|
|
ASML ANNUAL REPORT 2009
F-40
Performance
Stock
Members of the Board of Management are eligible for a maximum
performance stock award, under the conditions set out in the
2008 remuneration policy, with a value equal to a maximum of
96.25 percent of their base salary (whereas the value at
target performance equals 55 percent of their base salary).
In 2008 the Supervisory Board decided that the maximum number of
performance stock to be granted conditionally in 2009, would be
equal to the maximum number of stock determined for 2008. The
ultimately awarded number of performance stock will be
determined over a three-year period upon achievement of targets
set in 2009 relating to the Companys relative ROAIC
position in the peer group. ASML accounts for this stock award
performance plan as a variable plan. The fair value of the stock
granted in 2007, 2008 and 2009 was EUR 20.39,
EUR 17.20 and EUR 13.05, respectively. The
compensation expenses recorded in the consolidated statements of
operations for the year ended December 31, 2009 amount to
EUR 2.5 million (2008: EUR 3.3 million and
2007: EUR 3.3 million).
The maximum number of performance stock which can be awarded in
relation to performance targets are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual number of
|
|
|
Maximum number of
|
|
|
Maximum number of
|
|
|
Maximum number of
|
|
|
|
performance stock
|
|
|
performance stock
|
|
|
performance stock
|
|
|
performance stock
|
|
|
|
granted in 2006
|
|
|
granted in 2007 to be
|
|
|
granted in 2008 to be
|
|
|
granted in 2009 to be
|
|
|
|
awarded in 2009
|
|
|
awarded in
20101
|
|
|
awarded in 2011
|
|
|
awarded in 2012
|
|
E. Meurice
|
|
|
72,136
|
|
|
|
66,338
|
|
|
|
57,002
|
|
|
|
57,002
|
|
P.T.F.M. Wennink
|
|
|
45,905
|
|
|
|
41,111
|
|
|
|
35,287
|
|
|
|
35,287
|
|
M.A. van den Brink
|
|
|
48,241
|
|
|
|
42,980
|
|
|
|
37,458
|
|
|
|
37,458
|
|
F.J. van
Hout2
|
|
|
|
|
|
|
1,667
|
|
|
|
4,000
|
|
|
|
31,021
|
|
|
|
|
1
|
The actual number of performance
stock will be determined by the RemunerationCommittee in the
first half of 2010.
|
2
|
The 2007 and 2008 grants relate to
services provided by Mr. van Hout prior to his appointment as a
member of the Board of Management
|
Benefits upon
termination of employment
The employment agreements with Mr. P. Wennink and
Mr. M. van den Brink do not contain specific provisions
regarding benefits upon termination of those agreements.
Potential severance payments will be according to applicable law.
The employment agreements with Mr. E. Meurice, Mr. F.
van Hout and Mr. F. Schneider-Maunoury contain specific
provisions regarding benefits upon termination of their
employment. If ASML gives notice of termination of the
employment agreement for reasons which are not exclusively or
mainly found in acts or omissions on the side of either
Mr. E. Meurice, Mr. F. van Hout or Mr. F.
Schneider-Maunoury, a severance payment equal to one year base
salary will be paid upon the effective date of termination. This
severance payment will also be paid in case either Mr. E.
Meurice, Mr. F. van Hout or Mr. F. Schneider-Maunoury
gives notice of termination of the employment agreement in
connection with a substantial difference of opinion between him
and the Supervisory Board regarding his employment agreement,
his function or the Companys strategy.
Furthermore, Mr. E. Meurice, Mr. F. van Hout and
Mr. F. Schneider-Maunoury would also be entitled to the
aforementioned severance amount in the event ASML or its legal
successor gives notice of termination in connection with a
Change of Control (as defined in the employment agreement) or if
either person gives notice of termination, that is directly
related to such Change of Control and such notice is given
within twelve months from the date on which the Change of
Control occurs.
Supervisory
Board
The annual remuneration for Supervisory Board members covers the
period from one annual General Meeting of Shareholders to the
next one. The annual remuneration is paid in quarterly
installments starting after the annual General Meeting of
Shareholders.
The general meeting of shareholders is the body that determines
the remuneration package for Supervisory Board members. At
ASMLs annual General Meeting of Shareholders held on
March 28, 2007, ASMLs shareholders adopted the
following remuneration package: each European Supervisory Board
member receives EUR 40,000 with the Chairman receiving
EUR 55,000. Each non-European Supervisory Board member
receives EUR 70,000. Additionally, members of the Audit
Committee are paid EUR 10,000 for their membership, with
the Chairman of the Audit Committee receiving EUR 15,000
for his chairmanship. The members of the other Committees are
paid EUR 7,500 per Committee membership, with the Chairmen
receiving EUR 10,000 per Committee chairmanship. To
compensate for certain obligations ASML has towards the US
government as a result of the merger with SVG in 2001, and which
obligations this member needs to fulfill, one US member receives
an additional EUR 10,000.
ASML ANNUAL REPORT 2009
F-41
During 2008 and 2009, ASML paid the following amounts to the
individual members of the Supervisory Board:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
Year ended December 31
|
|
|
|
|
EUR
|
|
|
EUR
|
|
OB Bilous
|
|
|
|
|
|
|
95,000
|
|
|
|
95,000
|
|
J.A.
Dekker1
|
|
|
|
|
|
|
60,000
|
|
|
|
15,000
|
|
J.W.B. Westerburgen
|
|
|
|
|
|
|
60,000
|
|
|
|
60,000
|
|
F.W. Fröhlich
|
|
|
|
|
|
|
55,000
|
|
|
|
55,000
|
|
A.P.M. van der Poel
|
|
|
|
|
|
|
80,000
|
|
|
|
80,000
|
|
H.C.J. van den Burg
|
|
|
|
|
|
|
47,500
|
|
|
|
47,500
|
|
W.T. Siegle
|
|
|
|
|
|
|
77,500
|
|
|
|
79,375
|
|
W.
Ziebart2
|
|
|
|
|
|
|
|
|
|
|
43,125
|
|
P.F.M. van der Meer
Mohr2,3
|
|
|
|
|
|
|
|
|
|
|
47,500
|
|
|
|
|
|
1 |
|
Membership ended March 26,
2009.
|
2 |
|
Membership started March 26,
2009.
|
3 |
|
The amount paid to Ms. P. van
der Meer Mohr in 2009 consists of an amount paid to Ms. P.
van der Meer Mohr as observer to the Supervisory Board prior to
her appointment, and an amount for her membership of the
Supervisory Board and Remuneration Committee.
|
In addition, a net cost allowance was paid to each Supervisory
Board member in 2009, amounting to EUR 1,800 per year, and
EUR 2,400 per year for the Chairman of the Supervisory
Board.
In 2010, ASML expects to pay the following amounts to the
individual members of the Supervisory Board (in Euros):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
Year ended December 31
|
|
|
|
|
|
|
|
EUR
|
|
OB Bilous
|
|
|
|
|
|
|
|
|
|
|
95,000
|
|
H.C.J. van den Burg
|
|
|
|
|
|
|
|
|
|
|
47,500
|
|
F.W. Fröhlich
|
|
|
|
|
|
|
|
|
|
|
55,000
|
|
P.F.M. van der Meer Mohr
|
|
|
|
|
|
|
|
|
|
|
47,500
|
|
A.P.M. van der Poel
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
W.T. Siegle
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
J.W.B. Westerburgen
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
W. Ziebart
|
|
|
|
|
|
|
|
|
|
|
57,500
|
|
|
In addition, in 2010, ASML expects to pay a net cost allowance
amounting to EUR 1,800 per year to each Supervisory Board
member, and EUR 2,400 per year to the Chairman of the
Supervisory Board.
Members of the Board of Management
and/or
Supervisory Board are free to acquire or dispose of ASML shares
or options for their own account, provided they comply with the
applicable ASML Insider Trading Rules. Those securities are not
part of members remuneration from the Company and are
therefore not included.
21. Selected
operating expenses and additional information
Personnel expenses for all payroll employees were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
(in thousands)
|
|
EUR
|
|
|
EUR
|
|
|
EUR
|
|
Wages and salaries
|
|
|
469,214
|
|
|
|
477,374
|
|
|
|
436,817
|
|
Social security expenses
|
|
|
35,905
|
|
|
|
37,877
|
|
|
|
38,533
|
|
Pension and retirement expenses
|
|
|
33,478
|
|
|
|
39,045
|
|
|
|
39,825
|
|
Share-based payments
|
|
|
16,506
|
|
|
|
13,535
|
|
|
|
13,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
555,103
|
|
|
|
567,831
|
|
|
|
528,640
|
|
|
ASML ANNUAL REPORT 2009
F-42
The average number of payroll employees in FTEs employed during
2007, 2008 and 2009 was 6,191, 6,840 and 6,624 respectively. The
total number of payroll personnel employed in FTEs per sector
was:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
Research and development
|
|
|
1,831
|
|
|
|
2,042
|
|
|
|
2,014
|
|
Goodsflow
|
|
|
1,699
|
|
|
|
1,936
|
|
|
|
1,749
|
|
Industrial engineering
|
|
|
|
|
|
|
|
|
|
|
269
|
|
Customer support
|
|
|
2,475
|
|
|
|
2,346
|
|
|
|
1,893
|
|
General
|
|
|
468
|
|
|
|
488
|
|
|
|
497
|
|
Sales
|
|
|
109
|
|
|
|
118
|
|
|
|
126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
6,582
|
|
|
|
6,930
|
|
|
|
6,548
|
|
|
As of December 31, 2007, 2008 and 2009, a total of 1,725,
1,329 and 1,137 temporary employees in FTEs, respectively, were
employed in the Companys operations.
In 2007, 2008 and 2009, a total of 3,112, 3,510 and 3,601 (on
average) payroll employees in FTEs in the Companys
operations (excluding temporary employees), respectively, were
employed in the Netherlands.
22. Research and
development costs
R&D costs include credits for an amount of
EUR 24.4 million, EUR 22.2 million and
EUR 28.1 million during 2007, 2008 and 2009,
respectively. R&D credits relate to world-wide
(inter)governmental funding for certain strategic development
programs.
23. Interest
income and expense
Interest and similar income of EUR 42.8 million (2008:
EUR 72.5 million and 2007: EUR 78.2 million)
mainly relates to interest income on deposits, money market
funds and on bank accounts, of which EUR 27.9 million
(2008: EUR 12.9 million and 2007
EUR 9.3 million) relates to interest on cash pools
which is reported on a gross basis in the consolidated
statements of operations.
From an economic and legal perspective this
EUR 27.9 million (2008: EUR 12.9 million and
2007: EUR 9.3 million) interest income nets off
against the same amount of interest expense.
24. Vulnerability
due to certain concentrations
ASML relies on outside vendors to manufacture the components and
subassemblies used in its systems, each of which is obtained
from a sole supplier or a limited number of suppliers.
ASMLs reliance on a limited group of suppliers involves
several risks, including a potential inability to obtain an
adequate supply of required components and reduced control over
pricing and timely delivery of these subassemblies and
components. In particular, from time to time, the number of
systems ASML has been able to produce has been limited by the
production capacity of Zeiss. Zeiss is currently ASMLs
sole external supplier of lenses and other critical optical
components and is capable of producing these lenses only in
limited numbers and only through the use of its manufacturing
and testing facility in Oberkochen and Wetzlar, Germany. During
2009, ASMLs sales were not limited by the deliveries from
Zeiss.
ASML sells a substantial number of lithography systems to a
limited number of customers. See Note 19. Business failure
of one of ASMLs main customers may result in adverse
effects on its business, financial condition and results of
operations.
25. Capital
stock
Share
capital
ASMLs authorized share capital consists of ordinary shares
and cumulative preference shares. Currently, only ordinary
shares are issued.
The Companys Board of Management has the power to issue
shares if and to the extent the Board of Management has been
authorized to do so by the General Meeting of Shareholders
(either by means of a resolution or by an amendment to the
Companys Articles of Association). However, the
Supervisory Board must approve any issuance of shares.
ASML ANNUAL REPORT 2009
F-43
Ordinary
shares
At ASMLs annual General Meeting of Shareholders, held on
March 26, 2009, the Board of Management was granted the
authorization to issue shares
and/or
rights thereto representing up to a maximum of 5 percent of
the Companys issued share capital as of the date of
authorization, plus an additional 5 percent of the
Companys issued share capital as of the date of
authorization that may be issued in connection with mergers and
acquisitions. At ASMLs annual General Meeting of
Shareholders to be held on March 24, 2010, its shareholders
will be asked to authorize the Board of Management (subject to
the approval of the Supervisory Board) to issue shares
and/or
rights thereto through September 24, 2011.
Holders of ASMLs ordinary shares have a preemptive right
of subscription to any issuance of ordinary shares for cash,
which right may be limited or excluded. Ordinary shareholders
have no pro rata preemptive right of subscription to any
ordinary shares issued for consideration other than cash or
ordinary shares issued to employees. If authorized for this
purpose by the General Meeting of Shareholders (either by means
of a resolution or by an amendment to ASMLs Articles of
Association), the Board of Management has the power, with the
approval of the Supervisory Board, to limit or exclude the
preemptive rights of holders of ordinary shares. A designation
may be renewed. At ASMLs annual General Meeting of
Shareholders, held on March 26, 2009, the Board of
Management was authorized, subject to the aforementioned
approval, to restrict or exclude preemptive rights of holders of
ordinary shares. At ASMLs annual General Meeting of
Shareholders to be held on March 24, 2010, its shareholders
will be asked to grant this authority through September 24,
2011. At this annual General Meeting of Shareholders, the
shareholders will be asked to grant authority to the Board of
Management to issue shares and options separately for a period
of 18 months.
The Company may repurchase its issued ordinary shares at any
time, subject to compliance with the requirements of Netherlands
law and its Articles of Association. Although Netherlands law
provides since June 11, 2008 that after such repurchases
the aggregate nominal value of the ordinary shares held by ASML
or a subsidiary must not be more than 50 percent of the
issued share capital, the Companys current Articles of
Association provide that after such repurchases the aggregate
nominal value of the ordinary shares held by ASML or a
subsidiary must not be more than 10 percent of the issued
share capital. Any such purchases are subject to the approval of
the Supervisory Board and the authorization (either by means of
a resolution or by an amendment to the Companys Articles
of Association) of shareholders at ASMLs General Meeting
of Shareholders, which authorization may not be for more than
18 months. The Board of Management is currently authorized,
subject to Supervisory Board approval, to repurchase through
September 26, 2010 up to a maximum of approximately
27 percent of the Companys issued share capital as of
the date of authorization (March 26, 2009) at a price
between the nominal value of the ordinary shares purchased and
110 percent of the market price of these securities on
Euronext Amsterdam or NASDAQ. At ASMLs annual General
Meeting of Shareholders to be held on March 24, 2010, its
shareholders will be asked to extend this authority through
September 24, 2011.
Cumulative
preference shares
In 1998, the Company granted to the preference share foundation,
Stichting Preferente Aandelen ASML (the
Foundation) an option to acquire cumulative
preference shares in the capital of the Company (the
Preference Share Option). This option was amended
and extended in 2003 and 2007. A third amendment to the option
agreement between the Foundation and ASML has become effective
as from January 1, 2009, to clarify the procedure for the
repurchase and cancellation of the preference shares when issued.
The Foundation may exercise the Preference Share Option in
situations where, in the opinion of the Board of Directors of
the Foundation, the interests of the Company, its business or
the interests of its stakeholders are at stake. This may be the
case if a public bid for the ordinary shares of the Company has
been announced or has been made, or the justified expectation
exists that such a bid will be made without any agreement having
been reached in relation to such a bid with the Company. The
same may apply if one shareholder, or more shareholders acting
in concert, hold a substantial percentage of the issued ordinary
shares of the Company without making an offer or if, in the
opinion of the Board of Directors of the Foundation, the
(attempted) exercise of the voting rights by one shareholder or
more shareholders, acting in concert, is materially in conflict
with the interests of the Company, its business or its
stakeholders.
The objects of the Foundation are to look after the interests of
ASML and of the enterprises maintained by ASML and of the
companies which are affiliated in a group with ASML, in such way
that the interests of ASML, of those enterprises and of all
parties concerned are safeguarded in the best possible way, and
influences in conflict with these interests which might affect
the independence or the identity of ASML and those companies are
deterred to the best of the Foundations ability, and
everything related to the above or possibly conducive thereto.
The Foundation seeks to realize its objects by the acquiring and
holding of cumulative preference shares in the capital of ASML
and by exercising the rights attached to these shares,
particularly the voting rights attached to these shares.
The Preference Share Option gives the Foundation the right to
acquire a number of cumulative preference shares, provided that
the aggregate nominal value of such number of cumulative
preference shares shall not exceed the aggregate nominal value
of
ASML ANNUAL REPORT 2009
F-44
the ordinary shares that have been issued at the time of
exercise of the Preference Share Option for a subscription price
equal to their EUR 0.02 nominal value. Exercise of the
Preference Share Option could effectively dilute the voting
power of the ordinary shares then outstanding by one-half. Only
one-fourth of the subscription price is payable at the time of
initial issuance of the cumulative preference shares.
Cancellation and repayment of the issued cumulative preference
shares by the Company requires the authorization by the General
Meeting of Shareholders of a proposal to do so by the Board of
Management approved by the Supervisory Board. If the Preference
Share Option is exercised and as a result cumulative preference
shares are issued, the Company, at the request of the
Foundation, will initiate the repurchase or cancellation of all
cumulative preference shares held by the Foundation as a result
of such issuance with repayment of the amount paid and exemption
from the obligation to pay up on the cumulative preference
shares. In that case the Company is obliged to effect the
repurchase and cancellation respectively as soon as possible.
If the Foundation will not request the Company to repurchase or
cancel all cumulative preference shares held by the Foundation
within 20 months after issuance of these shares, the
Company will be obliged to convene a General Meeting of
Shareholders in order to decide on a repurchase or cancellation
of these shares.
The Foundation is independent of the Company. The Board of
Directors of the Foundation comprises four independent voting
members from the Netherlands business and academic communities:
Mr. R.E. Selman, Mr. M.W. den Boogert, Mr. J.M.
de Jong and Mr. A. Baan.
Dividend
proposal
Annually, the Board of Management will assess the amount of
dividend that will be proposed to the Annual General Meeting of
Shareholders. For 2008, a dividend was declared of EUR 0.20
per ordinary share of EUR 0.09 which was paid in 2009.
A proposal will be submitted to the Annual General Meeting of
Shareholders on March 24, 2010 to declare a dividend for
2009 of EUR 0.20 per ordinary share of EUR 0.09.
26. Purchases of
Equity Securities by the Issuer and Affiliated
Purchasers
The following table provides a summary of shares repurchased by
the Company between 2006 and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total value
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number
|
|
|
Maximum
|
|
|
of Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
of Shares
|
|
|
Number of
|
|
|
Purchased as
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchased as
|
|
|
Shares That
|
|
|
Part of Publicly
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Part of Publicly
|
|
|
May Yet be
|
|
|
Announced
|
|
|
|
|
|
|
Total Number
|
|
|
Price Paid
|
|
|
Announced
|
|
|
Purchased
|
|
|
Plans or
|
|
|
|
|
|
|
of Shares
|
|
|
per Share
|
|
|
Plans or
|
|
|
Under the
|
|
|
Programs (in
|
|
Program
|
|
Period
|
|
|
purchased
|
|
|
(EUR)
|
|
|
Programs
|
|
|
Programs
|
|
|
EUR million)
|
|
2006-2007 Share
program
|
|
|
May 17-26, 2006
|
|
|
|
6,412,920
|
|
|
|
15.59
|
|
|
|
6,412,920
|
|
|
|
19,037,376
|
|
|
|
100
|
|
2006-2007 Share
program
|
|
|
June 7-30, 2006
|
|
|
|
13,517,078
|
|
|
|
15.81
|
|
|
|
19,929,998
|
|
|
|
5,520,298
|
|
|
|
314
|
|
2006-2007 Share
program
|
|
|
July 3-13, 2006
|
|
|
|
5,520,298
|
|
|
|
15.62
|
|
|
|
25,450,296
|
|
|
|
|
|
|
|
400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006-2007 Share
program
|
|
|
October 12, 2006
|
|
|
|
14,934,843
|
|
|
|
18.55
|
|
|
|
14,934,843
|
|
|
|
|
|
|
|
277
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006-2007 Share
program
|
|
|
February 14-23, 2007
|
|
|
|
8,000,000
|
|
|
|
19.53
|
|
|
|
8,000,000
|
|
|
|
|
|
|
|
156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital repayment program 2007
|
|
|
September - October 2007
|
|
|
|
55,093,409
|
|
|
|
18.36
|
|
|
|
55,093,409
|
|
|
|
|
|
|
|
1,012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007-2008 Share
program
|
|
|
November 14-26, 2007
|
|
|
|
9,000,000
|
|
|
|
22.62
|
|
|
|
9,000,000
|
|
|
|
5,000,000
|
|
|
|
204
|
|
2007-2008 Share
program
|
|
|
January 17-22, 2008
|
|
|
|
5,000,000
|
|
|
|
17.52
|
|
|
|
14,000,000
|
|
|
|
|
|
|
|
292
|
|
|
2006-2007 Share
program
On March 23, 2006, the General Meeting of Shareholders
authorized the repurchase of up to a maximum of 10 percent
of the Companys issued shares through September 23,
2007. The number of shares bought back in the initial phase of
this Repurchase Program was 25,450,296 shares, representing
100 percent of the announced objective for the initial
phase of the Repurchase Program of maximum
EUR 400 million and 5.25 percent of outstanding
shares. This 2006 Repurchase Program was completed in the third
quarter of 2006. Shares repurchased were recorded at cost and
classified within shareholders equity. ASML cancelled
these repurchased shares in 2007.
ASML ANNUAL REPORT 2009
F-45
In the second phase of the Repurchase Program, ASML repurchased
14,934,843 additional shares pursuant to a call option
transaction announced on October 9, 2006. These repurchased
shares represented 100 percent of the announced objective
of the second phase of the Repurchase Program. In order to
mitigate the dilution due to the issuance of shares upon
conversion of its convertible bond due October 2006, these
shares were subsequently used to satisfy the conversion rights
of holders of ASMLs 5.75 percent Convertible
Subordinated Notes. The Company paid an aggregate of
EUR 277 million in cash for these shares. This
repurchase program was completed in the fourth quarter of 2006.
These shares were purchased from a third party who issued the
call option.
In February 2007, ASML repurchased the final phase of shares
under the Repurchase Program of the remaining 1.7 percent
of outstanding shares, being 8,000,000 shares. The share
program was announced on February 14, 2007 and was
completed in the first quarter of 2007. Shares repurchased have
been used to cover outstanding stock options and to satisfy
partly the conversion rights of holders of ASMLs
5.50 percent Convertible Subordinated Notes.
Capital repayment
program 2007
On July 17, 2007 the Extraordinary General Meeting of
Shareholders approved three proposals to amend the
Companys Articles of Association. The first amendment
involved an increase of share capital by an increase in the
nominal value per ordinary share from EUR 0.02 to
EUR 2.12 and a corresponding reduction in share premium.
The second amendment was a reduction of the nominal value per
ordinary share from EUR 2.12 to EUR 0.08 resulting in
the payment to shareholders of EUR 2.04 per ordinary share.
The third amendment involved a reduction in stock, whereby nine
ordinary shares with a nominal value of EUR 0.08 each were
consolidated into eight ordinary shares with a nominal value of
EUR 0.09 each. As a result of these amendments, which in
substance constitute a synthetic share buyback,
EUR 1,012 million has been repaid to the
Companys shareholders and the outstanding number of
ordinary shares was reduced by 55,093,409 shares or
11 percent. The capital repayment program was completed in
October 2007.
2007-2008 Share
program
On March 28, 2007, the General Meeting of Shareholders
authorized the repurchase of up to a maximum of three times
10 percent of the Companys issued shares through
September 28, 2008.
In 2007, the aggregate number of shares bought back under the
2007-2008 share
program was 9,000,000, representing 64.3 percent of the
announced objective of 14,000,000 shares to be repurchased
during a period ending on September 28, 2008. The share
program was announced on October 17, 2007. Shares
repurchased will be used to cover outstanding stock options.
In January 2008, ASML bought back 5,000,000 shares. The
aggregate number of shares bought back up to and including
January 2008, represents 100 percent of the announced
objective of 14,000,000 shares.
Authorization of
share repurchases
On March 26, 2009, the General Meeting of Shareholders
authorized the repurchase of up to a maximum of approximately
27 percent of the Companys issued share capital as of
the date of authorization (March 26, 2009) through
September 26, 2010. The Company did not buyback any shares
in 2009.
ASML ANNUAL REPORT 2009
F-46
27. Subsequent
Events
Subsequent events have been evaluated by the Company until
January 29, 2010 which is the issuance date of this Annual
Report 2009. There are no subsequent events to report.
Veldhoven,
the Netherlands
January 29, 2010
/s/ Eric Meurice
Eric Meurice, Chief Executive Officer
/s/ Peter T.F.M. Wennink
Peter T.F.M. Wennink, Chief Financial Officer
ASML ANNUAL REPORT 2009
F-47
Report
of Independent Registered Public Accounting Firm
To the Supervisory Board and Shareholders of ASML Holding N.V.:
We have audited the accompanying consolidated balance sheets of
ASML Holding N.V. and subsidiaries (collectively, the
Company) as of December 31, 2009 and 2008, and
the related consolidated statements of operations, comprehensive
income, shareholders equity and cash flows for each of the
three years in the period ended December 31, 2009 (all
expressed in Euros). We also have audited the Companys
internal control over financial reporting as of
December 31, 2009, based on criteria established in
Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway
Commission. The Companys management is responsible for
these financial statements, for maintaining effective internal
control over financial reporting, and for its assessment of the
effectiveness of internal control over financial reporting,
included in the accompanying Managements Report on
Internal Control over Financial Reporting. Our responsibility is
to express an opinion on these financial statements and an
opinion on the Companys internal control over financial
reporting based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement and whether effective internal
control over financial reporting was maintained in all material
respects. Our audit of the financial statements included
examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by
management, and evaluating the overall financial statement
presentation. Our audit of internal control over financial
reporting included obtaining an understanding of internal
control over financial reporting, assessing the risk that a
material weakness exists, and testing and evaluating the design
and operating effectiveness of internal control based on the
assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We
believe that our audits provide a reasonable basis for our
opinions.
A companys internal control over financial reporting is a
process designed by, or under the supervision of, the
companys principal executive and principal financial
officers, or persons performing similar functions, and effected
by the companys board of directors, management, and other
personnel to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over
financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements
due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the
effectiveness of the internal control over financial reporting
to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of ASML Holding N.V. and subsidiaries as of
December 31, 2009 and 2008, and the results of their
operations and their cash flows for each of the three years in
the period ended December 31, 2009, in conformity with
accounting principles generally accepted in the United States of
America. Also, in our opinion, the Company maintained, in all
material respects, effective internal control over financial
reporting as of December 31, 2009, based on the criteria
established in Internal Control Integrated Framework
issued by the Committee of Sponsoring Organizations of the
Treadway Commission.
/s/ Deloitte
Accountants B.V.
Deloitte Accountants B.V.
Eindhoven, The Netherlands
January 29, 2010
ASML ANNUAL REPORT 2009
F-48
Exhibits
ASML ANNUAL REPORT 2009
Exhibit Index
|
|
|
|
|
Exhibit No.
|
|
Description
|
1
|
|
Articles of Association of ASML Holding N.V. (English
translation) (Incorporated by reference to Amendment No.
11 to the Registrants Registration Statement on
Form 8-A/A,
filed with the Commission on November 2, 2007)
|
2.1
|
|
Fiscal Agency Agreement between ASML Holding N.V., Deutsche Bank
AG, London Branch and Deutsche Bank Luxembourg S.A. relating to
the Registrants 5.75 percent Notes due 2017
(Incorporated by reference to the Registrants Annual
Report for the year ended December 31, 2008)
|
4.1
|
|
Agreement between ASML Lithography B.V. and Carl Zeiss, dated
March 17, 2000 (Incorporated by reference to the
Registrants Annual Report on
Form 20-F
for the fiscal year ended December 31, 2000) #
|
4.2
|
|
Agreement between ASML Holding N.V. and Carl Zeiss, dated
October 24, 2003 (Incorporated by reference to the
Registrants Annual Report on
Form 20-F
for the year ended December 31, 2003) #
|
4.3
|
|
Form of Indemnity Agreement between ASML Holding N.V. and
members of its Board of Management (Incorporated by reference to
the Registrants Annual Report on
Form 20-F
for the year ended December 31, 2003)
|
4.4
|
|
Form of Indemnity Agreement between ASML Holding N.V. and
members of its Supervisory Board (Incorporated by reference to
the Registrants Annual Report on
Form 20-F
for the year ended December 31, 2003)
|
4.5
|
|
Form of Employment Agreement for members of the Board of
Management (Incorporated by reference to the Registrants
Annual Report on
Form 20-F
for the fiscal year ended December 31, 2003)
|
4.6
|
|
Nikon-ASML Patent Cross-License Agreement, dated
December 10, 2004, between ASML Holding N.V. and Nikon
Corporation (Incorporated by reference to the Registrants
Annual Report on
Form 20-F
for the fiscal year ended December 31, 2004) #
|
4.7
|
|
ASML/Zeiss Sublicense Agreement, 2004, dated December 10,
2004, between Carl Zeiss SMT AG and ASML Holding N.V.
(Incorporated by reference to the Registrants Annual
Report on
Form 20-F
for the fiscal year ended December 31, 2004) #
|
4.8
|
|
ASML New Hires and Incentive Stock Option Plan For Management
(Version 2003) (Incorporated by reference to the
Registrants Statement on
Form S-8,
filed with the Commission on September 2, 2003 (File
No. 333-109154))
|
4.9
|
|
ASML Incentive and New Hire Option Plan for Board of Management
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8,
filed with the Commission on June 9, 2004 (File
No. 333-116337))
|
4.10
|
|
ASML Option Plan for Management of ASML Holding Group Companies
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on June 30, 2005 (file
No. 333-126340))
|
4.11
|
|
ASML Stock Option Plan for New Hire Options granted to Members
of the Board of Management (Version April 2006) (Incorporated by
reference to the Registrants Registration Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.12
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version April 2006)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.13
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version July 2006)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.14
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version October 2006)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on August 7, 2006 (file
No. 333-136362))
|
4.15
|
|
ASML Restricted Stock Plan (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on March 7, 2007 (file
No. 333-141125))
|
4.16
|
|
Brion Technologies, Inc., 2002 Stock Option Plan (as amended on
March 25, 2005; March 24, 2006; and November 17,
2006) (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on April 20, 2007 (file
No. 333-142254))
|
4.17
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version January 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.18
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version April 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.19
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version July 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.20
|
|
ASML Stock Option Plan for Incentive or New Hire Options granted
to Senior and Executive Management (Version October 2007)
(Incorporated by reference to the Registrants Registration
Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.21
|
|
ASML Performance Stock Plan for Members of the Board of
Management (Version 1) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.22
|
|
ASML Performance Stock Option Plan for Members of the Board of
Management (Version 2) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on July 5, 2007 (file
No. 333-144356))
|
4.23
|
|
ASML Stock Option Plan from Base Salary for Senior &
Executive Management (Version October 2007) (Incorporated by
reference to the Registrants Registration Statement on
Form S-8
filed with the Commission on November 2, 2007 (file
No. 333-147128))
|
4.24
|
|
ASML Performance Stock Option Plan for Senior and Executive
Management (version 1) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on August 29, 2008 (file
No. 333-153277))
|
4.25
|
|
ASML Performance Share Plan for Senior and Executive Management
(version 1) (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on August 29, 2008 (file
No. 333-153277))
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
4.26
|
|
ASML Restricted Stock Plan (version 2) (Incorporated by
reference to the Registrants Registration Statement on
Form S-8
filed with the Commission on August 29, 2008 (file
No. 333-153277))
|
4.27
|
|
ASML Performance Stock Plan for Members of the Board of
Management (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on October 13, 2009 (file
No. 333-162439))
|
4.28
|
|
ASML Performance Stock Option Plan for Senior and Executive
Management (version 1) (Incorporated by reference to the
Registrants Registration Statement on
Form S-8
filed with the Commission on October 13, 2009 (file
No. 333-162439))
|
4.29
|
|
ASML Performance Share Plan for Senior and Executive Management
(version 1) (Incorporated by reference to the Registrants
Registration Statement on
Form S-8
filed with the Commission on October 13, 2009 (file
No. 333-162439))
|
8.1
|
|
List of Material Subsidiaries*
|
12.1
|
|
Certification of CEO and CFO Pursuant to
Rule 13a-14(a)
of the Securities Exchange Act of 1934*
|
13.1
|
|
Certification of CEO and CFO Pursuant to
Rule 13a-14(b)
of the Securities Exchange Act of 1934 and 18 U.S.C.
Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002*
|
15.1
|
|
Consent of Deloitte Accountants B.V.*
|
|
|
|
|
*
|
|
Filed at the Commission herewith
|
#
|
|
Certain information omitted
pursuant to a request for confidential treatment filed
separately with the Securities and Exchange Commission
|